id	sid	tid	token	lemma	pos
cord-303322-d69o3z8d	1	1	key	key	JJ
cord-303322-d69o3z8d	1	2	:	:	:
cord-303322-d69o3z8d	1	3	cord-303322-d69o3z8d	cord-303322-d69o3z8d	NNP
cord-303322-d69o3z8d	1	4	authors	author	NNS
cord-303322-d69o3z8d	1	5	:	:	:
cord-303322-d69o3z8d	1	6	Chang	Chang	NNP
cord-303322-d69o3z8d	1	7	,	,	,
cord-303322-d69o3z8d	1	8	Anne	Anne	NNP
cord-303322-d69o3z8d	1	9	B	B	NNP
cord-303322-d69o3z8d	1	10	;	;	:
cord-303322-d69o3z8d	1	11	Grimwood	Grimwood	NNP
cord-303322-d69o3z8d	1	12	,	,	,
cord-303322-d69o3z8d	1	13	Keith	Keith	NNP
cord-303322-d69o3z8d	1	14	;	;	:
cord-303322-d69o3z8d	1	15	White	White	NNP
cord-303322-d69o3z8d	1	16	,	,	,
cord-303322-d69o3z8d	1	17	Andrew	Andrew	NNP
cord-303322-d69o3z8d	1	18	V	V	NNP
cord-303322-d69o3z8d	1	19	;	;	:
cord-303322-d69o3z8d	1	20	Maclennan	Maclennan	NNP
cord-303322-d69o3z8d	1	21	,	,	,
cord-303322-d69o3z8d	1	22	Carolyn	Carolyn	NNP
cord-303322-d69o3z8d	1	23	;	;	:
cord-303322-d69o3z8d	1	24	Sloots	Sloots	NNP
cord-303322-d69o3z8d	1	25	,	,	,
cord-303322-d69o3z8d	1	26	Theo	Theo	NNP
cord-303322-d69o3z8d	1	27	P	P	NNP
cord-303322-d69o3z8d	1	28	;	;	:
cord-303322-d69o3z8d	1	29	Sive	Sive	NNP
cord-303322-d69o3z8d	1	30	,	,	,
cord-303322-d69o3z8d	1	31	Alan	Alan	NNP
cord-303322-d69o3z8d	1	32	;	;	:
cord-303322-d69o3z8d	1	33	McCallum	McCallum	NNP
cord-303322-d69o3z8d	1	34	,	,	,
cord-303322-d69o3z8d	1	35	Gabrielle	Gabrielle	NNP
cord-303322-d69o3z8d	1	36	B	B	NNP
cord-303322-d69o3z8d	1	37	;	;	:
cord-303322-d69o3z8d	1	38	Mackay	Mackay	NNP
cord-303322-d69o3z8d	1	39	,	,	,
cord-303322-d69o3z8d	1	40	Ian	Ian	NNP
cord-303322-d69o3z8d	1	41	M	M	NNP
cord-303322-d69o3z8d	1	42	;	;	:
cord-303322-d69o3z8d	1	43	Morris	Morris	NNP
cord-303322-d69o3z8d	1	44	,	,	,
cord-303322-d69o3z8d	1	45	Peter	Peter	NNP
cord-303322-d69o3z8d	1	46	S	S	NNP
cord-303322-d69o3z8d	1	47	title	title	NN
cord-303322-d69o3z8d	1	48	:	:	:
cord-303322-d69o3z8d	2	1	Randomized	randomized	JJ
cord-303322-d69o3z8d	2	2	placebo	placebo	NN
cord-303322-d69o3z8d	2	3	-	-	HYPH
cord-303322-d69o3z8d	2	4	controlled	control	VBN
cord-303322-d69o3z8d	2	5	trial	trial	NN
cord-303322-d69o3z8d	2	6	on	on	IN
cord-303322-d69o3z8d	2	7	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	2	8	to	to	TO
cord-303322-d69o3z8d	2	9	reduce	reduce	VB
cord-303322-d69o3z8d	2	10	the	the	DT
cord-303322-d69o3z8d	2	11	morbidity	morbidity	NN
cord-303322-d69o3z8d	2	12	of	of	IN
cord-303322-d69o3z8d	2	13	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	2	14	in	in	IN
cord-303322-d69o3z8d	2	15	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	2	16	Australian	australian	JJ
cord-303322-d69o3z8d	2	17	infants	infant	NNS
cord-303322-d69o3z8d	2	18	:	:	:
cord-303322-d69o3z8d	3	1	rationale	rationale	NN
cord-303322-d69o3z8d	3	2	and	and	CC
cord-303322-d69o3z8d	3	3	protocol	protocol	NN
cord-303322-d69o3z8d	3	4	date	date	NN
cord-303322-d69o3z8d	3	5	:	:	:
cord-303322-d69o3z8d	3	6	2011	2011	CD
cord-303322-d69o3z8d	3	7	-	-	HYPH
cord-303322-d69o3z8d	3	8	04	04	CD
cord-303322-d69o3z8d	3	9	-	-	SYM
cord-303322-d69o3z8d	3	10	14	14	CD
cord-303322-d69o3z8d	3	11	journal	journal	NN
cord-303322-d69o3z8d	3	12	:	:	:
cord-303322-d69o3z8d	4	1	Trials	trial	NNS
cord-303322-d69o3z8d	4	2	DOI	DOI	NNP
cord-303322-d69o3z8d	4	3	:	:	:
cord-303322-d69o3z8d	4	4	10.1186/1745	10.1186/1745	CD
cord-303322-d69o3z8d	4	5	-	-	HYPH
cord-303322-d69o3z8d	4	6	6215	6215	CD
cord-303322-d69o3z8d	4	7	-	-	HYPH
cord-303322-d69o3z8d	4	8	12	12	CD
cord-303322-d69o3z8d	4	9	-	-	SYM
cord-303322-d69o3z8d	4	10	94	94	CD
cord-303322-d69o3z8d	5	1	sha	sha	NNP
cord-303322-d69o3z8d	5	2	:	:	:
cord-303322-d69o3z8d	5	3	b34cc3d570e41a80c01088f73600357cf071a4da	b34cc3d570e41a80c01088f73600357cf071a4da	NNP
cord-303322-d69o3z8d	5	4	doc_id	doc_id	CD
cord-303322-d69o3z8d	5	5	:	:	:
cord-303322-d69o3z8d	5	6	303322	303322	CD
cord-303322-d69o3z8d	5	7	cord_uid	cord_uid	NNS
cord-303322-d69o3z8d	5	8	:	:	:
cord-303322-d69o3z8d	5	9	d69o3z8d	d69o3z8d	VB
cord-303322-d69o3z8d	5	10	BACKGROUND	background	NN
cord-303322-d69o3z8d	5	11	:	:	:
cord-303322-d69o3z8d	6	1	Acute	acute	JJ
cord-303322-d69o3z8d	6	2	lower	low	JJR
cord-303322-d69o3z8d	6	3	respiratory	respiratory	JJ
cord-303322-d69o3z8d	6	4	infections	infection	NNS
cord-303322-d69o3z8d	6	5	are	be	VBP
cord-303322-d69o3z8d	6	6	the	the	DT
cord-303322-d69o3z8d	6	7	commonest	common	JJS
cord-303322-d69o3z8d	6	8	cause	cause	NN
cord-303322-d69o3z8d	6	9	of	of	IN
cord-303322-d69o3z8d	6	10	morbidity	morbidity	NN
cord-303322-d69o3z8d	6	11	and	and	CC
cord-303322-d69o3z8d	6	12	potentially	potentially	RB
cord-303322-d69o3z8d	6	13	preventable	preventable	JJ
cord-303322-d69o3z8d	6	14	mortality	mortality	NN
cord-303322-d69o3z8d	6	15	in	in	IN
cord-303322-d69o3z8d	6	16	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	6	17	infants	infant	NNS
cord-303322-d69o3z8d	6	18	.	.	.
cord-303322-d69o3z8d	7	1	Infancy	infancy	NN
cord-303322-d69o3z8d	7	2	is	be	VBZ
cord-303322-d69o3z8d	7	3	also	also	RB
cord-303322-d69o3z8d	7	4	a	a	DT
cord-303322-d69o3z8d	7	5	critical	critical	JJ
cord-303322-d69o3z8d	7	6	time	time	NN
cord-303322-d69o3z8d	7	7	for	for	IN
cord-303322-d69o3z8d	7	8	post	post	JJ
cord-303322-d69o3z8d	7	9	-	-	JJ
cord-303322-d69o3z8d	7	10	natal	natal	JJ
cord-303322-d69o3z8d	7	11	lung	lung	NN
cord-303322-d69o3z8d	7	12	growth	growth	NN
cord-303322-d69o3z8d	7	13	and	and	CC
cord-303322-d69o3z8d	7	14	development	development	NN
cord-303322-d69o3z8d	7	15	.	.	.
cord-303322-d69o3z8d	8	1	Severe	severe	JJ
cord-303322-d69o3z8d	8	2	or	or	CC
cord-303322-d69o3z8d	8	3	repeated	repeat	VBN
cord-303322-d69o3z8d	8	4	lower	low	JJR
cord-303322-d69o3z8d	8	5	airway	airway	NN
cord-303322-d69o3z8d	8	6	injury	injury	NN
cord-303322-d69o3z8d	8	7	in	in	IN
cord-303322-d69o3z8d	8	8	very	very	RB
cord-303322-d69o3z8d	8	9	young	young	JJ
cord-303322-d69o3z8d	8	10	children	child	NNS
cord-303322-d69o3z8d	8	11	likely	likely	RB
cord-303322-d69o3z8d	8	12	increases	increase	VBZ
cord-303322-d69o3z8d	8	13	the	the	DT
cord-303322-d69o3z8d	8	14	likelihood	likelihood	NN
cord-303322-d69o3z8d	8	15	of	of	IN
cord-303322-d69o3z8d	8	16	chronic	chronic	JJ
cord-303322-d69o3z8d	8	17	pulmonary	pulmonary	JJ
cord-303322-d69o3z8d	8	18	disorders	disorder	NNS
cord-303322-d69o3z8d	8	19	later	later	RB
cord-303322-d69o3z8d	8	20	in	in	IN
cord-303322-d69o3z8d	8	21	life	life	NN
cord-303322-d69o3z8d	8	22	.	.	.
cord-303322-d69o3z8d	9	1	Globally	globally	RB
cord-303322-d69o3z8d	9	2	,	,	,
cord-303322-d69o3z8d	9	3	bronchiolitis	bronchiolitis	NNP
cord-303322-d69o3z8d	9	4	is	be	VBZ
cord-303322-d69o3z8d	9	5	the	the	DT
cord-303322-d69o3z8d	9	6	most	most	RBS
cord-303322-d69o3z8d	9	7	common	common	JJ
cord-303322-d69o3z8d	9	8	form	form	NN
cord-303322-d69o3z8d	9	9	of	of	IN
cord-303322-d69o3z8d	9	10	acute	acute	JJ
cord-303322-d69o3z8d	9	11	lower	low	JJR
cord-303322-d69o3z8d	9	12	respiratory	respiratory	JJ
cord-303322-d69o3z8d	9	13	infections	infection	NNS
cord-303322-d69o3z8d	9	14	during	during	IN
cord-303322-d69o3z8d	9	15	infancy	infancy	NN
cord-303322-d69o3z8d	9	16	.	.	.
cord-303322-d69o3z8d	10	1	Compared	compare	VBN
cord-303322-d69o3z8d	10	2	with	with	IN
cord-303322-d69o3z8d	10	3	non	non	JJ
cord-303322-d69o3z8d	10	4	-	-	JJ
cord-303322-d69o3z8d	10	5	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	10	6	Australian	australian	JJ
cord-303322-d69o3z8d	10	7	infants	infant	NNS
cord-303322-d69o3z8d	10	8	,	,	,
cord-303322-d69o3z8d	10	9	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	10	10	infants	infant	NNS
cord-303322-d69o3z8d	10	11	have	have	VBP
cord-303322-d69o3z8d	10	12	greater	great	JJR
cord-303322-d69o3z8d	10	13	bacterial	bacterial	JJ
cord-303322-d69o3z8d	10	14	density	density	NN
cord-303322-d69o3z8d	10	15	in	in	IN
cord-303322-d69o3z8d	10	16	their	-PRON-	PRP$
cord-303322-d69o3z8d	10	17	upper	upper	JJ
cord-303322-d69o3z8d	10	18	airways	airway	NNS
cord-303322-d69o3z8d	10	19	and	and	CC
cord-303322-d69o3z8d	10	20	more	more	RBR
cord-303322-d69o3z8d	10	21	severe	severe	JJ
cord-303322-d69o3z8d	10	22	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	10	23	episodes	episode	NNS
cord-303322-d69o3z8d	10	24	.	.	.
cord-303322-d69o3z8d	11	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	11	2	study	study	NN
cord-303322-d69o3z8d	11	3	tests	test	VBZ
cord-303322-d69o3z8d	11	4	the	the	DT
cord-303322-d69o3z8d	11	5	hypothesis	hypothesis	NN
cord-303322-d69o3z8d	11	6	that	that	IN
cord-303322-d69o3z8d	11	7	the	the	DT
cord-303322-d69o3z8d	11	8	anti	anti	JJ
cord-303322-d69o3z8d	11	9	-	-	JJ
cord-303322-d69o3z8d	11	10	microbial	microbial	JJ
cord-303322-d69o3z8d	11	11	and	and	CC
cord-303322-d69o3z8d	11	12	anti	anti	JJ
cord-303322-d69o3z8d	11	13	-	-	JJ
cord-303322-d69o3z8d	11	14	inflammatory	inflammatory	JJ
cord-303322-d69o3z8d	11	15	properties	property	NNS
cord-303322-d69o3z8d	11	16	of	of	IN
cord-303322-d69o3z8d	11	17	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	11	18	,	,	,
cord-303322-d69o3z8d	11	19	improve	improve	VB
cord-303322-d69o3z8d	11	20	the	the	DT
cord-303322-d69o3z8d	11	21	clinical	clinical	JJ
cord-303322-d69o3z8d	11	22	outcomes	outcome	NNS
cord-303322-d69o3z8d	11	23	of	of	IN
cord-303322-d69o3z8d	11	24	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	11	25	Australian	australian	JJ
cord-303322-d69o3z8d	11	26	infants	infant	NNS
cord-303322-d69o3z8d	11	27	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	11	28	with	with	IN
cord-303322-d69o3z8d	11	29	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	11	30	.	.	.
cord-303322-d69o3z8d	12	1	METHODS	methods	NN
cord-303322-d69o3z8d	12	2	:	:	:
cord-303322-d69o3z8d	13	1	We	-PRON-	PRP
cord-303322-d69o3z8d	13	2	are	be	VBP
cord-303322-d69o3z8d	13	3	conducting	conduct	VBG
cord-303322-d69o3z8d	13	4	a	a	DT
cord-303322-d69o3z8d	13	5	dual	dual	JJ
cord-303322-d69o3z8d	13	6	centre	centre	NN
cord-303322-d69o3z8d	13	7	,	,	,
cord-303322-d69o3z8d	13	8	randomised	randomised	JJ
cord-303322-d69o3z8d	13	9	,	,	,
cord-303322-d69o3z8d	13	10	double	double	JJ
cord-303322-d69o3z8d	13	11	-	-	HYPH
cord-303322-d69o3z8d	13	12	blind	blind	JJ
cord-303322-d69o3z8d	13	13	,	,	,
cord-303322-d69o3z8d	13	14	placebo	placebo	NN
cord-303322-d69o3z8d	13	15	-	-	HYPH
cord-303322-d69o3z8d	13	16	controlled	control	VBN
cord-303322-d69o3z8d	13	17	,	,	,
cord-303322-d69o3z8d	13	18	parallel	parallel	JJ
cord-303322-d69o3z8d	13	19	group	group	NN
cord-303322-d69o3z8d	13	20	trial	trial	NN
cord-303322-d69o3z8d	13	21	in	in	IN
cord-303322-d69o3z8d	13	22	northern	northern	JJ
cord-303322-d69o3z8d	13	23	Australia	Australia	NNP
cord-303322-d69o3z8d	13	24	.	.	.
cord-303322-d69o3z8d	14	1	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	14	2	infants	infant	NNS
cord-303322-d69o3z8d	14	3	(	(	-LRB-
cord-303322-d69o3z8d	14	4	aged	aged	JJ
cord-303322-d69o3z8d	14	5	≤	≤	NN
cord-303322-d69o3z8d	14	6	24-months	24-months	CD
cord-303322-d69o3z8d	14	7	,	,	,
cord-303322-d69o3z8d	14	8	expected	expect	VBN
cord-303322-d69o3z8d	14	9	number	number	NN
cord-303322-d69o3z8d	14	10	=	=	SYM
cord-303322-d69o3z8d	14	11	200	200	CD
cord-303322-d69o3z8d	14	12	)	)	-RRB-
cord-303322-d69o3z8d	14	13	admitted	admit	VBN
cord-303322-d69o3z8d	14	14	to	to	IN
cord-303322-d69o3z8d	14	15	one	one	CD
cord-303322-d69o3z8d	14	16	of	of	IN
cord-303322-d69o3z8d	14	17	two	two	CD
cord-303322-d69o3z8d	14	18	regional	regional	JJ
cord-303322-d69o3z8d	14	19	hospitals	hospital	NNS
cord-303322-d69o3z8d	14	20	(	(	-LRB-
cord-303322-d69o3z8d	14	21	Darwin	Darwin	NNP
cord-303322-d69o3z8d	14	22	,	,	,
cord-303322-d69o3z8d	14	23	Northern	Northern	NNP
cord-303322-d69o3z8d	14	24	Territory	Territory	NNP
cord-303322-d69o3z8d	14	25	and	and	CC
cord-303322-d69o3z8d	14	26	Townsville	Townsville	NNP
cord-303322-d69o3z8d	14	27	,	,	,
cord-303322-d69o3z8d	14	28	Queensland	Queensland	NNP
cord-303322-d69o3z8d	14	29	)	)	-RRB-
cord-303322-d69o3z8d	14	30	with	with	IN
cord-303322-d69o3z8d	14	31	a	a	DT
cord-303322-d69o3z8d	14	32	clinical	clinical	JJ
cord-303322-d69o3z8d	14	33	diagnosis	diagnosis	NN
cord-303322-d69o3z8d	14	34	of	of	IN
cord-303322-d69o3z8d	14	35	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	14	36	and	and	CC
cord-303322-d69o3z8d	14	37	fulfilling	fulfil	VBG
cord-303322-d69o3z8d	14	38	inclusion	inclusion	NN
cord-303322-d69o3z8d	14	39	criteria	criterion	NNS
cord-303322-d69o3z8d	14	40	are	be	VBP
cord-303322-d69o3z8d	14	41	randomised	randomised	JJ
cord-303322-d69o3z8d	14	42	(	(	-LRB-
cord-303322-d69o3z8d	14	43	allocation	allocation	NN
cord-303322-d69o3z8d	14	44	concealed	conceal	VBN
cord-303322-d69o3z8d	14	45	)	)	-RRB-
cord-303322-d69o3z8d	14	46	to	to	IN
cord-303322-d69o3z8d	14	47	either	either	CC
cord-303322-d69o3z8d	14	48	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	14	49	(	(	-LRB-
cord-303322-d69o3z8d	14	50	30	30	CD
cord-303322-d69o3z8d	14	51	mg	mg	NN
cord-303322-d69o3z8d	14	52	/	/	SYM
cord-303322-d69o3z8d	14	53	kg	kg	NN
cord-303322-d69o3z8d	14	54	/	/	SYM
cord-303322-d69o3z8d	14	55	dose	dose	NN
cord-303322-d69o3z8d	14	56	)	)	-RRB-
cord-303322-d69o3z8d	14	57	or	or	CC
cord-303322-d69o3z8d	14	58	placebo	placebo	NN
cord-303322-d69o3z8d	15	1	administered	administer	VBN
cord-303322-d69o3z8d	15	2	once	once	RB
cord-303322-d69o3z8d	15	3	weekly	weekly	RB
cord-303322-d69o3z8d	15	4	for	for	IN
cord-303322-d69o3z8d	15	5	three	three	CD
cord-303322-d69o3z8d	15	6	doses	dose	NNS
cord-303322-d69o3z8d	15	7	.	.	.
cord-303322-d69o3z8d	16	1	Clinical	clinical	JJ
cord-303322-d69o3z8d	16	2	data	datum	NNS
cord-303322-d69o3z8d	16	3	are	be	VBP
cord-303322-d69o3z8d	16	4	recorded	record	VBN
cord-303322-d69o3z8d	16	5	twice	twice	RB
cord-303322-d69o3z8d	16	6	daily	daily	JJ
cord-303322-d69o3z8d	16	7	and	and	CC
cord-303322-d69o3z8d	16	8	nasopharyngeal	nasopharyngeal	JJ
cord-303322-d69o3z8d	16	9	swab	swab	NN
cord-303322-d69o3z8d	16	10	are	be	VBP
cord-303322-d69o3z8d	16	11	collected	collect	VBN
cord-303322-d69o3z8d	16	12	at	at	IN
cord-303322-d69o3z8d	16	13	enrolment	enrolment	NN
cord-303322-d69o3z8d	16	14	and	and	CC
cord-303322-d69o3z8d	16	15	at	at	IN
cord-303322-d69o3z8d	16	16	the	the	DT
cord-303322-d69o3z8d	16	17	time	time	NN
cord-303322-d69o3z8d	16	18	of	of	IN
cord-303322-d69o3z8d	16	19	discharge	discharge	NN
cord-303322-d69o3z8d	16	20	from	from	IN
cord-303322-d69o3z8d	16	21	hospital	hospital	NN
cord-303322-d69o3z8d	16	22	.	.	.
cord-303322-d69o3z8d	17	1	Primary	primary	JJ
cord-303322-d69o3z8d	17	2	outcomes	outcome	NNS
cord-303322-d69o3z8d	17	3	are	be	VBP
cord-303322-d69o3z8d	17	4	'	'	``
cord-303322-d69o3z8d	17	5	length	length	NN
cord-303322-d69o3z8d	17	6	of	of	IN
cord-303322-d69o3z8d	17	7	oxygen	oxygen	NN
cord-303322-d69o3z8d	17	8	requirement	requirement	NN
cord-303322-d69o3z8d	17	9	'	'	''
cord-303322-d69o3z8d	17	10	and	and	CC
cord-303322-d69o3z8d	17	11	'	'	''
cord-303322-d69o3z8d	17	12	duration	duration	NN
cord-303322-d69o3z8d	17	13	of	of	IN
cord-303322-d69o3z8d	17	14	stay	stay	NN
cord-303322-d69o3z8d	17	15	,	,	,
cord-303322-d69o3z8d	17	16	'	'	''
cord-303322-d69o3z8d	17	17	the	the	DT
cord-303322-d69o3z8d	17	18	latter	latter	JJ
cord-303322-d69o3z8d	17	19	based	base	VBN
cord-303322-d69o3z8d	17	20	upon	upon	IN
cord-303322-d69o3z8d	17	21	being	be	VBG
cord-303322-d69o3z8d	17	22	judged	judge	VBN
cord-303322-d69o3z8d	17	23	as	as	IN
cord-303322-d69o3z8d	17	24	'	'	``
cord-303322-d69o3z8d	17	25	ready	ready	JJ
cord-303322-d69o3z8d	17	26	for	for	IN
cord-303322-d69o3z8d	17	27	respiratory	respiratory	JJ
cord-303322-d69o3z8d	17	28	discharge	discharge	NN
cord-303322-d69o3z8d	17	29	'	'	''
cord-303322-d69o3z8d	17	30	.	.	.
cord-303322-d69o3z8d	18	1	The	the	DT
cord-303322-d69o3z8d	18	2	main	main	JJ
cord-303322-d69o3z8d	18	3	secondary	secondary	JJ
cord-303322-d69o3z8d	18	4	outcome	outcome	NN
cord-303322-d69o3z8d	18	5	is	be	VBZ
cord-303322-d69o3z8d	18	6	readmission	readmission	NN
cord-303322-d69o3z8d	18	7	for	for	IN
cord-303322-d69o3z8d	18	8	a	a	DT
cord-303322-d69o3z8d	18	9	respiratory	respiratory	JJ
cord-303322-d69o3z8d	18	10	illness	illness	NN
cord-303322-d69o3z8d	18	11	within	within	IN
cord-303322-d69o3z8d	18	12	6-months	6-months	CD
cord-303322-d69o3z8d	18	13	of	of	IN
cord-303322-d69o3z8d	18	14	leaving	leave	VBG
cord-303322-d69o3z8d	18	15	hospital	hospital	NN
cord-303322-d69o3z8d	18	16	.	.	.
cord-303322-d69o3z8d	19	1	Descriptive	descriptive	JJ
cord-303322-d69o3z8d	19	2	virological	virological	JJ
cord-303322-d69o3z8d	19	3	and	and	CC
cord-303322-d69o3z8d	19	4	bacteriological	bacteriological	JJ
cord-303322-d69o3z8d	19	5	(	(	-LRB-
cord-303322-d69o3z8d	19	6	including	include	VBG
cord-303322-d69o3z8d	19	7	development	development	NN
cord-303322-d69o3z8d	19	8	of	of	IN
cord-303322-d69o3z8d	19	9	antibiotic	antibiotic	JJ
cord-303322-d69o3z8d	19	10	resistance	resistance	NN
cord-303322-d69o3z8d	19	11	)	)	-RRB-
cord-303322-d69o3z8d	19	12	data	datum	NNS
cord-303322-d69o3z8d	19	13	from	from	IN
cord-303322-d69o3z8d	19	14	nasopharyngeal	nasopharyngeal	JJ
cord-303322-d69o3z8d	19	15	samples	sample	NNS
cord-303322-d69o3z8d	19	16	will	will	MD
cord-303322-d69o3z8d	19	17	also	also	RB
cord-303322-d69o3z8d	19	18	be	be	VB
cord-303322-d69o3z8d	19	19	reported	report	VBN
cord-303322-d69o3z8d	19	20	.	.	.
cord-303322-d69o3z8d	20	1	DISCUSSION	discussion	NN
cord-303322-d69o3z8d	20	2	:	:	:
cord-303322-d69o3z8d	21	1	Two	two	CD
cord-303322-d69o3z8d	21	2	published	publish	VBN
cord-303322-d69o3z8d	21	3	studies	study	NNS
cord-303322-d69o3z8d	21	4	,	,	,
cord-303322-d69o3z8d	21	5	both	both	DT
cord-303322-d69o3z8d	21	6	involving	involve	VBG
cord-303322-d69o3z8d	21	7	different	different	JJ
cord-303322-d69o3z8d	21	8	patient	patient	JJ
cord-303322-d69o3z8d	21	9	populations	population	NNS
cord-303322-d69o3z8d	21	10	and	and	CC
cord-303322-d69o3z8d	21	11	settings	setting	NNS
cord-303322-d69o3z8d	21	12	,	,	,
cord-303322-d69o3z8d	21	13	as	as	RB
cord-303322-d69o3z8d	21	14	well	well	RB
cord-303322-d69o3z8d	21	15	as	as	IN
cord-303322-d69o3z8d	21	16	different	different	JJ
cord-303322-d69o3z8d	21	17	macrolide	macrolide	NN
cord-303322-d69o3z8d	21	18	antibiotics	antibiotic	NNS
cord-303322-d69o3z8d	21	19	and	and	CC
cord-303322-d69o3z8d	21	20	treatment	treatment	NN
cord-303322-d69o3z8d	21	21	duration	duration	NN
cord-303322-d69o3z8d	21	22	,	,	,
cord-303322-d69o3z8d	21	23	have	have	VBP
cord-303322-d69o3z8d	21	24	produced	produce	VBN
cord-303322-d69o3z8d	21	25	conflicting	conflicting	JJ
cord-303322-d69o3z8d	21	26	results	result	NNS
cord-303322-d69o3z8d	21	27	.	.	.
cord-303322-d69o3z8d	22	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	22	2	randomised	randomised	JJ
cord-303322-d69o3z8d	22	3	,	,	,
cord-303322-d69o3z8d	22	4	placebo	placebo	NN
cord-303322-d69o3z8d	22	5	-	-	HYPH
cord-303322-d69o3z8d	22	6	controlled	control	VBN
cord-303322-d69o3z8d	22	7	trial	trial	NN
cord-303322-d69o3z8d	22	8	of	of	IN
cord-303322-d69o3z8d	22	9	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	22	10	in	in	IN
cord-303322-d69o3z8d	22	11	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	22	12	infants	infant	NNS
cord-303322-d69o3z8d	22	13	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	22	14	with	with	IN
cord-303322-d69o3z8d	22	15	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	22	16	is	be	VBZ
cord-303322-d69o3z8d	22	17	designed	design	VBN
cord-303322-d69o3z8d	22	18	to	to	TO
cord-303322-d69o3z8d	22	19	determine	determine	VB
cord-303322-d69o3z8d	22	20	whether	whether	IN
cord-303322-d69o3z8d	22	21	it	-PRON-	PRP
cord-303322-d69o3z8d	22	22	can	can	MD
cord-303322-d69o3z8d	22	23	reduce	reduce	VB
cord-303322-d69o3z8d	22	24	short	short	JJ
cord-303322-d69o3z8d	22	25	-	-	HYPH
cord-303322-d69o3z8d	22	26	term	term	NN
cord-303322-d69o3z8d	22	27	(	(	-LRB-
cord-303322-d69o3z8d	22	28	and	and	CC
cord-303322-d69o3z8d	22	29	potentially	potentially	RB
cord-303322-d69o3z8d	22	30	long	long	JJ
cord-303322-d69o3z8d	22	31	-	-	HYPH
cord-303322-d69o3z8d	22	32	term	term	NN
cord-303322-d69o3z8d	22	33	)	)	-RRB-
cord-303322-d69o3z8d	22	34	morbidity	morbidity	NN
cord-303322-d69o3z8d	22	35	from	from	IN
cord-303322-d69o3z8d	22	36	respiratory	respiratory	JJ
cord-303322-d69o3z8d	22	37	illness	illness	NN
cord-303322-d69o3z8d	22	38	in	in	IN
cord-303322-d69o3z8d	22	39	Australian	australian	JJ
cord-303322-d69o3z8d	22	40	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	22	41	infants	infant	NNS
cord-303322-d69o3z8d	22	42	who	who	WP
cord-303322-d69o3z8d	22	43	are	be	VBP
cord-303322-d69o3z8d	22	44	at	at	IN
cord-303322-d69o3z8d	22	45	high	high	JJ
cord-303322-d69o3z8d	22	46	risk	risk	NN
cord-303322-d69o3z8d	22	47	of	of	IN
cord-303322-d69o3z8d	22	48	developing	develop	VBG
cord-303322-d69o3z8d	22	49	chronic	chronic	JJ
cord-303322-d69o3z8d	22	50	respiratory	respiratory	JJ
cord-303322-d69o3z8d	22	51	illness	illness	NN
cord-303322-d69o3z8d	22	52	.	.	.
cord-303322-d69o3z8d	23	1	If	if	IN
cord-303322-d69o3z8d	23	2	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	23	3	is	be	VBZ
cord-303322-d69o3z8d	23	4	efficacious	efficacious	JJ
cord-303322-d69o3z8d	23	5	in	in	IN
cord-303322-d69o3z8d	23	6	reducing	reduce	VBG
cord-303322-d69o3z8d	23	7	the	the	DT
cord-303322-d69o3z8d	23	8	morbidly	morbidly	JJ
cord-303322-d69o3z8d	23	9	of	of	IN
cord-303322-d69o3z8d	23	10	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	23	11	infants	infant	NNS
cord-303322-d69o3z8d	23	12	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	23	13	with	with	IN
cord-303322-d69o3z8d	23	14	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	23	15	,	,	,
cord-303322-d69o3z8d	23	16	the	the	DT
cord-303322-d69o3z8d	23	17	intervention	intervention	NN
cord-303322-d69o3z8d	23	18	would	would	MD
cord-303322-d69o3z8d	23	19	lead	lead	VB
cord-303322-d69o3z8d	23	20	to	to	IN
cord-303322-d69o3z8d	23	21	improved	improve	VBN
cord-303322-d69o3z8d	23	22	short	short	JJ
cord-303322-d69o3z8d	23	23	term	term	NN
cord-303322-d69o3z8d	23	24	(	(	-LRB-
cord-303322-d69o3z8d	23	25	and	and	CC
cord-303322-d69o3z8d	23	26	possibly	possibly	RB
cord-303322-d69o3z8d	23	27	long	long	JJ
cord-303322-d69o3z8d	23	28	term	term	NN
cord-303322-d69o3z8d	23	29	)	)	-RRB-
cord-303322-d69o3z8d	23	30	health	health	NN
cord-303322-d69o3z8d	23	31	benefits	benefit	NNS
cord-303322-d69o3z8d	23	32	.	.	.
cord-303322-d69o3z8d	24	1	TRIAL	trial	NN
cord-303322-d69o3z8d	24	2	REGISTRATION	registration	NN
cord-303322-d69o3z8d	24	3	:	:	:
cord-303322-d69o3z8d	25	1	Australia	Australia	NNP
cord-303322-d69o3z8d	25	2	and	and	CC
cord-303322-d69o3z8d	25	3	New	New	NNP
cord-303322-d69o3z8d	25	4	Zealand	Zealand	NNP
cord-303322-d69o3z8d	26	1	Clinical	clinical	JJ
cord-303322-d69o3z8d	26	2	Trials	trial	NNS
cord-303322-d69o3z8d	26	3	Register	Register	NNP
cord-303322-d69o3z8d	26	4	(	(	-LRB-
cord-303322-d69o3z8d	26	5	ANZCTR	ANZCTR	NNP
cord-303322-d69o3z8d	26	6	)	)	-RRB-
cord-303322-d69o3z8d	26	7	:	:	:
cord-303322-d69o3z8d	27	1	ACTRN12610000326099	actrn12610000326099	CD
cord-303322-d69o3z8d	28	1	We	-PRON-	PRP
cord-303322-d69o3z8d	28	2	are	be	VBP
cord-303322-d69o3z8d	28	3	conducting	conduct	VBG
cord-303322-d69o3z8d	28	4	a	a	DT
cord-303322-d69o3z8d	28	5	dual	dual	JJ
cord-303322-d69o3z8d	28	6	centre	centre	NN
cord-303322-d69o3z8d	28	7	,	,	,
cord-303322-d69o3z8d	28	8	randomised	randomised	JJ
cord-303322-d69o3z8d	28	9	,	,	,
cord-303322-d69o3z8d	28	10	double	double	JJ
cord-303322-d69o3z8d	28	11	-	-	HYPH
cord-303322-d69o3z8d	28	12	blind	blind	JJ
cord-303322-d69o3z8d	28	13	,	,	,
cord-303322-d69o3z8d	28	14	placebo	placebo	NN
cord-303322-d69o3z8d	28	15	-	-	HYPH
cord-303322-d69o3z8d	28	16	controlled	control	VBN
cord-303322-d69o3z8d	28	17	,	,	,
cord-303322-d69o3z8d	28	18	parallel	parallel	JJ
cord-303322-d69o3z8d	28	19	group	group	NN
cord-303322-d69o3z8d	28	20	trial	trial	NN
cord-303322-d69o3z8d	28	21	in	in	IN
cord-303322-d69o3z8d	28	22	northern	northern	JJ
cord-303322-d69o3z8d	28	23	Australia	Australia	NNP
cord-303322-d69o3z8d	28	24	.	.	.
cord-303322-d69o3z8d	29	1	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	29	2	infants	infant	NNS
cord-303322-d69o3z8d	29	3	(	(	-LRB-
cord-303322-d69o3z8d	29	4	aged	aged	JJ
cord-303322-d69o3z8d	29	5	≤	≤	NN
cord-303322-d69o3z8d	29	6	24-months	24-months	CD
cord-303322-d69o3z8d	29	7	,	,	,
cord-303322-d69o3z8d	29	8	expected	expect	VBN
cord-303322-d69o3z8d	29	9	number	number	NN
cord-303322-d69o3z8d	29	10	=	=	SYM
cord-303322-d69o3z8d	29	11	200	200	CD
cord-303322-d69o3z8d	29	12	)	)	-RRB-
cord-303322-d69o3z8d	29	13	admitted	admit	VBN
cord-303322-d69o3z8d	29	14	to	to	IN
cord-303322-d69o3z8d	29	15	one	one	CD
cord-303322-d69o3z8d	29	16	of	of	IN
cord-303322-d69o3z8d	29	17	two	two	CD
cord-303322-d69o3z8d	29	18	regional	regional	JJ
cord-303322-d69o3z8d	29	19	hospitals	hospital	NNS
cord-303322-d69o3z8d	29	20	(	(	-LRB-
cord-303322-d69o3z8d	29	21	Darwin	Darwin	NNP
cord-303322-d69o3z8d	29	22	,	,	,
cord-303322-d69o3z8d	29	23	Northern	Northern	NNP
cord-303322-d69o3z8d	29	24	Territory	Territory	NNP
cord-303322-d69o3z8d	29	25	and	and	CC
cord-303322-d69o3z8d	29	26	Townsville	Townsville	NNP
cord-303322-d69o3z8d	29	27	,	,	,
cord-303322-d69o3z8d	29	28	Queensland	Queensland	NNP
cord-303322-d69o3z8d	29	29	)	)	-RRB-
cord-303322-d69o3z8d	29	30	with	with	IN
cord-303322-d69o3z8d	29	31	a	a	DT
cord-303322-d69o3z8d	29	32	clinical	clinical	JJ
cord-303322-d69o3z8d	29	33	diagnosis	diagnosis	NN
cord-303322-d69o3z8d	29	34	of	of	IN
cord-303322-d69o3z8d	29	35	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	29	36	and	and	CC
cord-303322-d69o3z8d	29	37	fulfilling	fulfil	VBG
cord-303322-d69o3z8d	29	38	inclusion	inclusion	NN
cord-303322-d69o3z8d	29	39	criteria	criterion	NNS
cord-303322-d69o3z8d	29	40	are	be	VBP
cord-303322-d69o3z8d	29	41	randomised	randomised	JJ
cord-303322-d69o3z8d	29	42	(	(	-LRB-
cord-303322-d69o3z8d	29	43	allocation	allocation	NN
cord-303322-d69o3z8d	29	44	concealed	conceal	VBN
cord-303322-d69o3z8d	29	45	)	)	-RRB-
cord-303322-d69o3z8d	29	46	to	to	IN
cord-303322-d69o3z8d	29	47	either	either	CC
cord-303322-d69o3z8d	29	48	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	29	49	(	(	-LRB-
cord-303322-d69o3z8d	29	50	30	30	CD
cord-303322-d69o3z8d	29	51	mg	mg	NN
cord-303322-d69o3z8d	29	52	/	/	SYM
cord-303322-d69o3z8d	29	53	kg	kg	NN
cord-303322-d69o3z8d	29	54	/	/	SYM
cord-303322-d69o3z8d	29	55	dose	dose	NN
cord-303322-d69o3z8d	29	56	)	)	-RRB-
cord-303322-d69o3z8d	29	57	or	or	CC
cord-303322-d69o3z8d	29	58	placebo	placebo	NN
cord-303322-d69o3z8d	30	1	administered	administer	VBN
cord-303322-d69o3z8d	30	2	once	once	RB
cord-303322-d69o3z8d	30	3	weekly	weekly	RB
cord-303322-d69o3z8d	30	4	for	for	IN
cord-303322-d69o3z8d	30	5	three	three	CD
cord-303322-d69o3z8d	30	6	doses	dose	NNS
cord-303322-d69o3z8d	30	7	.	.	.
cord-303322-d69o3z8d	31	1	Clinical	clinical	JJ
cord-303322-d69o3z8d	31	2	data	datum	NNS
cord-303322-d69o3z8d	31	3	are	be	VBP
cord-303322-d69o3z8d	31	4	recorded	record	VBN
cord-303322-d69o3z8d	31	5	twice	twice	RB
cord-303322-d69o3z8d	31	6	daily	daily	JJ
cord-303322-d69o3z8d	31	7	and	and	CC
cord-303322-d69o3z8d	31	8	nasopharyngeal	nasopharyngeal	JJ
cord-303322-d69o3z8d	31	9	swab	swab	NN
cord-303322-d69o3z8d	31	10	are	be	VBP
cord-303322-d69o3z8d	31	11	collected	collect	VBN
cord-303322-d69o3z8d	31	12	at	at	IN
cord-303322-d69o3z8d	31	13	enrolment	enrolment	NN
cord-303322-d69o3z8d	31	14	and	and	CC
cord-303322-d69o3z8d	31	15	at	at	IN
cord-303322-d69o3z8d	31	16	the	the	DT
cord-303322-d69o3z8d	31	17	time	time	NN
cord-303322-d69o3z8d	31	18	of	of	IN
cord-303322-d69o3z8d	31	19	discharge	discharge	NN
cord-303322-d69o3z8d	31	20	from	from	IN
cord-303322-d69o3z8d	31	21	hospital	hospital	NN
cord-303322-d69o3z8d	31	22	.	.	.
cord-303322-d69o3z8d	32	1	Primary	primary	JJ
cord-303322-d69o3z8d	32	2	outcomes	outcome	NNS
cord-303322-d69o3z8d	32	3	are	be	VBP
cord-303322-d69o3z8d	32	4	'	'	``
cord-303322-d69o3z8d	32	5	length	length	NN
cord-303322-d69o3z8d	32	6	of	of	IN
cord-303322-d69o3z8d	32	7	oxygen	oxygen	NN
cord-303322-d69o3z8d	32	8	requirement	requirement	NN
cord-303322-d69o3z8d	32	9	'	'	''
cord-303322-d69o3z8d	32	10	and	and	CC
cord-303322-d69o3z8d	32	11	'	'	''
cord-303322-d69o3z8d	32	12	duration	duration	NN
cord-303322-d69o3z8d	32	13	of	of	IN
cord-303322-d69o3z8d	32	14	stay	stay	NN
cord-303322-d69o3z8d	32	15	,	,	,
cord-303322-d69o3z8d	32	16	'	'	''
cord-303322-d69o3z8d	32	17	the	the	DT
cord-303322-d69o3z8d	32	18	latter	latter	JJ
cord-303322-d69o3z8d	32	19	based	base	VBN
cord-303322-d69o3z8d	32	20	upon	upon	IN
cord-303322-d69o3z8d	32	21	being	be	VBG
cord-303322-d69o3z8d	32	22	judged	judge	VBN
cord-303322-d69o3z8d	32	23	as	as	IN
cord-303322-d69o3z8d	32	24	'	'	``
cord-303322-d69o3z8d	32	25	ready	ready	JJ
cord-303322-d69o3z8d	32	26	for	for	IN
cord-303322-d69o3z8d	32	27	respiratory	respiratory	JJ
cord-303322-d69o3z8d	32	28	discharge	discharge	NN
cord-303322-d69o3z8d	32	29	'	'	''
cord-303322-d69o3z8d	32	30	.	.	.
cord-303322-d69o3z8d	33	1	The	the	DT
cord-303322-d69o3z8d	33	2	main	main	JJ
cord-303322-d69o3z8d	33	3	secondary	secondary	JJ
cord-303322-d69o3z8d	33	4	outcome	outcome	NN
cord-303322-d69o3z8d	33	5	is	be	VBZ
cord-303322-d69o3z8d	33	6	readmission	readmission	NN
cord-303322-d69o3z8d	33	7	for	for	IN
cord-303322-d69o3z8d	33	8	a	a	DT
cord-303322-d69o3z8d	33	9	respiratory	respiratory	JJ
cord-303322-d69o3z8d	33	10	illness	illness	NN
cord-303322-d69o3z8d	33	11	within	within	IN
cord-303322-d69o3z8d	33	12	6-months	6-months	CD
cord-303322-d69o3z8d	33	13	of	of	IN
cord-303322-d69o3z8d	33	14	leaving	leave	VBG
cord-303322-d69o3z8d	33	15	hospital	hospital	NN
cord-303322-d69o3z8d	33	16	.	.	.
cord-303322-d69o3z8d	34	1	Descriptive	descriptive	JJ
cord-303322-d69o3z8d	34	2	virological	virological	JJ
cord-303322-d69o3z8d	34	3	and	and	CC
cord-303322-d69o3z8d	34	4	bacteriological	bacteriological	JJ
cord-303322-d69o3z8d	34	5	(	(	-LRB-
cord-303322-d69o3z8d	34	6	including	include	VBG
cord-303322-d69o3z8d	34	7	development	development	NN
cord-303322-d69o3z8d	34	8	of	of	IN
cord-303322-d69o3z8d	34	9	antibiotic	antibiotic	JJ
cord-303322-d69o3z8d	34	10	resistance	resistance	NN
cord-303322-d69o3z8d	34	11	)	)	-RRB-
cord-303322-d69o3z8d	34	12	data	datum	NNS
cord-303322-d69o3z8d	34	13	from	from	IN
cord-303322-d69o3z8d	34	14	nasopharyngeal	nasopharyngeal	JJ
cord-303322-d69o3z8d	34	15	samples	sample	NNS
cord-303322-d69o3z8d	34	16	will	will	MD
cord-303322-d69o3z8d	34	17	also	also	RB
cord-303322-d69o3z8d	34	18	be	be	VB
cord-303322-d69o3z8d	34	19	reported	report	VBN
cord-303322-d69o3z8d	34	20	.	.	.
cord-303322-d69o3z8d	35	1	Discussion	discussion	NN
cord-303322-d69o3z8d	35	2	:	:	:
cord-303322-d69o3z8d	36	1	Two	two	CD
cord-303322-d69o3z8d	36	2	published	publish	VBN
cord-303322-d69o3z8d	36	3	studies	study	NNS
cord-303322-d69o3z8d	36	4	,	,	,
cord-303322-d69o3z8d	36	5	both	both	DT
cord-303322-d69o3z8d	36	6	involving	involve	VBG
cord-303322-d69o3z8d	36	7	different	different	JJ
cord-303322-d69o3z8d	36	8	patient	patient	JJ
cord-303322-d69o3z8d	36	9	populations	population	NNS
cord-303322-d69o3z8d	36	10	and	and	CC
cord-303322-d69o3z8d	36	11	settings	setting	NNS
cord-303322-d69o3z8d	36	12	,	,	,
cord-303322-d69o3z8d	36	13	as	as	RB
cord-303322-d69o3z8d	36	14	well	well	RB
cord-303322-d69o3z8d	36	15	as	as	IN
cord-303322-d69o3z8d	36	16	different	different	JJ
cord-303322-d69o3z8d	36	17	macrolide	macrolide	NN
cord-303322-d69o3z8d	36	18	antibiotics	antibiotic	NNS
cord-303322-d69o3z8d	36	19	and	and	CC
cord-303322-d69o3z8d	36	20	treatment	treatment	NN
cord-303322-d69o3z8d	36	21	duration	duration	NN
cord-303322-d69o3z8d	36	22	,	,	,
cord-303322-d69o3z8d	36	23	have	have	VBP
cord-303322-d69o3z8d	36	24	produced	produce	VBN
cord-303322-d69o3z8d	36	25	conflicting	conflicting	JJ
cord-303322-d69o3z8d	36	26	results	result	NNS
cord-303322-d69o3z8d	36	27	.	.	.
cord-303322-d69o3z8d	37	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	37	2	randomised	randomised	JJ
cord-303322-d69o3z8d	37	3	,	,	,
cord-303322-d69o3z8d	37	4	placebocontrolled	placebocontrolled	JJ
cord-303322-d69o3z8d	37	5	trial	trial	NN
cord-303322-d69o3z8d	37	6	of	of	IN
cord-303322-d69o3z8d	37	7	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	37	8	in	in	IN
cord-303322-d69o3z8d	37	9	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	37	10	infants	infant	NNS
cord-303322-d69o3z8d	37	11	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	37	12	with	with	IN
cord-303322-d69o3z8d	37	13	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	37	14	is	be	VBZ
cord-303322-d69o3z8d	37	15	designed	design	VBN
cord-303322-d69o3z8d	37	16	to	to	TO
cord-303322-d69o3z8d	37	17	determine	determine	VB
cord-303322-d69o3z8d	37	18	whether	whether	IN
cord-303322-d69o3z8d	37	19	it	-PRON-	PRP
cord-303322-d69o3z8d	37	20	can	can	MD
cord-303322-d69o3z8d	37	21	reduce	reduce	VB
cord-303322-d69o3z8d	37	22	short	short	JJ
cord-303322-d69o3z8d	37	23	-	-	HYPH
cord-303322-d69o3z8d	37	24	term	term	NN
cord-303322-d69o3z8d	37	25	(	(	-LRB-
cord-303322-d69o3z8d	37	26	and	and	CC
cord-303322-d69o3z8d	37	27	potentially	potentially	RB
cord-303322-d69o3z8d	37	28	long	long	JJ
cord-303322-d69o3z8d	37	29	-	-	HYPH
cord-303322-d69o3z8d	37	30	term	term	NN
cord-303322-d69o3z8d	37	31	)	)	-RRB-
cord-303322-d69o3z8d	37	32	morbidity	morbidity	NN
cord-303322-d69o3z8d	37	33	from	from	IN
cord-303322-d69o3z8d	37	34	respiratory	respiratory	JJ
cord-303322-d69o3z8d	37	35	illness	illness	NN
cord-303322-d69o3z8d	37	36	in	in	IN
cord-303322-d69o3z8d	37	37	Australian	australian	JJ
cord-303322-d69o3z8d	37	38	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	37	39	infants	infant	NNS
cord-303322-d69o3z8d	37	40	who	who	WP
cord-303322-d69o3z8d	37	41	are	be	VBP
cord-303322-d69o3z8d	37	42	at	at	IN
cord-303322-d69o3z8d	37	43	high	high	JJ
cord-303322-d69o3z8d	37	44	risk	risk	NN
cord-303322-d69o3z8d	37	45	of	of	IN
cord-303322-d69o3z8d	37	46	developing	develop	VBG
cord-303322-d69o3z8d	37	47	chronic	chronic	JJ
cord-303322-d69o3z8d	37	48	respiratory	respiratory	JJ
cord-303322-d69o3z8d	37	49	illness	illness	NN
cord-303322-d69o3z8d	37	50	.	.	.
cord-303322-d69o3z8d	38	1	If	if	IN
cord-303322-d69o3z8d	38	2	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	38	3	is	be	VBZ
cord-303322-d69o3z8d	38	4	efficacious	efficacious	JJ
cord-303322-d69o3z8d	38	5	in	in	IN
cord-303322-d69o3z8d	38	6	reducing	reduce	VBG
cord-303322-d69o3z8d	38	7	the	the	DT
cord-303322-d69o3z8d	38	8	morbidly	morbidly	JJ
cord-303322-d69o3z8d	38	9	of	of	IN
cord-303322-d69o3z8d	38	10	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	38	11	infants	infant	NNS
cord-303322-d69o3z8d	38	12	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	38	13	with	with	IN
cord-303322-d69o3z8d	38	14	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	38	15	,	,	,
cord-303322-d69o3z8d	38	16	the	the	DT
cord-303322-d69o3z8d	38	17	intervention	intervention	NN
cord-303322-d69o3z8d	38	18	would	would	MD
cord-303322-d69o3z8d	38	19	lead	lead	VB
cord-303322-d69o3z8d	38	20	to	to	IN
cord-303322-d69o3z8d	38	21	improved	improve	VBN
cord-303322-d69o3z8d	38	22	short	short	JJ
cord-303322-d69o3z8d	38	23	term	term	NN
cord-303322-d69o3z8d	38	24	(	(	-LRB-
cord-303322-d69o3z8d	38	25	and	and	CC
cord-303322-d69o3z8d	38	26	possibly	possibly	RB
cord-303322-d69o3z8d	38	27	long	long	JJ
cord-303322-d69o3z8d	38	28	term	term	NN
cord-303322-d69o3z8d	38	29	)	)	-RRB-
cord-303322-d69o3z8d	38	30	health	health	NN
cord-303322-d69o3z8d	38	31	benefits	benefit	NNS
cord-303322-d69o3z8d	38	32	.	.	.
cord-303322-d69o3z8d	39	1	Trial	trial	NN
cord-303322-d69o3z8d	39	2	registration	registration	NN
cord-303322-d69o3z8d	39	3	:	:	:
cord-303322-d69o3z8d	40	1	Australia	Australia	NNP
cord-303322-d69o3z8d	40	2	and	and	CC
cord-303322-d69o3z8d	40	3	New	New	NNP
cord-303322-d69o3z8d	40	4	Zealand	Zealand	NNP
cord-303322-d69o3z8d	40	5	Clinical	Clinical	NNP
cord-303322-d69o3z8d	40	6	Trials	Trials	NNPS
cord-303322-d69o3z8d	40	7	Register	Register	NNP
cord-303322-d69o3z8d	40	8	(	(	-LRB-
cord-303322-d69o3z8d	40	9	ANZCTR	ANZCTR	NNP
cord-303322-d69o3z8d	40	10	)	)	-RRB-
cord-303322-d69o3z8d	40	11	:	:	:
cord-303322-d69o3z8d	41	1	ACTRN12610000326099	actrn12610000326099	CD
cord-303322-d69o3z8d	42	1	Background	Background	NNP
cord-303322-d69o3z8d	42	2	Worldwide	Worldwide	NNP
cord-303322-d69o3z8d	42	3	,	,	,
cord-303322-d69o3z8d	42	4	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	42	5	is	be	VBZ
cord-303322-d69o3z8d	42	6	the	the	DT
cord-303322-d69o3z8d	42	7	most	most	RBS
cord-303322-d69o3z8d	42	8	common	common	JJ
cord-303322-d69o3z8d	42	9	acute	acute	JJ
cord-303322-d69o3z8d	42	10	lower	low	JJR
cord-303322-d69o3z8d	42	11	respiratory	respiratory	JJ
cord-303322-d69o3z8d	42	12	tract	tract	NN
cord-303322-d69o3z8d	42	13	infection	infection	NN
cord-303322-d69o3z8d	42	14	(	(	-LRB-
cord-303322-d69o3z8d	42	15	ALRI	ALRI	NNP
cord-303322-d69o3z8d	42	16	)	)	-RRB-
cord-303322-d69o3z8d	42	17	in	in	IN
cord-303322-d69o3z8d	42	18	infants	infant	NNS
cord-303322-d69o3z8d	42	19	[	[	-LRB-
cord-303322-d69o3z8d	42	20	1	1	CD
cord-303322-d69o3z8d	42	21	]	]	-RRB-
cord-303322-d69o3z8d	42	22	[	[	-LRB-
cord-303322-d69o3z8d	42	23	2	2	CD
cord-303322-d69o3z8d	42	24	]	]	-RRB-
cord-303322-d69o3z8d	42	25	[	[	-LRB-
cord-303322-d69o3z8d	42	26	3	3	CD
cord-303322-d69o3z8d	42	27	]	]	-RRB-
cord-303322-d69o3z8d	42	28	.	.	.
cord-303322-d69o3z8d	43	1	In	in	IN
cord-303322-d69o3z8d	43	2	the	the	DT
cord-303322-d69o3z8d	43	3	Northern	Northern	NNP
cord-303322-d69o3z8d	43	4	Territory	Territory	NNP
cord-303322-d69o3z8d	43	5	(	(	-LRB-
cord-303322-d69o3z8d	43	6	NT	NT	NNP
cord-303322-d69o3z8d	43	7	,	,	,
cord-303322-d69o3z8d	43	8	Australia	Australia	NNP
cord-303322-d69o3z8d	43	9	)	)	-RRB-
cord-303322-d69o3z8d	43	10	,	,	,
cord-303322-d69o3z8d	43	11	ALRIs	alri	NNS
cord-303322-d69o3z8d	43	12	are	be	VBP
cord-303322-d69o3z8d	43	13	the	the	DT
cord-303322-d69o3z8d	43	14	most	most	RBS
cord-303322-d69o3z8d	43	15	frequent	frequent	JJ
cord-303322-d69o3z8d	43	16	reason	reason	NN
cord-303322-d69o3z8d	43	17	for	for	IN
cord-303322-d69o3z8d	43	18	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	43	19	of	of	IN
cord-303322-d69o3z8d	43	20	young	young	JJ
cord-303322-d69o3z8d	43	21	children	child	NNS
cord-303322-d69o3z8d	43	22	(	(	-LRB-
cord-303322-d69o3z8d	43	23	aged	aged	JJ
cord-303322-d69o3z8d	43	24	<	<	XX
cord-303322-d69o3z8d	43	25	5-years	5-years	CD
cord-303322-d69o3z8d	43	26	)	)	-RRB-
cord-303322-d69o3z8d	43	27	.	.	.
cord-303322-d69o3z8d	44	1	ALRIs	alri	NNS
cord-303322-d69o3z8d	44	2	are	be	VBP
cord-303322-d69o3z8d	44	3	also	also	RB
cord-303322-d69o3z8d	44	4	the	the	DT
cord-303322-d69o3z8d	44	5	commonest	common	JJS
cord-303322-d69o3z8d	44	6	cause	cause	NN
cord-303322-d69o3z8d	44	7	of	of	IN
cord-303322-d69o3z8d	44	8	preventable	preventable	JJ
cord-303322-d69o3z8d	44	9	deaths	death	NNS
cord-303322-d69o3z8d	44	10	in	in	IN
cord-303322-d69o3z8d	44	11	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	44	12	infants	infant	NNS
cord-303322-d69o3z8d	44	13	(	(	-LRB-
cord-303322-d69o3z8d	44	14	5	5	CD
cord-303322-d69o3z8d	44	15	times	time	NNS
cord-303322-d69o3z8d	44	16	that	that	DT
cord-303322-d69o3z8d	44	17	of	of	IN
cord-303322-d69o3z8d	44	18	non	non	JJ
cord-303322-d69o3z8d	44	19	-	-	JJ
cord-303322-d69o3z8d	44	20	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	44	21	)	)	-RRB-
cord-303322-d69o3z8d	44	22	[	[	-LRB-
cord-303322-d69o3z8d	44	23	4	4	CD
cord-303322-d69o3z8d	44	24	]	]	-RRB-
cord-303322-d69o3z8d	44	25	.	.	.
cord-303322-d69o3z8d	45	1	Of	of	IN
cord-303322-d69o3z8d	45	2	ALRIs	alri	NNS
cord-303322-d69o3z8d	45	3	,	,	,
cord-303322-d69o3z8d	45	4	bronchiolitis	bronchiolitis	NNP
cord-303322-d69o3z8d	45	5	(	(	-LRB-
cord-303322-d69o3z8d	45	6	with	with	IN
cord-303322-d69o3z8d	45	7	or	or	CC
cord-303322-d69o3z8d	45	8	without	without	IN
cord-303322-d69o3z8d	45	9	pneumonia	pneumonia	NN
cord-303322-d69o3z8d	45	10	)	)	-RRB-
cord-303322-d69o3z8d	45	11	is	be	VBZ
cord-303322-d69o3z8d	45	12	the	the	DT
cord-303322-d69o3z8d	45	13	most	most	RBS
cord-303322-d69o3z8d	45	14	frequent	frequent	JJ
cord-303322-d69o3z8d	45	15	reason	reason	NN
cord-303322-d69o3z8d	45	16	for	for	IN
cord-303322-d69o3z8d	45	17	hospital	hospital	NN
cord-303322-d69o3z8d	45	18	admission	admission	NN
cord-303322-d69o3z8d	45	19	in	in	IN
cord-303322-d69o3z8d	45	20	NT	NT	NNP
cord-303322-d69o3z8d	45	21	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	45	22	infants	infant	NNS
cord-303322-d69o3z8d	45	23	aged	age	VBN
cord-303322-d69o3z8d	45	24	under	under	IN
cord-303322-d69o3z8d	45	25	12-months	12-months	CD
cord-303322-d69o3z8d	45	26	[	[	-LRB-
cord-303322-d69o3z8d	45	27	5	5	CD
cord-303322-d69o3z8d	45	28	]	]	-RRB-
cord-303322-d69o3z8d	45	29	.	.	.
cord-303322-d69o3z8d	46	1	Despite	despite	IN
cord-303322-d69o3z8d	46	2	this	this	DT
cord-303322-d69o3z8d	46	3	heavy	heavy	JJ
cord-303322-d69o3z8d	46	4	burden	burden	NN
cord-303322-d69o3z8d	46	5	of	of	IN
cord-303322-d69o3z8d	46	6	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	46	7	in	in	IN
cord-303322-d69o3z8d	46	8	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	46	9	infants	infant	NNS
cord-303322-d69o3z8d	46	10	,	,	,
cord-303322-d69o3z8d	46	11	currently	currently	RB
cord-303322-d69o3z8d	46	12	no	no	DT
cord-303322-d69o3z8d	46	13	prospective	prospective	JJ
cord-303322-d69o3z8d	46	14	studies	study	NNS
cord-303322-d69o3z8d	46	15	have	have	VBP
cord-303322-d69o3z8d	46	16	been	be	VBN
cord-303322-d69o3z8d	46	17	published	publish	VBN
cord-303322-d69o3z8d	46	18	.	.	.
cord-303322-d69o3z8d	47	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	47	2	retrospective	retrospective	JJ
cord-303322-d69o3z8d	47	3	review	review	NN
cord-303322-d69o3z8d	47	4	of	of	IN
cord-303322-d69o3z8d	47	5	101	101	CD
cord-303322-d69o3z8d	47	6	infants	infant	NNS
cord-303322-d69o3z8d	47	7	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	47	8	with	with	IN
cord-303322-d69o3z8d	47	9	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	47	10	at	at	IN
cord-303322-d69o3z8d	47	11	the	the	DT
cord-303322-d69o3z8d	47	12	Royal	Royal	NNP
cord-303322-d69o3z8d	47	13	Darwin	Darwin	NNP
cord-303322-d69o3z8d	47	14	Hospital	Hospital	NNP
cord-303322-d69o3z8d	47	15	(	(	-LRB-
cord-303322-d69o3z8d	47	16	Darwin	Darwin	NNP
cord-303322-d69o3z8d	47	17	,	,	,
cord-303322-d69o3z8d	47	18	Northern	Northern	NNP
cord-303322-d69o3z8d	47	19	Territory	Territory	NNP
cord-303322-d69o3z8d	47	20	)	)	-RRB-
cord-303322-d69o3z8d	47	21	found	find	VBD
cord-303322-d69o3z8d	47	22	that	that	IN
cord-303322-d69o3z8d	47	23	33.7	33.7	CD
cord-303322-d69o3z8d	47	24	%	%	NN
cord-303322-d69o3z8d	47	25	of	of	IN
cord-303322-d69o3z8d	47	26	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	47	27	infants	infant	NNS
cord-303322-d69o3z8d	47	28	were	be	VBD
cord-303322-d69o3z8d	47	29	readmitted	readmitte	VBN
cord-303322-d69o3z8d	47	30	within	within	IN
cord-303322-d69o3z8d	47	31	six	six	CD
cord-303322-d69o3z8d	47	32	-	-	HYPH
cord-303322-d69o3z8d	47	33	months	month	NNS
cord-303322-d69o3z8d	47	34	of	of	IN
cord-303322-d69o3z8d	47	35	discharge	discharge	NN
cord-303322-d69o3z8d	47	36	from	from	IN
cord-303322-d69o3z8d	47	37	hospital	hospital	NN
cord-303322-d69o3z8d	47	38	[	[	-LRB-
cord-303322-d69o3z8d	47	39	6	6	CD
cord-303322-d69o3z8d	47	40	]	]	-RRB-
cord-303322-d69o3z8d	47	41	.	.	.
cord-303322-d69o3z8d	48	1	As	as	IN
cord-303322-d69o3z8d	48	2	most	most	JJS
cord-303322-d69o3z8d	48	3	were	be	VBD
cord-303322-d69o3z8d	48	4	retrieved	retrieve	VBN
cord-303322-d69o3z8d	48	5	from	from	IN
cord-303322-d69o3z8d	48	6	remote	remote	JJ
cord-303322-d69o3z8d	48	7	communities	community	NNS
cord-303322-d69o3z8d	48	8	,	,	,
cord-303322-d69o3z8d	48	9	the	the	DT
cord-303322-d69o3z8d	48	10	impact	impact	NN
cord-303322-d69o3z8d	48	11	of	of	IN
cord-303322-d69o3z8d	48	12	the	the	DT
cord-303322-d69o3z8d	48	13	illness	illness	NN
cord-303322-d69o3z8d	48	14	,	,	,
cord-303322-d69o3z8d	48	15	its	-PRON-	PRP$
cord-303322-d69o3z8d	48	16	costs	cost	NNS
cord-303322-d69o3z8d	48	17	and	and	CC
cord-303322-d69o3z8d	48	18	social	social	JJ
cord-303322-d69o3z8d	48	19	dislocation	dislocation	NN
cord-303322-d69o3z8d	48	20	were	be	VBD
cord-303322-d69o3z8d	48	21	likely	likely	JJ
cord-303322-d69o3z8d	48	22	to	to	TO
cord-303322-d69o3z8d	48	23	have	have	VB
cord-303322-d69o3z8d	48	24	been	be	VBN
cord-303322-d69o3z8d	48	25	substantial	substantial	JJ
cord-303322-d69o3z8d	48	26	.	.	.
cord-303322-d69o3z8d	49	1	Recurrent	recurrent	JJ
cord-303322-d69o3z8d	49	2	ALRIs	alri	NNS
cord-303322-d69o3z8d	49	3	are	be	VBP
cord-303322-d69o3z8d	49	4	independently	independently	RB
cord-303322-d69o3z8d	49	5	associated	associate	VBN
cord-303322-d69o3z8d	49	6	with	with	IN
cord-303322-d69o3z8d	49	7	the	the	DT
cord-303322-d69o3z8d	49	8	development	development	NN
cord-303322-d69o3z8d	49	9	of	of	IN
cord-303322-d69o3z8d	49	10	bronchiectasis	bronchiectasis	NN
cord-303322-d69o3z8d	49	11	[	[	-LRB-
cord-303322-d69o3z8d	49	12	7	7	CD
cord-303322-d69o3z8d	49	13	]	]	-RRB-
cord-303322-d69o3z8d	49	14	and	and	CC
cord-303322-d69o3z8d	49	15	reduced	reduce	VBN
cord-303322-d69o3z8d	49	16	pulmonary	pulmonary	JJ
cord-303322-d69o3z8d	49	17	function	function	NN
cord-303322-d69o3z8d	49	18	later	later	RB
cord-303322-d69o3z8d	49	19	in	in	IN
cord-303322-d69o3z8d	49	20	life	life	NN
cord-303322-d69o3z8d	49	21	[	[	-LRB-
cord-303322-d69o3z8d	49	22	8	8	CD
cord-303322-d69o3z8d	49	23	]	]	-RRB-
cord-303322-d69o3z8d	49	24	.	.	.
cord-303322-d69o3z8d	50	1	Low	low	JJ
cord-303322-d69o3z8d	50	2	birth	birth	NN
cord-303322-d69o3z8d	50	3	weight	weight	NN
cord-303322-d69o3z8d	50	4	and	and	CC
cord-303322-d69o3z8d	50	5	pre	pre	JJ
cord-303322-d69o3z8d	50	6	-	-	JJ
cord-303322-d69o3z8d	50	7	existing	existing	JJ
cord-303322-d69o3z8d	50	8	small	small	JJ
cord-303322-d69o3z8d	50	9	lungs	lung	NNS
cord-303322-d69o3z8d	50	10	are	be	VBP
cord-303322-d69o3z8d	50	11	important	important	JJ
cord-303322-d69o3z8d	50	12	determinants	determinant	NNS
cord-303322-d69o3z8d	50	13	of	of	IN
cord-303322-d69o3z8d	50	14	future	future	JJ
cord-303322-d69o3z8d	50	15	lung	lung	NN
cord-303322-d69o3z8d	50	16	function	function	NN
cord-303322-d69o3z8d	50	17	,	,	,
cord-303322-d69o3z8d	50	18	but	but	CC
cord-303322-d69o3z8d	50	19	there	there	EX
cord-303322-d69o3z8d	50	20	is	be	VBZ
cord-303322-d69o3z8d	50	21	increasing	increase	VBG
cord-303322-d69o3z8d	50	22	evidence	evidence	NN
cord-303322-d69o3z8d	50	23	that	that	IN
cord-303322-d69o3z8d	50	24	events	event	NNS
cord-303322-d69o3z8d	50	25	in	in	IN
cord-303322-d69o3z8d	50	26	early	early	JJ
cord-303322-d69o3z8d	50	27	life	life	NN
cord-303322-d69o3z8d	50	28	are	be	VBP
cord-303322-d69o3z8d	50	29	at	at	IN
cord-303322-d69o3z8d	50	30	least	least	JJS
cord-303322-d69o3z8d	50	31	equally	equally	RB
cord-303322-d69o3z8d	50	32	important	important	JJ
cord-303322-d69o3z8d	50	33	determinants	determinant	NNS
cord-303322-d69o3z8d	50	34	of	of	IN
cord-303322-d69o3z8d	50	35	adult	adult	JJ
cord-303322-d69o3z8d	50	36	pulmonary	pulmonary	JJ
cord-303322-d69o3z8d	50	37	dysfunction	dysfunction	NN
cord-303322-d69o3z8d	50	38	[	[	-LRB-
cord-303322-d69o3z8d	50	39	8	8	CD
cord-303322-d69o3z8d	50	40	]	]	-RRB-
cord-303322-d69o3z8d	50	41	[	[	-LRB-
cord-303322-d69o3z8d	50	42	9	9	CD
cord-303322-d69o3z8d	50	43	]	]	-RRB-
cord-303322-d69o3z8d	50	44	[	[	-LRB-
cord-303322-d69o3z8d	50	45	10	10	CD
cord-303322-d69o3z8d	50	46	]	]	-RRB-
cord-303322-d69o3z8d	50	47	.	.	.
cord-303322-d69o3z8d	51	1	The	the	DT
cord-303322-d69o3z8d	51	2	first	first	JJ
cord-303322-d69o3z8d	51	3	few	few	JJ
cord-303322-d69o3z8d	51	4	years	year	NNS
cord-303322-d69o3z8d	51	5	of	of	IN
cord-303322-d69o3z8d	51	6	life	life	NN
cord-303322-d69o3z8d	51	7	are	be	VBP
cord-303322-d69o3z8d	51	8	the	the	DT
cord-303322-d69o3z8d	51	9	most	most	RBS
cord-303322-d69o3z8d	51	10	critical	critical	JJ
cord-303322-d69o3z8d	51	11	period	period	NN
cord-303322-d69o3z8d	51	12	[	[	-LRB-
cord-303322-d69o3z8d	51	13	11	11	CD
cord-303322-d69o3z8d	51	14	]	]	-RRB-
cord-303322-d69o3z8d	51	15	.	.	.
cord-303322-d69o3z8d	52	1	Thus	thus	RB
cord-303322-d69o3z8d	52	2	events	event	NNS
cord-303322-d69o3z8d	52	3	such	such	JJ
cord-303322-d69o3z8d	52	4	as	as	IN
cord-303322-d69o3z8d	52	5	severe	severe	JJ
cord-303322-d69o3z8d	52	6	ALRIs	alri	NNS
cord-303322-d69o3z8d	52	7	during	during	IN
cord-303322-d69o3z8d	52	8	this	this	DT
cord-303322-d69o3z8d	52	9	critical	critical	JJ
cord-303322-d69o3z8d	52	10	period	period	NN
cord-303322-d69o3z8d	52	11	are	be	VBP
cord-303322-d69o3z8d	52	12	likely	likely	JJ
cord-303322-d69o3z8d	52	13	to	to	TO
cord-303322-d69o3z8d	52	14	have	have	VB
cord-303322-d69o3z8d	52	15	long	long	JJ
cord-303322-d69o3z8d	52	16	term	term	NN
cord-303322-d69o3z8d	52	17	effects	effect	NNS
cord-303322-d69o3z8d	52	18	.	.	.
cord-303322-d69o3z8d	53	1	Australia	Australia	NNP
cord-303322-d69o3z8d	53	2	-	-	HYPH
cord-303322-d69o3z8d	53	3	wide	wide	RB
cord-303322-d69o3z8d	53	4	,	,	,
cord-303322-d69o3z8d	53	5	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	53	6	rates	rate	NNS
cord-303322-d69o3z8d	53	7	of	of	IN
cord-303322-d69o3z8d	53	8	respiratory	respiratory	JJ
cord-303322-d69o3z8d	53	9	disorders	disorder	NNS
cord-303322-d69o3z8d	53	10	among	among	IN
cord-303322-d69o3z8d	53	11	Indigenous	Indigenous	NNP
cord-303322-d69o3z8d	53	12	Australians	Australians	NNPS
cord-303322-d69o3z8d	53	13	are	be	VBP
cord-303322-d69o3z8d	53	14	second	second	JJ
cord-303322-d69o3z8d	53	15	only	only	RB
cord-303322-d69o3z8d	53	16	to	to	IN
cord-303322-d69o3z8d	53	17	those	those	DT
cord-303322-d69o3z8d	53	18	for	for	IN
cord-303322-d69o3z8d	53	19	renal	renal	JJ
cord-303322-d69o3z8d	53	20	dialysis	dialysis	NN
cord-303322-d69o3z8d	53	21	[	[	-LRB-
cord-303322-d69o3z8d	53	22	12	12	CD
cord-303322-d69o3z8d	53	23	]	]	-RRB-
cord-303322-d69o3z8d	53	24	.	.	.
cord-303322-d69o3z8d	54	1	Furthermore	furthermore	RB
cord-303322-d69o3z8d	54	2	,	,	,
cord-303322-d69o3z8d	54	3	we	-PRON-	PRP
cord-303322-d69o3z8d	54	4	have	have	VBP
cord-303322-d69o3z8d	54	5	previously	previously	RB
cord-303322-d69o3z8d	54	6	documented	document	VBN
cord-303322-d69o3z8d	54	7	that	that	IN
cord-303322-d69o3z8d	54	8	the	the	DT
cord-303322-d69o3z8d	54	9	severity	severity	NN
cord-303322-d69o3z8d	54	10	of	of	IN
cord-303322-d69o3z8d	54	11	the	the	DT
cord-303322-d69o3z8d	54	12	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	54	13	ALRI	ALRI	NNP
cord-303322-d69o3z8d	54	14	episode	episode	NN
cord-303322-d69o3z8d	54	15	,	,	,
cord-303322-d69o3z8d	54	16	as	as	IN
cord-303322-d69o3z8d	54	17	determined	determine	VBN
cord-303322-d69o3z8d	54	18	by	by	IN
cord-303322-d69o3z8d	54	19	oxygen	oxygen	NN
cord-303322-d69o3z8d	54	20	requirement	requirement	NN
cord-303322-d69o3z8d	54	21	and	and	CC
cord-303322-d69o3z8d	54	22	duration	duration	NN
cord-303322-d69o3z8d	54	23	of	of	IN
cord-303322-d69o3z8d	54	24	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	54	25	,	,	,
cord-303322-d69o3z8d	54	26	was	be	VBD
cord-303322-d69o3z8d	54	27	an	an	DT
cord-303322-d69o3z8d	54	28	independent	independent	JJ
cord-303322-d69o3z8d	54	29	risk	risk	NN
cord-303322-d69o3z8d	54	30	factor	factor	NN
cord-303322-d69o3z8d	54	31	for	for	IN
cord-303322-d69o3z8d	54	32	subsequent	subsequent	JJ
cord-303322-d69o3z8d	54	33	bronchiectasis	bronchiectasis	NN
cord-303322-d69o3z8d	54	34	[	[	-LRB-
cord-303322-d69o3z8d	54	35	7	7	CD
cord-303322-d69o3z8d	54	36	]	]	-RRB-
cord-303322-d69o3z8d	54	37	.	.	.
cord-303322-d69o3z8d	55	1	In	in	IN
cord-303322-d69o3z8d	55	2	the	the	DT
cord-303322-d69o3z8d	55	3	Northern	Northern	NNP
cord-303322-d69o3z8d	55	4	Territory	Territory	NNP
cord-303322-d69o3z8d	55	5	(	(	-LRB-
cord-303322-d69o3z8d	55	6	NT	NT	NNP
cord-303322-d69o3z8d	55	7	)	)	-RRB-
cord-303322-d69o3z8d	55	8	,	,	,
cord-303322-d69o3z8d	55	9	bronchiectasis	bronchiectasis	NN
cord-303322-d69o3z8d	55	10	affects	affect	VBZ
cord-303322-d69o3z8d	55	11	one	one	CD
cord-303322-d69o3z8d	55	12	in	in	IN
cord-303322-d69o3z8d	55	13	every	every	DT
cord-303322-d69o3z8d	55	14	68	68	CD
cord-303322-d69o3z8d	55	15	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	55	16	children	child	NNS
cord-303322-d69o3z8d	55	17	,	,	,
cord-303322-d69o3z8d	55	18	far	far	RB
cord-303322-d69o3z8d	55	19	exceeding	exceed	VBG
cord-303322-d69o3z8d	55	20	that	that	DT
cord-303322-d69o3z8d	55	21	of	of	IN
cord-303322-d69o3z8d	55	22	cystic	cystic	JJ
cord-303322-d69o3z8d	55	23	fibrosis	fibrosis	NN
cord-303322-d69o3z8d	55	24	(	(	-LRB-
cord-303322-d69o3z8d	55	25	CF	CF	NNP
cord-303322-d69o3z8d	55	26	)	)	-RRB-
cord-303322-d69o3z8d	55	27	in	in	IN
cord-303322-d69o3z8d	55	28	non	non	JJ
cord-303322-d69o3z8d	55	29	-	-	JJ
cord-303322-d69o3z8d	55	30	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	55	31	Australian	australian	JJ
cord-303322-d69o3z8d	55	32	children	child	NNS
cord-303322-d69o3z8d	55	33	(	(	-LRB-
cord-303322-d69o3z8d	55	34	1	1	CD
cord-303322-d69o3z8d	55	35	in	in	IN
cord-303322-d69o3z8d	55	36	2857	2857	CD
cord-303322-d69o3z8d	55	37	)	)	-RRB-
cord-303322-d69o3z8d	55	38	[	[	-LRB-
cord-303322-d69o3z8d	55	39	13	13	CD
cord-303322-d69o3z8d	55	40	,	,	,
cord-303322-d69o3z8d	55	41	14	14	CD
cord-303322-d69o3z8d	55	42	]	]	-RRB-
cord-303322-d69o3z8d	55	43	.	.	.
cord-303322-d69o3z8d	56	1	Thus	thus	RB
cord-303322-d69o3z8d	56	2	,	,	,
cord-303322-d69o3z8d	56	3	any	any	DT
cord-303322-d69o3z8d	56	4	intervention	intervention	NN
cord-303322-d69o3z8d	56	5	that	that	WDT
cord-303322-d69o3z8d	56	6	reduces	reduce	VBZ
cord-303322-d69o3z8d	56	7	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	56	8	severity	severity	NN
cord-303322-d69o3z8d	56	9	and/or	and/or	CC
cord-303322-d69o3z8d	56	10	risk	risk	NN
cord-303322-d69o3z8d	56	11	of	of	IN
cord-303322-d69o3z8d	56	12	readmission	readmission	NN
cord-303322-d69o3z8d	56	13	for	for	IN
cord-303322-d69o3z8d	56	14	respiratory	respiratory	JJ
cord-303322-d69o3z8d	56	15	illness	illness	NN
cord-303322-d69o3z8d	56	16	in	in	IN
cord-303322-d69o3z8d	56	17	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	56	18	infants	infant	NNS
cord-303322-d69o3z8d	56	19	may	may	MD
cord-303322-d69o3z8d	56	20	have	have	VB
cord-303322-d69o3z8d	56	21	both	both	DT
cord-303322-d69o3z8d	56	22	short	short	JJ
cord-303322-d69o3z8d	56	23	term	term	NN
cord-303322-d69o3z8d	56	24	and	and	CC
cord-303322-d69o3z8d	56	25	potential	potential	JJ
cord-303322-d69o3z8d	56	26	long	long	JJ
cord-303322-d69o3z8d	56	27	term	term	NN
cord-303322-d69o3z8d	56	28	benefits	benefit	NNS
cord-303322-d69o3z8d	56	29	in	in	IN
cord-303322-d69o3z8d	56	30	our	-PRON-	PRP$
cord-303322-d69o3z8d	56	31	setting	setting	NN
cord-303322-d69o3z8d	56	32	.	.	.
cord-303322-d69o3z8d	57	1	Bronchiolitis	Bronchiolitis	NNP
cord-303322-d69o3z8d	57	2	is	be	VBZ
cord-303322-d69o3z8d	57	3	characterised	characterise	VBN
cord-303322-d69o3z8d	57	4	by	by	IN
cord-303322-d69o3z8d	57	5	extensive	extensive	JJ
cord-303322-d69o3z8d	57	6	inflammation	inflammation	NN
cord-303322-d69o3z8d	57	7	of	of	IN
cord-303322-d69o3z8d	57	8	the	the	DT
cord-303322-d69o3z8d	57	9	airways	airway	NNS
cord-303322-d69o3z8d	57	10	accompanied	accompany	VBN
cord-303322-d69o3z8d	57	11	by	by	IN
cord-303322-d69o3z8d	57	12	increased	increase	VBN
cord-303322-d69o3z8d	57	13	mucous	mucous	JJ
cord-303322-d69o3z8d	57	14	production	production	NN
cord-303322-d69o3z8d	57	15	and	and	CC
cord-303322-d69o3z8d	57	16	necrosis	necrosis	NN
cord-303322-d69o3z8d	57	17	of	of	IN
cord-303322-d69o3z8d	57	18	airway	airway	NN
cord-303322-d69o3z8d	57	19	epithelial	epithelial	JJ
cord-303322-d69o3z8d	57	20	cells	cell	NNS
cord-303322-d69o3z8d	57	21	.	.	.
cord-303322-d69o3z8d	58	1	In	in	IN
cord-303322-d69o3z8d	58	2	paediatrics	paediatric	NNS
cord-303322-d69o3z8d	58	3	,	,	,
cord-303322-d69o3z8d	58	4	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	58	5	is	be	VBZ
cord-303322-d69o3z8d	58	6	a	a	DT
cord-303322-d69o3z8d	58	7	clinical	clinical	JJ
cord-303322-d69o3z8d	58	8	diagnosis	diagnosis	NN
cord-303322-d69o3z8d	58	9	characterised	characterise	VBN
cord-303322-d69o3z8d	58	10	by	by	IN
cord-303322-d69o3z8d	58	11	tachypnoea	tachypnoea	NNS
cord-303322-d69o3z8d	58	12	,	,	,
cord-303322-d69o3z8d	58	13	wheeze	wheeze	NN
cord-303322-d69o3z8d	58	14	and/or	and/or	CC
cord-303322-d69o3z8d	58	15	crepitations	crepitation	NNS
cord-303322-d69o3z8d	58	16	in	in	IN
cord-303322-d69o3z8d	58	17	infants	infant	NNS
cord-303322-d69o3z8d	58	18	following	follow	VBG
cord-303322-d69o3z8d	58	19	a	a	DT
cord-303322-d69o3z8d	58	20	preceding	precede	VBG
cord-303322-d69o3z8d	58	21	upper	upper	JJ
cord-303322-d69o3z8d	58	22	respiratory	respiratory	JJ
cord-303322-d69o3z8d	58	23	illness	illness	NN
cord-303322-d69o3z8d	58	24	[	[	-LRB-
cord-303322-d69o3z8d	58	25	1	1	CD
cord-303322-d69o3z8d	58	26	]	]	-RRB-
cord-303322-d69o3z8d	58	27	.	.	.
cord-303322-d69o3z8d	59	1	It	-PRON-	PRP
cord-303322-d69o3z8d	59	2	is	be	VBZ
cord-303322-d69o3z8d	59	3	primarily	primarily	RB
cord-303322-d69o3z8d	59	4	caused	cause	VBN
cord-303322-d69o3z8d	59	5	by	by	IN
cord-303322-d69o3z8d	59	6	infection	infection	NN
cord-303322-d69o3z8d	59	7	of	of	IN
cord-303322-d69o3z8d	59	8	the	the	DT
cord-303322-d69o3z8d	59	9	respiratory	respiratory	JJ
cord-303322-d69o3z8d	59	10	epithelial	epithelial	JJ
cord-303322-d69o3z8d	59	11	cells	cell	NNS
cord-303322-d69o3z8d	59	12	by	by	IN
cord-303322-d69o3z8d	59	13	a	a	DT
cord-303322-d69o3z8d	59	14	variety	variety	NN
cord-303322-d69o3z8d	59	15	of	of	IN
cord-303322-d69o3z8d	59	16	viruses	virus	NNS
cord-303322-d69o3z8d	59	17	,	,	,
cord-303322-d69o3z8d	59	18	especially	especially	RB
cord-303322-d69o3z8d	59	19	respiratory	respiratory	JJ
cord-303322-d69o3z8d	59	20	syncytial	syncytial	JJ
cord-303322-d69o3z8d	59	21	virus	virus	NN
cord-303322-d69o3z8d	59	22	(	(	-LRB-
cord-303322-d69o3z8d	59	23	RSV	RSV	NNP
cord-303322-d69o3z8d	59	24	)	)	-RRB-
cord-303322-d69o3z8d	59	25	.	.	.
cord-303322-d69o3z8d	60	1	Other	other	JJ
cord-303322-d69o3z8d	60	2	viruses	virus	NNS
cord-303322-d69o3z8d	60	3	(	(	-LRB-
cord-303322-d69o3z8d	60	4	adenovirus	adenovirus	NN
cord-303322-d69o3z8d	60	5	,	,	,
cord-303322-d69o3z8d	60	6	influenza	influenza	NN
cord-303322-d69o3z8d	60	7	,	,	,
cord-303322-d69o3z8d	60	8	parainfluenza	parainfluenza	NNP
cord-303322-d69o3z8d	60	9	,	,	,
cord-303322-d69o3z8d	60	10	human	human	NNP
cord-303322-d69o3z8d	60	11	metapneumovirus	metapneumovirus	NNP
cord-303322-d69o3z8d	60	12	,	,	,
cord-303322-d69o3z8d	60	13	rhinovirus	rhinovirus	NN
cord-303322-d69o3z8d	60	14	)	)	-RRB-
cord-303322-d69o3z8d	60	15	are	be	VBP
cord-303322-d69o3z8d	60	16	also	also	RB
cord-303322-d69o3z8d	60	17	implicated	implicate	VBN
cord-303322-d69o3z8d	60	18	and	and	CC
cord-303322-d69o3z8d	60	19	increasingly	increasingly	RB
cord-303322-d69o3z8d	60	20	new	new	JJ
cord-303322-d69o3z8d	60	21	viruses	virus	NNS
cord-303322-d69o3z8d	60	22	are	be	VBP
cord-303322-d69o3z8d	60	23	being	be	VBG
cord-303322-d69o3z8d	60	24	detected	detect	VBN
cord-303322-d69o3z8d	60	25	in	in	IN
cord-303322-d69o3z8d	60	26	association	association	NN
cord-303322-d69o3z8d	60	27	with	with	IN
cord-303322-d69o3z8d	60	28	this	this	DT
cord-303322-d69o3z8d	60	29	illness	illness	NN
cord-303322-d69o3z8d	60	30	[	[	-LRB-
cord-303322-d69o3z8d	60	31	15	15	CD
cord-303322-d69o3z8d	60	32	]	]	-RRB-
cord-303322-d69o3z8d	60	33	.	.	.
cord-303322-d69o3z8d	61	1	In	in	IN
cord-303322-d69o3z8d	61	2	addition	addition	NN
cord-303322-d69o3z8d	61	3	,	,	,
cord-303322-d69o3z8d	61	4	Mycoplasma	mycoplasma	NN
cord-303322-d69o3z8d	61	5	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	61	6	and	and	CC
cord-303322-d69o3z8d	61	7	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	61	8	species	specie	NNS
cord-303322-d69o3z8d	61	9	are	be	VBP
cord-303322-d69o3z8d	61	10	recognised	recognise	VBN
cord-303322-d69o3z8d	61	11	increasingly	increasingly	RB
cord-303322-d69o3z8d	61	12	as	as	IN
cord-303322-d69o3z8d	61	13	important	important	JJ
cord-303322-d69o3z8d	61	14	contributors	contributor	NNS
cord-303322-d69o3z8d	61	15	to	to	IN
cord-303322-d69o3z8d	61	16	the	the	DT
cord-303322-d69o3z8d	61	17	development	development	NN
cord-303322-d69o3z8d	61	18	of	of	IN
cord-303322-d69o3z8d	61	19	chronic	chronic	JJ
cord-303322-d69o3z8d	61	20	lung	lung	NN
cord-303322-d69o3z8d	61	21	disease	disease	NN
cord-303322-d69o3z8d	61	22	and	and	CC
cord-303322-d69o3z8d	61	23	altered	altered	JJ
cord-303322-d69o3z8d	61	24	lung	lung	NN
cord-303322-d69o3z8d	61	25	maturation	maturation	NN
cord-303322-d69o3z8d	61	26	[	[	-LRB-
cord-303322-d69o3z8d	61	27	16	16	CD
cord-303322-d69o3z8d	61	28	]	]	-RRB-
cord-303322-d69o3z8d	61	29	[	[	-LRB-
cord-303322-d69o3z8d	61	30	17	17	CD
cord-303322-d69o3z8d	61	31	]	]	-RRB-
cord-303322-d69o3z8d	61	32	[	[	-LRB-
cord-303322-d69o3z8d	61	33	18	18	CD
cord-303322-d69o3z8d	61	34	]	]	-RRB-
cord-303322-d69o3z8d	61	35	[	[	-LRB-
cord-303322-d69o3z8d	61	36	19	19	CD
cord-303322-d69o3z8d	61	37	]	]	-RRB-
cord-303322-d69o3z8d	61	38	.	.	.
cord-303322-d69o3z8d	62	1	New	new	JJ
cord-303322-d69o3z8d	62	2	treatable	treatable	JJ
cord-303322-d69o3z8d	62	3	bacteria	bacteria	NNS
cord-303322-d69o3z8d	62	4	such	such	JJ
cord-303322-d69o3z8d	62	5	as	as	IN
cord-303322-d69o3z8d	62	6	Simkania	Simkania	NNP
cord-303322-d69o3z8d	62	7	negevensis	negevensis	NNP
cord-303322-d69o3z8d	62	8	(	(	-LRB-
cord-303322-d69o3z8d	62	9	a	a	DT
cord-303322-d69o3z8d	62	10	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	62	11	-	-	HYPH
cord-303322-d69o3z8d	62	12	like	like	JJ
cord-303322-d69o3z8d	62	13	microbe	microbe	NN
cord-303322-d69o3z8d	62	14	)	)	-RRB-
cord-303322-d69o3z8d	62	15	has	have	VBZ
cord-303322-d69o3z8d	62	16	been	be	VBN
cord-303322-d69o3z8d	62	17	found	find	VBN
cord-303322-d69o3z8d	62	18	in	in	IN
cord-303322-d69o3z8d	62	19	Canadian	canadian	JJ
cord-303322-d69o3z8d	62	20	Inuit	inuit	JJ
cord-303322-d69o3z8d	62	21	infants	infant	NNS
cord-303322-d69o3z8d	62	22	with	with	IN
cord-303322-d69o3z8d	62	23	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	62	24	[	[	-LRB-
cord-303322-d69o3z8d	62	25	20	20	CD
cord-303322-d69o3z8d	62	26	]	]	-RRB-
cord-303322-d69o3z8d	62	27	.	.	.
cord-303322-d69o3z8d	63	1	There	there	EX
cord-303322-d69o3z8d	63	2	are	be	VBP
cord-303322-d69o3z8d	63	3	no	no	DT
cord-303322-d69o3z8d	63	4	published	publish	VBN
cord-303322-d69o3z8d	63	5	data	datum	NNS
cord-303322-d69o3z8d	63	6	on	on	IN
cord-303322-d69o3z8d	63	7	the	the	DT
cord-303322-d69o3z8d	63	8	nature	nature	NN
cord-303322-d69o3z8d	63	9	or	or	CC
cord-303322-d69o3z8d	63	10	diversity	diversity	NN
cord-303322-d69o3z8d	63	11	of	of	IN
cord-303322-d69o3z8d	63	12	respiratory	respiratory	JJ
cord-303322-d69o3z8d	63	13	pathogens	pathogen	NNS
cord-303322-d69o3z8d	63	14	associated	associate	VBN
cord-303322-d69o3z8d	63	15	with	with	IN
cord-303322-d69o3z8d	63	16	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	63	17	in	in	IN
cord-303322-d69o3z8d	63	18	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	63	19	Australians	Australians	NNPS
cord-303322-d69o3z8d	63	20	infants	infant	NNS
cord-303322-d69o3z8d	63	21	.	.	.
cord-303322-d69o3z8d	64	1	Typically	typically	RB
cord-303322-d69o3z8d	64	2	anti	anti	NNS
cord-303322-d69o3z8d	64	3	-	-	NNS
cord-303322-d69o3z8d	64	4	microbials	microbial	NNS
cord-303322-d69o3z8d	64	5	are	be	VBP
cord-303322-d69o3z8d	64	6	not	not	RB
cord-303322-d69o3z8d	64	7	recommended	recommend	VBN
cord-303322-d69o3z8d	64	8	in	in	IN
cord-303322-d69o3z8d	64	9	the	the	DT
cord-303322-d69o3z8d	64	10	routine	routine	JJ
cord-303322-d69o3z8d	64	11	management	management	NN
cord-303322-d69o3z8d	64	12	of	of	IN
cord-303322-d69o3z8d	64	13	bronchiolitis	bronchiolitis	NNP
cord-303322-d69o3z8d	64	14	[	[	-LRB-
cord-303322-d69o3z8d	64	15	1	1	CD
cord-303322-d69o3z8d	64	16	,	,	,
cord-303322-d69o3z8d	64	17	21	21	CD
cord-303322-d69o3z8d	64	18	]	]	-RRB-
cord-303322-d69o3z8d	64	19	.	.	.
cord-303322-d69o3z8d	65	1	While	while	IN
cord-303322-d69o3z8d	65	2	there	there	EX
cord-303322-d69o3z8d	65	3	are	be	VBP
cord-303322-d69o3z8d	65	4	two	two	CD
cord-303322-d69o3z8d	65	5	RCTs	RCTs	NNPS
cord-303322-d69o3z8d	65	6	on	on	IN
cord-303322-d69o3z8d	65	7	macrolides	macrolide	NNS
cord-303322-d69o3z8d	65	8	for	for	IN
cord-303322-d69o3z8d	65	9	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	65	10	,	,	,
cord-303322-d69o3z8d	65	11	the	the	DT
cord-303322-d69o3z8d	65	12	single	single	JJ
cord-303322-d69o3z8d	65	13	available	available	JJ
cord-303322-d69o3z8d	65	14	RCT	RCT	NNP
cord-303322-d69o3z8d	65	15	on	on	IN
cord-303322-d69o3z8d	65	16	a	a	DT
cord-303322-d69o3z8d	65	17	non	non	JJ
cord-303322-d69o3z8d	65	18	-	-	JJ
cord-303322-d69o3z8d	65	19	macrolide	macrolide	JJ
cord-303322-d69o3z8d	65	20	anti	anti	JJ
cord-303322-d69o3z8d	65	21	-	-	JJ
cord-303322-d69o3z8d	65	22	microbial	microbial	JJ
cord-303322-d69o3z8d	65	23	was	be	VBD
cord-303322-d69o3z8d	65	24	a	a	DT
cord-303322-d69o3z8d	65	25	negative	negative	JJ
cord-303322-d69o3z8d	65	26	study	study	NN
cord-303322-d69o3z8d	65	27	[	[	-LRB-
cord-303322-d69o3z8d	65	28	22	22	CD
cord-303322-d69o3z8d	65	29	]	]	-RRB-
cord-303322-d69o3z8d	65	30	.	.	.
cord-303322-d69o3z8d	66	1	However	however	RB
cord-303322-d69o3z8d	66	2	in	in	IN
cord-303322-d69o3z8d	66	3	our	-PRON-	PRP$
cord-303322-d69o3z8d	66	4	setting	setting	NN
cord-303322-d69o3z8d	66	5	,	,	,
cord-303322-d69o3z8d	66	6	there	there	EX
cord-303322-d69o3z8d	66	7	are	be	VBP
cord-303322-d69o3z8d	66	8	several	several	JJ
cord-303322-d69o3z8d	66	9	reasons	reason	NNS
cord-303322-d69o3z8d	66	10	why	why	WRB
cord-303322-d69o3z8d	66	11	anti	anti	NNS
cord-303322-d69o3z8d	66	12	-	-	NNS
cord-303322-d69o3z8d	66	13	microbials	microbial	NNS
cord-303322-d69o3z8d	66	14	may	may	MD
cord-303322-d69o3z8d	66	15	reduce	reduce	VB
cord-303322-d69o3z8d	66	16	the	the	DT
cord-303322-d69o3z8d	66	17	morbidity	morbidity	NN
cord-303322-d69o3z8d	66	18	of	of	IN
cord-303322-d69o3z8d	66	19	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	66	20	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	66	21	infants	infant	NNS
cord-303322-d69o3z8d	66	22	with	with	IN
cord-303322-d69o3z8d	66	23	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	66	24	.	.	.
cord-303322-d69o3z8d	67	1	Colonisation	colonisation	NN
cord-303322-d69o3z8d	67	2	of	of	IN
cord-303322-d69o3z8d	67	3	nasopharynx	nasopharynx	NN
cord-303322-d69o3z8d	67	4	with	with	IN
cord-303322-d69o3z8d	67	5	bacteria	bacteria	NNS
cord-303322-d69o3z8d	67	6	is	be	VBZ
cord-303322-d69o3z8d	67	7	a	a	DT
cord-303322-d69o3z8d	67	8	known	know	VBN
cord-303322-d69o3z8d	67	9	risk	risk	NN
cord-303322-d69o3z8d	67	10	factor	factor	NN
cord-303322-d69o3z8d	67	11	for	for	IN
cord-303322-d69o3z8d	67	12	childhood	childhood	NN
cord-303322-d69o3z8d	67	13	pneumonia	pneumonia	NN
cord-303322-d69o3z8d	67	14	[	[	-LRB-
cord-303322-d69o3z8d	67	15	23	23	CD
cord-303322-d69o3z8d	67	16	]	]	-RRB-
cord-303322-d69o3z8d	67	17	.	.	.
cord-303322-d69o3z8d	68	1	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	68	2	infants	infant	NNS
cord-303322-d69o3z8d	68	3	not	not	RB
cord-303322-d69o3z8d	68	4	only	only	RB
cord-303322-d69o3z8d	68	5	have	have	VBP
cord-303322-d69o3z8d	68	6	colonised	colonise	VBN
cord-303322-d69o3z8d	68	7	nasopharynx	nasopharynx	NN
cord-303322-d69o3z8d	68	8	very	very	RB
cord-303322-d69o3z8d	68	9	early	early	RB
cord-303322-d69o3z8d	68	10	in	in	IN
cord-303322-d69o3z8d	68	11	life	life	NN
cord-303322-d69o3z8d	68	12	(	(	-LRB-
cord-303322-d69o3z8d	68	13	as	as	RB
cord-303322-d69o3z8d	68	14	early	early	RB
cord-303322-d69o3z8d	68	15	as	as	IN
cord-303322-d69o3z8d	68	16	aged	aged	JJ
cord-303322-d69o3z8d	68	17	2-weeks	2-weeks	CD
cord-303322-d69o3z8d	68	18	)	)	-RRB-
cord-303322-d69o3z8d	68	19	,	,	,
cord-303322-d69o3z8d	68	20	but	but	CC
cord-303322-d69o3z8d	68	21	the	the	DT
cord-303322-d69o3z8d	68	22	colonisation	colonisation	NN
cord-303322-d69o3z8d	68	23	is	be	VBZ
cord-303322-d69o3z8d	68	24	also	also	RB
cord-303322-d69o3z8d	68	25	dense	dense	JJ
cord-303322-d69o3z8d	68	26	with	with	IN
cord-303322-d69o3z8d	68	27	common	common	JJ
cord-303322-d69o3z8d	68	28	respiratory	respiratory	JJ
cord-303322-d69o3z8d	68	29	bacterial	bacterial	JJ
cord-303322-d69o3z8d	68	30	pathogens	pathogen	NNS
cord-303322-d69o3z8d	68	31	,	,	,
cord-303322-d69o3z8d	68	32	notably	notably	RB
cord-303322-d69o3z8d	68	33	Streptococcus	streptococcus	NN
cord-303322-d69o3z8d	68	34	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	68	35	,	,	,
cord-303322-d69o3z8d	68	36	Haemophilus	Haemophilus	NNP
cord-303322-d69o3z8d	68	37	infleunzae	infleunzae	NN
cord-303322-d69o3z8d	68	38	and	and	CC
cord-303322-d69o3z8d	68	39	Moraxella	Moraxella	NNP
cord-303322-d69o3z8d	68	40	catarrhalis	catarrhalis	NNP
cord-303322-d69o3z8d	68	41	[	[	-LRB-
cord-303322-d69o3z8d	68	42	24	24	CD
cord-303322-d69o3z8d	68	43	]	]	-RRB-
cord-303322-d69o3z8d	68	44	.	.	.
cord-303322-d69o3z8d	69	1	Repeated	repeat	VBN
cord-303322-d69o3z8d	69	2	micro	micro	NN
cord-303322-d69o3z8d	69	3	-	-	NN
cord-303322-d69o3z8d	69	4	aspiration	aspiration	NN
cord-303322-d69o3z8d	69	5	of	of	IN
cord-303322-d69o3z8d	69	6	nasopharyngeal	nasopharyngeal	JJ
cord-303322-d69o3z8d	69	7	secretions	secretion	NNS
cord-303322-d69o3z8d	69	8	heavily	heavily	RB
cord-303322-d69o3z8d	69	9	laden	laden	JJ
cord-303322-d69o3z8d	69	10	with	with	IN
cord-303322-d69o3z8d	69	11	pathogenic	pathogenic	JJ
cord-303322-d69o3z8d	69	12	bacteria	bacteria	NNS
cord-303322-d69o3z8d	69	13	during	during	IN
cord-303322-d69o3z8d	69	14	ALRI	ALRI	NNP
cord-303322-d69o3z8d	69	15	may	may	MD
cord-303322-d69o3z8d	69	16	overwhelm	overwhelm	VB
cord-303322-d69o3z8d	69	17	already	already	RB
cord-303322-d69o3z8d	69	18	compromised	compromise	VBN
cord-303322-d69o3z8d	69	19	pulmonary	pulmonary	JJ
cord-303322-d69o3z8d	69	20	defences	defence	NNS
cord-303322-d69o3z8d	69	21	,	,	,
cord-303322-d69o3z8d	69	22	increasing	increase	VBG
cord-303322-d69o3z8d	69	23	the	the	DT
cord-303322-d69o3z8d	69	24	risk	risk	NN
cord-303322-d69o3z8d	69	25	of	of	IN
cord-303322-d69o3z8d	69	26	a	a	DT
cord-303322-d69o3z8d	69	27	secondary	secondary	JJ
cord-303322-d69o3z8d	69	28	pneumonia	pneumonia	NN
cord-303322-d69o3z8d	69	29	or	or	CC
cord-303322-d69o3z8d	69	30	other	other	JJ
cord-303322-d69o3z8d	69	31	lower	low	JJR
cord-303322-d69o3z8d	69	32	airway	airway	NN
cord-303322-d69o3z8d	69	33	infection	infection	NN
cord-303322-d69o3z8d	69	34	.	.	.
cord-303322-d69o3z8d	70	1	Indeed	indeed	RB
cord-303322-d69o3z8d	70	2	,	,	,
cord-303322-d69o3z8d	70	3	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	70	4	infants	infant	NNS
cord-303322-d69o3z8d	70	5	are	be	VBP
cord-303322-d69o3z8d	70	6	more	more	RBR
cord-303322-d69o3z8d	70	7	likely	likely	JJ
cord-303322-d69o3z8d	70	8	to	to	TO
cord-303322-d69o3z8d	70	9	receive	receive	VB
cord-303322-d69o3z8d	70	10	antibiotics	antibiotic	NNS
cord-303322-d69o3z8d	70	11	for	for	IN
cord-303322-d69o3z8d	70	12	an	an	DT
cord-303322-d69o3z8d	70	13	episode	episode	NN
cord-303322-d69o3z8d	70	14	of	of	IN
cord-303322-d69o3z8d	70	15	pneumonia	pneumonia	NN
cord-303322-d69o3z8d	70	16	diagnosed	diagnose	VBN
cord-303322-d69o3z8d	70	17	during	during	IN
cord-303322-d69o3z8d	70	18	an	an	DT
cord-303322-d69o3z8d	70	19	admission	admission	NN
cord-303322-d69o3z8d	70	20	for	for	IN
cord-303322-d69o3z8d	70	21	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	70	22	than	than	IN
cord-303322-d69o3z8d	70	23	non	non	JJ
cord-303322-d69o3z8d	70	24	-	-	JJ
cord-303322-d69o3z8d	70	25	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	70	26	infants	infant	NNS
cord-303322-d69o3z8d	70	27	nursed	nurse	VBN
cord-303322-d69o3z8d	70	28	in	in	IN
cord-303322-d69o3z8d	70	29	the	the	DT
cord-303322-d69o3z8d	70	30	same	same	JJ
cord-303322-d69o3z8d	70	31	paediatric	paediatric	JJ
cord-303322-d69o3z8d	70	32	unit	unit	NN
cord-303322-d69o3z8d	70	33	[	[	-LRB-
cord-303322-d69o3z8d	70	34	6	6	CD
cord-303322-d69o3z8d	70	35	]	]	-RRB-
cord-303322-d69o3z8d	70	36	.	.	.
cord-303322-d69o3z8d	71	1	Macrolides	macrolide	NNS
cord-303322-d69o3z8d	71	2	are	be	VBP
cord-303322-d69o3z8d	71	3	a	a	DT
cord-303322-d69o3z8d	71	4	class	class	NN
cord-303322-d69o3z8d	71	5	of	of	IN
cord-303322-d69o3z8d	71	6	antibiotics	antibiotic	NNS
cord-303322-d69o3z8d	71	7	containing	contain	VBG
cord-303322-d69o3z8d	71	8	a	a	DT
cord-303322-d69o3z8d	71	9	macrocyclic	macrocyclic	JJ
cord-303322-d69o3z8d	71	10	lactone	lactone	NN
cord-303322-d69o3z8d	71	11	ring	ring	NN
cord-303322-d69o3z8d	71	12	with	with	IN
cord-303322-d69o3z8d	71	13	excellent	excellent	JJ
cord-303322-d69o3z8d	71	14	tissue	tissue	NN
cord-303322-d69o3z8d	71	15	penetration	penetration	NN
cord-303322-d69o3z8d	71	16	and	and	CC
cord-303322-d69o3z8d	71	17	antimicrobial	antimicrobial	JJ
cord-303322-d69o3z8d	71	18	activity	activity	NN
cord-303322-d69o3z8d	71	19	against	against	IN
cord-303322-d69o3z8d	71	20	a	a	DT
cord-303322-d69o3z8d	71	21	broad	broad	JJ
cord-303322-d69o3z8d	71	22	range	range	NN
cord-303322-d69o3z8d	71	23	of	of	IN
cord-303322-d69o3z8d	71	24	gram	gram	NN
cord-303322-d69o3z8d	71	25	positive	positive	JJ
cord-303322-d69o3z8d	71	26	and	and	CC
cord-303322-d69o3z8d	71	27	gram	gram	JJ
cord-303322-d69o3z8d	71	28	negative	negative	JJ
cord-303322-d69o3z8d	71	29	bacteria	bacteria	NNS
cord-303322-d69o3z8d	71	30	,	,	,
cord-303322-d69o3z8d	71	31	including	include	VBG
cord-303322-d69o3z8d	71	32	intracellular	intracellular	JJ
cord-303322-d69o3z8d	71	33	pathogens	pathogen	NNS
cord-303322-d69o3z8d	71	34	such	such	JJ
cord-303322-d69o3z8d	71	35	as	as	IN
cord-303322-d69o3z8d	71	36	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	71	37	.	.	.
cord-303322-d69o3z8d	72	1	Those	those	DT
cord-303322-d69o3z8d	72	2	with	with	IN
cord-303322-d69o3z8d	72	3	a	a	DT
cord-303322-d69o3z8d	72	4	14-or	14-or	CD
cord-303322-d69o3z8d	72	5	15-membered	15-membered	CD
cord-303322-d69o3z8d	72	6	lactone	lactone	NN
cord-303322-d69o3z8d	72	7	ring	ring	NN
cord-303322-d69o3z8d	72	8	also	also	RB
cord-303322-d69o3z8d	72	9	have	have	VBP
cord-303322-d69o3z8d	72	10	several	several	JJ
cord-303322-d69o3z8d	72	11	non	non	JJ
cord-303322-d69o3z8d	72	12	-	-	JJ
cord-303322-d69o3z8d	72	13	antimicrobial	antimicrobial	JJ
cord-303322-d69o3z8d	72	14	properties	property	NNS
cord-303322-d69o3z8d	72	15	that	that	WDT
cord-303322-d69o3z8d	72	16	have	have	VBP
cord-303322-d69o3z8d	72	17	been	be	VBN
cord-303322-d69o3z8d	72	18	studied	study	VBN
cord-303322-d69o3z8d	72	19	extensively	extensively	RB
cord-303322-d69o3z8d	72	20	in	in	IN
cord-303322-d69o3z8d	72	21	-	-	HYPH
cord-303322-d69o3z8d	72	22	vitro	vitro	FW
cord-303322-d69o3z8d	72	23	and	and	CC
cord-303322-d69o3z8d	72	24	in	in	IN
cord-303322-d69o3z8d	72	25	experimental	experimental	JJ
cord-303322-d69o3z8d	72	26	models	model	NNS
cord-303322-d69o3z8d	72	27	and	and	CC
cord-303322-d69o3z8d	72	28	,	,	,
cord-303322-d69o3z8d	72	29	to	to	IN
cord-303322-d69o3z8d	72	30	a	a	DT
cord-303322-d69o3z8d	72	31	lesser	less	JJR
cord-303322-d69o3z8d	72	32	extent	extent	NN
cord-303322-d69o3z8d	72	33	,	,	,
cord-303322-d69o3z8d	72	34	in	in	IN
cord-303322-d69o3z8d	72	35	humans	human	NNS
cord-303322-d69o3z8d	72	36	[	[	-LRB-
cord-303322-d69o3z8d	72	37	25	25	CD
cord-303322-d69o3z8d	72	38	]	]	-RRB-
cord-303322-d69o3z8d	72	39	.	.	.
cord-303322-d69o3z8d	73	1	One	one	CD
cord-303322-d69o3z8d	73	2	of	of	IN
cord-303322-d69o3z8d	73	3	these	these	DT
cord-303322-d69o3z8d	73	4	effects	effect	NNS
cord-303322-d69o3z8d	73	5	is	be	VBZ
cord-303322-d69o3z8d	73	6	modulation	modulation	NN
cord-303322-d69o3z8d	73	7	of	of	IN
cord-303322-d69o3z8d	73	8	the	the	DT
cord-303322-d69o3z8d	73	9	immune	immune	JJ
cord-303322-d69o3z8d	73	10	response	response	NN
cord-303322-d69o3z8d	73	11	.	.	.
cord-303322-d69o3z8d	74	1	The	the	DT
cord-303322-d69o3z8d	74	2	immune	immune	JJ
cord-303322-d69o3z8d	74	3	modulating	modulate	VBG
cord-303322-d69o3z8d	74	4	properties	property	NNS
cord-303322-d69o3z8d	74	5	of	of	IN
cord-303322-d69o3z8d	74	6	macrolides	macrolide	NNS
cord-303322-d69o3z8d	74	7	make	make	VBP
cord-303322-d69o3z8d	74	8	them	-PRON-	PRP
cord-303322-d69o3z8d	74	9	attractive	attractive	JJ
cord-303322-d69o3z8d	74	10	candidates	candidate	NNS
cord-303322-d69o3z8d	74	11	for	for	IN
cord-303322-d69o3z8d	74	12	treating	treat	VBG
cord-303322-d69o3z8d	74	13	inflammatory	inflammatory	JJ
cord-303322-d69o3z8d	74	14	airways	airway	NNS
cord-303322-d69o3z8d	74	15	diseases	disease	NNS
cord-303322-d69o3z8d	74	16	.	.	.
cord-303322-d69o3z8d	75	1	The	the	DT
cord-303322-d69o3z8d	75	2	two	two	CD
cord-303322-d69o3z8d	75	3	published	publish	VBN
cord-303322-d69o3z8d	75	4	[	[	-LRB-
cord-303322-d69o3z8d	75	5	26	26	CD
cord-303322-d69o3z8d	75	6	,	,	,
cord-303322-d69o3z8d	75	7	27	27	CD
cord-303322-d69o3z8d	75	8	]	]	-RRB-
cord-303322-d69o3z8d	75	9	placebo	placebo	NN
cord-303322-d69o3z8d	75	10	-	-	HYPH
cord-303322-d69o3z8d	75	11	controlled	control	VBN
cord-303322-d69o3z8d	75	12	RCTs	rct	NNS
cord-303322-d69o3z8d	75	13	on	on	IN
cord-303322-d69o3z8d	75	14	macrolides	macrolide	NNS
cord-303322-d69o3z8d	75	15	for	for	IN
cord-303322-d69o3z8d	75	16	RSV	RSV	NNP
cord-303322-d69o3z8d	75	17	-	-	HYPH
cord-303322-d69o3z8d	75	18	bronchiolitis	bronchiolitis	NNP
cord-303322-d69o3z8d	75	19	reported	report	VBD
cord-303322-d69o3z8d	75	20	contradictory	contradictory	JJ
cord-303322-d69o3z8d	75	21	results	result	NNS
cord-303322-d69o3z8d	75	22	.	.	.
cord-303322-d69o3z8d	76	1	In	in	IN
cord-303322-d69o3z8d	76	2	a	a	DT
cord-303322-d69o3z8d	76	3	small	small	JJ
cord-303322-d69o3z8d	76	4	Turkish	turkish	JJ
cord-303322-d69o3z8d	76	5	study	study	NN
cord-303322-d69o3z8d	76	6	of	of	IN
cord-303322-d69o3z8d	76	7	21	21	CD
cord-303322-d69o3z8d	76	8	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	76	9	infants	infant	NNS
cord-303322-d69o3z8d	76	10	with	with	IN
cord-303322-d69o3z8d	76	11	moderate	moderate	JJ
cord-303322-d69o3z8d	76	12	to	to	IN
cord-303322-d69o3z8d	76	13	severe	severe	JJ
cord-303322-d69o3z8d	76	14	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	76	15	,	,	,
cord-303322-d69o3z8d	76	16	3-weeks	3-weeks	CD
cord-303322-d69o3z8d	76	17	of	of	IN
cord-303322-d69o3z8d	76	18	daily	daily	JJ
cord-303322-d69o3z8d	76	19	clarithromycin	clarithromycin	NNP
cord-303322-d69o3z8d	76	20	significantly	significantly	RB
cord-303322-d69o3z8d	76	21	reduced	reduce	VBD
cord-303322-d69o3z8d	76	22	severity	severity	NN
cord-303322-d69o3z8d	76	23	of	of	IN
cord-303322-d69o3z8d	76	24	illness	illness	NN
cord-303322-d69o3z8d	76	25	(	(	-LRB-
cord-303322-d69o3z8d	76	26	oxygen	oxygen	NN
cord-303322-d69o3z8d	76	27	use	use	NN
cord-303322-d69o3z8d	76	28	,	,	,
cord-303322-d69o3z8d	76	29	hospital	hospital	NN
cord-303322-d69o3z8d	76	30	stay	stay	NN
cord-303322-d69o3z8d	76	31	)	)	-RRB-
cord-303322-d69o3z8d	76	32	and	and	CC
cord-303322-d69o3z8d	76	33	risk	risk	NN
cord-303322-d69o3z8d	76	34	of	of	IN
cord-303322-d69o3z8d	76	35	hospital	hospital	NN
cord-303322-d69o3z8d	76	36	readmission	readmission	NN
cord-303322-d69o3z8d	76	37	for	for	IN
cord-303322-d69o3z8d	76	38	respiratory	respiratory	JJ
cord-303322-d69o3z8d	76	39	illness	illness	NN
cord-303322-d69o3z8d	76	40	during	during	IN
cord-303322-d69o3z8d	76	41	the	the	DT
cord-303322-d69o3z8d	76	42	next	next	JJ
cord-303322-d69o3z8d	76	43	6	6	CD
cord-303322-d69o3z8d	76	44	months	month	NNS
cord-303322-d69o3z8d	76	45	[	[	-LRB-
cord-303322-d69o3z8d	76	46	26	26	CD
cord-303322-d69o3z8d	76	47	]	]	-RRB-
cord-303322-d69o3z8d	76	48	.	.	.
cord-303322-d69o3z8d	77	1	However	however	RB
cord-303322-d69o3z8d	77	2	in	in	IN
cord-303322-d69o3z8d	77	3	another	another	DT
cord-303322-d69o3z8d	77	4	larger	large	JJR
cord-303322-d69o3z8d	77	5	study	study	NN
cord-303322-d69o3z8d	77	6	involving	involve	VBG
cord-303322-d69o3z8d	77	7	71	71	CD
cord-303322-d69o3z8d	77	8	infants	infant	NNS
cord-303322-d69o3z8d	77	9	from	from	IN
cord-303322-d69o3z8d	77	10	the	the	DT
cord-303322-d69o3z8d	77	11	Netherlands	Netherlands	NNP
cord-303322-d69o3z8d	77	12	,	,	,
cord-303322-d69o3z8d	77	13	3-days	3-days	CD
cord-303322-d69o3z8d	77	14	of	of	IN
cord-303322-d69o3z8d	77	15	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	77	16	was	be	VBD
cord-303322-d69o3z8d	77	17	not	not	RB
cord-303322-d69o3z8d	77	18	efficacious	efficacious	JJ
cord-303322-d69o3z8d	77	19	in	in	IN
cord-303322-d69o3z8d	77	20	infants	infant	NNS
cord-303322-d69o3z8d	77	21	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	77	22	with	with	IN
cord-303322-d69o3z8d	77	23	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	77	24	[	[	-LRB-
cord-303322-d69o3z8d	77	25	27	27	CD
cord-303322-d69o3z8d	77	26	]	]	-RRB-
cord-303322-d69o3z8d	77	27	.	.	.
cord-303322-d69o3z8d	78	1	The	the	DT
cord-303322-d69o3z8d	78	2	difference	difference	NN
cord-303322-d69o3z8d	78	3	in	in	IN
cord-303322-d69o3z8d	78	4	outcomes	outcome	NNS
cord-303322-d69o3z8d	78	5	seen	see	VBN
cord-303322-d69o3z8d	78	6	in	in	IN
cord-303322-d69o3z8d	78	7	the	the	DT
cord-303322-d69o3z8d	78	8	two	two	CD
cord-303322-d69o3z8d	78	9	trials	trial	NNS
cord-303322-d69o3z8d	78	10	may	may	MD
cord-303322-d69o3z8d	78	11	be	be	VB
cord-303322-d69o3z8d	78	12	related	relate	VBN
cord-303322-d69o3z8d	78	13	to	to	IN
cord-303322-d69o3z8d	78	14	the	the	DT
cord-303322-d69o3z8d	78	15	dose	dose	NN
cord-303322-d69o3z8d	78	16	or	or	CC
cord-303322-d69o3z8d	78	17	length	length	NN
cord-303322-d69o3z8d	78	18	of	of	IN
cord-303322-d69o3z8d	78	19	treatment	treatment	NN
cord-303322-d69o3z8d	78	20	,	,	,
cord-303322-d69o3z8d	78	21	chance	chance	NN
cord-303322-d69o3z8d	78	22	,	,	,
cord-303322-d69o3z8d	78	23	or	or	CC
cord-303322-d69o3z8d	78	24	heterogeneity	heterogeneity	NN
cord-303322-d69o3z8d	78	25	of	of	IN
cord-303322-d69o3z8d	78	26	the	the	DT
cord-303322-d69o3z8d	78	27	study	study	NN
cord-303322-d69o3z8d	78	28	populations	population	NNS
cord-303322-d69o3z8d	78	29	.	.	.
cord-303322-d69o3z8d	79	1	Infants	infant	NNS
cord-303322-d69o3z8d	79	2	in	in	IN
cord-303322-d69o3z8d	79	3	Turkey	Turkey	NNP
cord-303322-d69o3z8d	79	4	are	be	VBP
cord-303322-d69o3z8d	79	5	more	more	RBR
cord-303322-d69o3z8d	79	6	likely	likely	JJ
cord-303322-d69o3z8d	79	7	to	to	TO
cord-303322-d69o3z8d	79	8	have	have	VB
cord-303322-d69o3z8d	79	9	concomitant	concomitant	JJ
cord-303322-d69o3z8d	79	10	bacterial	bacterial	JJ
cord-303322-d69o3z8d	79	11	infection	infection	NN
cord-303322-d69o3z8d	79	12	compared	compare	VBN
cord-303322-d69o3z8d	79	13	to	to	IN
cord-303322-d69o3z8d	79	14	an	an	DT
cord-303322-d69o3z8d	79	15	affluent	affluent	JJ
cord-303322-d69o3z8d	79	16	European	european	JJ
cord-303322-d69o3z8d	79	17	group	group	NN
cord-303322-d69o3z8d	79	18	and	and	CC
cord-303322-d69o3z8d	79	19	moreover	moreover	RB
cord-303322-d69o3z8d	79	20	in	in	IN
cord-303322-d69o3z8d	79	21	Turkey	Turkey	NNP
cord-303322-d69o3z8d	79	22	,	,	,
cord-303322-d69o3z8d	79	23	post	post	JJ
cord-303322-d69o3z8d	79	24	-	-	JJ
cord-303322-d69o3z8d	79	25	infectious	infectious	JJ
cord-303322-d69o3z8d	79	26	childhood	childhood	NN
cord-303322-d69o3z8d	79	27	bronchiectasis	bronchiectasis	NN
cord-303322-d69o3z8d	79	28	remains	remain	VBZ
cord-303322-d69o3z8d	79	29	an	an	DT
cord-303322-d69o3z8d	79	30	important	important	JJ
cord-303322-d69o3z8d	79	31	health	health	NN
cord-303322-d69o3z8d	79	32	problem	problem	NN
cord-303322-d69o3z8d	79	33	[	[	-LRB-
cord-303322-d69o3z8d	79	34	28	28	CD
cord-303322-d69o3z8d	79	35	]	]	-RRB-
cord-303322-d69o3z8d	79	36	.	.	.
cord-303322-d69o3z8d	80	1	The	the	DT
cord-303322-d69o3z8d	80	2	populations	population	NNS
cord-303322-d69o3z8d	80	3	also	also	RB
cord-303322-d69o3z8d	80	4	differed	differ	VBD
cord-303322-d69o3z8d	80	5	in	in	IN
cord-303322-d69o3z8d	80	6	age	age	NN
cord-303322-d69o3z8d	80	7	.	.	.
cord-303322-d69o3z8d	81	1	The	the	DT
cord-303322-d69o3z8d	81	2	European	european	JJ
cord-303322-d69o3z8d	81	3	study	study	NN
cord-303322-d69o3z8d	81	4	included	include	VBD
cord-303322-d69o3z8d	81	5	infants	infant	NNS
cord-303322-d69o3z8d	81	6	up	up	RP
cord-303322-d69o3z8d	81	7	to	to	IN
cord-303322-d69o3z8d	81	8	24-months	24-months	CD
cord-303322-d69o3z8d	81	9	of	of	IN
cord-303322-d69o3z8d	81	10	age	age	NN
cord-303322-d69o3z8d	81	11	,	,	,
cord-303322-d69o3z8d	81	12	whereas	whereas	IN
cord-303322-d69o3z8d	81	13	the	the	DT
cord-303322-d69o3z8d	81	14	Turkish	turkish	JJ
cord-303322-d69o3z8d	81	15	study	study	NN
cord-303322-d69o3z8d	81	16	involved	involve	VBN
cord-303322-d69o3z8d	81	17	only	only	RB
cord-303322-d69o3z8d	81	18	infants	infant	NNS
cord-303322-d69o3z8d	81	19	aged	age	VBN
cord-303322-d69o3z8d	81	20	<	<	XX
cord-303322-d69o3z8d	81	21	7-months	7-months	CD
cord-303322-d69o3z8d	81	22	[	[	-LRB-
cord-303322-d69o3z8d	81	23	26	26	CD
cord-303322-d69o3z8d	81	24	,	,	,
cord-303322-d69o3z8d	81	25	27	27	CD
cord-303322-d69o3z8d	81	26	]	]	-RRB-
cord-303322-d69o3z8d	81	27	.	.	.
cord-303322-d69o3z8d	82	1	Clearly	clearly	RB
cord-303322-d69o3z8d	82	2	,	,	,
cord-303322-d69o3z8d	82	3	a	a	DT
cord-303322-d69o3z8d	82	4	well	well	RB
cord-303322-d69o3z8d	82	5	designed	design	VBN
cord-303322-d69o3z8d	82	6	RCT	RCT	NNP
cord-303322-d69o3z8d	82	7	on	on	IN
cord-303322-d69o3z8d	82	8	the	the	DT
cord-303322-d69o3z8d	82	9	efficacy	efficacy	NN
cord-303322-d69o3z8d	82	10	of	of	IN
cord-303322-d69o3z8d	82	11	macrolides	macrolide	NNS
cord-303322-d69o3z8d	82	12	to	to	TO
cord-303322-d69o3z8d	82	13	reduce	reduce	VB
cord-303322-d69o3z8d	82	14	the	the	DT
cord-303322-d69o3z8d	82	15	burden	burden	NN
cord-303322-d69o3z8d	82	16	of	of	IN
cord-303322-d69o3z8d	82	17	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	82	18	in	in	IN
cord-303322-d69o3z8d	82	19	a	a	DT
cord-303322-d69o3z8d	82	20	population	population	NN
cord-303322-d69o3z8d	82	21	at	at	IN
cord-303322-d69o3z8d	82	22	high	high	JJ
cord-303322-d69o3z8d	82	23	risk	risk	NN
cord-303322-d69o3z8d	82	24	of	of	IN
cord-303322-d69o3z8d	82	25	acute	acute	JJ
cord-303322-d69o3z8d	82	26	and	and	CC
cord-303322-d69o3z8d	82	27	chronic	chronic	JJ
cord-303322-d69o3z8d	82	28	respiratory	respiratory	JJ
cord-303322-d69o3z8d	82	29	disease	disease	NN
cord-303322-d69o3z8d	82	30	would	would	MD
cord-303322-d69o3z8d	82	31	be	be	VB
cord-303322-d69o3z8d	82	32	beneficial	beneficial	JJ
cord-303322-d69o3z8d	82	33	.	.	.
cord-303322-d69o3z8d	83	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	83	2	primary	primary	JJ
cord-303322-d69o3z8d	83	3	research	research	NN
cord-303322-d69o3z8d	83	4	question	question	NN
cord-303322-d69o3z8d	83	5	is	be	VBZ
cord-303322-d69o3z8d	83	6	:	:	:
cord-303322-d69o3z8d	84	1	Amongst	amongst	IN
cord-303322-d69o3z8d	84	2	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	84	3	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	84	4	infants	infant	NNS
cord-303322-d69o3z8d	84	5	with	with	IN
cord-303322-d69o3z8d	84	6	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	84	7	,	,	,
cord-303322-d69o3z8d	84	8	does	do	VBZ
cord-303322-d69o3z8d	84	9	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	84	10	(	(	-LRB-
cord-303322-d69o3z8d	84	11	compared	compare	VBN
cord-303322-d69o3z8d	84	12	to	to	IN
cord-303322-d69o3z8d	84	13	placebo	placebo	NN
cord-303322-d69o3z8d	84	14	)	)	-RRB-
cord-303322-d69o3z8d	84	15	improve	improve	VB
cord-303322-d69o3z8d	84	16	clinical	clinical	JJ
cord-303322-d69o3z8d	84	17	outcomes	outcome	NNS
cord-303322-d69o3z8d	84	18	(	(	-LRB-
cord-303322-d69o3z8d	84	19	length	length	NN
cord-303322-d69o3z8d	84	20	of	of	IN
cord-303322-d69o3z8d	84	21	stay	stay	NN
cord-303322-d69o3z8d	84	22	in	in	IN
cord-303322-d69o3z8d	84	23	hospital	hospital	NN
cord-303322-d69o3z8d	84	24	and	and	CC
cord-303322-d69o3z8d	84	25	duration	duration	NN
cord-303322-d69o3z8d	84	26	of	of	IN
cord-303322-d69o3z8d	84	27	oxygen	oxygen	NN
cord-303322-d69o3z8d	84	28	supplementation	supplementation	NN
cord-303322-d69o3z8d	84	29	)	)	-RRB-
cord-303322-d69o3z8d	84	30	?	?	.
cord-303322-d69o3z8d	85	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	85	2	primary	primary	JJ
cord-303322-d69o3z8d	85	3	hypothesis	hypothesis	NN
cord-303322-d69o3z8d	85	4	is	be	VBZ
cord-303322-d69o3z8d	85	5	that	that	DT
cord-303322-d69o3z8d	85	6	:	:	:
cord-303322-d69o3z8d	85	7	The	the	DT
cord-303322-d69o3z8d	85	8	anti	anti	JJ
cord-303322-d69o3z8d	85	9	-	-	JJ
cord-303322-d69o3z8d	85	10	microbial	microbial	JJ
cord-303322-d69o3z8d	85	11	and	and	CC
cord-303322-d69o3z8d	85	12	anti	anti	JJ
cord-303322-d69o3z8d	85	13	-	-	JJ
cord-303322-d69o3z8d	85	14	inflammatory	inflammatory	JJ
cord-303322-d69o3z8d	85	15	properties	property	NNS
cord-303322-d69o3z8d	85	16	of	of	IN
cord-303322-d69o3z8d	85	17	the	the	DT
cord-303322-d69o3z8d	85	18	macrolide	macrolide	NN
cord-303322-d69o3z8d	85	19	,	,	,
cord-303322-d69o3z8d	85	20	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	85	21	,	,	,
cord-303322-d69o3z8d	85	22	will	will	MD
cord-303322-d69o3z8d	85	23	improve	improve	VB
cord-303322-d69o3z8d	85	24	the	the	DT
cord-303322-d69o3z8d	85	25	clinical	clinical	JJ
cord-303322-d69o3z8d	85	26	outcomes	outcome	NNS
cord-303322-d69o3z8d	85	27	of	of	IN
cord-303322-d69o3z8d	85	28	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	85	29	infants	infant	NNS
cord-303322-d69o3z8d	85	30	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	85	31	with	with	IN
cord-303322-d69o3z8d	85	32	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	85	33	.	.	.
cord-303322-d69o3z8d	86	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	86	2	secondary	secondary	JJ
cord-303322-d69o3z8d	86	3	aims	aim	NNS
cord-303322-d69o3z8d	86	4	are	be	VBP
cord-303322-d69o3z8d	86	5	:	:	:
cord-303322-d69o3z8d	86	6	2	2	CD
cord-303322-d69o3z8d	86	7	.	.	.
cord-303322-d69o3z8d	87	1	To	to	TO
cord-303322-d69o3z8d	87	2	determine	determine	VB
cord-303322-d69o3z8d	87	3	the	the	DT
cord-303322-d69o3z8d	87	4	effect	effect	NN
cord-303322-d69o3z8d	87	5	of	of	IN
cord-303322-d69o3z8d	87	6	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	87	7	on	on	IN
cord-303322-d69o3z8d	87	8	readmissions	readmission	NNS
cord-303322-d69o3z8d	87	9	into	into	IN
cord-303322-d69o3z8d	87	10	hospital	hospital	NN
cord-303322-d69o3z8d	87	11	within	within	IN
cord-303322-d69o3z8d	87	12	6	6	CD
cord-303322-d69o3z8d	87	13	months	month	NNS
cord-303322-d69o3z8d	87	14	of	of	IN
cord-303322-d69o3z8d	87	15	treatment	treatment	NN
cord-303322-d69o3z8d	87	16	;	;	:
cord-303322-d69o3z8d	87	17	3	3	CD
cord-303322-d69o3z8d	87	18	.	.	.
cord-303322-d69o3z8d	88	1	To	to	TO
cord-303322-d69o3z8d	88	2	assess	assess	VB
cord-303322-d69o3z8d	88	3	the	the	DT
cord-303322-d69o3z8d	88	4	short	short	JJ
cord-303322-d69o3z8d	88	5	-	-	HYPH
cord-303322-d69o3z8d	88	6	term	term	NN
cord-303322-d69o3z8d	88	7	impact	impact	NN
cord-303322-d69o3z8d	88	8	of	of	IN
cord-303322-d69o3z8d	88	9	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	88	10	on	on	IN
cord-303322-d69o3z8d	88	11	macrolide	macrolide	JJ
cord-303322-d69o3z8d	88	12	resistance	resistance	NN
cord-303322-d69o3z8d	88	13	patterns	pattern	NNS
cord-303322-d69o3z8d	88	14	of	of	IN
cord-303322-d69o3z8d	88	15	respiratory	respiratory	JJ
cord-303322-d69o3z8d	88	16	bacterial	bacterial	JJ
cord-303322-d69o3z8d	88	17	pathogens	pathogen	NNS
cord-303322-d69o3z8d	88	18	in	in	IN
cord-303322-d69o3z8d	88	19	the	the	DT
cord-303322-d69o3z8d	88	20	nasopharynx	nasopharynx	NN
cord-303322-d69o3z8d	88	21	;	;	:
cord-303322-d69o3z8d	88	22	and	and	CC
cord-303322-d69o3z8d	88	23	4	4	CD
cord-303322-d69o3z8d	88	24	.	.	.
cord-303322-d69o3z8d	89	1	To	to	TO
cord-303322-d69o3z8d	89	2	describe	describe	VB
cord-303322-d69o3z8d	89	3	the	the	DT
cord-303322-d69o3z8d	89	4	point	point	NN
cord-303322-d69o3z8d	89	5	prevalence	prevalence	NN
cord-303322-d69o3z8d	89	6	and	and	CC
cord-303322-d69o3z8d	89	7	diversity	diversity	NN
cord-303322-d69o3z8d	89	8	of	of	IN
cord-303322-d69o3z8d	89	9	respiratory	respiratory	JJ
cord-303322-d69o3z8d	89	10	viruses	virus	NNS
cord-303322-d69o3z8d	89	11	,	,	,
cord-303322-d69o3z8d	89	12	Mycoplasma	mycoplasma	NN
cord-303322-d69o3z8d	89	13	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	89	14	and	and	CC
cord-303322-d69o3z8d	89	15	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	89	16	species	specie	NNS
cord-303322-d69o3z8d	89	17	using	use	VBG
cord-303322-d69o3z8d	89	18	sensitive	sensitive	JJ
cord-303322-d69o3z8d	89	19	molecular	molecular	JJ
cord-303322-d69o3z8d	89	20	diagnostic	diagnostic	JJ
cord-303322-d69o3z8d	89	21	techniques	technique	NNS
cord-303322-d69o3z8d	89	22	.	.	.
cord-303322-d69o3z8d	90	1	We	-PRON-	PRP
cord-303322-d69o3z8d	90	2	are	be	VBP
cord-303322-d69o3z8d	90	3	conducting	conduct	VBG
cord-303322-d69o3z8d	90	4	a	a	DT
cord-303322-d69o3z8d	90	5	parallel	parallel	JJ
cord-303322-d69o3z8d	90	6	group	group	NN
cord-303322-d69o3z8d	90	7	,	,	,
cord-303322-d69o3z8d	90	8	double	double	JJ
cord-303322-d69o3z8d	90	9	-	-	HYPH
cord-303322-d69o3z8d	90	10	blind	blind	JJ
cord-303322-d69o3z8d	90	11	placebo	placebo	NN
cord-303322-d69o3z8d	90	12	RCT	RCT	NNP
cord-303322-d69o3z8d	90	13	(	(	-LRB-
cord-303322-d69o3z8d	90	14	with	with	IN
cord-303322-d69o3z8d	90	15	concealed	conceal	VBN
cord-303322-d69o3z8d	90	16	allocation	allocation	NN
cord-303322-d69o3z8d	90	17	)	)	-RRB-
cord-303322-d69o3z8d	90	18	to	to	TO
cord-303322-d69o3z8d	90	19	assess	assess	VB
cord-303322-d69o3z8d	90	20	the	the	DT
cord-303322-d69o3z8d	90	21	impact	impact	NN
cord-303322-d69o3z8d	90	22	of	of	IN
cord-303322-d69o3z8d	90	23	additional	additional	JJ
cord-303322-d69o3z8d	90	24	treatment	treatment	NN
cord-303322-d69o3z8d	90	25	with	with	IN
cord-303322-d69o3z8d	90	26	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	90	27	in	in	IN
cord-303322-d69o3z8d	90	28	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	90	29	infants	infant	NNS
cord-303322-d69o3z8d	90	30	admitted	admit	VBD
cord-303322-d69o3z8d	90	31	to	to	IN
cord-303322-d69o3z8d	90	32	two	two	CD
cord-303322-d69o3z8d	90	33	regional	regional	JJ
cord-303322-d69o3z8d	90	34	hospitals	hospital	NNS
cord-303322-d69o3z8d	90	35	(	(	-LRB-
cord-303322-d69o3z8d	90	36	Darwin	Darwin	NNP
cord-303322-d69o3z8d	90	37	,	,	,
cord-303322-d69o3z8d	90	38	Northern	Northern	NNP
cord-303322-d69o3z8d	90	39	Territory	Territory	NNP
cord-303322-d69o3z8d	90	40	and	and	CC
cord-303322-d69o3z8d	90	41	Townsville	Townsville	NNP
cord-303322-d69o3z8d	90	42	,	,	,
cord-303322-d69o3z8d	90	43	Queensland	Queensland	NNP
cord-303322-d69o3z8d	90	44	)	)	-RRB-
cord-303322-d69o3z8d	90	45	with	with	IN
cord-303322-d69o3z8d	90	46	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	90	47	.	.	.
cord-303322-d69o3z8d	91	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	91	2	study	study	NN
cord-303322-d69o3z8d	91	3	plan	plan	NN
cord-303322-d69o3z8d	91	4	is	be	VBZ
cord-303322-d69o3z8d	91	5	summarised	summarise	VBN
cord-303322-d69o3z8d	91	6	in	in	IN
cord-303322-d69o3z8d	91	7	Figure	Figure	NNP
cord-303322-d69o3z8d	91	8	1	1	CD
cord-303322-d69o3z8d	91	9	.	.	.
cord-303322-d69o3z8d	92	1	The	the	DT
cord-303322-d69o3z8d	92	2	inclusion	inclusion	NN
cord-303322-d69o3z8d	92	3	criteria	criterion	NNS
cord-303322-d69o3z8d	92	4	are	be	VBP
cord-303322-d69o3z8d	92	5	:	:	:
cord-303322-d69o3z8d	92	6	Baseline	baseline	JJ
cord-303322-d69o3z8d	92	7	data	datum	NNS
cord-303322-d69o3z8d	92	8	,	,	,
cord-303322-d69o3z8d	92	9	NPS-1	NPS-1	NNP
cord-303322-d69o3z8d	92	10	1	1	CD
cord-303322-d69o3z8d	92	11	.	.	.
cord-303322-d69o3z8d	93	1	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	93	2	infants	infant	NNS
cord-303322-d69o3z8d	93	3	(	(	-LRB-
cord-303322-d69o3z8d	93	4	aged	aged	JJ
cord-303322-d69o3z8d	93	5	≤	≤	NN
cord-303322-d69o3z8d	93	6	24-months	24-months	CD
cord-303322-d69o3z8d	93	7	)	)	-RRB-
cord-303322-d69o3z8d	93	8	admitted	admit	VBD
cord-303322-d69o3z8d	93	9	to	to	IN
cord-303322-d69o3z8d	93	10	one	one	CD
cord-303322-d69o3z8d	93	11	of	of	IN
cord-303322-d69o3z8d	93	12	our	-PRON-	PRP$
cord-303322-d69o3z8d	93	13	hospitals	hospital	NNS
cord-303322-d69o3z8d	93	14	(	(	-LRB-
cord-303322-d69o3z8d	93	15	Darwin	Darwin	NNP
cord-303322-d69o3z8d	93	16	and	and	CC
cord-303322-d69o3z8d	93	17	Townsville	Townsville	NNP
cord-303322-d69o3z8d	93	18	)	)	-RRB-
cord-303322-d69o3z8d	93	19	with	with	IN
cord-303322-d69o3z8d	93	20	a	a	DT
cord-303322-d69o3z8d	93	21	clinical	clinical	JJ
cord-303322-d69o3z8d	93	22	diagnosis	diagnosis	NN
cord-303322-d69o3z8d	93	23	of	of	IN
cord-303322-d69o3z8d	93	24	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	93	25	.	.	.
cord-303322-d69o3z8d	94	1	In	in	IN
cord-303322-d69o3z8d	94	2	the	the	DT
cord-303322-d69o3z8d	94	3	absence	absence	NN
cord-303322-d69o3z8d	94	4	of	of	IN
cord-303322-d69o3z8d	94	5	an	an	DT
cord-303322-d69o3z8d	94	6	international	international	JJ
cord-303322-d69o3z8d	94	7	standardised	standardised	JJ
cord-303322-d69o3z8d	94	8	diagnosis	diagnosis	NN
cord-303322-d69o3z8d	94	9	of	of	IN
cord-303322-d69o3z8d	94	10	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	94	11	,	,	,
cord-303322-d69o3z8d	94	12	[	[	-LRB-
cord-303322-d69o3z8d	94	13	29	29	CD
cord-303322-d69o3z8d	94	14	,	,	,
cord-303322-d69o3z8d	94	15	30	30	CD
cord-303322-d69o3z8d	94	16	]	]	-RRB-
cord-303322-d69o3z8d	94	17	the	the	DT
cord-303322-d69o3z8d	94	18	accepted	accept	VBN
cord-303322-d69o3z8d	94	19	Australian	australian	JJ
cord-303322-d69o3z8d	94	20	clinical	clinical	JJ
cord-303322-d69o3z8d	94	21	diagnosis	diagnosis	NN
cord-303322-d69o3z8d	94	22	is	be	VBZ
cord-303322-d69o3z8d	94	23	used	use	VBN
cord-303322-d69o3z8d	94	24	(	(	-LRB-
cord-303322-d69o3z8d	94	25	tachypnoea	tachypnoea	NNP
cord-303322-d69o3z8d	94	26	(	(	-LRB-
cord-303322-d69o3z8d	94	27	respiratory	respiratory	JJ
cord-303322-d69o3z8d	94	28	rate	rate	NN
cord-303322-d69o3z8d	94	29	≥60	≥60	NNP
cord-303322-d69o3z8d	94	30	/	/	SYM
cord-303322-d69o3z8d	94	31	min	min	NN
cord-303322-d69o3z8d	94	32	in	in	IN
cord-303322-d69o3z8d	94	33	infants	infant	NNS
cord-303322-d69o3z8d	94	34	aged	age	VBN
cord-303322-d69o3z8d	95	1	<	<	XX
cord-303322-d69o3z8d	95	2	2-months	2-months	CD
cord-303322-d69o3z8d	95	3	,	,	,
cord-303322-d69o3z8d	95	4	≥50	≥50	NNP
cord-303322-d69o3z8d	95	5	/	/	SYM
cord-303322-d69o3z8d	95	6	min	min	NNP
cord-303322-d69o3z8d	96	1	if	if	IN
cord-303322-d69o3z8d	96	2	2	2	CD
cord-303322-d69o3z8d	96	3	-	-	SYM
cord-303322-d69o3z8d	96	4	12	12	CD
cord-303322-d69o3z8d	96	5	months	month	NNS
cord-303322-d69o3z8d	96	6	,	,	,
cord-303322-d69o3z8d	96	7	and	and	CC
cord-303322-d69o3z8d	96	8	>	>	XX
cord-303322-d69o3z8d	96	9	40	40	CD
cord-303322-d69o3z8d	96	10	/	/	SYM
cord-303322-d69o3z8d	96	11	min	min	NN
cord-303322-d69o3z8d	96	12	if	if	IN
cord-303322-d69o3z8d	96	13	13	13	CD
cord-303322-d69o3z8d	96	14	-	-	SYM
cord-303322-d69o3z8d	96	15	24	24	CD
cord-303322-d69o3z8d	96	16	months	month	NNS
cord-303322-d69o3z8d	96	17	)	)	-RRB-
cord-303322-d69o3z8d	96	18	,	,	,
cord-303322-d69o3z8d	96	19	with	with	IN
cord-303322-d69o3z8d	96	20	wheeze	wheeze	NN
cord-303322-d69o3z8d	96	21	or	or	CC
cord-303322-d69o3z8d	96	22	crackles	crackle	NNS
cord-303322-d69o3z8d	96	23	)	)	-RRB-
cord-303322-d69o3z8d	96	24	;	;	:
cord-303322-d69o3z8d	96	25	[	[	-LRB-
cord-303322-d69o3z8d	96	26	31	31	CD
cord-303322-d69o3z8d	96	27	,	,	,
cord-303322-d69o3z8d	96	28	32	32	CD
cord-303322-d69o3z8d	96	29	]	]	-RRB-
cord-303322-d69o3z8d	96	30	and	and	CC
cord-303322-d69o3z8d	96	31	2	2	CD
cord-303322-d69o3z8d	96	32	.	.	.
cord-303322-d69o3z8d	97	1	Recruited	recruit	VBN
cord-303322-d69o3z8d	97	2	and	and	CC
cord-303322-d69o3z8d	97	3	consented	consent	VBN
cord-303322-d69o3z8d	97	4	within	within	IN
cord-303322-d69o3z8d	97	5	24-hours	24-hours	CD
cord-303322-d69o3z8d	97	6	of	of	IN
cord-303322-d69o3z8d	97	7	presentation	presentation	NN
cord-303322-d69o3z8d	97	8	to	to	IN
cord-303322-d69o3z8d	97	9	the	the	DT
cord-303322-d69o3z8d	97	10	hospital	hospital	NN
cord-303322-d69o3z8d	97	11	for	for	IN
cord-303322-d69o3z8d	97	12	the	the	DT
cord-303322-d69o3z8d	97	13	illness	illness	NN
cord-303322-d69o3z8d	97	14	.	.	.
cord-303322-d69o3z8d	98	1	Exclusion	exclusion	NN
cord-303322-d69o3z8d	98	2	criteria	criterion	NNS
cord-303322-d69o3z8d	98	3	:	:	:
cord-303322-d69o3z8d	98	4	admission	admission	NN
cord-303322-d69o3z8d	98	5	into	into	IN
cord-303322-d69o3z8d	98	6	intensive	intensive	JJ
cord-303322-d69o3z8d	98	7	care	care	NN
cord-303322-d69o3z8d	98	8	,	,	,
cord-303322-d69o3z8d	98	9	macrolide	macrolide	NN
cord-303322-d69o3z8d	98	10	therapy	therapy	NN
cord-303322-d69o3z8d	98	11	contraindicated	contraindicate	VBN
cord-303322-d69o3z8d	98	12	(	(	-LRB-
cord-303322-d69o3z8d	98	13	e.g.	e.g.	IN
cord-303322-d69o3z8d	98	14	liver	liver	NN
cord-303322-d69o3z8d	98	15	dysfunction	dysfunction	NN
cord-303322-d69o3z8d	98	16	,	,	,
cord-303322-d69o3z8d	98	17	hypersensitivity	hypersensitivity	NN
cord-303322-d69o3z8d	98	18	)	)	-RRB-
cord-303322-d69o3z8d	98	19	,	,	,
cord-303322-d69o3z8d	98	20	presence	presence	NN
cord-303322-d69o3z8d	98	21	of	of	IN
cord-303322-d69o3z8d	98	22	diarrhoea	diarrhoea	NN
cord-303322-d69o3z8d	98	23	(	(	-LRB-
cord-303322-d69o3z8d	98	24	stools	stool	NNS
cord-303322-d69o3z8d	98	25	of	of	IN
cord-303322-d69o3z8d	98	26	increased	increase	VBN
cord-303322-d69o3z8d	98	27	watery	watery	JJ
cord-303322-d69o3z8d	98	28	consistency	consistency	NN
cord-303322-d69o3z8d	98	29	and	and	CC
cord-303322-d69o3z8d	98	30	more	more	JJR
cord-303322-d69o3z8d	98	31	than	than	IN
cord-303322-d69o3z8d	98	32	two	two	CD
cord-303322-d69o3z8d	98	33	stools	stool	NNS
cord-303322-d69o3z8d	98	34	above	above	IN
cord-303322-d69o3z8d	98	35	usual	usual	JJ
cord-303322-d69o3z8d	98	36	stooling	stooling	NN
cord-303322-d69o3z8d	98	37	frequency	frequency	NN
cord-303322-d69o3z8d	98	38	)	)	-RRB-
cord-303322-d69o3z8d	98	39	,	,	,
cord-303322-d69o3z8d	98	40	received	receive	VBD
cord-303322-d69o3z8d	98	41	macrolides	macrolide	NNS
cord-303322-d69o3z8d	98	42	(	(	-LRB-
cord-303322-d69o3z8d	98	43	in	in	IN
cord-303322-d69o3z8d	98	44	last	last	JJ
cord-303322-d69o3z8d	98	45	7-days	7-days	CD
cord-303322-d69o3z8d	98	46	)	)	-RRB-
cord-303322-d69o3z8d	98	47	,	,	,
cord-303322-d69o3z8d	98	48	or	or	CC
cord-303322-d69o3z8d	98	49	clinical	clinical	JJ
cord-303322-d69o3z8d	98	50	and	and	CC
cord-303322-d69o3z8d	98	51	radiological	radiological	JJ
cord-303322-d69o3z8d	98	52	features	feature	NNS
cord-303322-d69o3z8d	98	53	consistent	consistent	JJ
cord-303322-d69o3z8d	98	54	with	with	IN
cord-303322-d69o3z8d	98	55	a	a	DT
cord-303322-d69o3z8d	98	56	primary	primary	JJ
cord-303322-d69o3z8d	98	57	diagnosis	diagnosis	NN
cord-303322-d69o3z8d	98	58	of	of	IN
cord-303322-d69o3z8d	98	59	pneumonia	pneumonia	NN
cord-303322-d69o3z8d	98	60	,	,	,
cord-303322-d69o3z8d	98	61	[	[	-LRB-
cord-303322-d69o3z8d	98	62	33	33	CD
cord-303322-d69o3z8d	98	63	]	]	-RRB-
cord-303322-d69o3z8d	98	64	at	at	IN
cord-303322-d69o3z8d	98	65	time	time	NN
cord-303322-d69o3z8d	98	66	of	of	IN
cord-303322-d69o3z8d	98	67	randomisation	randomisation	NN
cord-303322-d69o3z8d	98	68	.	.	.
cord-303322-d69o3z8d	99	1	At	at	IN
cord-303322-d69o3z8d	99	2	each	each	DT
cord-303322-d69o3z8d	99	3	site	site	NN
cord-303322-d69o3z8d	99	4	,	,	,
cord-303322-d69o3z8d	99	5	the	the	DT
cord-303322-d69o3z8d	99	6	site	site	NN
cord-303322-d69o3z8d	99	7	-	-	HYPH
cord-303322-d69o3z8d	99	8	specific	specific	JJ
cord-303322-d69o3z8d	99	9	study	study	NN
cord-303322-d69o3z8d	99	10	nurse	nurse	NN
cord-303322-d69o3z8d	99	11	visits	visit	VBZ
cord-303322-d69o3z8d	99	12	the	the	DT
cord-303322-d69o3z8d	99	13	wards	ward	NNS
cord-303322-d69o3z8d	99	14	twice	twice	RB
cord-303322-d69o3z8d	99	15	daily	daily	RB
cord-303322-d69o3z8d	99	16	to	to	TO
cord-303322-d69o3z8d	99	17	screen	screen	VB
cord-303322-d69o3z8d	99	18	all	all	DT
cord-303322-d69o3z8d	99	19	newly	newly	RB
cord-303322-d69o3z8d	99	20	admitted	admit	VBN
cord-303322-d69o3z8d	99	21	infants	infant	NNS
cord-303322-d69o3z8d	99	22	.	.	.
cord-303322-d69o3z8d	100	1	A	a	DT
cord-303322-d69o3z8d	100	2	standardised	standardised	JJ
cord-303322-d69o3z8d	100	3	collection	collection	NN
cord-303322-d69o3z8d	100	4	form	form	NN
cord-303322-d69o3z8d	100	5	is	be	VBZ
cord-303322-d69o3z8d	100	6	used	use	VBN
cord-303322-d69o3z8d	100	7	to	to	TO
cord-303322-d69o3z8d	100	8	collect	collect	VB
cord-303322-d69o3z8d	100	9	clinical	clinical	JJ
cord-303322-d69o3z8d	100	10	data	datum	NNS
cord-303322-d69o3z8d	100	11	(	(	-LRB-
cord-303322-d69o3z8d	100	12	see	see	VB
cord-303322-d69o3z8d	100	13	below	below	RB
cord-303322-d69o3z8d	100	14	)	)	-RRB-
cord-303322-d69o3z8d	100	15	and	and	CC
cord-303322-d69o3z8d	100	16	hospital	hospital	NN
cord-303322-d69o3z8d	100	17	outcomes	outcome	NNS
cord-303322-d69o3z8d	100	18	associated	associate	VBN
cord-303322-d69o3z8d	100	19	with	with	IN
cord-303322-d69o3z8d	100	20	the	the	DT
cord-303322-d69o3z8d	100	21	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	100	22	episode	episode	NN
cord-303322-d69o3z8d	100	23	.	.	.
cord-303322-d69o3z8d	101	1	All	all	DT
cord-303322-d69o3z8d	101	2	infants	infant	NNS
cord-303322-d69o3z8d	101	3	are	be	VBP
cord-303322-d69o3z8d	101	4	managed	manage	VBN
cord-303322-d69o3z8d	101	5	according	accord	VBG
cord-303322-d69o3z8d	101	6	to	to	IN
cord-303322-d69o3z8d	101	7	a	a	DT
cord-303322-d69o3z8d	101	8	standardised	standardised	JJ
cord-303322-d69o3z8d	101	9	protocol	protocol	NN
cord-303322-d69o3z8d	101	10	.	.	.
cord-303322-d69o3z8d	102	1	This	this	DT
cord-303322-d69o3z8d	102	2	has	have	VBZ
cord-303322-d69o3z8d	102	3	been	be	VBN
cord-303322-d69o3z8d	102	4	used	use	VBN
cord-303322-d69o3z8d	102	5	at	at	IN
cord-303322-d69o3z8d	102	6	the	the	DT
cord-303322-d69o3z8d	102	7	Royal	Royal	NNP
cord-303322-d69o3z8d	102	8	Darwin	Darwin	NNP
cord-303322-d69o3z8d	102	9	Hospital	Hospital	NNP
cord-303322-d69o3z8d	102	10	since	since	IN
cord-303322-d69o3z8d	102	11	2008	2008	CD
cord-303322-d69o3z8d	102	12	.	.	.
cord-303322-d69o3z8d	103	1	The	the	DT
cord-303322-d69o3z8d	103	2	protocol	protocol	NN
cord-303322-d69o3z8d	103	3	outlines	outline	VBZ
cord-303322-d69o3z8d	103	4	when	when	WRB
cord-303322-d69o3z8d	103	5	supplementary	supplementary	JJ
cord-303322-d69o3z8d	103	6	oxygen	oxygen	NN
cord-303322-d69o3z8d	103	7	is	be	VBZ
cord-303322-d69o3z8d	103	8	prescribed	prescribe	VBN
cord-303322-d69o3z8d	103	9	(	(	-LRB-
cord-303322-d69o3z8d	103	10	Sp0	sp0	NN
cord-303322-d69o3z8d	103	11	2	2	CD
cord-303322-d69o3z8d	103	12	<	<	XX
cord-303322-d69o3z8d	103	13	94	94	CD
cord-303322-d69o3z8d	103	14	%	%	NN
cord-303322-d69o3z8d	103	15	)	)	-RRB-
cord-303322-d69o3z8d	103	16	and	and	CC
cord-303322-d69o3z8d	103	17	reduced	reduce	VBN
cord-303322-d69o3z8d	103	18	,	,	,
cord-303322-d69o3z8d	103	19	and	and	CC
cord-303322-d69o3z8d	103	20	when	when	WRB
cord-303322-d69o3z8d	103	21	nasogastric	nasogastric	NN
cord-303322-d69o3z8d	103	22	feeds	feed	VBZ
cord-303322-d69o3z8d	103	23	or	or	CC
cord-303322-d69o3z8d	103	24	intravenous	intravenous	JJ
cord-303322-d69o3z8d	103	25	fluids	fluid	NNS
cord-303322-d69o3z8d	103	26	are	be	VBP
cord-303322-d69o3z8d	103	27	used	use	VBN
cord-303322-d69o3z8d	103	28	.	.	.
cord-303322-d69o3z8d	104	1	Enrolled	enrol	VBN
cord-303322-d69o3z8d	104	2	infants	infant	NNS
cord-303322-d69o3z8d	104	3	may	may	MD
cord-303322-d69o3z8d	104	4	receive	receive	VB
cord-303322-d69o3z8d	104	5	additional	additional	JJ
cord-303322-d69o3z8d	104	6	therapies	therapy	NNS
cord-303322-d69o3z8d	104	7	(	(	-LRB-
cord-303322-d69o3z8d	104	8	other	other	JJ
cord-303322-d69o3z8d	104	9	than	than	IN
cord-303322-d69o3z8d	104	10	macrolides	macrolide	NNS
cord-303322-d69o3z8d	104	11	)	)	-RRB-
cord-303322-d69o3z8d	104	12	at	at	IN
cord-303322-d69o3z8d	104	13	the	the	DT
cord-303322-d69o3z8d	104	14	discretion	discretion	NN
cord-303322-d69o3z8d	104	15	of	of	IN
cord-303322-d69o3z8d	104	16	the	the	DT
cord-303322-d69o3z8d	104	17	attending	attend	VBG
cord-303322-d69o3z8d	104	18	paediatrician	paediatrician	NN
cord-303322-d69o3z8d	104	19	.	.	.
cord-303322-d69o3z8d	105	1	If	if	IN
cord-303322-d69o3z8d	105	2	eligibility	eligibility	NN
cord-303322-d69o3z8d	105	3	is	be	VBZ
cord-303322-d69o3z8d	105	4	fulfilled	fulfil	VBN
cord-303322-d69o3z8d	105	5	and	and	CC
cord-303322-d69o3z8d	105	6	after	after	IN
cord-303322-d69o3z8d	105	7	informed	informed	JJ
cord-303322-d69o3z8d	105	8	consent	consent	NN
cord-303322-d69o3z8d	105	9	has	have	VBZ
cord-303322-d69o3z8d	105	10	been	be	VBN
cord-303322-d69o3z8d	105	11	obtained	obtain	VBN
cord-303322-d69o3z8d	105	12	,	,	,
cord-303322-d69o3z8d	105	13	the	the	DT
cord-303322-d69o3z8d	105	14	infant	infant	NN
cord-303322-d69o3z8d	105	15	is	be	VBZ
cord-303322-d69o3z8d	105	16	randomised	randomised	JJ
cord-303322-d69o3z8d	105	17	to	to	TO
cord-303322-d69o3z8d	105	18	receive	receive	VB
cord-303322-d69o3z8d	105	19	either	either	CC
cord-303322-d69o3z8d	105	20	a	a	DT
cord-303322-d69o3z8d	105	21	single	single	JJ
cord-303322-d69o3z8d	105	22	,	,	,
cord-303322-d69o3z8d	105	23	oral	oral	JJ
cord-303322-d69o3z8d	105	24	liquid	liquid	NN
cord-303322-d69o3z8d	105	25	dose	dose	NN
cord-303322-d69o3z8d	105	26	of	of	IN
cord-303322-d69o3z8d	105	27	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	105	28	syrup	syrup	NN
cord-303322-d69o3z8d	105	29	(	(	-LRB-
cord-303322-d69o3z8d	105	30	30	30	CD
cord-303322-d69o3z8d	105	31	mg	mg	NN
cord-303322-d69o3z8d	105	32	per	per	IN
cord-303322-d69o3z8d	105	33	kg	kg	NN
cord-303322-d69o3z8d	105	34	)	)	-RRB-
cord-303322-d69o3z8d	105	35	or	or	CC
cord-303322-d69o3z8d	105	36	an	an	DT
cord-303322-d69o3z8d	105	37	equivalent	equivalent	JJ
cord-303322-d69o3z8d	105	38	volume	volume	NN
cord-303322-d69o3z8d	105	39	of	of	IN
cord-303322-d69o3z8d	105	40	placebo	placebo	NN
cord-303322-d69o3z8d	105	41	.	.	.
cord-303322-d69o3z8d	106	1	Medication	medication	NN
cord-303322-d69o3z8d	106	2	is	be	VBZ
cord-303322-d69o3z8d	106	3	given	give	VBN
cord-303322-d69o3z8d	106	4	within	within	IN
cord-303322-d69o3z8d	106	5	24-hours	24-hours	CD
cord-303322-d69o3z8d	106	6	of	of	IN
cord-303322-d69o3z8d	106	7	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	106	8	.	.	.
cord-303322-d69o3z8d	107	1	Infants	infant	NNS
cord-303322-d69o3z8d	107	2	randomised	randomised	JJ
cord-303322-d69o3z8d	107	3	to	to	IN
cord-303322-d69o3z8d	107	4	the	the	DT
cord-303322-d69o3z8d	107	5	intervention	intervention	NN
cord-303322-d69o3z8d	107	6	arm	arm	NN
cord-303322-d69o3z8d	107	7	of	of	IN
cord-303322-d69o3z8d	107	8	the	the	DT
cord-303322-d69o3z8d	107	9	study	study	NN
cord-303322-d69o3z8d	107	10	will	will	MD
cord-303322-d69o3z8d	107	11	receive	receive	VB
cord-303322-d69o3z8d	107	12	additional	additional	JJ
cord-303322-d69o3z8d	107	13	treatment	treatment	NN
cord-303322-d69o3z8d	107	14	doses	dose	NNS
cord-303322-d69o3z8d	107	15	of	of	IN
cord-303322-d69o3z8d	107	16	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	107	17	syrup	syrup	NN
cord-303322-d69o3z8d	107	18	(	(	-LRB-
cord-303322-d69o3z8d	107	19	30	30	CD
cord-303322-d69o3z8d	107	20	mg	mg	NN
cord-303322-d69o3z8d	107	21	per	per	IN
cord-303322-d69o3z8d	107	22	kg	kg	NNP
cord-303322-d69o3z8d	107	23	)	)	-RRB-
cord-303322-d69o3z8d	107	24	on	on	IN
cord-303322-d69o3z8d	107	25	day-7	day-7	NNP
cord-303322-d69o3z8d	107	26	and	and	CC
cord-303322-d69o3z8d	107	27	day-14	day-14	NNP
cord-303322-d69o3z8d	107	28	.	.	.
cord-303322-d69o3z8d	108	1	Those	those	DT
cord-303322-d69o3z8d	108	2	randomised	randomised	JJ
cord-303322-d69o3z8d	108	3	to	to	IN
cord-303322-d69o3z8d	108	4	the	the	DT
cord-303322-d69o3z8d	108	5	control	control	NN
cord-303322-d69o3z8d	108	6	arm	arm	NN
cord-303322-d69o3z8d	108	7	receive	receive	VB
cord-303322-d69o3z8d	108	8	an	an	DT
cord-303322-d69o3z8d	108	9	equivalent	equivalent	JJ
cord-303322-d69o3z8d	108	10	volume	volume	NN
cord-303322-d69o3z8d	108	11	of	of	IN
cord-303322-d69o3z8d	108	12	the	the	DT
cord-303322-d69o3z8d	108	13	placebo	placebo	NN
cord-303322-d69o3z8d	108	14	syrup	syrup	NN
cord-303322-d69o3z8d	108	15	.	.	.
cord-303322-d69o3z8d	109	1	The	the	DT
cord-303322-d69o3z8d	109	2	later	later	JJ
cord-303322-d69o3z8d	109	3	doses	dose	NNS
cord-303322-d69o3z8d	109	4	will	will	MD
cord-303322-d69o3z8d	109	5	be	be	VB
cord-303322-d69o3z8d	109	6	either	either	RB
cord-303322-d69o3z8d	109	7	supervised	supervise	VBN
cord-303322-d69o3z8d	109	8	by	by	IN
cord-303322-d69o3z8d	109	9	study	study	NN
cord-303322-d69o3z8d	109	10	nurses	nurse	NNS
cord-303322-d69o3z8d	109	11	or	or	CC
cord-303322-d69o3z8d	109	12	administered	administer	VBN
cord-303322-d69o3z8d	109	13	by	by	IN
cord-303322-d69o3z8d	109	14	families	family	NNS
cord-303322-d69o3z8d	109	15	with	with	IN
cord-303322-d69o3z8d	109	16	phone	phone	NN
cord-303322-d69o3z8d	109	17	support	support	NN
cord-303322-d69o3z8d	109	18	on	on	IN
cord-303322-d69o3z8d	109	19	the	the	DT
cord-303322-d69o3z8d	109	20	day	day	NN
cord-303322-d69o3z8d	109	21	the	the	DT
cord-303322-d69o3z8d	109	22	medication	medication	NN
cord-303322-d69o3z8d	109	23	is	be	VBZ
cord-303322-d69o3z8d	109	24	due	due	JJ
cord-303322-d69o3z8d	109	25	.	.	.
cord-303322-d69o3z8d	110	1	Final	final	JJ
cord-303322-d69o3z8d	110	2	clinical	clinical	JJ
cord-303322-d69o3z8d	110	3	follow	follow	NN
cord-303322-d69o3z8d	110	4	up	up	RP
cord-303322-d69o3z8d	110	5	will	will	MD
cord-303322-d69o3z8d	110	6	occur	occur	VB
cord-303322-d69o3z8d	110	7	in	in	IN
cord-303322-d69o3z8d	110	8	the	the	DT
cord-303322-d69o3z8d	110	9	local	local	JJ
cord-303322-d69o3z8d	110	10	health	health	NN
cord-303322-d69o3z8d	110	11	clinic	clinic	NN
cord-303322-d69o3z8d	110	12	on	on	IN
cord-303322-d69o3z8d	110	13	day-21	day-21	NNP
cord-303322-d69o3z8d	110	14	(	(	-LRB-
cord-303322-d69o3z8d	110	15	or	or	CC
cord-303322-d69o3z8d	110	16	closest	close	JJS
cord-303322-d69o3z8d	110	17	available	available	JJ
cord-303322-d69o3z8d	110	18	date	date	NN
cord-303322-d69o3z8d	110	19	from	from	IN
cord-303322-d69o3z8d	110	20	day	day	NN
cord-303322-d69o3z8d	110	21	20	20	CD
cord-303322-d69o3z8d	110	22	to	to	TO
cord-303322-d69o3z8d	110	23	24	24	CD
cord-303322-d69o3z8d	110	24	)	)	-RRB-
cord-303322-d69o3z8d	110	25	.	.	.
cord-303322-d69o3z8d	111	1	The	the	DT
cord-303322-d69o3z8d	111	2	randomisation	randomisation	NN
cord-303322-d69o3z8d	111	3	sequence	sequence	NN
cord-303322-d69o3z8d	111	4	was	be	VBD
cord-303322-d69o3z8d	111	5	computer	computer	NN
cord-303322-d69o3z8d	111	6	generated	generate	VBN
cord-303322-d69o3z8d	111	7	and	and	CC
cord-303322-d69o3z8d	111	8	used	use	VBD
cord-303322-d69o3z8d	111	9	permutated	permutate	VBN
cord-303322-d69o3z8d	111	10	blocks	block	NNS
cord-303322-d69o3z8d	111	11	(	(	-LRB-
cord-303322-d69o3z8d	111	12	4	4	CD
cord-303322-d69o3z8d	111	13	or	or	CC
cord-303322-d69o3z8d	111	14	6	6	CD
cord-303322-d69o3z8d	111	15	participants	participant	NNS
cord-303322-d69o3z8d	111	16	per	per	IN
cord-303322-d69o3z8d	111	17	block	block	NN
cord-303322-d69o3z8d	111	18	)	)	-RRB-
cord-303322-d69o3z8d	111	19	.	.	.
cord-303322-d69o3z8d	112	1	The	the	DT
cord-303322-d69o3z8d	112	2	allocation	allocation	NN
cord-303322-d69o3z8d	112	3	sequence	sequence	NN
cord-303322-d69o3z8d	112	4	is	be	VBZ
cord-303322-d69o3z8d	112	5	concealed	conceal	VBN
cord-303322-d69o3z8d	112	6	at	at	IN
cord-303322-d69o3z8d	112	7	all	all	DT
cord-303322-d69o3z8d	112	8	times	time	NNS
cord-303322-d69o3z8d	112	9	throughout	throughout	IN
cord-303322-d69o3z8d	112	10	the	the	DT
cord-303322-d69o3z8d	112	11	study	study	NN
cord-303322-d69o3z8d	112	12	.	.	.
cord-303322-d69o3z8d	113	1	The	the	DT
cord-303322-d69o3z8d	113	2	computer	computer	NN
cord-303322-d69o3z8d	113	3	generation	generation	NN
cord-303322-d69o3z8d	113	4	and	and	CC
cord-303322-d69o3z8d	113	5	allocation	allocation	NN
cord-303322-d69o3z8d	113	6	were	be	VBD
cord-303322-d69o3z8d	113	7	performed	perform	VBN
cord-303322-d69o3z8d	113	8	by	by	IN
cord-303322-d69o3z8d	113	9	a	a	DT
cord-303322-d69o3z8d	113	10	statistician	statistician	NN
cord-303322-d69o3z8d	113	11	,	,	,
cord-303322-d69o3z8d	113	12	external	external	JJ
cord-303322-d69o3z8d	113	13	to	to	IN
cord-303322-d69o3z8d	113	14	the	the	DT
cord-303322-d69o3z8d	113	15	study	study	NN
cord-303322-d69o3z8d	113	16	team	team	NN
cord-303322-d69o3z8d	113	17	.	.	.
cord-303322-d69o3z8d	114	1	Upon	upon	IN
cord-303322-d69o3z8d	114	2	enrolment	enrolment	NN
cord-303322-d69o3z8d	114	3	,	,	,
cord-303322-d69o3z8d	114	4	an	an	DT
cord-303322-d69o3z8d	114	5	infant	infant	NN
cord-303322-d69o3z8d	114	6	is	be	VBZ
cord-303322-d69o3z8d	114	7	assigned	assign	VBN
cord-303322-d69o3z8d	114	8	to	to	IN
cord-303322-d69o3z8d	114	9	the	the	DT
cord-303322-d69o3z8d	114	10	next	next	JJ
cord-303322-d69o3z8d	114	11	number	number	NN
cord-303322-d69o3z8d	114	12	on	on	IN
cord-303322-d69o3z8d	114	13	the	the	DT
cord-303322-d69o3z8d	114	14	appropriate	appropriate	JJ
cord-303322-d69o3z8d	114	15	stratified	stratified	JJ
cord-303322-d69o3z8d	114	16	list	list	NN
cord-303322-d69o3z8d	114	17	.	.	.
cord-303322-d69o3z8d	115	1	Each	each	DT
cord-303322-d69o3z8d	115	2	unique	unique	JJ
cord-303322-d69o3z8d	115	3	number	number	NN
cord-303322-d69o3z8d	115	4	is	be	VBZ
cord-303322-d69o3z8d	115	5	assigned	assign	VBN
cord-303322-d69o3z8d	115	6	to	to	IN
cord-303322-d69o3z8d	115	7	one	one	CD
cord-303322-d69o3z8d	115	8	of	of	IN
cord-303322-d69o3z8d	115	9	the	the	DT
cord-303322-d69o3z8d	115	10	eight	eight	CD
cord-303322-d69o3z8d	115	11	treatment	treatment	NN
cord-303322-d69o3z8d	115	12	alphabets	alphabet	NNS
cord-303322-d69o3z8d	115	13	(	(	-LRB-
cord-303322-d69o3z8d	115	14	see	see	VB
cord-303322-d69o3z8d	115	15	below	below	RB
cord-303322-d69o3z8d	115	16	)	)	-RRB-
cord-303322-d69o3z8d	115	17	.	.	.
cord-303322-d69o3z8d	116	1	Treatment	treatment	NN
cord-303322-d69o3z8d	116	2	groups	group	NNS
cord-303322-d69o3z8d	116	3	are	be	VBP
cord-303322-d69o3z8d	116	4	stratified	stratify	VBN
cord-303322-d69o3z8d	116	5	by	by	IN
cord-303322-d69o3z8d	116	6	age	age	NN
cord-303322-d69o3z8d	116	7	(	(	-LRB-
cord-303322-d69o3z8d	116	8	≤6	≤6	NNS
cord-303322-d69o3z8d	116	9	or	or	CC
cord-303322-d69o3z8d	116	10	>	>	XX
cord-303322-d69o3z8d	116	11	6	6	CD
cord-303322-d69o3z8d	116	12	months	month	NNS
cord-303322-d69o3z8d	116	13	)	)	-RRB-
cord-303322-d69o3z8d	116	14	,	,	,
cord-303322-d69o3z8d	116	15	site	site	NN
cord-303322-d69o3z8d	116	16	(	(	-LRB-
cord-303322-d69o3z8d	116	17	Darwin	Darwin	NNP
cord-303322-d69o3z8d	116	18	or	or	CC
cord-303322-d69o3z8d	116	19	Townsville	Townsville	NNP
cord-303322-d69o3z8d	116	20	)	)	-RRB-
cord-303322-d69o3z8d	116	21	and	and	CC
cord-303322-d69o3z8d	116	22	requirement	requirement	NN
cord-303322-d69o3z8d	116	23	(	(	-LRB-
cord-303322-d69o3z8d	116	24	yes	yes	UH
cord-303322-d69o3z8d	116	25	or	or	CC
cord-303322-d69o3z8d	116	26	no	no	UH
cord-303322-d69o3z8d	116	27	)	)	-RRB-
cord-303322-d69o3z8d	116	28	for	for	IN
cord-303322-d69o3z8d	116	29	oxygen	oxygen	NN
cord-303322-d69o3z8d	116	30	at	at	IN
cord-303322-d69o3z8d	116	31	point	point	NN
cord-303322-d69o3z8d	116	32	of	of	IN
cord-303322-d69o3z8d	116	33	randomisation	randomisation	NN
cord-303322-d69o3z8d	116	34	.	.	.
cord-303322-d69o3z8d	117	1	The	the	DT
cord-303322-d69o3z8d	117	2	importance	importance	NN
cord-303322-d69o3z8d	117	3	of	of	IN
cord-303322-d69o3z8d	117	4	excluding	exclude	VBG
cord-303322-d69o3z8d	117	5	older	old	JJR
cord-303322-d69o3z8d	117	6	children	child	NNS
cord-303322-d69o3z8d	117	7	and	and	CC
cord-303322-d69o3z8d	117	8	stratifying	stratify	VBG
cord-303322-d69o3z8d	117	9	at	at	IN
cord-303322-d69o3z8d	117	10	the	the	DT
cord-303322-d69o3z8d	117	11	6	6	CD
cord-303322-d69o3z8d	117	12	month	month	NN
cord-303322-d69o3z8d	117	13	age	age	NN
cord-303322-d69o3z8d	117	14	group	group	NN
cord-303322-d69o3z8d	117	15	is	be	VBZ
cord-303322-d69o3z8d	117	16	well	well	RB
cord-303322-d69o3z8d	117	17	described	describe	VBN
cord-303322-d69o3z8d	117	18	[	[	-LRB-
cord-303322-d69o3z8d	117	19	30	30	CD
cord-303322-d69o3z8d	117	20	,	,	,
cord-303322-d69o3z8d	117	21	34	34	CD
cord-303322-d69o3z8d	117	22	]	]	-RRB-
cord-303322-d69o3z8d	117	23	.	.	.
cord-303322-d69o3z8d	118	1	A	a	DT
cord-303322-d69o3z8d	118	2	placebo	placebo	NN
cord-303322-d69o3z8d	118	3	medication	medication	NN
cord-303322-d69o3z8d	118	4	ensures	ensure	VBZ
cord-303322-d69o3z8d	118	5	that	that	IN
cord-303322-d69o3z8d	118	6	all	all	DT
cord-303322-d69o3z8d	118	7	children	child	NNS
cord-303322-d69o3z8d	118	8	,	,	,
cord-303322-d69o3z8d	118	9	carers	carer	NNS
cord-303322-d69o3z8d	118	10	,	,	,
cord-303322-d69o3z8d	118	11	researchers	researcher	NNS
cord-303322-d69o3z8d	118	12	,	,	,
cord-303322-d69o3z8d	118	13	hospital	hospital	NN
cord-303322-d69o3z8d	118	14	staff	staff	NN
cord-303322-d69o3z8d	118	15	,	,	,
cord-303322-d69o3z8d	118	16	and	and	CC
cord-303322-d69o3z8d	118	17	clinic	clinic	NN
cord-303322-d69o3z8d	118	18	staff	staff	NN
cord-303322-d69o3z8d	118	19	are	be	VBP
cord-303322-d69o3z8d	118	20	blinded	blind	VBN
cord-303322-d69o3z8d	118	21	to	to	IN
cord-303322-d69o3z8d	118	22	treatment	treatment	NN
cord-303322-d69o3z8d	118	23	group	group	NN
cord-303322-d69o3z8d	118	24	until	until	IN
cord-303322-d69o3z8d	118	25	analyses	analysis	NNS
cord-303322-d69o3z8d	118	26	of	of	IN
cord-303322-d69o3z8d	118	27	the	the	DT
cord-303322-d69o3z8d	118	28	data	datum	NNS
cord-303322-d69o3z8d	118	29	.	.	.
cord-303322-d69o3z8d	119	1	The	the	DT
cord-303322-d69o3z8d	119	2	placebo	placebo	NN
cord-303322-d69o3z8d	119	3	medication	medication	NN
cord-303322-d69o3z8d	119	4	has	have	VBZ
cord-303322-d69o3z8d	119	5	been	be	VBN
cord-303322-d69o3z8d	119	6	specifically	specifically	RB
cord-303322-d69o3z8d	119	7	manufactured	manufacture	VBN
cord-303322-d69o3z8d	119	8	by	by	IN
cord-303322-d69o3z8d	119	9	the	the	DT
cord-303322-d69o3z8d	119	10	Institute	Institute	NNP
cord-303322-d69o3z8d	119	11	of	of	IN
cord-303322-d69o3z8d	119	12	Drug	Drug	NNP
cord-303322-d69o3z8d	119	13	Technology	Technology	NNP
cord-303322-d69o3z8d	119	14	(	(	-LRB-
cord-303322-d69o3z8d	119	15	IDT	IDT	NNP
cord-303322-d69o3z8d	119	16	)	)	-RRB-
cord-303322-d69o3z8d	120	1	Australia	Australia	NNP
cord-303322-d69o3z8d	120	2	Limited	Limited	NNP
cord-303322-d69o3z8d	120	3	(	(	-LRB-
cord-303322-d69o3z8d	120	4	Melbourne	Melbourne	NNP
cord-303322-d69o3z8d	120	5	,	,	,
cord-303322-d69o3z8d	120	6	Vic	Vic	NNP
cord-303322-d69o3z8d	120	7	)	)	-RRB-
cord-303322-d69o3z8d	120	8	which	which	WDT
cord-303322-d69o3z8d	120	9	has	have	VBZ
cord-303322-d69o3z8d	120	10	a	a	DT
cord-303322-d69o3z8d	120	11	similar	similar	JJ
cord-303322-d69o3z8d	120	12	taste	taste	NN
cord-303322-d69o3z8d	120	13	and	and	CC
cord-303322-d69o3z8d	120	14	colour	colour	NN
cord-303322-d69o3z8d	120	15	to	to	IN
cord-303322-d69o3z8d	120	16	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	120	17	.	.	.
cord-303322-d69o3z8d	121	1	The	the	DT
cord-303322-d69o3z8d	121	2	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	121	3	medications	medication	NNS
cord-303322-d69o3z8d	121	4	were	be	VBD
cord-303322-d69o3z8d	121	5	repackaged	repackage	VBN
cord-303322-d69o3z8d	121	6	by	by	IN
cord-303322-d69o3z8d	121	7	IDT	IDT	NNP
cord-303322-d69o3z8d	121	8	.	.	.
cord-303322-d69o3z8d	122	1	Thus	thus	RB
cord-303322-d69o3z8d	122	2	both	both	DT
cord-303322-d69o3z8d	122	3	the	the	DT
cord-303322-d69o3z8d	122	4	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	122	5	and	and	CC
cord-303322-d69o3z8d	122	6	placebo	placebo	NN
cord-303322-d69o3z8d	122	7	are	be	VBP
cord-303322-d69o3z8d	122	8	in	in	IN
cord-303322-d69o3z8d	122	9	identical	identical	JJ
cord-303322-d69o3z8d	122	10	opaque	opaque	JJ
cord-303322-d69o3z8d	122	11	bottles	bottle	NNS
cord-303322-d69o3z8d	122	12	and	and	CC
cord-303322-d69o3z8d	122	13	sealed	seal	VBN
cord-303322-d69o3z8d	122	14	with	with	IN
cord-303322-d69o3z8d	122	15	an	an	DT
cord-303322-d69o3z8d	122	16	aluminium	aluminium	NN
cord-303322-d69o3z8d	122	17	foil	foil	NN
cord-303322-d69o3z8d	122	18	.	.	.
cord-303322-d69o3z8d	123	1	For	for	IN
cord-303322-d69o3z8d	123	2	both	both	DT
cord-303322-d69o3z8d	123	3	,	,	,
cord-303322-d69o3z8d	123	4	equal	equal	JJ
cord-303322-d69o3z8d	123	5	volumes	volume	NNS
cord-303322-d69o3z8d	123	6	of	of	IN
cord-303322-d69o3z8d	123	7	water	water	NN
cord-303322-d69o3z8d	123	8	are	be	VBP
cord-303322-d69o3z8d	123	9	added	add	VBN
cord-303322-d69o3z8d	123	10	using	use	VBG
cord-303322-d69o3z8d	123	11	a	a	DT
cord-303322-d69o3z8d	123	12	syringe	syringe	NN
cord-303322-d69o3z8d	123	13	and	and	CC
cord-303322-d69o3z8d	123	14	needle	needle	NN
cord-303322-d69o3z8d	123	15	by	by	IN
cord-303322-d69o3z8d	123	16	punching	punch	VBG
cord-303322-d69o3z8d	123	17	the	the	DT
cord-303322-d69o3z8d	123	18	seal	seal	NN
cord-303322-d69o3z8d	123	19	.	.	.
cord-303322-d69o3z8d	124	1	Eight	eight	CD
cord-303322-d69o3z8d	124	2	alphabets	alphabet	NNS
cord-303322-d69o3z8d	124	3	(	(	-LRB-
cord-303322-d69o3z8d	124	4	N	n	CC
cord-303322-d69o3z8d	124	5	,	,	,
cord-303322-d69o3z8d	124	6	O	o	UH
cord-303322-d69o3z8d	124	7	,	,	,
cord-303322-d69o3z8d	124	8	P	p	NN
cord-303322-d69o3z8d	124	9	,	,	,
cord-303322-d69o3z8d	124	10	Q	Q	NNP
cord-303322-d69o3z8d	124	11	,	,	,
cord-303322-d69o3z8d	124	12	R	r	NN
cord-303322-d69o3z8d	124	13	,	,	,
cord-303322-d69o3z8d	124	14	S	S	NNP
cord-303322-d69o3z8d	124	15	,	,	,
cord-303322-d69o3z8d	124	16	T	T	NNP
cord-303322-d69o3z8d	124	17	,	,	,
cord-303322-d69o3z8d	124	18	U	U	NNP
cord-303322-d69o3z8d	124	19	)	)	-RRB-
cord-303322-d69o3z8d	124	20	were	be	VBD
cord-303322-d69o3z8d	124	21	used	use	VBN
cord-303322-d69o3z8d	124	22	for	for	IN
cord-303322-d69o3z8d	124	23	the	the	DT
cord-303322-d69o3z8d	124	24	bottles	bottle	NNS
cord-303322-d69o3z8d	124	25	of	of	IN
cord-303322-d69o3z8d	124	26	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	124	27	and	and	CC
cord-303322-d69o3z8d	124	28	placebo	placebo	NN
cord-303322-d69o3z8d	124	29	medications	medication	NNS
cord-303322-d69o3z8d	124	30	(	(	-LRB-
cord-303322-d69o3z8d	124	31	4	4	CD
cord-303322-d69o3z8d	124	32	alphabets	alphabet	NNS
cord-303322-d69o3z8d	124	33	each	each	DT
cord-303322-d69o3z8d	124	34	)	)	-RRB-
cord-303322-d69o3z8d	124	35	.	.	.
cord-303322-d69o3z8d	125	1	We	-PRON-	PRP
cord-303322-d69o3z8d	125	2	used	use	VBD
cord-303322-d69o3z8d	125	3	multiple	multiple	JJ
cord-303322-d69o3z8d	125	4	alphabets	alphabet	NNS
cord-303322-d69o3z8d	125	5	rather	rather	RB
cord-303322-d69o3z8d	125	6	than	than	IN
cord-303322-d69o3z8d	125	7	sequential	sequential	JJ
cord-303322-d69o3z8d	125	8	numbers	number	NNS
cord-303322-d69o3z8d	125	9	on	on	IN
cord-303322-d69o3z8d	125	10	the	the	DT
cord-303322-d69o3z8d	125	11	bottles	bottle	NNS
cord-303322-d69o3z8d	125	12	to	to	TO
cord-303322-d69o3z8d	125	13	allow	allow	VB
cord-303322-d69o3z8d	125	14	storage	storage	NN
cord-303322-d69o3z8d	125	15	of	of	IN
cord-303322-d69o3z8d	125	16	extra	extra	JJ
cord-303322-d69o3z8d	125	17	bottles	bottle	NNS
cord-303322-d69o3z8d	125	18	of	of	IN
cord-303322-d69o3z8d	125	19	trial	trial	NN
cord-303322-d69o3z8d	125	20	medications	medication	NNS
cord-303322-d69o3z8d	125	21	in	in	IN
cord-303322-d69o3z8d	125	22	clinics	clinic	NNS
cord-303322-d69o3z8d	125	23	for	for	IN
cord-303322-d69o3z8d	125	24	the	the	DT
cord-303322-d69o3z8d	125	25	day-7	day-7	JJ
cord-303322-d69o3z8d	125	26	and	and	CC
cord-303322-d69o3z8d	125	27	day-14	day-14	NNP
cord-303322-d69o3z8d	125	28	doses	dose	NNS
cord-303322-d69o3z8d	125	29	.	.	.
cord-303322-d69o3z8d	126	1	This	this	DT
cord-303322-d69o3z8d	126	2	was	be	VBD
cord-303322-d69o3z8d	126	3	necessary	necessary	JJ
cord-303322-d69o3z8d	126	4	in	in	IN
cord-303322-d69o3z8d	126	5	the	the	DT
cord-303322-d69o3z8d	126	6	context	context	NN
cord-303322-d69o3z8d	126	7	of	of	IN
cord-303322-d69o3z8d	126	8	our	-PRON-	PRP$
cord-303322-d69o3z8d	126	9	study	study	NN
cord-303322-d69o3z8d	126	10	setting	set	VBG
cord-303322-d69o3z8d	126	11	(	(	-LRB-
cord-303322-d69o3z8d	126	12	children	child	NNS
cord-303322-d69o3z8d	126	13	mainly	mainly	RB
cord-303322-d69o3z8d	126	14	from	from	IN
cord-303322-d69o3z8d	126	15	remote	remote	JJ
cord-303322-d69o3z8d	126	16	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	126	17	communities	community	NNS
cord-303322-d69o3z8d	126	18	)	)	-RRB-
cord-303322-d69o3z8d	126	19	,	,	,
cord-303322-d69o3z8d	126	20	to	to	TO
cord-303322-d69o3z8d	126	21	enhance	enhance	VB
cord-303322-d69o3z8d	126	22	availability	availability	NN
cord-303322-d69o3z8d	126	23	and	and	CC
cord-303322-d69o3z8d	126	24	administration	administration	NN
cord-303322-d69o3z8d	126	25	of	of	IN
cord-303322-d69o3z8d	126	26	trial	trial	NN
cord-303322-d69o3z8d	126	27	medications	medication	NNS
cord-303322-d69o3z8d	126	28	once	once	IN
cord-303322-d69o3z8d	126	29	the	the	DT
cord-303322-d69o3z8d	126	30	child	child	NN
cord-303322-d69o3z8d	126	31	has	have	VBZ
cord-303322-d69o3z8d	126	32	been	be	VBN
cord-303322-d69o3z8d	126	33	discharged	discharge	VBN
cord-303322-d69o3z8d	126	34	from	from	IN
cord-303322-d69o3z8d	126	35	the	the	DT
cord-303322-d69o3z8d	126	36	hospital	hospital	NN
cord-303322-d69o3z8d	126	37	.	.	.
cord-303322-d69o3z8d	127	1	All	all	DT
cord-303322-d69o3z8d	127	2	data	datum	NNS
cord-303322-d69o3z8d	127	3	are	be	VBP
cord-303322-d69o3z8d	127	4	recorded	record	VBN
cord-303322-d69o3z8d	127	5	on	on	IN
cord-303322-d69o3z8d	127	6	standardised	standardised	JJ
cord-303322-d69o3z8d	127	7	forms	form	NNS
cord-303322-d69o3z8d	127	8	.	.	.
cord-303322-d69o3z8d	128	1	Demographic	demographic	JJ
cord-303322-d69o3z8d	128	2	information	information	NN
cord-303322-d69o3z8d	128	3	(	(	-LRB-
cord-303322-d69o3z8d	128	4	age	age	NN
cord-303322-d69o3z8d	128	5	,	,	,
cord-303322-d69o3z8d	128	6	gender	gender	NN
cord-303322-d69o3z8d	128	7	,	,	,
cord-303322-d69o3z8d	128	8	region	region	NN
cord-303322-d69o3z8d	128	9	,	,	,
cord-303322-d69o3z8d	128	10	birth	birth	NN
cord-303322-d69o3z8d	128	11	details	detail	NNS
cord-303322-d69o3z8d	128	12	,	,	,
cord-303322-d69o3z8d	128	13	smoke	smoke	NN
cord-303322-d69o3z8d	128	14	exposure	exposure	NN
cord-303322-d69o3z8d	128	15	,	,	,
cord-303322-d69o3z8d	128	16	breast	breast	NN
cord-303322-d69o3z8d	128	17	feeding	feeding	NN
cord-303322-d69o3z8d	128	18	,	,	,
cord-303322-d69o3z8d	128	19	household	household	NN
cord-303322-d69o3z8d	128	20	size	size	NN
cord-303322-d69o3z8d	128	21	,	,	,
cord-303322-d69o3z8d	128	22	etc	etc	FW
cord-303322-d69o3z8d	128	23	)	)	-RRB-
cord-303322-d69o3z8d	128	24	and	and	CC
cord-303322-d69o3z8d	128	25	medical	medical	JJ
cord-303322-d69o3z8d	128	26	history	history	NN
cord-303322-d69o3z8d	128	27	are	be	VBP
cord-303322-d69o3z8d	128	28	obtained	obtain	VBN
cord-303322-d69o3z8d	128	29	from	from	IN
cord-303322-d69o3z8d	128	30	the	the	DT
cord-303322-d69o3z8d	128	31	primary	primary	JJ
cord-303322-d69o3z8d	128	32	caregiver	caregiver	NN
cord-303322-d69o3z8d	128	33	and	and	CC
cord-303322-d69o3z8d	128	34	the	the	DT
cord-303322-d69o3z8d	128	35	medical	medical	JJ
cord-303322-d69o3z8d	128	36	charts	chart	NNS
cord-303322-d69o3z8d	128	37	.	.	.
cord-303322-d69o3z8d	129	1	The	the	DT
cord-303322-d69o3z8d	129	2	primary	primary	JJ
cord-303322-d69o3z8d	129	3	and	and	CC
cord-303322-d69o3z8d	129	4	secondary	secondary	JJ
cord-303322-d69o3z8d	129	5	outcome	outcome	NN
cord-303322-d69o3z8d	129	6	measures	measure	NNS
cord-303322-d69o3z8d	129	7	(	(	-LRB-
cord-303322-d69o3z8d	129	8	see	see	VB
cord-303322-d69o3z8d	129	9	below	below	RB
cord-303322-d69o3z8d	129	10	)	)	-RRB-
cord-303322-d69o3z8d	129	11	are	be	VBP
cord-303322-d69o3z8d	129	12	monitored	monitor	VBN
cord-303322-d69o3z8d	129	13	twice	twice	RB
cord-303322-d69o3z8d	129	14	daily	daily	RB
cord-303322-d69o3z8d	129	15	until	until	IN
cord-303322-d69o3z8d	129	16	the	the	DT
cord-303322-d69o3z8d	129	17	hospital	hospital	NN
cord-303322-d69o3z8d	129	18	admission	admission	NN
cord-303322-d69o3z8d	129	19	's	's	POS
cord-303322-d69o3z8d	129	20	end	end	NN
cord-303322-d69o3z8d	129	21	-	-	HYPH
cord-303322-d69o3z8d	129	22	point	point	NN
cord-303322-d69o3z8d	129	23	is	be	VBZ
cord-303322-d69o3z8d	129	24	reached	reach	VBN
cord-303322-d69o3z8d	129	25	(	(	-LRB-
cord-303322-d69o3z8d	129	26	ready	ready	JJ
cord-303322-d69o3z8d	129	27	for	for	IN
cord-303322-d69o3z8d	129	28	respiratory	respiratory	JJ
cord-303322-d69o3z8d	129	29	discharge	discharge	NN
cord-303322-d69o3z8d	129	30	,	,	,
cord-303322-d69o3z8d	129	31	defined	define	VBN
cord-303322-d69o3z8d	129	32	as	as	IN
cord-303322-d69o3z8d	129	33	>	>	XX
cord-303322-d69o3z8d	129	34	16-hours	16-hours	CD
cord-303322-d69o3z8d	129	35	without	without	IN
cord-303322-d69o3z8d	129	36	supplemental	supplemental	JJ
cord-303322-d69o3z8d	129	37	oxygen	oxygen	NN
cord-303322-d69o3z8d	129	38	and	and	CC
cord-303322-d69o3z8d	129	39	infant	infant	NN
cord-303322-d69o3z8d	129	40	is	be	VBZ
cord-303322-d69o3z8d	129	41	feeding	feed	VBG
cord-303322-d69o3z8d	129	42	well	well	RB
cord-303322-d69o3z8d	129	43	)	)	-RRB-
cord-303322-d69o3z8d	129	44	.	.	.
cord-303322-d69o3z8d	130	1	Clinical	clinical	JJ
cord-303322-d69o3z8d	130	2	assessment	assessment	NN
cord-303322-d69o3z8d	130	3	data	datum	NNS
cord-303322-d69o3z8d	130	4	include	include	VBP
cord-303322-d69o3z8d	130	5	oxygen	oxygen	NN
cord-303322-d69o3z8d	130	6	requirement	requirement	NN
cord-303322-d69o3z8d	130	7	and	and	CC
cord-303322-d69o3z8d	130	8	level	level	NN
cord-303322-d69o3z8d	130	9	,	,	,
cord-303322-d69o3z8d	130	10	physiological	physiological	JJ
cord-303322-d69o3z8d	130	11	measurements	measurement	NNS
cord-303322-d69o3z8d	130	12	for	for	IN
cord-303322-d69o3z8d	130	13	clinical	clinical	JJ
cord-303322-d69o3z8d	130	14	severity	severity	NN
cord-303322-d69o3z8d	130	15	score	score	NN
cord-303322-d69o3z8d	130	16	(	(	-LRB-
cord-303322-d69o3z8d	130	17	respiratory	respiratory	JJ
cord-303322-d69o3z8d	130	18	rate	rate	NN
cord-303322-d69o3z8d	130	19	,	,	,
cord-303322-d69o3z8d	130	20	accessory	accessory	JJ
cord-303322-d69o3z8d	130	21	muscle	muscle	NN
cord-303322-d69o3z8d	130	22	use	use	NN
cord-303322-d69o3z8d	130	23	,	,	,
cord-303322-d69o3z8d	130	24	degree	degree	NN
cord-303322-d69o3z8d	130	25	of	of	IN
cord-303322-d69o3z8d	130	26	wheeze	wheeze	NN
cord-303322-d69o3z8d	130	27	)	)	-RRB-
cord-303322-d69o3z8d	130	28	,	,	,
cord-303322-d69o3z8d	130	29	[	[	-LRB-
cord-303322-d69o3z8d	130	30	27	27	CD
cord-303322-d69o3z8d	130	31	]	]	-RRB-
cord-303322-d69o3z8d	130	32	other	other	JJ
cord-303322-d69o3z8d	130	33	physiological	physiological	JJ
cord-303322-d69o3z8d	130	34	measurement	measurement	NN
cord-303322-d69o3z8d	130	35	(	(	-LRB-
cord-303322-d69o3z8d	130	36	temperature	temperature	NN
cord-303322-d69o3z8d	130	37	,	,	,
cord-303322-d69o3z8d	130	38	heart	heart	NN
cord-303322-d69o3z8d	130	39	rate	rate	NN
cord-303322-d69o3z8d	130	40	)	)	-RRB-
cord-303322-d69o3z8d	130	41	,	,	,
cord-303322-d69o3z8d	130	42	requirement	requirement	NN
cord-303322-d69o3z8d	130	43	and	and	CC
cord-303322-d69o3z8d	130	44	duration	duration	NN
cord-303322-d69o3z8d	130	45	of	of	IN
cord-303322-d69o3z8d	130	46	other	other	JJ
cord-303322-d69o3z8d	130	47	therapies	therapy	NNS
cord-303322-d69o3z8d	130	48	required	require	VBN
cord-303322-d69o3z8d	130	49	(	(	-LRB-
cord-303322-d69o3z8d	130	50	intravenous	intravenous	JJ
cord-303322-d69o3z8d	130	51	fluids	fluid	NNS
cord-303322-d69o3z8d	130	52	,	,	,
cord-303322-d69o3z8d	130	53	nutritional	nutritional	JJ
cord-303322-d69o3z8d	130	54	support	support	NN
cord-303322-d69o3z8d	130	55	,	,	,
cord-303322-d69o3z8d	130	56	antibiotics	antibiotic	NNS
cord-303322-d69o3z8d	130	57	)	)	-RRB-
cord-303322-d69o3z8d	130	58	,	,	,
cord-303322-d69o3z8d	130	59	ear	ear	NN
cord-303322-d69o3z8d	130	60	examination	examination	NN
cord-303322-d69o3z8d	130	61	findings	finding	NNS
cord-303322-d69o3z8d	130	62	(	(	-LRB-
cord-303322-d69o3z8d	130	63	signs	sign	NNS
cord-303322-d69o3z8d	130	64	of	of	IN
cord-303322-d69o3z8d	130	65	suppuration	suppuration	NN
cord-303322-d69o3z8d	130	66	)	)	-RRB-
cord-303322-d69o3z8d	130	67	and	and	CC
cord-303322-d69o3z8d	130	68	subsequent	subsequent	JJ
cord-303322-d69o3z8d	130	69	pneumonia	pneumonia	NN
cord-303322-d69o3z8d	130	70	(	(	-LRB-
cord-303322-d69o3z8d	130	71	diagnosed	diagnose	VBN
cord-303322-d69o3z8d	130	72	by	by	IN
cord-303322-d69o3z8d	130	73	the	the	DT
cord-303322-d69o3z8d	130	74	independent	independent	JJ
cord-303322-d69o3z8d	130	75	treating	treat	VBG
cord-303322-d69o3z8d	130	76	'	'	``
cord-303322-d69o3z8d	130	77	blinded	blinded	JJ
cord-303322-d69o3z8d	130	78	'	'	''
cord-303322-d69o3z8d	130	79	paediatrician	paediatrician	NN
cord-303322-d69o3z8d	130	80	)	)	-RRB-
cord-303322-d69o3z8d	130	81	.	.	.
cord-303322-d69o3z8d	131	1	In	in	IN
cord-303322-d69o3z8d	131	2	addition	addition	NN
cord-303322-d69o3z8d	131	3	,	,	,
cord-303322-d69o3z8d	131	4	the	the	DT
cord-303322-d69o3z8d	131	5	results	result	NNS
cord-303322-d69o3z8d	131	6	of	of	IN
cord-303322-d69o3z8d	131	7	routine	routine	JJ
cord-303322-d69o3z8d	131	8	investigations	investigation	NNS
cord-303322-d69o3z8d	131	9	(	(	-LRB-
cord-303322-d69o3z8d	131	10	full	full	JJ
cord-303322-d69o3z8d	131	11	blood	blood	NN
cord-303322-d69o3z8d	131	12	count	count	NN
cord-303322-d69o3z8d	131	13	and	and	CC
cord-303322-d69o3z8d	131	14	chest	chest	NN
cord-303322-d69o3z8d	131	15	radiographic	radiographic	JJ
cord-303322-d69o3z8d	131	16	findings	finding	NNS
cord-303322-d69o3z8d	131	17	)	)	-RRB-
cord-303322-d69o3z8d	131	18	are	be	VBP
cord-303322-d69o3z8d	131	19	recorded	record	VBN
cord-303322-d69o3z8d	131	20	.	.	.
cord-303322-d69o3z8d	132	1	On	on	IN
cord-303322-d69o3z8d	132	2	day-21	day-21	NNP
cord-303322-d69o3z8d	132	3	,	,	,
cord-303322-d69o3z8d	132	4	the	the	DT
cord-303322-d69o3z8d	132	5	presence	presence	NN
cord-303322-d69o3z8d	132	6	of	of	IN
cord-303322-d69o3z8d	132	7	cough	cough	NN
cord-303322-d69o3z8d	132	8	,	,	,
cord-303322-d69o3z8d	132	9	wheeze	wheeze	VB
cord-303322-d69o3z8d	132	10	and	and	CC
cord-303322-d69o3z8d	132	11	auscultatory	auscultatory	RB
cord-303322-d69o3z8d	132	12	abnormality	abnormality	NN
cord-303322-d69o3z8d	132	13	on	on	IN
cord-303322-d69o3z8d	132	14	clinical	clinical	JJ
cord-303322-d69o3z8d	132	15	review	review	NN
cord-303322-d69o3z8d	132	16	are	be	VBP
cord-303322-d69o3z8d	132	17	documented	document	VBN
cord-303322-d69o3z8d	132	18	.	.	.
cord-303322-d69o3z8d	133	1	Adverse	adverse	JJ
cord-303322-d69o3z8d	133	2	effects	effect	NNS
cord-303322-d69o3z8d	133	3	(	(	-LRB-
cord-303322-d69o3z8d	133	4	vomiting	vomit	VBG
cord-303322-d69o3z8d	133	5	,	,	,
cord-303322-d69o3z8d	133	6	diarrhoea	diarrhoea	NN
cord-303322-d69o3z8d	133	7	,	,	,
cord-303322-d69o3z8d	133	8	rash	rash	JJ
cord-303322-d69o3z8d	133	9	)	)	-RRB-
cord-303322-d69o3z8d	133	10	are	be	VBP
cord-303322-d69o3z8d	133	11	also	also	RB
cord-303322-d69o3z8d	133	12	documented	document	VBN
cord-303322-d69o3z8d	133	13	.	.	.
cord-303322-d69o3z8d	134	1	A	a	DT
cord-303322-d69o3z8d	134	2	single	single	JJ
cord-303322-d69o3z8d	134	3	nasopharyngeal	nasopharyngeal	JJ
cord-303322-d69o3z8d	134	4	swab	swab	NN
cord-303322-d69o3z8d	134	5	(	(	-LRB-
cord-303322-d69o3z8d	134	6	NPS	NPS	NNP
cord-303322-d69o3z8d	134	7	)	)	-RRB-
cord-303322-d69o3z8d	134	8	specimen	specimen	NN
cord-303322-d69o3z8d	134	9	for	for	IN
cord-303322-d69o3z8d	134	10	respiratory	respiratory	JJ
cord-303322-d69o3z8d	134	11	virus	virus	NN
cord-303322-d69o3z8d	134	12	and	and	CC
cord-303322-d69o3z8d	134	13	other	other	JJ
cord-303322-d69o3z8d	134	14	potentially	potentially	RB
cord-303322-d69o3z8d	134	15	important	important	JJ
cord-303322-d69o3z8d	134	16	respiratory	respiratory	JJ
cord-303322-d69o3z8d	134	17	pathogen	pathogen	NN
cord-303322-d69o3z8d	134	18	(	(	-LRB-
cord-303322-d69o3z8d	134	19	M.	M.	NNP
cord-303322-d69o3z8d	134	20	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	134	21	,	,	,
cord-303322-d69o3z8d	134	22	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	134	23	spp	spp	NNS
cord-303322-d69o3z8d	134	24	)	)	-RRB-
cord-303322-d69o3z8d	135	1	testing	testing	NN
cord-303322-d69o3z8d	135	2	is	be	VBZ
cord-303322-d69o3z8d	135	3	collected	collect	VBN
cord-303322-d69o3z8d	135	4	from	from	IN
cord-303322-d69o3z8d	135	5	each	each	DT
cord-303322-d69o3z8d	135	6	subject	subject	NN
cord-303322-d69o3z8d	135	7	at	at	IN
cord-303322-d69o3z8d	135	8	enrolment	enrolment	NN
cord-303322-d69o3z8d	135	9	.	.	.
cord-303322-d69o3z8d	136	1	In	in	IN
cord-303322-d69o3z8d	136	2	addition	addition	NN
cord-303322-d69o3z8d	136	3	,	,	,
cord-303322-d69o3z8d	136	4	NPS	NPS	NNP
cord-303322-d69o3z8d	136	5	is	be	VBZ
cord-303322-d69o3z8d	136	6	repeated	repeat	VBN
cord-303322-d69o3z8d	136	7	before	before	IN
cord-303322-d69o3z8d	136	8	hospital	hospital	NN
cord-303322-d69o3z8d	136	9	discharge	discharge	NN
cord-303322-d69o3z8d	136	10	for	for	IN
cord-303322-d69o3z8d	136	11	bacterial	bacterial	JJ
cord-303322-d69o3z8d	136	12	culture	culture	NN
cord-303322-d69o3z8d	136	13	and	and	CC
cord-303322-d69o3z8d	136	14	antibiotic	antibiotic	JJ
cord-303322-d69o3z8d	136	15	susceptibility	susceptibility	NN
cord-303322-d69o3z8d	136	16	testing	testing	NN
cord-303322-d69o3z8d	136	17	,	,	,
cord-303322-d69o3z8d	136	18	as	as	IN
cord-303322-d69o3z8d	136	19	per	per	IN
cord-303322-d69o3z8d	136	20	our	-PRON-	PRP$
cord-303322-d69o3z8d	136	21	laboratory	laboratory	NN
cord-303322-d69o3z8d	136	22	research	research	NN
cord-303322-d69o3z8d	136	23	protocol	protocol	NN
cord-303322-d69o3z8d	136	24	(	(	-LRB-
cord-303322-d69o3z8d	136	25	see	see	VB
cord-303322-d69o3z8d	136	26	below	below	RB
cord-303322-d69o3z8d	136	27	)	)	-RRB-
cord-303322-d69o3z8d	136	28	[	[	-LRB-
cord-303322-d69o3z8d	136	29	35	35	CD
cord-303322-d69o3z8d	136	30	,	,	,
cord-303322-d69o3z8d	136	31	36	36	CD
cord-303322-d69o3z8d	136	32	]	]	-RRB-
cord-303322-d69o3z8d	136	33	.	.	.
cord-303322-d69o3z8d	137	1	Culturing	culture	VBG
cord-303322-d69o3z8d	137	2	,	,	,
cord-303322-d69o3z8d	137	3	identifying	identify	VBG
cord-303322-d69o3z8d	137	4	and	and	CC
cord-303322-d69o3z8d	137	5	serotyping	serotype	VBG
cord-303322-d69o3z8d	137	6	common	common	JJ
cord-303322-d69o3z8d	137	7	respiratory	respiratory	JJ
cord-303322-d69o3z8d	137	8	bacteria	bacteria	NNS
cord-303322-d69o3z8d	137	9	from	from	IN
cord-303322-d69o3z8d	137	10	NPS	NPS	NNP
cord-303322-d69o3z8d	137	11	is	be	VBZ
cord-303322-d69o3z8d	137	12	an	an	DT
cord-303322-d69o3z8d	137	13	established	established	JJ
cord-303322-d69o3z8d	137	14	technique	technique	NN
cord-303322-d69o3z8d	137	15	in	in	IN
cord-303322-d69o3z8d	137	16	our	-PRON-	PRP$
cord-303322-d69o3z8d	137	17	laboratory	laboratory	NN
cord-303322-d69o3z8d	137	18	at	at	IN
cord-303322-d69o3z8d	137	19	Menzies	Menzies	NNP
cord-303322-d69o3z8d	137	20	in	in	IN
cord-303322-d69o3z8d	137	21	Darwin	Darwin	NNP
cord-303322-d69o3z8d	137	22	[	[	-LRB-
cord-303322-d69o3z8d	137	23	35	35	CD
cord-303322-d69o3z8d	137	24	]	]	-RRB-
cord-303322-d69o3z8d	137	25	.	.	.
cord-303322-d69o3z8d	138	1	Swabs	swab	NNS
cord-303322-d69o3z8d	138	2	are	be	VBP
cord-303322-d69o3z8d	138	3	stored	store	VBN
cord-303322-d69o3z8d	138	4	in	in	IN
cord-303322-d69o3z8d	138	5	SMGGB	SMGGB	NNP
cord-303322-d69o3z8d	138	6	at	at	IN
cord-303322-d69o3z8d	138	7	-80	-80	NNP
cord-303322-d69o3z8d	138	8	°	°	NN
cord-303322-d69o3z8d	138	9	C	C	NNP
cord-303322-d69o3z8d	138	10	before	before	IN
cord-303322-d69o3z8d	138	11	being	be	VBG
cord-303322-d69o3z8d	138	12	batch	batch	NN
cord-303322-d69o3z8d	138	13	processed	process	VBN
cord-303322-d69o3z8d	138	14	for	for	IN
cord-303322-d69o3z8d	138	15	typical	typical	JJ
cord-303322-d69o3z8d	138	16	respiratory	respiratory	JJ
cord-303322-d69o3z8d	138	17	bacterial	bacterial	JJ
cord-303322-d69o3z8d	138	18	pathogens	pathogen	NNS
cord-303322-d69o3z8d	138	19	,	,	,
cord-303322-d69o3z8d	138	20	notably	notably	RB
cord-303322-d69o3z8d	138	21	H	h	NN
cord-303322-d69o3z8d	138	22	influenzae	influenzae	NN
cord-303322-d69o3z8d	138	23	and	and	CC
cord-303322-d69o3z8d	138	24	non	non	JJ
cord-303322-d69o3z8d	138	25	-	-	JJ
cord-303322-d69o3z8d	138	26	typeable	typeable	JJ
cord-303322-d69o3z8d	138	27	H	h	NN
cord-303322-d69o3z8d	138	28	influenzae	influenzae	NN
cord-303322-d69o3z8d	138	29	,	,	,
cord-303322-d69o3z8d	138	30	M.	M.	NNP
cord-303322-d69o3z8d	138	31	catarrhalis	catarrhalis	NNP
cord-303322-d69o3z8d	138	32	and	and	CC
cord-303322-d69o3z8d	138	33	S.	S.	NNP
cord-303322-d69o3z8d	138	34	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	138	35	.	.	.
cord-303322-d69o3z8d	139	1	Batches	batch	NNS
cord-303322-d69o3z8d	139	2	of	of	IN
cord-303322-d69o3z8d	139	3	swabs	swab	NNS
cord-303322-d69o3z8d	139	4	are	be	VBP
cord-303322-d69o3z8d	139	5	thawed	thaw	VBN
cord-303322-d69o3z8d	139	6	and	and	CC
cord-303322-d69o3z8d	139	7	10	10	CD
cord-303322-d69o3z8d	139	8	μL	μl	NN
cord-303322-d69o3z8d	139	9	aliquots	aliquot	NNS
cord-303322-d69o3z8d	139	10	cultured	culture	VBN
cord-303322-d69o3z8d	139	11	overnight	overnight	RB
cord-303322-d69o3z8d	139	12	on	on	IN
cord-303322-d69o3z8d	139	13	selective	selective	JJ
cord-303322-d69o3z8d	139	14	media	medium	NNS
cord-303322-d69o3z8d	139	15	at	at	IN
cord-303322-d69o3z8d	139	16	37	37	CD
cord-303322-d69o3z8d	139	17	°	°	NN
cord-303322-d69o3z8d	139	18	C	c	NN
cord-303322-d69o3z8d	139	19	in	in	IN
cord-303322-d69o3z8d	139	20	5	5	CD
cord-303322-d69o3z8d	139	21	%	%	NN
cord-303322-d69o3z8d	139	22	CO	co	NN
cord-303322-d69o3z8d	139	23	2	2	CD
cord-303322-d69o3z8d	139	24	.	.	.
cord-303322-d69o3z8d	140	1	Growth	growth	NN
cord-303322-d69o3z8d	140	2	of	of	IN
cord-303322-d69o3z8d	140	3	S.	S.	NNP
cord-303322-d69o3z8d	140	4	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	140	5	,	,	,
cord-303322-d69o3z8d	140	6	H.	H.	NNP
cord-303322-d69o3z8d	140	7	influenzae	influenzae	NN
cord-303322-d69o3z8d	140	8	and	and	CC
cord-303322-d69o3z8d	140	9	M.	M.	NNP
cord-303322-d69o3z8d	140	10	catarrhalis	catarrhalis	NNP
cord-303322-d69o3z8d	140	11	is	be	VBZ
cord-303322-d69o3z8d	140	12	recorded	record	VBN
cord-303322-d69o3z8d	140	13	and	and	CC
cord-303322-d69o3z8d	140	14	confirmed	confirm	VBN
cord-303322-d69o3z8d	140	15	.	.	.
cord-303322-d69o3z8d	141	1	Four	four	CD
cord-303322-d69o3z8d	141	2	isolates	isolate	VBZ
cord-303322-d69o3z8d	141	3	each	each	DT
cord-303322-d69o3z8d	141	4	of	of	IN
cord-303322-d69o3z8d	141	5	S.	S.	NNP
cord-303322-d69o3z8d	141	6	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	141	7	and	and	CC
cord-303322-d69o3z8d	141	8	H.	h.	NN
cord-303322-d69o3z8d	141	9	influenzae	influenzae	NN
cord-303322-d69o3z8d	141	10	and	and	CC
cord-303322-d69o3z8d	141	11	two	two	CD
cord-303322-d69o3z8d	141	12	isolates	isolate	NNS
cord-303322-d69o3z8d	141	13	of	of	IN
cord-303322-d69o3z8d	141	14	M.	M.	NNP
cord-303322-d69o3z8d	141	15	catarrhalis	catarrhalis	FW
cord-303322-d69o3z8d	141	16	per	per	IN
cord-303322-d69o3z8d	141	17	positive	positive	JJ
cord-303322-d69o3z8d	141	18	swab	swab	NN
cord-303322-d69o3z8d	141	19	are	be	VBP
cord-303322-d69o3z8d	141	20	tested	test	VBN
cord-303322-d69o3z8d	141	21	for	for	IN
cord-303322-d69o3z8d	141	22	anti	anti	JJ
cord-303322-d69o3z8d	141	23	-	-	JJ
cord-303322-d69o3z8d	141	24	microbial	microbial	JJ
cord-303322-d69o3z8d	141	25	resistance	resistance	NN
cord-303322-d69o3z8d	141	26	and	and	CC
cord-303322-d69o3z8d	141	27	stored	store	VBD
cord-303322-d69o3z8d	141	28	[	[	-LRB-
cord-303322-d69o3z8d	141	29	35	35	CD
cord-303322-d69o3z8d	141	30	,	,	,
cord-303322-d69o3z8d	141	31	37	37	CD
cord-303322-d69o3z8d	141	32	]	]	-RRB-
cord-303322-d69o3z8d	141	33	.	.	.
cord-303322-d69o3z8d	142	1	S.	S.	NNP
cord-303322-d69o3z8d	142	2	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	142	3	isolates	isolate	NNS
cord-303322-d69o3z8d	142	4	are	be	VBP
cord-303322-d69o3z8d	142	5	serotyped	serotyped	JJ
cord-303322-d69o3z8d	142	6	using	use	VBG
cord-303322-d69o3z8d	142	7	the	the	DT
cord-303322-d69o3z8d	142	8	Quellung	Quellung	NNP
cord-303322-d69o3z8d	142	9	method	method	NN
cord-303322-d69o3z8d	142	10	(	(	-LRB-
cord-303322-d69o3z8d	142	11	antisera	antisera	NN
cord-303322-d69o3z8d	142	12	from	from	IN
cord-303322-d69o3z8d	142	13	Statens	Statens	NNP
cord-303322-d69o3z8d	142	14	Serum	Serum	NNP
cord-303322-d69o3z8d	142	15	Institute	Institute	NNP
cord-303322-d69o3z8d	142	16	,	,	,
cord-303322-d69o3z8d	142	17	Denmark	Denmark	NNP
cord-303322-d69o3z8d	142	18	)	)	-RRB-
cord-303322-d69o3z8d	142	19	.	.	.
cord-303322-d69o3z8d	143	1	In	in	IN
cord-303322-d69o3z8d	143	2	addition	addition	NN
cord-303322-d69o3z8d	143	3	to	to	IN
cord-303322-d69o3z8d	143	4	routine	routine	JJ
cord-303322-d69o3z8d	143	5	susceptibility	susceptibility	NN
cord-303322-d69o3z8d	143	6	testing	testing	NN
cord-303322-d69o3z8d	143	7	using	use	VBG
cord-303322-d69o3z8d	143	8	the	the	DT
cord-303322-d69o3z8d	143	9	calibrated	calibrate	VBN
cord-303322-d69o3z8d	143	10	dichotomous	dichotomous	JJ
cord-303322-d69o3z8d	143	11	susceptibility	susceptibility	NN
cord-303322-d69o3z8d	143	12	(	(	-LRB-
cord-303322-d69o3z8d	143	13	CDS	CDS	NNP
cord-303322-d69o3z8d	143	14	)	)	-RRB-
cord-303322-d69o3z8d	143	15	disc	disc	NN
cord-303322-d69o3z8d	143	16	diffusion	diffusion	NN
cord-303322-d69o3z8d	143	17	method	method	NN
cord-303322-d69o3z8d	143	18	,	,	,
cord-303322-d69o3z8d	143	19	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	143	20	minimum	minimum	JJ
cord-303322-d69o3z8d	143	21	inhibitory	inhibitory	JJ
cord-303322-d69o3z8d	143	22	concentration	concentration	NN
cord-303322-d69o3z8d	143	23	(	(	-LRB-
cord-303322-d69o3z8d	143	24	MIC	MIC	NNP
cord-303322-d69o3z8d	143	25	)	)	-RRB-
cord-303322-d69o3z8d	143	26	will	will	MD
cord-303322-d69o3z8d	143	27	be	be	VB
cord-303322-d69o3z8d	143	28	determined	determine	VBN
cord-303322-d69o3z8d	143	29	using	use	VBG
cord-303322-d69o3z8d	143	30	Etest	Etest	NNP
cord-303322-d69o3z8d	143	31	(	(	-LRB-
cord-303322-d69o3z8d	143	32	AB	AB	NNP
cord-303322-d69o3z8d	143	33	Biodisk	Biodisk	NNP
cord-303322-d69o3z8d	143	34	,	,	,
cord-303322-d69o3z8d	143	35	Sweden	Sweden	NNP
cord-303322-d69o3z8d	143	36	)	)	-RRB-
cord-303322-d69o3z8d	143	37	if	if	IN
cord-303322-d69o3z8d	143	38	the	the	DT
cord-303322-d69o3z8d	143	39	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	143	40	disc	disc	NN
cord-303322-d69o3z8d	143	41	annulus	annulus	NN
cord-303322-d69o3z8d	143	42	is	be	VBZ
cord-303322-d69o3z8d	143	43	less	less	JJR
cord-303322-d69o3z8d	143	44	than	than	IN
cord-303322-d69o3z8d	143	45	6	6	CD
cord-303322-d69o3z8d	143	46	mm	mm	NNS
cord-303322-d69o3z8d	143	47	.	.	.
cord-303322-d69o3z8d	144	1	For	for	IN
cord-303322-d69o3z8d	144	2	S.	S.	NNP
cord-303322-d69o3z8d	144	3	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	144	4	,	,	,
cord-303322-d69o3z8d	144	5	the	the	DT
cord-303322-d69o3z8d	144	6	penicillin	penicillin	NN
cord-303322-d69o3z8d	144	7	MIC	MIC	NNP
cord-303322-d69o3z8d	144	8	is	be	VBZ
cord-303322-d69o3z8d	144	9	determined	determine	VBN
cord-303322-d69o3z8d	144	10	for	for	IN
cord-303322-d69o3z8d	144	11	penicillin	penicillin	NN
cord-303322-d69o3z8d	144	12	non	non	JJ
cord-303322-d69o3z8d	144	13	-	-	JJ
cord-303322-d69o3z8d	144	14	susceptible	susceptible	JJ
cord-303322-d69o3z8d	144	15	isolates	isolate	NNS
cord-303322-d69o3z8d	144	16	(	(	-LRB-
cord-303322-d69o3z8d	144	17	oxacillin	oxacillin	NNP
cord-303322-d69o3z8d	144	18	and/or	and/or	CC
cord-303322-d69o3z8d	144	19	penicillin	penicillin	NN
cord-303322-d69o3z8d	144	20	disc	disc	NN
cord-303322-d69o3z8d	144	21	annulus	annulus	NN
cord-303322-d69o3z8d	144	22	<	<	XX
cord-303322-d69o3z8d	144	23	6	6	CD
cord-303322-d69o3z8d	144	24	mm	mm	NNP
cord-303322-d69o3z8d	144	25	)	)	-RRB-
cord-303322-d69o3z8d	144	26	and	and	CC
cord-303322-d69o3z8d	144	27	for	for	IN
cord-303322-d69o3z8d	144	28	H.	H.	NNP
cord-303322-d69o3z8d	144	29	influenzae	influenzae	NN
cord-303322-d69o3z8d	144	30	,	,	,
cord-303322-d69o3z8d	144	31	the	the	DT
cord-303322-d69o3z8d	144	32	ampicillin	ampicillin	NNP
cord-303322-d69o3z8d	144	33	MIC	MIC	NNP
cord-303322-d69o3z8d	144	34	is	be	VBZ
cord-303322-d69o3z8d	144	35	determined	determine	VBN
cord-303322-d69o3z8d	144	36	for	for	IN
cord-303322-d69o3z8d	144	37	isolates	isolate	NNS
cord-303322-d69o3z8d	144	38	if	if	IN
cord-303322-d69o3z8d	145	1	the	the	DT
cord-303322-d69o3z8d	145	2	ampicillin	ampicillin	NNP
cord-303322-d69o3z8d	146	1	disc	disc	NN
cord-303322-d69o3z8d	146	2	annulus	annulus	NN
cord-303322-d69o3z8d	146	3	is	be	VBZ
cord-303322-d69o3z8d	146	4	less	less	JJR
cord-303322-d69o3z8d	146	5	than	than	IN
cord-303322-d69o3z8d	146	6	6	6	CD
cord-303322-d69o3z8d	146	7	mm	mm	NNS
cord-303322-d69o3z8d	146	8	.	.	.
cord-303322-d69o3z8d	147	1	Interpretive	interpretive	JJ
cord-303322-d69o3z8d	147	2	criteria	criterion	NNS
cord-303322-d69o3z8d	147	3	(	(	-LRB-
cord-303322-d69o3z8d	147	4	CSLI	CSLI	NNP
cord-303322-d69o3z8d	147	5	breakpoints	breakpoint	NNS
cord-303322-d69o3z8d	147	6	)	)	-RRB-
cord-303322-d69o3z8d	147	7	used	use	VBN
cord-303322-d69o3z8d	147	8	for	for	IN
cord-303322-d69o3z8d	147	9	S.	S.	NNP
cord-303322-d69o3z8d	147	10	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	148	1	are	be	VBP
cord-303322-d69o3z8d	148	2	penicillin	penicillin	NN
cord-303322-d69o3z8d	148	3	non	non	JJ
cord-303322-d69o3z8d	148	4	-	-	JJ
cord-303322-d69o3z8d	148	5	susceptible	susceptible	JJ
cord-303322-d69o3z8d	148	6	MIC	mic	NN
cord-303322-d69o3z8d	148	7	>	>	XX
cord-303322-d69o3z8d	149	1	0.12	0.12	CD
cord-303322-d69o3z8d	149	2	μg	μg	NNP
cord-303322-d69o3z8d	149	3	/	/	SYM
cord-303322-d69o3z8d	149	4	mL	mL	NNP
cord-303322-d69o3z8d	149	5	,	,	,
cord-303322-d69o3z8d	149	6	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	149	7	resistant	resistant	JJ
cord-303322-d69o3z8d	149	8	MIC	MIC	NNP
cord-303322-d69o3z8d	149	9	≥	≥	CD
cord-303322-d69o3z8d	149	10	2	2	CD
cord-303322-d69o3z8d	149	11	μg	μg	NN
cord-303322-d69o3z8d	149	12	/	/	SYM
cord-303322-d69o3z8d	149	13	mL	mL	NNP
cord-303322-d69o3z8d	149	14	,	,	,
cord-303322-d69o3z8d	149	15	and	and	CC
cord-303322-d69o3z8d	149	16	for	for	IN
cord-303322-d69o3z8d	149	17	H.	h.	NN
cord-303322-d69o3z8d	149	18	influenzae	influenzae	NN
cord-303322-d69o3z8d	149	19	,	,	,
cord-303322-d69o3z8d	149	20	ampicillin	ampicillin	JJ
cord-303322-d69o3z8d	149	21	resistant	resistant	JJ
cord-303322-d69o3z8d	149	22	MIC	MIC	NNP
cord-303322-d69o3z8d	149	23	≥	≥	CD
cord-303322-d69o3z8d	149	24	4	4	CD
cord-303322-d69o3z8d	149	25	μg	μg	NN
cord-303322-d69o3z8d	149	26	/	/	SYM
cord-303322-d69o3z8d	149	27	mL	mL	NNP
cord-303322-d69o3z8d	149	28	,	,	,
cord-303322-d69o3z8d	149	29	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	149	30	resistant	resistant	JJ
cord-303322-d69o3z8d	149	31	MIC	MIC	NNP
cord-303322-d69o3z8d	150	1	>	>	XX
cord-303322-d69o3z8d	151	1	4	4	CD
cord-303322-d69o3z8d	151	2	μg/	μg/	ADD
cord-303322-d69o3z8d	152	1	mL.	mL.	NNP
cord-303322-d69o3z8d	152	2	Beta	beta	NN
cord-303322-d69o3z8d	152	3	-	-	HYPH
cord-303322-d69o3z8d	152	4	lactamase	lactamase	NN
cord-303322-d69o3z8d	152	5	activity	activity	NN
cord-303322-d69o3z8d	152	6	will	will	MD
cord-303322-d69o3z8d	152	7	be	be	VB
cord-303322-d69o3z8d	152	8	determined	determine	VBN
cord-303322-d69o3z8d	152	9	for	for	IN
cord-303322-d69o3z8d	152	10	H.	h.	NN
cord-303322-d69o3z8d	152	11	influenzae	influenzae	NN
cord-303322-d69o3z8d	152	12	and	and	CC
cord-303322-d69o3z8d	152	13	M.	M.	NNP
cord-303322-d69o3z8d	152	14	catarrhalis	catarrhalis	FW
cord-303322-d69o3z8d	152	15	isolates	isolate	VBZ
cord-303322-d69o3z8d	152	16	.	.	.
cord-303322-d69o3z8d	153	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	153	2	previous	previous	JJ
cord-303322-d69o3z8d	153	3	methods	method	NNS
cord-303322-d69o3z8d	153	4	will	will	MD
cord-303322-d69o3z8d	153	5	be	be	VB
cord-303322-d69o3z8d	153	6	utilised	utilise	VBN
cord-303322-d69o3z8d	153	7	[	[	-LRB-
cord-303322-d69o3z8d	153	8	15	15	CD
cord-303322-d69o3z8d	153	9	,	,	,
cord-303322-d69o3z8d	153	10	38	38	CD
cord-303322-d69o3z8d	153	11	,	,	,
cord-303322-d69o3z8d	153	12	39	39	CD
cord-303322-d69o3z8d	153	13	]	]	-RRB-
cord-303322-d69o3z8d	153	14	.	.	.
cord-303322-d69o3z8d	154	1	NPS	NPS	NNP
cord-303322-d69o3z8d	154	2	are	be	VBP
cord-303322-d69o3z8d	154	3	frozen	freeze	VBN
cord-303322-d69o3z8d	154	4	at	at	IN
cord-303322-d69o3z8d	154	5	-80	-80	NNP
cord-303322-d69o3z8d	154	6	°	°	NN
cord-303322-d69o3z8d	154	7	C	C	NNP
cord-303322-d69o3z8d	154	8	.	.	.
cord-303322-d69o3z8d	155	1	Upon	upon	IN
cord-303322-d69o3z8d	155	2	thawing	thaw	VBG
cord-303322-d69o3z8d	155	3	nucleic	nucleic	JJ
cord-303322-d69o3z8d	155	4	acids	acid	NNS
cord-303322-d69o3z8d	155	5	will	will	MD
cord-303322-d69o3z8d	155	6	be	be	VB
cord-303322-d69o3z8d	155	7	extracted	extract	VBN
cord-303322-d69o3z8d	155	8	from	from	IN
cord-303322-d69o3z8d	155	9	0.2	0.2	CD
cord-303322-d69o3z8d	155	10	ml	ml	NNS
cord-303322-d69o3z8d	155	11	of	of	IN
cord-303322-d69o3z8d	155	12	each	each	DT
cord-303322-d69o3z8d	155	13	NPS	NPS	NNP
cord-303322-d69o3z8d	155	14	specimen	specimen	NN
cord-303322-d69o3z8d	155	15	using	use	VBG
cord-303322-d69o3z8d	155	16	the	the	DT
cord-303322-d69o3z8d	155	17	High	high	JJ
cord-303322-d69o3z8d	155	18	Pure	pure	JJ
cord-303322-d69o3z8d	155	19	Viral	Viral	NNP
cord-303322-d69o3z8d	155	20	Nucleic	Nucleic	NNP
cord-303322-d69o3z8d	155	21	Acid	acid	NN
cord-303322-d69o3z8d	155	22	kit	kit	NN
cord-303322-d69o3z8d	155	23	(	(	-LRB-
cord-303322-d69o3z8d	155	24	Roche	Roche	NNP
cord-303322-d69o3z8d	155	25	Diagnostics	Diagnostics	NNP
cord-303322-d69o3z8d	155	26	,	,	,
cord-303322-d69o3z8d	155	27	Australia	Australia	NNP
cord-303322-d69o3z8d	155	28	)	)	-RRB-
cord-303322-d69o3z8d	155	29	,	,	,
cord-303322-d69o3z8d	155	30	according	accord	VBG
cord-303322-d69o3z8d	155	31	to	to	IN
cord-303322-d69o3z8d	155	32	the	the	DT
cord-303322-d69o3z8d	155	33	manufacturer	manufacturer	NN
cord-303322-d69o3z8d	155	34	's	's	POS
cord-303322-d69o3z8d	155	35	instructions	instruction	NNS
cord-303322-d69o3z8d	155	36	.	.	.
cord-303322-d69o3z8d	156	1	Mono	mono	JJ
cord-303322-d69o3z8d	156	2	-	-	HYPH
cord-303322-d69o3z8d	156	3	specific	specific	JJ
cord-303322-d69o3z8d	156	4	PCR	PCR	NNP
cord-303322-d69o3z8d	156	5	and	and	CC
cord-303322-d69o3z8d	156	6	reverse	reverse	VB
cord-303322-d69o3z8d	156	7	transcriptase	transcriptase	NN
cord-303322-d69o3z8d	156	8	PCR	PCR	NNP
cord-303322-d69o3z8d	156	9	(	(	-LRB-
cord-303322-d69o3z8d	156	10	RT	RT	NNP
cord-303322-d69o3z8d	156	11	-	-	HYPH
cord-303322-d69o3z8d	156	12	PCR	PCR	NNP
cord-303322-d69o3z8d	156	13	)	)	-RRB-
cord-303322-d69o3z8d	156	14	method	method	NN
cord-303322-d69o3z8d	156	15	will	will	MD
cord-303322-d69o3z8d	156	16	be	be	VB
cord-303322-d69o3z8d	156	17	used	use	VBN
cord-303322-d69o3z8d	156	18	to	to	TO
cord-303322-d69o3z8d	156	19	detect	detect	VB
cord-303322-d69o3z8d	156	20	Mycoplasma	mycoplasma	NN
cord-303322-d69o3z8d	156	21	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	156	22	,	,	,
cord-303322-d69o3z8d	156	23	coronaviruses	coronaviruse	NNS
cord-303322-d69o3z8d	156	24	,	,	,
cord-303322-d69o3z8d	156	25	bocavirus	bocavirus	NNP
cord-303322-d69o3z8d	156	26	and	and	CC
cord-303322-d69o3z8d	156	27	human	human	NNP
cord-303322-d69o3z8d	156	28	metapneumovirus	metapneumovirus	NNP
cord-303322-d69o3z8d	156	29	(	(	-LRB-
cord-303322-d69o3z8d	156	30	hMPV	hMPV	NNP
cord-303322-d69o3z8d	156	31	)	)	-RRB-
cord-303322-d69o3z8d	156	32	,	,	,
cord-303322-d69o3z8d	156	33	whereas	whereas	IN
cord-303322-d69o3z8d	156	34	multiplex	multiplex	NN
cord-303322-d69o3z8d	156	35	PCR	PCR	NNP
cord-303322-d69o3z8d	156	36	and	and	CC
cord-303322-d69o3z8d	156	37	RT	RT	NNP
cord-303322-d69o3z8d	156	38	-	-	HYPH
cord-303322-d69o3z8d	156	39	PCR	PCR	NNP
cord-303322-d69o3z8d	156	40	was	be	VBD
cord-303322-d69o3z8d	156	41	used	use	VBN
cord-303322-d69o3z8d	156	42	to	to	TO
cord-303322-d69o3z8d	156	43	detect	detect	VB
cord-303322-d69o3z8d	156	44	adenovirus	adenovirus	NN
cord-303322-d69o3z8d	156	45	,	,	,
cord-303322-d69o3z8d	156	46	parainfluenza	parainfluenza	NNP
cord-303322-d69o3z8d	156	47	(	(	-LRB-
cord-303322-d69o3z8d	156	48	1	1	CD
cord-303322-d69o3z8d	156	49	,	,	,
cord-303322-d69o3z8d	156	50	2	2	CD
cord-303322-d69o3z8d	156	51	3	3	CD
cord-303322-d69o3z8d	156	52	)	)	-RRB-
cord-303322-d69o3z8d	156	53	,	,	,
cord-303322-d69o3z8d	156	54	influenza	influenza	NN
cord-303322-d69o3z8d	156	55	(	(	-LRB-
cord-303322-d69o3z8d	156	56	A	a	NN
cord-303322-d69o3z8d	156	57	and	and	CC
cord-303322-d69o3z8d	156	58	B	B	NNP
cord-303322-d69o3z8d	156	59	)	)	-RRB-
cord-303322-d69o3z8d	156	60	,	,	,
cord-303322-d69o3z8d	156	61	and	and	CC
cord-303322-d69o3z8d	156	62	respiratory	respiratory	JJ
cord-303322-d69o3z8d	156	63	syncytial	syncytial	JJ
cord-303322-d69o3z8d	156	64	virus	virus	NN
cord-303322-d69o3z8d	156	65	(	(	-LRB-
cord-303322-d69o3z8d	156	66	RSV	RSV	NNP
cord-303322-d69o3z8d	156	67	)	)	-RRB-
cord-303322-d69o3z8d	156	68	.	.	.
cord-303322-d69o3z8d	157	1	All	all	PDT
cord-303322-d69o3z8d	157	2	these	these	DT
cord-303322-d69o3z8d	157	3	methods	method	NNS
cord-303322-d69o3z8d	157	4	have	have	VBP
cord-303322-d69o3z8d	157	5	been	be	VBN
cord-303322-d69o3z8d	157	6	previously	previously	RB
cord-303322-d69o3z8d	157	7	validated	validate	VBN
cord-303322-d69o3z8d	157	8	in	in	IN
cord-303322-d69o3z8d	157	9	our	-PRON-	PRP$
cord-303322-d69o3z8d	157	10	viral	viral	JJ
cord-303322-d69o3z8d	157	11	laboratory	laboratory	NN
cord-303322-d69o3z8d	157	12	at	at	IN
cord-303322-d69o3z8d	157	13	the	the	DT
cord-303322-d69o3z8d	157	14	Royal	Royal	NNP
cord-303322-d69o3z8d	157	15	Children	Children	NNPS
cord-303322-d69o3z8d	157	16	's	's	POS
cord-303322-d69o3z8d	157	17	Hospital	Hospital	NNP
cord-303322-d69o3z8d	157	18	,	,	,
cord-303322-d69o3z8d	157	19	Brisbane	Brisbane	NNP
cord-303322-d69o3z8d	157	20	.	.	.
cord-303322-d69o3z8d	158	1	Participation	participation	NN
cord-303322-d69o3z8d	158	2	is	be	VBZ
cord-303322-d69o3z8d	158	3	complete	complete	JJ
cord-303322-d69o3z8d	158	4	when	when	WRB
cord-303322-d69o3z8d	158	5	day-21	day-21	JJ
cord-303322-d69o3z8d	158	6	outcomes	outcome	NNS
cord-303322-d69o3z8d	158	7	have	have	VBP
cord-303322-d69o3z8d	158	8	been	be	VBN
cord-303322-d69o3z8d	158	9	obtained	obtain	VBN
cord-303322-d69o3z8d	158	10	.	.	.
cord-303322-d69o3z8d	159	1	Other	other	JJ
cord-303322-d69o3z8d	159	2	exit	exit	NN
cord-303322-d69o3z8d	159	3	points	point	NNS
cord-303322-d69o3z8d	159	4	are	be	VBP
cord-303322-d69o3z8d	159	5	:	:	:
cord-303322-d69o3z8d	159	6	intolerance	intolerance	NN
cord-303322-d69o3z8d	159	7	to	to	IN
cord-303322-d69o3z8d	159	8	the	the	DT
cord-303322-d69o3z8d	159	9	trial	trial	NN
cord-303322-d69o3z8d	159	10	medications	medication	NNS
cord-303322-d69o3z8d	159	11	requiring	require	VBG
cord-303322-d69o3z8d	159	12	withdrawal	withdrawal	NN
cord-303322-d69o3z8d	159	13	from	from	IN
cord-303322-d69o3z8d	159	14	study	study	NN
cord-303322-d69o3z8d	159	15	(	(	-LRB-
cord-303322-d69o3z8d	159	16	as	as	IN
cord-303322-d69o3z8d	159	17	deemed	deem	VBN
cord-303322-d69o3z8d	159	18	by	by	IN
cord-303322-d69o3z8d	159	19	the	the	DT
cord-303322-d69o3z8d	159	20	treating	treat	VBG
cord-303322-d69o3z8d	159	21	paediatrician	paediatrician	NN
cord-303322-d69o3z8d	159	22	who	who	WP
cord-303322-d69o3z8d	159	23	is	be	VBZ
cord-303322-d69o3z8d	159	24	not	not	RB
cord-303322-d69o3z8d	159	25	directly	directly	RB
cord-303322-d69o3z8d	159	26	connected	connect	VBN
cord-303322-d69o3z8d	159	27	to	to	IN
cord-303322-d69o3z8d	159	28	the	the	DT
cord-303322-d69o3z8d	159	29	study	study	NN
cord-303322-d69o3z8d	159	30	team	team	NN
cord-303322-d69o3z8d	159	31	)	)	-RRB-
cord-303322-d69o3z8d	159	32	.	.	.
cord-303322-d69o3z8d	160	1	(	(	-LRB-
cord-303322-d69o3z8d	160	2	i	i	NN
cord-303322-d69o3z8d	160	3	)	)	-RRB-
cord-303322-d69o3z8d	160	4	Length	length	NN
cord-303322-d69o3z8d	160	5	of	of	IN
cord-303322-d69o3z8d	160	6	stay	stay	NN
cord-303322-d69o3z8d	160	7	(	(	-LRB-
cord-303322-d69o3z8d	160	8	LOS	LOS	NNP
cord-303322-d69o3z8d	160	9	)	)	-RRB-
cord-303322-d69o3z8d	160	10	for	for	IN
cord-303322-d69o3z8d	160	11	respiratory	respiratory	JJ
cord-303322-d69o3z8d	160	12	illness	illness	NN
cord-303322-d69o3z8d	160	13	in	in	IN
cord-303322-d69o3z8d	160	14	hospital	hospital	NN
cord-303322-d69o3z8d	160	15	-	-	HYPH
cord-303322-d69o3z8d	160	16	defined	define	VBN
cord-303322-d69o3z8d	160	17	as	as	IN
cord-303322-d69o3z8d	160	18	time	time	NN
cord-303322-d69o3z8d	160	19	from	from	IN
cord-303322-d69o3z8d	160	20	admission	admission	NN
cord-303322-d69o3z8d	160	21	to	to	IN
cord-303322-d69o3z8d	160	22	time	time	NN
cord-303322-d69o3z8d	160	23	'	'	``
cord-303322-d69o3z8d	160	24	ready	ready	JJ
cord-303322-d69o3z8d	160	25	for	for	IN
cord-303322-d69o3z8d	160	26	discharge	discharge	NN
cord-303322-d69o3z8d	160	27	'	'	''
cord-303322-d69o3z8d	160	28	for	for	IN
cord-303322-d69o3z8d	160	29	respiratory	respiratory	JJ
cord-303322-d69o3z8d	160	30	care	care	NN
cord-303322-d69o3z8d	160	31	.	.	.
cord-303322-d69o3z8d	160	32	'	'	''
cord-303322-d69o3z8d	161	1	Ready	ready	JJ
cord-303322-d69o3z8d	161	2	for	for	IN
cord-303322-d69o3z8d	161	3	discharge	discharge	NN
cord-303322-d69o3z8d	161	4	'	'	''
cord-303322-d69o3z8d	161	5	means	mean	VBZ
cord-303322-d69o3z8d	161	6	normoxic	normoxic	JJ
cord-303322-d69o3z8d	162	1	(	(	-LRB-
cord-303322-d69o3z8d	162	2	Sp0	sp0	NN
cord-303322-d69o3z8d	162	3	2	2	CD
cord-303322-d69o3z8d	162	4	consistently	consistently	RB
cord-303322-d69o3z8d	162	5	>	>	XX
cord-303322-d69o3z8d	162	6	94	94	CD
cord-303322-d69o3z8d	162	7	%	%	NN
cord-303322-d69o3z8d	162	8	in	in	IN
cord-303322-d69o3z8d	162	9	air	air	NN
cord-303322-d69o3z8d	162	10	for	for	IN
cord-303322-d69o3z8d	162	11	>	>	XX
cord-303322-d69o3z8d	162	12	16hrs	16hrs	LS
cord-303322-d69o3z8d	162	13	)	)	-RRB-
cord-303322-d69o3z8d	162	14	and	and	CC
cord-303322-d69o3z8d	162	15	feeding	feed	VBG
cord-303322-d69o3z8d	162	16	adequately	adequately	RB
cord-303322-d69o3z8d	162	17	;	;	:
cord-303322-d69o3z8d	162	18	and	and	CC
cord-303322-d69o3z8d	162	19	(	(	-LRB-
cord-303322-d69o3z8d	162	20	ii	ii	NN
cord-303322-d69o3z8d	162	21	)	)	-RRB-
cord-303322-d69o3z8d	162	22	Duration	duration	NN
cord-303322-d69o3z8d	162	23	of	of	IN
cord-303322-d69o3z8d	162	24	supplemental	supplemental	JJ
cord-303322-d69o3z8d	162	25	oxygen	oxygen	NN
cord-303322-d69o3z8d	162	26	required	require	VBN
cord-303322-d69o3z8d	162	27	.	.	.
cord-303322-d69o3z8d	162	28	'	'	''
cord-303322-d69o3z8d	163	1	Ready	ready	JJ
cord-303322-d69o3z8d	163	2	for	for	IN
cord-303322-d69o3z8d	163	3	discharge	discharge	NN
cord-303322-d69o3z8d	163	4	'	'	''
cord-303322-d69o3z8d	163	5	for	for	IN
cord-303322-d69o3z8d	163	6	respiratory	respiratory	JJ
cord-303322-d69o3z8d	163	7	care	care	NN
cord-303322-d69o3z8d	163	8	differs	differ	VBZ
cord-303322-d69o3z8d	163	9	from	from	IN
cord-303322-d69o3z8d	163	10	length	length	NN
cord-303322-d69o3z8d	163	11	of	of	IN
cord-303322-d69o3z8d	163	12	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	163	13	as	as	IN
cord-303322-d69o3z8d	163	14	discharge	discharge	NN
cord-303322-d69o3z8d	163	15	from	from	IN
cord-303322-d69o3z8d	163	16	hospital	hospital	NN
cord-303322-d69o3z8d	163	17	may	may	MD
cord-303322-d69o3z8d	163	18	be	be	VB
cord-303322-d69o3z8d	163	19	delayed	delay	VBN
cord-303322-d69o3z8d	163	20	because	because	IN
cord-303322-d69o3z8d	163	21	of	of	IN
cord-303322-d69o3z8d	163	22	social	social	JJ
cord-303322-d69o3z8d	163	23	or	or	CC
cord-303322-d69o3z8d	163	24	transport	transport	NN
cord-303322-d69o3z8d	163	25	factors	factor	NNS
cord-303322-d69o3z8d	163	26	especially	especially	RB
cord-303322-d69o3z8d	163	27	in	in	IN
cord-303322-d69o3z8d	163	28	children	child	NNS
cord-303322-d69o3z8d	163	29	from	from	IN
cord-303322-d69o3z8d	163	30	remote	remote	JJ
cord-303322-d69o3z8d	163	31	communities	community	NNS
cord-303322-d69o3z8d	163	32	.	.	.
cord-303322-d69o3z8d	164	1	The	the	DT
cord-303322-d69o3z8d	164	2	major	major	JJ
cord-303322-d69o3z8d	164	3	secondary	secondary	JJ
cord-303322-d69o3z8d	164	4	outcome	outcome	NN
cord-303322-d69o3z8d	164	5	is	be	VBZ
cord-303322-d69o3z8d	164	6	readmission	readmission	NN
cord-303322-d69o3z8d	164	7	for	for	IN
cord-303322-d69o3z8d	164	8	respiratory	respiratory	JJ
cord-303322-d69o3z8d	164	9	illness	illness	NN
cord-303322-d69o3z8d	164	10	(	(	-LRB-
cord-303322-d69o3z8d	164	11	within	within	IN
cord-303322-d69o3z8d	164	12	6-months	6-months	CD
cord-303322-d69o3z8d	164	13	of	of	IN
cord-303322-d69o3z8d	164	14	discharge	discharge	NN
cord-303322-d69o3z8d	164	15	from	from	IN
cord-303322-d69o3z8d	164	16	hospital	hospital	NN
cord-303322-d69o3z8d	164	17	)	)	-RRB-
cord-303322-d69o3z8d	164	18	.	.	.
cord-303322-d69o3z8d	165	1	Minor	minor	JJ
cord-303322-d69o3z8d	165	2	outcomes	outcome	NNS
cord-303322-d69o3z8d	165	3	during	during	IN
cord-303322-d69o3z8d	165	4	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	165	5	:	:	:
cord-303322-d69o3z8d	165	6	clinical	clinical	JJ
cord-303322-d69o3z8d	165	7	severity	severity	NN
cord-303322-d69o3z8d	165	8	score	score	NN
cord-303322-d69o3z8d	165	9	,	,	,
cord-303322-d69o3z8d	165	10	[	[	-LRB-
cord-303322-d69o3z8d	165	11	27	27	CD
cord-303322-d69o3z8d	165	12	]	]	-RRB-
cord-303322-d69o3z8d	165	13	additional	additional	JJ
cord-303322-d69o3z8d	165	14	use	use	NN
cord-303322-d69o3z8d	165	15	of	of	IN
cord-303322-d69o3z8d	165	16	antibiotics	antibiotic	NNS
cord-303322-d69o3z8d	165	17	,	,	,
cord-303322-d69o3z8d	165	18	and	and	CC
cord-303322-d69o3z8d	165	19	episodes	episode	NNS
cord-303322-d69o3z8d	165	20	of	of	IN
cord-303322-d69o3z8d	165	21	suppurative	suppurative	JJ
cord-303322-d69o3z8d	165	22	otitis	otitis	NN
cord-303322-d69o3z8d	165	23	media	medium	NNS
cord-303322-d69o3z8d	165	24	and	and	CC
cord-303322-d69o3z8d	165	25	development	development	NN
cord-303322-d69o3z8d	165	26	of	of	IN
cord-303322-d69o3z8d	165	27	pneumonia	pneumonia	NN
cord-303322-d69o3z8d	165	28	.	.	.
cord-303322-d69o3z8d	166	1	The	the	DT
cord-303322-d69o3z8d	166	2	Day-21	Day-21	NNP
cord-303322-d69o3z8d	166	3	outcomes	outcome	NNS
cord-303322-d69o3z8d	166	4	are	be	VBP
cord-303322-d69o3z8d	166	5	:	:	:
cord-303322-d69o3z8d	166	6	presence	presence	NN
cord-303322-d69o3z8d	166	7	of	of	IN
cord-303322-d69o3z8d	166	8	cough	cough	NN
cord-303322-d69o3z8d	166	9	,	,	,
cord-303322-d69o3z8d	166	10	wheeze	wheeze	NN
cord-303322-d69o3z8d	166	11	,	,	,
cord-303322-d69o3z8d	166	12	abnormal	abnormal	JJ
cord-303322-d69o3z8d	166	13	auscultatory	auscultatory	IN
cord-303322-d69o3z8d	166	14	chest	chest	NN
cord-303322-d69o3z8d	166	15	signs	sign	NNS
cord-303322-d69o3z8d	166	16	and	and	CC
cord-303322-d69o3z8d	166	17	suppurative	suppurative	JJ
cord-303322-d69o3z8d	166	18	otitis	otitis	NN
cord-303322-d69o3z8d	166	19	media	medium	NNS
cord-303322-d69o3z8d	166	20	.	.	.
cord-303322-d69o3z8d	167	1	We	-PRON-	PRP
cord-303322-d69o3z8d	167	2	will	will	MD
cord-303322-d69o3z8d	167	3	also	also	RB
cord-303322-d69o3z8d	167	4	analyse	analyse	VB
cord-303322-d69o3z8d	167	5	all	all	DT
cord-303322-d69o3z8d	167	6	clinical	clinical	JJ
cord-303322-d69o3z8d	167	7	outcomes	outcome	NNS
cord-303322-d69o3z8d	167	8	in	in	IN
cord-303322-d69o3z8d	167	9	the	the	DT
cord-303322-d69o3z8d	167	10	following	follow	VBG
cord-303322-d69o3z8d	167	11	pre	pre	JJ
cord-303322-d69o3z8d	167	12	-	-	JJ
cord-303322-d69o3z8d	167	13	determined	determined	JJ
cord-303322-d69o3z8d	167	14	sub	sub	NN
cord-303322-d69o3z8d	167	15	-	-	NNS
cord-303322-d69o3z8d	167	16	groups	group	NNS
cord-303322-d69o3z8d	167	17	:	:	:
cord-303322-d69o3z8d	168	1	(	(	-LRB-
cord-303322-d69o3z8d	168	2	i	i	NN
cord-303322-d69o3z8d	168	3	)	)	-RRB-
cord-303322-d69o3z8d	168	4	age	age	NN
cord-303322-d69o3z8d	168	5	≤	≤	NNS
cord-303322-d69o3z8d	168	6	6-months	6-months	CD
cord-303322-d69o3z8d	168	7	;	;	:
cord-303322-d69o3z8d	168	8	and	and	CC
cord-303322-d69o3z8d	168	9	(	(	-LRB-
cord-303322-d69o3z8d	168	10	ii	ii	NN
cord-303322-d69o3z8d	168	11	)	)	-RRB-
cord-303322-d69o3z8d	168	12	presence	presence	NN
cord-303322-d69o3z8d	168	13	of	of	IN
cord-303322-d69o3z8d	168	14	bacterial	bacterial	JJ
cord-303322-d69o3z8d	168	15	respiratory	respiratory	JJ
cord-303322-d69o3z8d	168	16	pathogens	pathogen	NNS
cord-303322-d69o3z8d	168	17	that	that	WDT
cord-303322-d69o3z8d	168	18	are	be	VBP
cord-303322-d69o3z8d	168	19	resistant	resistant	JJ
cord-303322-d69o3z8d	168	20	to	to	IN
cord-303322-d69o3z8d	168	21	macrolide	macrolide	JJ
cord-303322-d69o3z8d	168	22	antibiotics	antibiotic	NNS
cord-303322-d69o3z8d	168	23	.	.	.
cord-303322-d69o3z8d	169	1	(	(	-LRB-
cord-303322-d69o3z8d	169	2	i	i	NN
cord-303322-d69o3z8d	169	3	)	)	-RRB-
cord-303322-d69o3z8d	169	4	identification	identification	NN
cord-303322-d69o3z8d	169	5	of	of	IN
cord-303322-d69o3z8d	169	6	respiratory	respiratory	JJ
cord-303322-d69o3z8d	169	7	viruses	virus	NNS
cord-303322-d69o3z8d	169	8	and	and	CC
cord-303322-d69o3z8d	169	9	bacterial	bacterial	JJ
cord-303322-d69o3z8d	169	10	pathogens	pathogen	NNS
cord-303322-d69o3z8d	169	11	and	and	CC
cord-303322-d69o3z8d	169	12	(	(	-LRB-
cord-303322-d69o3z8d	169	13	ii	ii	NN
cord-303322-d69o3z8d	169	14	)	)	-RRB-
cord-303322-d69o3z8d	169	15	antibiotic	antibiotic	JJ
cord-303322-d69o3z8d	169	16	resistance	resistance	NN
cord-303322-d69o3z8d	169	17	to	to	IN
cord-303322-d69o3z8d	169	18	penicillin	penicillin	NN
cord-303322-d69o3z8d	169	19	and	and	CC
cord-303322-d69o3z8d	169	20	macrolides	macrolide	NNS
cord-303322-d69o3z8d	169	21	.	.	.
cord-303322-d69o3z8d	170	1	We	-PRON-	PRP
cord-303322-d69o3z8d	170	2	plan	plan	VBP
cord-303322-d69o3z8d	170	3	to	to	TO
cord-303322-d69o3z8d	170	4	enrol	enrol	VB
cord-303322-d69o3z8d	170	5	200	200	CD
cord-303322-d69o3z8d	170	6	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	170	7	infants	infant	NNS
cord-303322-d69o3z8d	170	8	.	.	.
cord-303322-d69o3z8d	171	1	In	in	IN
cord-303322-d69o3z8d	171	2	our	-PRON-	PRP$
cord-303322-d69o3z8d	171	3	retrospective	retrospective	JJ
cord-303322-d69o3z8d	171	4	study	study	NN
cord-303322-d69o3z8d	171	5	,	,	,
cord-303322-d69o3z8d	171	6	[	[	-LRB-
cord-303322-d69o3z8d	171	7	6	6	CD
cord-303322-d69o3z8d	171	8	]	]	-RRB-
cord-303322-d69o3z8d	171	9	the	the	DT
cord-303322-d69o3z8d	171	10	mean	mean	JJ
cord-303322-d69o3z8d	171	11	LOS	LOS	NNP
cord-303322-d69o3z8d	171	12	in	in	IN
cord-303322-d69o3z8d	171	13	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	171	14	infants	infant	NNS
cord-303322-d69o3z8d	171	15	with	with	IN
cord-303322-d69o3z8d	171	16	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	171	17	at	at	IN
cord-303322-d69o3z8d	171	18	RDH	RDH	NNP
cord-303322-d69o3z8d	171	19	was	be	VBD
cord-303322-d69o3z8d	171	20	96	96	CD
cord-303322-d69o3z8d	171	21	(	(	-LRB-
cord-303322-d69o3z8d	171	22	SD	SD	NNP
cord-303322-d69o3z8d	171	23	24	24	CD
cord-303322-d69o3z8d	171	24	)	)	-RRB-
cord-303322-d69o3z8d	171	25	hours	hour	NNS
cord-303322-d69o3z8d	171	26	.	.	.
cord-303322-d69o3z8d	172	1	The	the	DT
cord-303322-d69o3z8d	172	2	mean	mean	JJ
cord-303322-d69o3z8d	172	3	duration	duration	NN
cord-303322-d69o3z8d	172	4	of	of	IN
cord-303322-d69o3z8d	172	5	supplemental	supplemental	JJ
cord-303322-d69o3z8d	172	6	oxygen	oxygen	NN
cord-303322-d69o3z8d	172	7	requirement	requirement	NN
cord-303322-d69o3z8d	172	8	in	in	IN
cord-303322-d69o3z8d	172	9	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	172	10	infants	infant	NNS
cord-303322-d69o3z8d	172	11	with	with	IN
cord-303322-d69o3z8d	172	12	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	172	13	was	be	VBD
cord-303322-d69o3z8d	172	14	36	36	CD
cord-303322-d69o3z8d	172	15	(	(	-LRB-
cord-303322-d69o3z8d	172	16	SD	SD	NNP
cord-303322-d69o3z8d	172	17	14	14	CD
cord-303322-d69o3z8d	172	18	)	)	-RRB-
cord-303322-d69o3z8d	172	19	hours	hour	NNS
cord-303322-d69o3z8d	172	20	.	.	.
cord-303322-d69o3z8d	173	1	For	for	IN
cord-303322-d69o3z8d	173	2	a	a	DT
cord-303322-d69o3z8d	173	3	mean	mean	JJ
cord-303322-d69o3z8d	173	4	difference	difference	NN
cord-303322-d69o3z8d	173	5	of	of	IN
cord-303322-d69o3z8d	173	6	24-hours	24-hours	CD
cord-303322-d69o3z8d	173	7	in	in	IN
cord-303322-d69o3z8d	173	8	LOS	LOS	NNP
cord-303322-d69o3z8d	173	9	between	between	IN
cord-303322-d69o3z8d	173	10	groups	group	NNS
cord-303322-d69o3z8d	173	11	(	(	-LRB-
cord-303322-d69o3z8d	173	12	power	power	NN
cord-303322-d69o3z8d	173	13	=	=	SYM
cord-303322-d69o3z8d	173	14	90	90	CD
cord-303322-d69o3z8d	173	15	%	%	NN
cord-303322-d69o3z8d	173	16	,	,	,
cord-303322-d69o3z8d	173	17	α	α	NN
cord-303322-d69o3z8d	173	18	=	=	SYM
cord-303322-d69o3z8d	173	19	5	5	CD
cord-303322-d69o3z8d	173	20	%	%	NN
cord-303322-d69o3z8d	173	21	)	)	-RRB-
cord-303322-d69o3z8d	173	22	the	the	DT
cord-303322-d69o3z8d	173	23	required	require	VBN
cord-303322-d69o3z8d	173	24	sample	sample	NN
cord-303322-d69o3z8d	173	25	size	size	NN
cord-303322-d69o3z8d	173	26	is	be	VBZ
cord-303322-d69o3z8d	173	27	23	23	CD
cord-303322-d69o3z8d	173	28	per	per	IN
cord-303322-d69o3z8d	173	29	group	group	NN
cord-303322-d69o3z8d	173	30	.	.	.
cord-303322-d69o3z8d	174	1	The	the	DT
cord-303322-d69o3z8d	174	2	numbers	number	NNS
cord-303322-d69o3z8d	174	3	to	to	TO
cord-303322-d69o3z8d	174	4	detect	detect	VB
cord-303322-d69o3z8d	174	5	a	a	DT
cord-303322-d69o3z8d	174	6	12-hour	12-hour	JJ
cord-303322-d69o3z8d	174	7	difference	difference	NN
cord-303322-d69o3z8d	174	8	in	in	IN
cord-303322-d69o3z8d	174	9	supplemental	supplemental	JJ
cord-303322-d69o3z8d	174	10	oxygen	oxygen	NN
cord-303322-d69o3z8d	174	11	requirement	requirement	NN
cord-303322-d69o3z8d	174	12	is	be	VBZ
cord-303322-d69o3z8d	174	13	30	30	CD
cord-303322-d69o3z8d	174	14	per	per	IN
cord-303322-d69o3z8d	174	15	group	group	NN
cord-303322-d69o3z8d	174	16	.	.	.
cord-303322-d69o3z8d	175	1	These	these	DT
cord-303322-d69o3z8d	175	2	are	be	VBP
cord-303322-d69o3z8d	175	3	large	large	JJ
cord-303322-d69o3z8d	175	4	effect	effect	NN
cord-303322-d69o3z8d	175	5	sizes	size	NNS
cord-303322-d69o3z8d	175	6	but	but	CC
cord-303322-d69o3z8d	175	7	more	more	JJR
cord-303322-d69o3z8d	175	8	conservative	conservative	JJ
cord-303322-d69o3z8d	175	9	estimates	estimate	NNS
cord-303322-d69o3z8d	175	10	than	than	IN
cord-303322-d69o3z8d	175	11	seen	see	VBN
cord-303322-d69o3z8d	175	12	in	in	IN
cord-303322-d69o3z8d	175	13	the	the	DT
cord-303322-d69o3z8d	175	14	Turkish	turkish	JJ
cord-303322-d69o3z8d	175	15	study	study	NN
cord-303322-d69o3z8d	175	16	[	[	-LRB-
cord-303322-d69o3z8d	175	17	26	26	CD
cord-303322-d69o3z8d	175	18	]	]	-RRB-
cord-303322-d69o3z8d	175	19	.	.	.
cord-303322-d69o3z8d	176	1	In	in	IN
cord-303322-d69o3z8d	176	2	that	that	DT
cord-303322-d69o3z8d	176	3	study	study	NN
cord-303322-d69o3z8d	176	4	,	,	,
cord-303322-d69o3z8d	176	5	[	[	-LRB-
cord-303322-d69o3z8d	176	6	26	26	CD
cord-303322-d69o3z8d	176	7	]	]	-RRB-
cord-303322-d69o3z8d	176	8	the	the	DT
cord-303322-d69o3z8d	176	9	difference	difference	NN
cord-303322-d69o3z8d	176	10	between	between	IN
cord-303322-d69o3z8d	176	11	groups	group	NNS
cord-303322-d69o3z8d	176	12	was	be	VBD
cord-303322-d69o3z8d	176	13	30-hrs	30-hrs	CD
cord-303322-d69o3z8d	176	14	for	for	IN
cord-303322-d69o3z8d	176	15	LOS	LOS	NNP
cord-303322-d69o3z8d	176	16	and	and	CC
cord-303322-d69o3z8d	176	17	31-hours	31-hours	CD
cord-303322-d69o3z8d	176	18	for	for	IN
cord-303322-d69o3z8d	176	19	supplemental	supplemental	JJ
cord-303322-d69o3z8d	176	20	oxygen	oxygen	NN
cord-303322-d69o3z8d	176	21	requirement	requirement	NN
cord-303322-d69o3z8d	176	22	.	.	.
cord-303322-d69o3z8d	177	1	Assuming	assume	VBG
cord-303322-d69o3z8d	177	2	similar	similar	JJ
cord-303322-d69o3z8d	177	3	effects	effect	NNS
cord-303322-d69o3z8d	177	4	,	,	,
cord-303322-d69o3z8d	177	5	a	a	DT
cord-303322-d69o3z8d	177	6	sample	sample	NN
cord-303322-d69o3z8d	177	7	size	size	NN
cord-303322-d69o3z8d	177	8	of	of	IN
cord-303322-d69o3z8d	177	9	at	at	RB
cord-303322-d69o3z8d	177	10	least	least	RBS
cord-303322-d69o3z8d	177	11	100	100	CD
cord-303322-d69o3z8d	177	12	in	in	IN
cord-303322-d69o3z8d	177	13	each	each	DT
cord-303322-d69o3z8d	177	14	sub	sub	JJ
cord-303322-d69o3z8d	177	15	-	-	JJ
cord-303322-d69o3z8d	177	16	age	age	JJ
cord-303322-d69o3z8d	177	17	group	group	NN
cord-303322-d69o3z8d	177	18	is	be	VBZ
cord-303322-d69o3z8d	177	19	also	also	RB
cord-303322-d69o3z8d	177	20	sufficient	sufficient	JJ
cord-303322-d69o3z8d	177	21	for	for	IN
cord-303322-d69o3z8d	177	22	an	an	DT
cord-303322-d69o3z8d	177	23	a	a	DT
cord-303322-d69o3z8d	177	24	-	-	HYPH
cord-303322-d69o3z8d	177	25	priori	priori	JJ
cord-303322-d69o3z8d	177	26	subgroup	subgroup	NN
cord-303322-d69o3z8d	177	27	analysis	analysis	NN
cord-303322-d69o3z8d	177	28	based	base	VBN
cord-303322-d69o3z8d	177	29	on	on	IN
cord-303322-d69o3z8d	177	30	age	age	NN
cord-303322-d69o3z8d	177	31	(	(	-LRB-
cord-303322-d69o3z8d	177	32	power	power	NN
cord-303322-d69o3z8d	177	33	of	of	IN
cord-303322-d69o3z8d	177	34	90	90	CD
cord-303322-d69o3z8d	177	35	%	%	NN
cord-303322-d69o3z8d	177	36	and	and	CC
cord-303322-d69o3z8d	177	37	2-tailed	2-tailed	CD
cord-303322-d69o3z8d	177	38	α	α	NN
cord-303322-d69o3z8d	177	39	of	of	IN
cord-303322-d69o3z8d	177	40	5	5	CD
cord-303322-d69o3z8d	177	41	%	%	NN
cord-303322-d69o3z8d	177	42	)	)	-RRB-
cord-303322-d69o3z8d	177	43	.	.	.
cord-303322-d69o3z8d	178	1	If	if	IN
cord-303322-d69o3z8d	178	2	the	the	DT
cord-303322-d69o3z8d	178	3	effects	effect	NNS
cord-303322-d69o3z8d	178	4	are	be	VBP
cord-303322-d69o3z8d	178	5	smaller	small	JJR
cord-303322-d69o3z8d	178	6	,	,	,
cord-303322-d69o3z8d	178	7	we	-PRON-	PRP
cord-303322-d69o3z8d	178	8	will	will	MD
cord-303322-d69o3z8d	178	9	have	have	VB
cord-303322-d69o3z8d	178	10	an	an	DT
cord-303322-d69o3z8d	178	11	80	80	CD
cord-303322-d69o3z8d	178	12	%	%	NN
cord-303322-d69o3z8d	178	13	power	power	NN
cord-303322-d69o3z8d	178	14	to	to	TO
cord-303322-d69o3z8d	178	15	detect	detect	VB
cord-303322-d69o3z8d	178	16	a	a	DT
cord-303322-d69o3z8d	178	17	difference	difference	NN
cord-303322-d69o3z8d	178	18	of	of	IN
cord-303322-d69o3z8d	178	19	10hours	10hours	CD
cord-303322-d69o3z8d	178	20	in	in	IN
cord-303322-d69o3z8d	178	21	LOS	LOS	NNP
cord-303322-d69o3z8d	178	22	in	in	IN
cord-303322-d69o3z8d	178	23	all	all	DT
cord-303322-d69o3z8d	178	24	infants	infant	NNS
cord-303322-d69o3z8d	178	25	and	and	CC
cord-303322-d69o3z8d	178	26	an	an	DT
cord-303322-d69o3z8d	178	27	80	80	CD
cord-303322-d69o3z8d	178	28	%	%	NN
cord-303322-d69o3z8d	178	29	power	power	NN
cord-303322-d69o3z8d	178	30	to	to	TO
cord-303322-d69o3z8d	178	31	detect	detect	VB
cord-303322-d69o3z8d	178	32	a	a	DT
cord-303322-d69o3z8d	178	33	difference	difference	NN
cord-303322-d69o3z8d	178	34	of	of	IN
cord-303322-d69o3z8d	178	35	14-hours	14-hours	CD
cord-303322-d69o3z8d	178	36	in	in	IN
cord-303322-d69o3z8d	178	37	LOS	LOS	NNP
cord-303322-d69o3z8d	178	38	in	in	IN
cord-303322-d69o3z8d	178	39	the	the	DT
cord-303322-d69o3z8d	178	40	≤6-months	≤6-months	NNP
cord-303322-d69o3z8d	178	41	age	age	NN
cord-303322-d69o3z8d	178	42	group	group	NN
cord-303322-d69o3z8d	178	43	.	.	.
cord-303322-d69o3z8d	179	1	We	-PRON-	PRP
cord-303322-d69o3z8d	179	2	do	do	VBP
cord-303322-d69o3z8d	179	3	not	not	RB
cord-303322-d69o3z8d	179	4	believe	believe	VB
cord-303322-d69o3z8d	179	5	that	that	IN
cord-303322-d69o3z8d	179	6	smaller	small	JJR
cord-303322-d69o3z8d	179	7	benefits	benefit	NNS
cord-303322-d69o3z8d	179	8	than	than	IN
cord-303322-d69o3z8d	179	9	this	this	DT
cord-303322-d69o3z8d	179	10	would	would	MD
cord-303322-d69o3z8d	179	11	be	be	VB
cord-303322-d69o3z8d	179	12	sufficient	sufficient	JJ
cord-303322-d69o3z8d	179	13	to	to	TO
cord-303322-d69o3z8d	179	14	change	change	VB
cord-303322-d69o3z8d	179	15	clinical	clinical	JJ
cord-303322-d69o3z8d	179	16	practice	practice	NN
cord-303322-d69o3z8d	179	17	.	.	.
cord-303322-d69o3z8d	180	1	For	for	IN
cord-303322-d69o3z8d	180	2	the	the	DT
cord-303322-d69o3z8d	180	3	most	most	RBS
cord-303322-d69o3z8d	180	4	important	important	JJ
cord-303322-d69o3z8d	180	5	secondary	secondary	JJ
cord-303322-d69o3z8d	180	6	outcome	outcome	NN
cord-303322-d69o3z8d	180	7	(	(	-LRB-
cord-303322-d69o3z8d	180	8	readmission	readmission	NN
cord-303322-d69o3z8d	180	9	rate	rate	NN
cord-303322-d69o3z8d	180	10	for	for	IN
cord-303322-d69o3z8d	180	11	a	a	DT
cord-303322-d69o3z8d	180	12	respiratory	respiratory	JJ
cord-303322-d69o3z8d	180	13	illness	illness	NN
cord-303322-d69o3z8d	180	14	within	within	IN
cord-303322-d69o3z8d	180	15	6-months	6-months	CD
cord-303322-d69o3z8d	180	16	of	of	IN
cord-303322-d69o3z8d	180	17	discharge	discharge	NN
cord-303322-d69o3z8d	180	18	)	)	-RRB-
cord-303322-d69o3z8d	180	19	,	,	,
cord-303322-d69o3z8d	180	20	the	the	DT
cord-303322-d69o3z8d	180	21	power	power	NN
cord-303322-d69o3z8d	180	22	of	of	IN
cord-303322-d69o3z8d	180	23	our	-PRON-	PRP$
cord-303322-d69o3z8d	180	24	study	study	NN
cord-303322-d69o3z8d	180	25	to	to	TO
cord-303322-d69o3z8d	180	26	detect	detect	VB
cord-303322-d69o3z8d	180	27	a	a	DT
cord-303322-d69o3z8d	180	28	reduction	reduction	NN
cord-303322-d69o3z8d	180	29	from	from	IN
cord-303322-d69o3z8d	180	30	30	30	CD
cord-303322-d69o3z8d	180	31	%	%	NN
cord-303322-d69o3z8d	180	32	to	to	TO
cord-303322-d69o3z8d	180	33	10	10	CD
cord-303322-d69o3z8d	180	34	%	%	NN
cord-303322-d69o3z8d	180	35	is	be	VBZ
cord-303322-d69o3z8d	180	36	95	95	CD
cord-303322-d69o3z8d	180	37	%	%	NN
cord-303322-d69o3z8d	180	38	(	(	-LRB-
cord-303322-d69o3z8d	180	39	5	5	CD
cord-303322-d69o3z8d	180	40	%	%	NN
cord-303322-d69o3z8d	180	41	significance	significance	NN
cord-303322-d69o3z8d	180	42	)	)	-RRB-
cord-303322-d69o3z8d	180	43	.	.	.
cord-303322-d69o3z8d	181	1	This	this	DT
cord-303322-d69o3z8d	181	2	is	be	VBZ
cord-303322-d69o3z8d	181	3	a	a	DT
cord-303322-d69o3z8d	181	4	large	large	JJ
cord-303322-d69o3z8d	181	5	effect	effect	NN
cord-303322-d69o3z8d	181	6	but	but	CC
cord-303322-d69o3z8d	181	7	consistent	consistent	JJ
cord-303322-d69o3z8d	181	8	with	with	IN
cord-303322-d69o3z8d	181	9	the	the	DT
cord-303322-d69o3z8d	181	10	reduction	reduction	NN
cord-303322-d69o3z8d	181	11	described	describe	VBN
cord-303322-d69o3z8d	181	12	in	in	IN
cord-303322-d69o3z8d	181	13	the	the	DT
cord-303322-d69o3z8d	181	14	Turkish	turkish	JJ
cord-303322-d69o3z8d	181	15	study	study	NN
cord-303322-d69o3z8d	181	16	(	(	-LRB-
cord-303322-d69o3z8d	181	17	75	75	CD
cord-303322-d69o3z8d	181	18	%	%	NN
cord-303322-d69o3z8d	181	19	reduction	reduction	NN
cord-303322-d69o3z8d	181	20	)	)	-RRB-
cord-303322-d69o3z8d	181	21	[	[	-LRB-
cord-303322-d69o3z8d	181	22	26	26	CD
cord-303322-d69o3z8d	181	23	]	]	-RRB-
cord-303322-d69o3z8d	181	24	.	.	.
cord-303322-d69o3z8d	182	1	At	at	IN
cord-303322-d69o3z8d	182	2	80	80	CD
cord-303322-d69o3z8d	182	3	%	%	NN
cord-303322-d69o3z8d	182	4	power	power	NN
cord-303322-d69o3z8d	182	5	we	-PRON-	PRP
cord-303322-d69o3z8d	182	6	will	will	MD
cord-303322-d69o3z8d	182	7	be	be	VB
cord-303322-d69o3z8d	182	8	able	able	JJ
cord-303322-d69o3z8d	182	9	to	to	TO
cord-303322-d69o3z8d	182	10	detect	detect	VB
cord-303322-d69o3z8d	182	11	a	a	DT
cord-303322-d69o3z8d	182	12	reduction	reduction	NN
cord-303322-d69o3z8d	182	13	in	in	IN
cord-303322-d69o3z8d	182	14	readmission	readmission	NN
cord-303322-d69o3z8d	182	15	rates	rate	NNS
cord-303322-d69o3z8d	182	16	from	from	IN
cord-303322-d69o3z8d	182	17	30	30	CD
cord-303322-d69o3z8d	182	18	%	%	NN
cord-303322-d69o3z8d	182	19	to	to	TO
cord-303322-d69o3z8d	182	20	13	13	CD
cord-303322-d69o3z8d	182	21	%	%	NN
cord-303322-d69o3z8d	182	22	.	.	.
cord-303322-d69o3z8d	183	1	For	for	IN
cord-303322-d69o3z8d	183	2	our	-PRON-	PRP$
cord-303322-d69o3z8d	183	3	other	other	JJ
cord-303322-d69o3z8d	183	4	secondary	secondary	JJ
cord-303322-d69o3z8d	183	5	outcomes	outcome	NNS
cord-303322-d69o3z8d	183	6	,	,	,
cord-303322-d69o3z8d	183	7	accurate	accurate	JJ
cord-303322-d69o3z8d	183	8	sample	sample	NN
cord-303322-d69o3z8d	183	9	size	size	NN
cord-303322-d69o3z8d	183	10	estimations	estimation	NNS
cord-303322-d69o3z8d	183	11	are	be	VBP
cord-303322-d69o3z8d	183	12	not	not	RB
cord-303322-d69o3z8d	183	13	possible	possible	JJ
cord-303322-d69o3z8d	183	14	given	give	VBN
cord-303322-d69o3z8d	183	15	the	the	DT
cord-303322-d69o3z8d	183	16	lack	lack	NN
cord-303322-d69o3z8d	183	17	of	of	IN
cord-303322-d69o3z8d	183	18	any	any	DT
cord-303322-d69o3z8d	183	19	relevant	relevant	JJ
cord-303322-d69o3z8d	183	20	data	datum	NNS
cord-303322-d69o3z8d	183	21	.	.	.
cord-303322-d69o3z8d	184	1	Data	datum	NNS
cord-303322-d69o3z8d	184	2	will	will	MD
cord-303322-d69o3z8d	184	3	be	be	VB
cord-303322-d69o3z8d	184	4	reported	report	VBN
cord-303322-d69o3z8d	184	5	and	and	CC
cord-303322-d69o3z8d	184	6	presented	present	VBN
cord-303322-d69o3z8d	184	7	in	in	IN
cord-303322-d69o3z8d	184	8	accordance	accordance	NN
cord-303322-d69o3z8d	184	9	with	with	IN
cord-303322-d69o3z8d	184	10	the	the	DT
cord-303322-d69o3z8d	184	11	updated	update	VBN
cord-303322-d69o3z8d	184	12	CONSORT	CONSORT	NNP
cord-303322-d69o3z8d	184	13	criteria	criterion	NNS
cord-303322-d69o3z8d	184	14	[	[	-LRB-
cord-303322-d69o3z8d	184	15	40	40	CD
cord-303322-d69o3z8d	184	16	]	]	-RRB-
cord-303322-d69o3z8d	184	17	.	.	.
cord-303322-d69o3z8d	185	1	Children	child	NNS
cord-303322-d69o3z8d	185	2	will	will	MD
cord-303322-d69o3z8d	185	3	be	be	VB
cord-303322-d69o3z8d	185	4	analysed	analyse	VBN
cord-303322-d69o3z8d	185	5	according	accord	VBG
cord-303322-d69o3z8d	185	6	to	to	IN
cord-303322-d69o3z8d	185	7	allocation	allocation	NN
cord-303322-d69o3z8d	185	8	status	status	NN
cord-303322-d69o3z8d	185	9	(	(	-LRB-
cord-303322-d69o3z8d	185	10	regardless	regardless	RB
cord-303322-d69o3z8d	185	11	of	of	IN
cord-303322-d69o3z8d	185	12	subsequent	subsequent	JJ
cord-303322-d69o3z8d	185	13	management	management	NN
cord-303322-d69o3z8d	185	14	)	)	-RRB-
cord-303322-d69o3z8d	185	15	.	.	.
cord-303322-d69o3z8d	186	1	An	an	DT
cord-303322-d69o3z8d	186	2	interim	interim	JJ
cord-303322-d69o3z8d	186	3	analysis	analysis	NN
cord-303322-d69o3z8d	186	4	is	be	VBZ
cord-303322-d69o3z8d	186	5	planned	plan	VBN
cord-303322-d69o3z8d	186	6	and	and	CC
cord-303322-d69o3z8d	186	7	the	the	DT
cord-303322-d69o3z8d	186	8	data	data	NN
cord-303322-d69o3z8d	186	9	safety	safety	NN
cord-303322-d69o3z8d	186	10	and	and	CC
cord-303322-d69o3z8d	186	11	monitoring	monitoring	NN
cord-303322-d69o3z8d	186	12	committee	committee	NN
cord-303322-d69o3z8d	186	13	will	will	MD
cord-303322-d69o3z8d	186	14	determine	determine	VB
cord-303322-d69o3z8d	186	15	if	if	IN
cord-303322-d69o3z8d	186	16	the	the	DT
cord-303322-d69o3z8d	186	17	study	study	NN
cord-303322-d69o3z8d	186	18	should	should	MD
cord-303322-d69o3z8d	186	19	be	be	VB
cord-303322-d69o3z8d	186	20	ceased	cease	VBN
cord-303322-d69o3z8d	186	21	should	should	MD
cord-303322-d69o3z8d	186	22	superiority	superiority	NN
cord-303322-d69o3z8d	186	23	of	of	IN
cord-303322-d69o3z8d	186	24	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	186	25	be	be	VB
cord-303322-d69o3z8d	186	26	identified	identify	VBN
cord-303322-d69o3z8d	186	27	after	after	IN
cord-303322-d69o3z8d	186	28	70	70	CD
cord-303322-d69o3z8d	186	29	%	%	NN
cord-303322-d69o3z8d	186	30	of	of	IN
cord-303322-d69o3z8d	186	31	sample	sample	NN
cord-303322-d69o3z8d	186	32	size	size	NN
cord-303322-d69o3z8d	186	33	is	be	VBZ
cord-303322-d69o3z8d	186	34	achieved	achieve	VBN
cord-303322-d69o3z8d	186	35	.	.	.
cord-303322-d69o3z8d	187	1	The	the	DT
cord-303322-d69o3z8d	187	2	primary	primary	JJ
cord-303322-d69o3z8d	187	3	outcomes	outcome	NNS
cord-303322-d69o3z8d	187	4	(	(	-LRB-
cord-303322-d69o3z8d	187	5	LOS	LOS	NNP
cord-303322-d69o3z8d	187	6	and	and	CC
cord-303322-d69o3z8d	187	7	duration	duration	NN
cord-303322-d69o3z8d	187	8	of	of	IN
cord-303322-d69o3z8d	187	9	supplemental	supplemental	JJ
cord-303322-d69o3z8d	187	10	oxygen	oxygen	NN
cord-303322-d69o3z8d	187	11	requirement	requirement	NN
cord-303322-d69o3z8d	187	12	)	)	-RRB-
cord-303322-d69o3z8d	187	13	will	will	MD
cord-303322-d69o3z8d	187	14	be	be	VB
cord-303322-d69o3z8d	187	15	compared	compare	VBN
cord-303322-d69o3z8d	187	16	between	between	IN
cord-303322-d69o3z8d	187	17	infants	infant	NNS
cord-303322-d69o3z8d	187	18	receiving	receive	VBG
cord-303322-d69o3z8d	187	19	placebo	placebo	NN
cord-303322-d69o3z8d	187	20	or	or	CC
cord-303322-d69o3z8d	187	21	azithromycin	azithromycin	NNS
cord-303322-d69o3z8d	187	22	using	use	VBG
cord-303322-d69o3z8d	187	23	unpaired	unpaired	JJ
cord-303322-d69o3z8d	187	24	Student	Student	NNP
cord-303322-d69o3z8d	187	25	's	's	POS
cord-303322-d69o3z8d	187	26	T	t	NN
cord-303322-d69o3z8d	187	27	-	-	HYPH
cord-303322-d69o3z8d	187	28	tests	test	NNS
cord-303322-d69o3z8d	187	29	or	or	CC
cord-303322-d69o3z8d	187	30	Mann	Mann	NNP
cord-303322-d69o3z8d	187	31	-	-	HYPH
cord-303322-d69o3z8d	187	32	Whitney	Whitney	NNP
cord-303322-d69o3z8d	187	33	tests	test	VBZ
cord-303322-d69o3z8d	187	34	(	(	-LRB-
cord-303322-d69o3z8d	187	35	depending	depend	VBG
cord-303322-d69o3z8d	187	36	on	on	IN
cord-303322-d69o3z8d	187	37	normality	normality	NN
cord-303322-d69o3z8d	187	38	of	of	IN
cord-303322-d69o3z8d	187	39	distribution	distribution	NN
cord-303322-d69o3z8d	187	40	)	)	-RRB-
cord-303322-d69o3z8d	187	41	.	.	.
cord-303322-d69o3z8d	188	1	Although	although	IN
cord-303322-d69o3z8d	188	2	we	-PRON-	PRP
cord-303322-d69o3z8d	188	3	expect	expect	VBP
cord-303322-d69o3z8d	188	4	randomisation	randomisation	NN
cord-303322-d69o3z8d	188	5	to	to	TO
cord-303322-d69o3z8d	188	6	equally	equally	RB
cord-303322-d69o3z8d	188	7	distribute	distribute	VB
cord-303322-d69o3z8d	188	8	potential	potential	JJ
cord-303322-d69o3z8d	188	9	confounding	confounding	JJ
cord-303322-d69o3z8d	188	10	factors	factor	NNS
cord-303322-d69o3z8d	188	11	between	between	IN
cord-303322-d69o3z8d	188	12	each	each	DT
cord-303322-d69o3z8d	188	13	of	of	IN
cord-303322-d69o3z8d	188	14	the	the	DT
cord-303322-d69o3z8d	188	15	groups	group	NNS
cord-303322-d69o3z8d	188	16	,	,	,
cord-303322-d69o3z8d	188	17	we	-PRON-	PRP
cord-303322-d69o3z8d	188	18	will	will	MD
cord-303322-d69o3z8d	188	19	examine	examine	VB
cord-303322-d69o3z8d	188	20	the	the	DT
cord-303322-d69o3z8d	188	21	distribution	distribution	NN
cord-303322-d69o3z8d	188	22	of	of	IN
cord-303322-d69o3z8d	188	23	known	know	VBN
cord-303322-d69o3z8d	188	24	confounders	confounder	NNS
cord-303322-d69o3z8d	188	25	between	between	IN
cord-303322-d69o3z8d	188	26	groups	group	NNS
cord-303322-d69o3z8d	188	27	(	(	-LRB-
cord-303322-d69o3z8d	188	28	eg	eg	IN
cord-303322-d69o3z8d	188	29	.	.	.
cord-303322-d69o3z8d	188	30	birth	birth	NN
cord-303322-d69o3z8d	188	31	weight	weight	NN
cord-303322-d69o3z8d	188	32	,	,	,
cord-303322-d69o3z8d	188	33	smoke	smoke	NN
cord-303322-d69o3z8d	188	34	exposure	exposure	NN
cord-303322-d69o3z8d	188	35	status	status	NN
cord-303322-d69o3z8d	188	36	in	in	IN
cord-303322-d69o3z8d	188	37	-	-	HYPH
cord-303322-d69o3z8d	188	38	utero	utero	NN
cord-303322-d69o3z8d	188	39	and	and	CC
cord-303322-d69o3z8d	188	40	postnatal	postnatal	NN
cord-303322-d69o3z8d	188	41	,	,	,
cord-303322-d69o3z8d	188	42	breast	breast	NN
cord-303322-d69o3z8d	188	43	feeding	feeding	NN
cord-303322-d69o3z8d	188	44	,	,	,
cord-303322-d69o3z8d	188	45	etc	etc	FW
cord-303322-d69o3z8d	188	46	)	)	-RRB-
cord-303322-d69o3z8d	188	47	.	.	.
cord-303322-d69o3z8d	189	1	Should	Should	MD
cord-303322-d69o3z8d	189	2	baseline	baseline	JJ
cord-303322-d69o3z8d	189	3	data	datum	NNS
cord-303322-d69o3z8d	189	4	differ	differ	VBP
cord-303322-d69o3z8d	189	5	between	between	IN
cord-303322-d69o3z8d	189	6	groups	group	NNS
cord-303322-d69o3z8d	189	7	,	,	,
cord-303322-d69o3z8d	189	8	regression	regression	NN
cord-303322-d69o3z8d	189	9	will	will	MD
cord-303322-d69o3z8d	189	10	be	be	VB
cord-303322-d69o3z8d	189	11	used	use	VBN
cord-303322-d69o3z8d	189	12	to	to	TO
cord-303322-d69o3z8d	189	13	check	check	VB
cord-303322-d69o3z8d	189	14	that	that	IN
cord-303322-d69o3z8d	189	15	the	the	DT
cord-303322-d69o3z8d	189	16	primary	primary	JJ
cord-303322-d69o3z8d	189	17	outcomes	outcome	NNS
cord-303322-d69o3z8d	189	18	are	be	VBP
cord-303322-d69o3z8d	189	19	not	not	RB
cord-303322-d69o3z8d	189	20	affected	affect	VBN
cord-303322-d69o3z8d	189	21	by	by	IN
cord-303322-d69o3z8d	189	22	this	this	DT
cord-303322-d69o3z8d	189	23	chance	chance	NN
cord-303322-d69o3z8d	189	24	finding	finding	NN
cord-303322-d69o3z8d	189	25	.	.	.
cord-303322-d69o3z8d	190	1	An	an	DT
cord-303322-d69o3z8d	190	2	a	a	RB
cord-303322-d69o3z8d	190	3	-	-	HYPH
cord-303322-d69o3z8d	190	4	priori	priori	FW
cord-303322-d69o3z8d	190	5	sub	sub	NN
cord-303322-d69o3z8d	190	6	-	-	NN
cord-303322-d69o3z8d	190	7	analysis	analysis	NN
cord-303322-d69o3z8d	190	8	will	will	MD
cord-303322-d69o3z8d	190	9	compare	compare	VB
cord-303322-d69o3z8d	190	10	infants	infant	NNS
cord-303322-d69o3z8d	190	11	aged	age	VBN
cord-303322-d69o3z8d	190	12	≤	≤	NNS
cord-303322-d69o3z8d	190	13	6months	6months	CD
cord-303322-d69o3z8d	190	14	with	with	IN
cord-303322-d69o3z8d	190	15	those	those	DT
cord-303322-d69o3z8d	190	16	aged	age	VBN
cord-303322-d69o3z8d	190	17	>	>	XX
cord-303322-d69o3z8d	190	18	6-months	6-months	CD
cord-303322-d69o3z8d	190	19	.	.	.
cord-303322-d69o3z8d	191	1	When	when	WRB
cord-303322-d69o3z8d	191	2	examining	examine	VBG
cord-303322-d69o3z8d	191	3	the	the	DT
cord-303322-d69o3z8d	191	4	efficacy	efficacy	NN
cord-303322-d69o3z8d	191	5	of	of	IN
cord-303322-d69o3z8d	191	6	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	191	7	at	at	IN
cord-303322-d69o3z8d	191	8	reducing	reduce	VBG
cord-303322-d69o3z8d	191	9	readmission	readmission	NN
cord-303322-d69o3z8d	191	10	rate	rate	NN
cord-303322-d69o3z8d	191	11	for	for	IN
cord-303322-d69o3z8d	191	12	respiratory	respiratory	JJ
cord-303322-d69o3z8d	191	13	illness	illness	NN
cord-303322-d69o3z8d	191	14	(	(	-LRB-
cord-303322-d69o3z8d	191	15	Secondary	secondary	JJ
cord-303322-d69o3z8d	191	16	Aim-2	Aim-2	NNP
cord-303322-d69o3z8d	191	17	)	)	-RRB-
cord-303322-d69o3z8d	191	18	,	,	,
cord-303322-d69o3z8d	191	19	the	the	DT
cord-303322-d69o3z8d	191	20	Odds	Odds	NNPS
cord-303322-d69o3z8d	191	21	Ratio	Ratio	NNP
cord-303322-d69o3z8d	191	22	(	(	-LRB-
cord-303322-d69o3z8d	191	23	OR	OR	NNP
cord-303322-d69o3z8d	191	24	)	)	-RRB-
cord-303322-d69o3z8d	191	25	between	between	IN
cord-303322-d69o3z8d	191	26	groups	group	NNS
cord-303322-d69o3z8d	191	27	will	will	MD
cord-303322-d69o3z8d	191	28	be	be	VB
cord-303322-d69o3z8d	191	29	calculated	calculate	VBN
cord-303322-d69o3z8d	191	30	.	.	.
cord-303322-d69o3z8d	192	1	The	the	DT
cord-303322-d69o3z8d	192	2	OR	OR	NNP
cord-303322-d69o3z8d	192	3	will	will	MD
cord-303322-d69o3z8d	192	4	also	also	RB
cord-303322-d69o3z8d	192	5	be	be	VB
cord-303322-d69o3z8d	192	6	used	use	VBN
cord-303322-d69o3z8d	192	7	to	to	TO
cord-303322-d69o3z8d	192	8	compare	compare	VB
cord-303322-d69o3z8d	192	9	additional	additional	JJ
cord-303322-d69o3z8d	192	10	antibiotic	antibiotic	JJ
cord-303322-d69o3z8d	192	11	use	use	NN
cord-303322-d69o3z8d	192	12	between	between	IN
cord-303322-d69o3z8d	192	13	groups	group	NNS
cord-303322-d69o3z8d	192	14	.	.	.
cord-303322-d69o3z8d	193	1	The	the	DT
cord-303322-d69o3z8d	193	2	number	number	NN
cord-303322-d69o3z8d	193	3	needed	need	VBN
cord-303322-d69o3z8d	193	4	to	to	TO
cord-303322-d69o3z8d	193	5	treat	treat	VB
cord-303322-d69o3z8d	193	6	(	(	-LRB-
cord-303322-d69o3z8d	193	7	NNT	NNT	NNP
cord-303322-d69o3z8d	193	8	)	)	-RRB-
cord-303322-d69o3z8d	193	9	(	(	-LRB-
cord-303322-d69o3z8d	193	10	for	for	IN
cord-303322-d69o3z8d	193	11	benefit	benefit	NN
cord-303322-d69o3z8d	193	12	)	)	-RRB-
cord-303322-d69o3z8d	193	13	,	,	,
cord-303322-d69o3z8d	193	14	95	95	CD
cord-303322-d69o3z8d	193	15	%	%	NN
cord-303322-d69o3z8d	193	16	CI	CI	NNP
cord-303322-d69o3z8d	193	17	will	will	MD
cord-303322-d69o3z8d	193	18	be	be	VB
cord-303322-d69o3z8d	193	19	described	describe	VBN
cord-303322-d69o3z8d	193	20	if	if	IN
cord-303322-d69o3z8d	193	21	any	any	DT
cord-303322-d69o3z8d	193	22	significant	significant	JJ
cord-303322-d69o3z8d	193	23	differences	difference	NNS
cord-303322-d69o3z8d	193	24	are	be	VBP
cord-303322-d69o3z8d	193	25	found	find	VBN
cord-303322-d69o3z8d	193	26	.	.	.
cord-303322-d69o3z8d	194	1	If	if	IN
cord-303322-d69o3z8d	194	2	significant	significant	JJ
cord-303322-d69o3z8d	194	3	,	,	,
cord-303322-d69o3z8d	194	4	NNT	NNT	NNP
cord-303322-d69o3z8d	194	5	for	for	IN
cord-303322-d69o3z8d	194	6	harm	harm	NN
cord-303322-d69o3z8d	194	7	will	will	MD
cord-303322-d69o3z8d	194	8	be	be	VB
cord-303322-d69o3z8d	194	9	calculated	calculate	VBN
cord-303322-d69o3z8d	194	10	for	for	IN
cord-303322-d69o3z8d	194	11	adverse	adverse	JJ
cord-303322-d69o3z8d	194	12	events	event	NNS
cord-303322-d69o3z8d	194	13	.	.	.
cord-303322-d69o3z8d	195	1	For	for	IN
cord-303322-d69o3z8d	195	2	Secondary	Secondary	NNP
cord-303322-d69o3z8d	195	3	Aim-3	Aim-3	NNP
cord-303322-d69o3z8d	195	4	(	(	-LRB-
cord-303322-d69o3z8d	195	5	short	short	JJ
cord-303322-d69o3z8d	195	6	-	-	HYPH
cord-303322-d69o3z8d	195	7	term	term	NN
cord-303322-d69o3z8d	195	8	impact	impact	NN
cord-303322-d69o3z8d	195	9	of	of	IN
cord-303322-d69o3z8d	195	10	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	195	11	on	on	IN
cord-303322-d69o3z8d	195	12	macrolide	macrolide	NN
cord-303322-d69o3z8d	195	13	-	-	HYPH
cord-303322-d69o3z8d	195	14	resistance	resistance	NN
cord-303322-d69o3z8d	195	15	of	of	IN
cord-303322-d69o3z8d	195	16	pathogens	pathogen	NNS
cord-303322-d69o3z8d	195	17	in	in	IN
cord-303322-d69o3z8d	195	18	NPS	NPS	NNP
cord-303322-d69o3z8d	195	19	cultures	culture	NNS
cord-303322-d69o3z8d	195	20	)	)	-RRB-
cord-303322-d69o3z8d	195	21	:	:	:
cord-303322-d69o3z8d	195	22	the	the	DT
cord-303322-d69o3z8d	195	23	proportions	proportion	NNS
cord-303322-d69o3z8d	195	24	of	of	IN
cord-303322-d69o3z8d	195	25	children	child	NNS
cord-303322-d69o3z8d	195	26	with	with	IN
cord-303322-d69o3z8d	195	27	penicillinnon	penicillinnon	NN
cord-303322-d69o3z8d	195	28	-	-	JJ
cord-303322-d69o3z8d	195	29	susceptible	susceptible	JJ
cord-303322-d69o3z8d	195	30	S.	S.	NNP
cord-303322-d69o3z8d	195	31	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	195	32	and	and	CC
cord-303322-d69o3z8d	195	33	macrolide	macrolide	NN
cord-303322-d69o3z8d	195	34	-	-	HYPH
cord-303322-d69o3z8d	195	35	resistant	resistant	JJ
cord-303322-d69o3z8d	195	36	H.	h.	NN
cord-303322-d69o3z8d	195	37	influenzae	influenzae	NN
cord-303322-d69o3z8d	195	38	spp	spp	NN
cord-303322-d69o3z8d	195	39	and	and	CC
cord-303322-d69o3z8d	195	40	M.	M.	NNP
cord-303322-d69o3z8d	195	41	catarrhalis	catarrhalis	NNP
cord-303322-d69o3z8d	195	42	before	before	IN
cord-303322-d69o3z8d	195	43	and	and	CC
cord-303322-d69o3z8d	195	44	after	after	IN
cord-303322-d69o3z8d	195	45	trial	trial	NN
cord-303322-d69o3z8d	195	46	medications	medication	NNS
cord-303322-d69o3z8d	195	47	will	will	MD
cord-303322-d69o3z8d	195	48	be	be	VB
cord-303322-d69o3z8d	195	49	compared	compare	VBN
cord-303322-d69o3z8d	195	50	using	use	VBG
cord-303322-d69o3z8d	195	51	ORs	or	NNS
cord-303322-d69o3z8d	195	52	and	and	CC
cord-303322-d69o3z8d	195	53	95	95	CD
cord-303322-d69o3z8d	195	54	%	%	NN
cord-303322-d69o3z8d	195	55	CI	CI	NNP
cord-303322-d69o3z8d	195	56	.	.	.
cord-303322-d69o3z8d	196	1	Descriptive	descriptive	JJ
cord-303322-d69o3z8d	196	2	data	datum	NNS
cord-303322-d69o3z8d	196	3	will	will	MD
cord-303322-d69o3z8d	196	4	be	be	VB
cord-303322-d69o3z8d	196	5	utilised	utilise	VBN
cord-303322-d69o3z8d	196	6	for	for	IN
cord-303322-d69o3z8d	196	7	Secondary	Secondary	NNP
cord-303322-d69o3z8d	196	8	Aim-4	Aim-4	NNP
cord-303322-d69o3z8d	196	9	(	(	-LRB-
cord-303322-d69o3z8d	196	10	point	point	NN
cord-303322-d69o3z8d	196	11	prevalence	prevalence	NN
cord-303322-d69o3z8d	196	12	of	of	IN
cord-303322-d69o3z8d	196	13	respiratory	respiratory	JJ
cord-303322-d69o3z8d	196	14	viruses	virus	NNS
cord-303322-d69o3z8d	196	15	and	and	CC
cord-303322-d69o3z8d	196	16	other	other	JJ
cord-303322-d69o3z8d	196	17	respiratory	respiratory	JJ
cord-303322-d69o3z8d	196	18	pathogens	pathogen	NNS
cord-303322-d69o3z8d	196	19	)	)	-RRB-
cord-303322-d69o3z8d	196	20	.	.	.
cord-303322-d69o3z8d	197	1	The	the	DT
cord-303322-d69o3z8d	197	2	 	 	_SP
cord-303322-d69o3z8d	197	3	Acute	Acute	NNP
cord-303322-d69o3z8d	197	4	lower	low	JJR
cord-303322-d69o3z8d	197	5	respiratory	respiratory	JJ
cord-303322-d69o3z8d	197	6	tract	tract	NN
cord-303322-d69o3z8d	197	7	infections	infection	NNS
cord-303322-d69o3z8d	197	8	are	be	VBP
cord-303322-d69o3z8d	197	9	the	the	DT
cord-303322-d69o3z8d	197	10	commonest	common	JJS
cord-303322-d69o3z8d	197	11	cause	cause	NN
cord-303322-d69o3z8d	197	12	of	of	IN
cord-303322-d69o3z8d	197	13	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	197	14	and	and	CC
cord-303322-d69o3z8d	197	15	potentially	potentially	RB
cord-303322-d69o3z8d	197	16	preventable	preventable	JJ
cord-303322-d69o3z8d	197	17	deaths	death	NNS
cord-303322-d69o3z8d	197	18	in	in	IN
cord-303322-d69o3z8d	197	19	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	197	20	infants	infant	NNS
cord-303322-d69o3z8d	197	21	[	[	-LRB-
cord-303322-d69o3z8d	197	22	4	4	CD
cord-303322-d69o3z8d	197	23	]	]	-RRB-
cord-303322-d69o3z8d	197	24	.	.	.
cord-303322-d69o3z8d	198	1	Bronchiolitis	Bronchiolitis	NNP
cord-303322-d69o3z8d	198	2	in	in	IN
cord-303322-d69o3z8d	198	3	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	198	4	infants	infant	NNS
cord-303322-d69o3z8d	198	5	is	be	VBZ
cord-303322-d69o3z8d	198	6	more	more	RBR
cord-303322-d69o3z8d	198	7	severe	severe	JJ
cord-303322-d69o3z8d	198	8	than	than	IN
cord-303322-d69o3z8d	198	9	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	198	10	in	in	IN
cord-303322-d69o3z8d	198	11	non	non	JJ
cord-303322-d69o3z8d	198	12	-	-	JJ
cord-303322-d69o3z8d	198	13	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	198	14	infants	infant	NNS
cord-303322-d69o3z8d	198	15	[	[	-LRB-
cord-303322-d69o3z8d	198	16	6	6	CD
cord-303322-d69o3z8d	198	17	]	]	-RRB-
cord-303322-d69o3z8d	198	18	.	.	.
cord-303322-d69o3z8d	199	1	There	there	EX
cord-303322-d69o3z8d	199	2	are	be	VBP
cord-303322-d69o3z8d	199	3	higher	high	JJR
cord-303322-d69o3z8d	199	4	readmission	readmission	NN
cord-303322-d69o3z8d	199	5	rates	rate	NNS
cord-303322-d69o3z8d	199	6	and	and	CC
cord-303322-d69o3z8d	199	7	an	an	DT
cord-303322-d69o3z8d	199	8	increased	increase	VBN
cord-303322-d69o3z8d	199	9	risk	risk	NN
cord-303322-d69o3z8d	199	10	of	of	IN
cord-303322-d69o3z8d	199	11	ongoing	ongoing	JJ
cord-303322-d69o3z8d	199	12	respiratory	respiratory	JJ
cord-303322-d69o3z8d	199	13	morbidity	morbidity	NN
cord-303322-d69o3z8d	199	14	(	(	-LRB-
cord-303322-d69o3z8d	199	15	including	include	VBG
cord-303322-d69o3z8d	199	16	chronic	chronic	JJ
cord-303322-d69o3z8d	199	17	suppurative	suppurative	JJ
cord-303322-d69o3z8d	199	18	lung	lung	NN
cord-303322-d69o3z8d	199	19	disease	disease	NN
cord-303322-d69o3z8d	199	20	)	)	-RRB-
cord-303322-d69o3z8d	199	21	in	in	IN
cord-303322-d69o3z8d	199	22	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	199	23	infants	infant	NNS
cord-303322-d69o3z8d	199	24	[	[	-LRB-
cord-303322-d69o3z8d	199	25	7	7	CD
cord-303322-d69o3z8d	199	26	,	,	,
cord-303322-d69o3z8d	199	27	41	41	CD
cord-303322-d69o3z8d	199	28	]	]	-RRB-
cord-303322-d69o3z8d	199	29	.	.	.
cord-303322-d69o3z8d	200	1	This	this	DT
cord-303322-d69o3z8d	200	2	may	may	MD
cord-303322-d69o3z8d	200	3	be	be	VB
cord-303322-d69o3z8d	200	4	due	due	JJ
cord-303322-d69o3z8d	200	5	to	to	IN
cord-303322-d69o3z8d	200	6	an	an	DT
cord-303322-d69o3z8d	200	7	increased	increase	VBN
cord-303322-d69o3z8d	200	8	likelihood	likelihood	NN
cord-303322-d69o3z8d	200	9	of	of	IN
cord-303322-d69o3z8d	200	10	recurrent	recurrent	JJ
cord-303322-d69o3z8d	200	11	infections	infection	NNS
cord-303322-d69o3z8d	200	12	and	and	CC
cord-303322-d69o3z8d	200	13	virusbacteria	virusbacteria	NN
cord-303322-d69o3z8d	200	14	interactions	interaction	NNS
cord-303322-d69o3z8d	200	15	from	from	IN
cord-303322-d69o3z8d	200	16	an	an	DT
cord-303322-d69o3z8d	200	17	early	early	JJ
cord-303322-d69o3z8d	200	18	age	age	NN
cord-303322-d69o3z8d	200	19	(	(	-LRB-
cord-303322-d69o3z8d	200	20	as	as	RB
cord-303322-d69o3z8d	200	21	early	early	RB
cord-303322-d69o3z8d	200	22	as	as	IN
cord-303322-d69o3z8d	200	23	aged	aged	JJ
cord-303322-d69o3z8d	200	24	2-wks	2-wks	CD
cord-303322-d69o3z8d	200	25	)	)	-RRB-
cord-303322-d69o3z8d	200	26	along	along	IN
cord-303322-d69o3z8d	200	27	with	with	IN
cord-303322-d69o3z8d	200	28	heavy	heavy	JJ
cord-303322-d69o3z8d	200	29	bacterial	bacterial	JJ
cord-303322-d69o3z8d	200	30	colonisation	colonisation	NN
cord-303322-d69o3z8d	200	31	of	of	IN
cord-303322-d69o3z8d	200	32	the	the	DT
cord-303322-d69o3z8d	200	33	nasopharynx	nasopharynx	NN
cord-303322-d69o3z8d	200	34	[	[	-LRB-
cord-303322-d69o3z8d	200	35	36	36	CD
cord-303322-d69o3z8d	200	36	]	]	-RRB-
cord-303322-d69o3z8d	200	37	.	.	.
cord-303322-d69o3z8d	201	1	Despite	despite	IN
cord-303322-d69o3z8d	201	2	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	201	3	being	be	VBG
cord-303322-d69o3z8d	201	4	the	the	DT
cord-303322-d69o3z8d	201	5	most	most	RBS
cord-303322-d69o3z8d	201	6	common	common	JJ
cord-303322-d69o3z8d	201	7	cause	cause	NN
cord-303322-d69o3z8d	201	8	of	of	IN
cord-303322-d69o3z8d	201	9	ALRIs	alri	NNS
cord-303322-d69o3z8d	201	10	in	in	IN
cord-303322-d69o3z8d	201	11	infants	infant	NNS
cord-303322-d69o3z8d	201	12	resulting	result	VBG
cord-303322-d69o3z8d	201	13	in	in	IN
cord-303322-d69o3z8d	201	14	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	201	15	,	,	,
cord-303322-d69o3z8d	201	16	there	there	EX
cord-303322-d69o3z8d	201	17	are	be	VBP
cord-303322-d69o3z8d	201	18	no	no	DT
cord-303322-d69o3z8d	201	19	published	publish	VBN
cord-303322-d69o3z8d	201	20	prospective	prospective	JJ
cord-303322-d69o3z8d	201	21	studies	study	NNS
cord-303322-d69o3z8d	201	22	of	of	IN
cord-303322-d69o3z8d	201	23	this	this	DT
cord-303322-d69o3z8d	201	24	illness	illness	NN
cord-303322-d69o3z8d	201	25	in	in	IN
cord-303322-d69o3z8d	201	26	Australian	australian	JJ
cord-303322-d69o3z8d	201	27	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	201	28	infants	infant	NNS
cord-303322-d69o3z8d	201	29	.	.	.
cord-303322-d69o3z8d	202	1	Two	two	CD
cord-303322-d69o3z8d	202	2	small	small	JJ
cord-303322-d69o3z8d	202	3	clinical	clinical	JJ
cord-303322-d69o3z8d	202	4	trials	trial	NNS
cord-303322-d69o3z8d	202	5	have	have	VBP
cord-303322-d69o3z8d	202	6	studied	study	VBN
cord-303322-d69o3z8d	202	7	macrolides	macrolide	NNS
cord-303322-d69o3z8d	202	8	in	in	IN
cord-303322-d69o3z8d	202	9	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	202	10	,	,	,
cord-303322-d69o3z8d	202	11	but	but	CC
cord-303322-d69o3z8d	202	12	with	with	IN
cord-303322-d69o3z8d	202	13	contradictory	contradictory	JJ
cord-303322-d69o3z8d	202	14	results	result	NNS
cord-303322-d69o3z8d	202	15	.	.	.
cord-303322-d69o3z8d	203	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	203	2	population	population	NN
cord-303322-d69o3z8d	203	3	setting	setting	NN
cord-303322-d69o3z8d	203	4	is	be	VBZ
cord-303322-d69o3z8d	203	5	more	more	RBR
cord-303322-d69o3z8d	203	6	closely	closely	RB
cord-303322-d69o3z8d	203	7	related	related	JJ
cord-303322-d69o3z8d	203	8	to	to	IN
cord-303322-d69o3z8d	203	9	the	the	DT
cord-303322-d69o3z8d	203	10	Turkish	turkish	JJ
cord-303322-d69o3z8d	203	11	study	study	NN
cord-303322-d69o3z8d	203	12	[	[	-LRB-
cord-303322-d69o3z8d	203	13	26	26	CD
cord-303322-d69o3z8d	203	14	]	]	-RRB-
cord-303322-d69o3z8d	203	15	where	where	WRB
cord-303322-d69o3z8d	203	16	a	a	DT
cord-303322-d69o3z8d	203	17	beneficial	beneficial	JJ
cord-303322-d69o3z8d	203	18	effect	effect	NN
cord-303322-d69o3z8d	203	19	for	for	IN
cord-303322-d69o3z8d	203	20	macrolides	macrolide	NNS
cord-303322-d69o3z8d	203	21	was	be	VBD
cord-303322-d69o3z8d	203	22	shown	show	VBN
cord-303322-d69o3z8d	203	23	.	.	.
cord-303322-d69o3z8d	204	1	This	this	DT
cord-303322-d69o3z8d	204	2	is	be	VBZ
cord-303322-d69o3z8d	204	3	in	in	IN
cord-303322-d69o3z8d	204	4	contrast	contrast	NN
cord-303322-d69o3z8d	204	5	to	to	IN
cord-303322-d69o3z8d	204	6	the	the	DT
cord-303322-d69o3z8d	204	7	negative	negative	JJ
cord-303322-d69o3z8d	204	8	findings	finding	NNS
cord-303322-d69o3z8d	204	9	of	of	IN
cord-303322-d69o3z8d	204	10	the	the	DT
cord-303322-d69o3z8d	204	11	Dutch	dutch	JJ
cord-303322-d69o3z8d	204	12	study	study	NN
cord-303322-d69o3z8d	204	13	[	[	-LRB-
cord-303322-d69o3z8d	204	14	27	27	CD
cord-303322-d69o3z8d	204	15	]	]	-RRB-
cord-303322-d69o3z8d	204	16	in	in	IN
cord-303322-d69o3z8d	204	17	an	an	DT
cord-303322-d69o3z8d	204	18	affluent	affluent	JJ
cord-303322-d69o3z8d	204	19	urban	urban	JJ
cord-303322-d69o3z8d	204	20	setting	setting	NN
cord-303322-d69o3z8d	204	21	.	.	.
cord-303322-d69o3z8d	205	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	205	2	proposed	propose	VBN
cord-303322-d69o3z8d	205	3	double	double	JJ
cord-303322-d69o3z8d	205	4	-	-	HYPH
cord-303322-d69o3z8d	205	5	blind	blind	JJ
cord-303322-d69o3z8d	205	6	RCT	RCT	NNP
cord-303322-d69o3z8d	205	7	will	will	MD
cord-303322-d69o3z8d	205	8	determine	determine	VB
cord-303322-d69o3z8d	205	9	if	if	IN
cord-303322-d69o3z8d	205	10	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	205	11	is	be	VBZ
cord-303322-d69o3z8d	205	12	an	an	DT
cord-303322-d69o3z8d	205	13	effective	effective	JJ
cord-303322-d69o3z8d	205	14	additional	additional	JJ
cord-303322-d69o3z8d	205	15	treatment	treatment	NN
cord-303322-d69o3z8d	205	16	in	in	IN
cord-303322-d69o3z8d	205	17	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	205	18	infants	infant	NNS
cord-303322-d69o3z8d	205	19	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	205	20	with	with	IN
cord-303322-d69o3z8d	205	21	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	205	22	.	.	.
cord-303322-d69o3z8d	206	1	It	-PRON-	PRP
cord-303322-d69o3z8d	206	2	will	will	MD
cord-303322-d69o3z8d	206	3	also	also	RB
cord-303322-d69o3z8d	206	4	determine	determine	VB
cord-303322-d69o3z8d	206	5	whether	whether	IN
cord-303322-d69o3z8d	206	6	in	in	IN
cord-303322-d69o3z8d	206	7	the	the	DT
cord-303322-d69o3z8d	206	8	ensuing	ensue	VBG
cord-303322-d69o3z8d	206	9	6	6	CD
cord-303322-d69o3z8d	206	10	months	month	NNS
cord-303322-d69o3z8d	206	11	it	-PRON-	PRP
cord-303322-d69o3z8d	206	12	will	will	MD
cord-303322-d69o3z8d	206	13	prevent	prevent	VB
cord-303322-d69o3z8d	206	14	hospital	hospital	NN
cord-303322-d69o3z8d	206	15	readmissions	readmission	NNS
cord-303322-d69o3z8d	206	16	from	from	IN
cord-303322-d69o3z8d	206	17	respiratory	respiratory	JJ
cord-303322-d69o3z8d	206	18	illnesses	illness	NNS
cord-303322-d69o3z8d	206	19	,	,	,
cord-303322-d69o3z8d	206	20	which	which	WDT
cord-303322-d69o3z8d	206	21	potentially	potentially	RB
cord-303322-d69o3z8d	206	22	reduces	reduce	VBZ
cord-303322-d69o3z8d	206	23	the	the	DT
cord-303322-d69o3z8d	206	24	likelihood	likelihood	NN
cord-303322-d69o3z8d	206	25	of	of	IN
cord-303322-d69o3z8d	206	26	chronic	chronic	JJ
cord-303322-d69o3z8d	206	27	lung	lung	NN
cord-303322-d69o3z8d	206	28	dysfunction	dysfunction	NN
cord-303322-d69o3z8d	206	29	[	[	-LRB-
cord-303322-d69o3z8d	206	30	7	7	CD
cord-303322-d69o3z8d	206	31	]	]	-RRB-
cord-303322-d69o3z8d	206	32	in	in	IN
cord-303322-d69o3z8d	206	33	this	this	DT
cord-303322-d69o3z8d	206	34	high	high	JJ
cord-303322-d69o3z8d	206	35	-	-	HYPH
cord-303322-d69o3z8d	206	36	risk	risk	NN
cord-303322-d69o3z8d	206	37	population	population	NN
cord-303322-d69o3z8d	206	38	.	.	.
cord-303322-d69o3z8d	207	1	Azithromycin	Azithromycin	NNP
cord-303322-d69o3z8d	207	2	was	be	VBD
cord-303322-d69o3z8d	207	3	chosen	choose	VBN
cord-303322-d69o3z8d	207	4	over	over	IN
cord-303322-d69o3z8d	207	5	other	other	JJ
cord-303322-d69o3z8d	207	6	macrolides	macrolide	NNS
cord-303322-d69o3z8d	207	7	because	because	IN
cord-303322-d69o3z8d	207	8	of	of	IN
cord-303322-d69o3z8d	207	9	its	-PRON-	PRP$
cord-303322-d69o3z8d	207	10	prompt	prompt	JJ
cord-303322-d69o3z8d	207	11	and	and	CC
cord-303322-d69o3z8d	207	12	potent	potent	JJ
cord-303322-d69o3z8d	207	13	anti	anti	JJ
cord-303322-d69o3z8d	207	14	-	-	JJ
cord-303322-d69o3z8d	207	15	inflammatory	inflammatory	JJ
cord-303322-d69o3z8d	207	16	effects	effect	NNS
cord-303322-d69o3z8d	207	17	as	as	RB
cord-303322-d69o3z8d	207	18	well	well	RB
cord-303322-d69o3z8d	207	19	as	as	IN
cord-303322-d69o3z8d	207	20	its	-PRON-	PRP$
cord-303322-d69o3z8d	207	21	30	30	CD
cord-303322-d69o3z8d	207	22	-	-	SYM
cord-303322-d69o3z8d	207	23	40	40	CD
cord-303322-d69o3z8d	207	24	hours	hour	NNS
cord-303322-d69o3z8d	207	25	half	half	JJ
cord-303322-d69o3z8d	207	26	-	-	HYPH
cord-303322-d69o3z8d	207	27	life	life	NN
cord-303322-d69o3z8d	207	28	in	in	IN
cord-303322-d69o3z8d	207	29	children	child	NNS
cord-303322-d69o3z8d	207	30	,	,	,
cord-303322-d69o3z8d	207	31	which	which	WDT
cord-303322-d69o3z8d	207	32	permits	permit	VBZ
cord-303322-d69o3z8d	207	33	once	once	RB
cord-303322-d69o3z8d	207	34	weekly	weekly	JJ
cord-303322-d69o3z8d	207	35	dosing	dose	VBG
cord-303322-d69o3z8d	207	36	[	[	-LRB-
cord-303322-d69o3z8d	207	37	42	42	CD
cord-303322-d69o3z8d	207	38	]	]	-RRB-
cord-303322-d69o3z8d	207	39	.	.	.
cord-303322-d69o3z8d	208	1	The	the	DT
cord-303322-d69o3z8d	208	2	possible	possible	JJ
cord-303322-d69o3z8d	208	3	anti	anti	JJ
cord-303322-d69o3z8d	208	4	-	-	JJ
cord-303322-d69o3z8d	208	5	viral	viral	JJ
cord-303322-d69o3z8d	208	6	effects	effect	NNS
cord-303322-d69o3z8d	208	7	is	be	VBZ
cord-303322-d69o3z8d	208	8	also	also	RB
cord-303322-d69o3z8d	208	9	attractive	attractive	JJ
cord-303322-d69o3z8d	208	10	[	[	-LRB-
cord-303322-d69o3z8d	208	11	43	43	CD
cord-303322-d69o3z8d	208	12	]	]	-RRB-
cord-303322-d69o3z8d	208	13	.	.	.
cord-303322-d69o3z8d	209	1	An	an	DT
cord-303322-d69o3z8d	209	2	important	important	JJ
cord-303322-d69o3z8d	209	3	safety	safety	NN
cord-303322-d69o3z8d	209	4	component	component	NN
cord-303322-d69o3z8d	209	5	of	of	IN
cord-303322-d69o3z8d	209	6	the	the	DT
cord-303322-d69o3z8d	209	7	current	current	JJ
cord-303322-d69o3z8d	209	8	study	study	NN
cord-303322-d69o3z8d	209	9	is	be	VBZ
cord-303322-d69o3z8d	209	10	to	to	TO
cord-303322-d69o3z8d	209	11	monitor	monitor	VB
cord-303322-d69o3z8d	209	12	for	for	IN
cord-303322-d69o3z8d	209	13	antibiotic	antibiotic	JJ
cord-303322-d69o3z8d	209	14	resistance	resistance	NN
cord-303322-d69o3z8d	209	15	in	in	IN
cord-303322-d69o3z8d	209	16	potential	potential	JJ
cord-303322-d69o3z8d	209	17	respiratory	respiratory	JJ
cord-303322-d69o3z8d	209	18	bacterial	bacterial	JJ
cord-303322-d69o3z8d	209	19	pathogens	pathogen	NNS
cord-303322-d69o3z8d	209	20	colonising	colonise	VBG
cord-303322-d69o3z8d	209	21	the	the	DT
cord-303322-d69o3z8d	209	22	nasopharynx	nasopharynx	NN
cord-303322-d69o3z8d	209	23	.	.	.
cord-303322-d69o3z8d	210	1	For	for	IN
cord-303322-d69o3z8d	210	2	the	the	DT
cord-303322-d69o3z8d	210	3	first	first	JJ
cord-303322-d69o3z8d	210	4	time	time	NN
cord-303322-d69o3z8d	210	5	in	in	IN
cord-303322-d69o3z8d	210	6	this	this	DT
cord-303322-d69o3z8d	210	7	population	population	NN
cord-303322-d69o3z8d	210	8	,	,	,
cord-303322-d69o3z8d	210	9	we	-PRON-	PRP
cord-303322-d69o3z8d	210	10	will	will	MD
cord-303322-d69o3z8d	210	11	determine	determine	VB
cord-303322-d69o3z8d	210	12	the	the	DT
cord-303322-d69o3z8d	210	13	nature	nature	NN
cord-303322-d69o3z8d	210	14	and	and	CC
cord-303322-d69o3z8d	210	15	diversity	diversity	NN
cord-303322-d69o3z8d	210	16	of	of	IN
cord-303322-d69o3z8d	210	17	respiratory	respiratory	JJ
cord-303322-d69o3z8d	210	18	viruses	virus	NNS
cord-303322-d69o3z8d	210	19	,	,	,
cord-303322-d69o3z8d	210	20	Mycoplasma	Mycoplasma	NNP
cord-303322-d69o3z8d	210	21	,	,	,
cord-303322-d69o3z8d	210	22	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	210	23	and	and	CC
cord-303322-d69o3z8d	210	24	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	210	25	-	-	HYPH
cord-303322-d69o3z8d	210	26	like	like	JJ
cord-303322-d69o3z8d	210	27	species	specie	NNS
cord-303322-d69o3z8d	210	28	in	in	IN
cord-303322-d69o3z8d	210	29	association	association	NN
cord-303322-d69o3z8d	210	30	with	with	IN
cord-303322-d69o3z8d	210	31	cases	case	NNS
cord-303322-d69o3z8d	210	32	of	of	IN
cord-303322-d69o3z8d	210	33	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	210	34	requiring	require	VBG
cord-303322-d69o3z8d	210	35	hospital	hospital	NN
cord-303322-d69o3z8d	210	36	admission	admission	NN
cord-303322-d69o3z8d	210	37	.	.	.
cord-303322-d69o3z8d	211	1	The	the	DT
cord-303322-d69o3z8d	211	2	range	range	NN
cord-303322-d69o3z8d	211	3	of	of	IN
cord-303322-d69o3z8d	211	4	organisms	organism	NNS
cord-303322-d69o3z8d	211	5	includes	include	VBZ
cord-303322-d69o3z8d	211	6	newly	newly	RB
cord-303322-d69o3z8d	211	7	discovered	discover	VBN
cord-303322-d69o3z8d	211	8	viruses	virus	NNS
cord-303322-d69o3z8d	211	9	,	,	,
cord-303322-d69o3z8d	211	10	[	[	-LRB-
cord-303322-d69o3z8d	211	11	44	44	CD
cord-303322-d69o3z8d	211	12	]	]	-RRB-
cord-303322-d69o3z8d	211	13	and	and	CC
cord-303322-d69o3z8d	211	14	treatable	treatable	JJ
cord-303322-d69o3z8d	211	15	bacteria	bacteria	NNS
cord-303322-d69o3z8d	211	16	that	that	WDT
cord-303322-d69o3z8d	211	17	may	may	MD
cord-303322-d69o3z8d	211	18	contribute	contribute	VB
cord-303322-d69o3z8d	211	19	to	to	IN
cord-303322-d69o3z8d	211	20	chronic	chronic	JJ
cord-303322-d69o3z8d	211	21	lung	lung	NN
cord-303322-d69o3z8d	211	22	dysfunction	dysfunction	NN
cord-303322-d69o3z8d	211	23	.	.	.
cord-303322-d69o3z8d	212	1	M.	M.	NNP
cord-303322-d69o3z8d	212	2	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	212	3	and	and	CC
cord-303322-d69o3z8d	212	4	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	212	5	species	specie	NNS
cord-303322-d69o3z8d	212	6	are	be	VBP
cord-303322-d69o3z8d	212	7	increasingly	increasingly	RB
cord-303322-d69o3z8d	212	8	recognised	recognise	VBN
cord-303322-d69o3z8d	212	9	as	as	IN
cord-303322-d69o3z8d	212	10	important	important	JJ
cord-303322-d69o3z8d	212	11	contributors	contributor	NNS
cord-303322-d69o3z8d	212	12	to	to	IN
cord-303322-d69o3z8d	212	13	development	development	NN
cord-303322-d69o3z8d	212	14	of	of	IN
cord-303322-d69o3z8d	212	15	chronic	chronic	JJ
cord-303322-d69o3z8d	212	16	lung	lung	NN
cord-303322-d69o3z8d	212	17	disease	disease	NN
cord-303322-d69o3z8d	212	18	and	and	CC
cord-303322-d69o3z8d	212	19	altered	altered	JJ
cord-303322-d69o3z8d	212	20	lung	lung	NN
cord-303322-d69o3z8d	212	21	maturation	maturation	NN
cord-303322-d69o3z8d	212	22	[	[	-LRB-
cord-303322-d69o3z8d	212	23	16	16	CD
cord-303322-d69o3z8d	212	24	]	]	-RRB-
cord-303322-d69o3z8d	212	25	[	[	-LRB-
cord-303322-d69o3z8d	212	26	17	17	CD
cord-303322-d69o3z8d	212	27	]	]	-RRB-
cord-303322-d69o3z8d	212	28	[	[	-LRB-
cord-303322-d69o3z8d	212	29	18	18	CD
cord-303322-d69o3z8d	212	30	]	]	-RRB-
cord-303322-d69o3z8d	212	31	[	[	-LRB-
cord-303322-d69o3z8d	212	32	19	19	CD
cord-303322-d69o3z8d	212	33	]	]	-RRB-
cord-303322-d69o3z8d	212	34	.	.	.
cord-303322-d69o3z8d	213	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	213	2	study	study	NN
cord-303322-d69o3z8d	213	3	addresses	address	VBZ
cord-303322-d69o3z8d	213	4	a	a	DT
cord-303322-d69o3z8d	213	5	large	large	JJ
cord-303322-d69o3z8d	213	6	clinical	clinical	JJ
cord-303322-d69o3z8d	213	7	research	research	NN
cord-303322-d69o3z8d	213	8	gap	gap	NN
cord-303322-d69o3z8d	213	9	for	for	IN
cord-303322-d69o3z8d	213	10	an	an	DT
cord-303322-d69o3z8d	213	11	important	important	JJ
cord-303322-d69o3z8d	213	12	and	and	CC
cord-303322-d69o3z8d	213	13	common	common	JJ
cord-303322-d69o3z8d	213	14	cause	cause	NN
cord-303322-d69o3z8d	213	15	of	of	IN
cord-303322-d69o3z8d	213	16	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	213	17	in	in	IN
cord-303322-d69o3z8d	213	18	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	213	19	infants	infant	NNS
cord-303322-d69o3z8d	213	20	.	.	.
cord-303322-d69o3z8d	214	1	If	if	IN
cord-303322-d69o3z8d	214	2	the	the	DT
cord-303322-d69o3z8d	214	3	intervention	intervention	NN
cord-303322-d69o3z8d	214	4	is	be	VBZ
cord-303322-d69o3z8d	214	5	successful	successful	JJ
cord-303322-d69o3z8d	214	6	,	,	,
cord-303322-d69o3z8d	214	7	it	-PRON-	PRP
cord-303322-d69o3z8d	214	8	would	would	MD
cord-303322-d69o3z8d	214	9	lead	lead	VB
cord-303322-d69o3z8d	214	10	to	to	IN
cord-303322-d69o3z8d	214	11	improved	improve	VBN
cord-303322-d69o3z8d	214	12	short	short	JJ
cord-303322-d69o3z8d	214	13	term	term	NN
cord-303322-d69o3z8d	214	14	(	(	-LRB-
cord-303322-d69o3z8d	214	15	and	and	CC
cord-303322-d69o3z8d	214	16	possibly	possibly	RB
cord-303322-d69o3z8d	214	17	long	long	JJ
cord-303322-d69o3z8d	214	18	term	term	NN
cord-303322-d69o3z8d	214	19	)	)	-RRB-
cord-303322-d69o3z8d	214	20	health	health	NN
cord-303322-d69o3z8d	214	21	benefits	benefit	NNS
cord-303322-d69o3z8d	214	22	.	.	.
cord-303322-d69o3z8d	215	1	Conclusive	conclusive	JJ
cord-303322-d69o3z8d	215	2	results	result	NNS
cord-303322-d69o3z8d	215	3	would	would	MD
cord-303322-d69o3z8d	215	4	produce	produce	VB
cord-303322-d69o3z8d	215	5	changes	change	NNS
cord-303322-d69o3z8d	215	6	to	to	IN
cord-303322-d69o3z8d	215	7	evidencebased	evidencebased	JJ
cord-303322-d69o3z8d	215	8	standard	standard	JJ
cord-303322-d69o3z8d	215	9	treatment	treatment	NN
cord-303322-d69o3z8d	215	10	guidelines	guideline	NNS
cord-303322-d69o3z8d	215	11	in	in	IN
cord-303322-d69o3z8d	215	12	our	-PRON-	PRP$
cord-303322-d69o3z8d	215	13	region	region	NN
cord-303322-d69o3z8d	215	14	and	and	CC
cord-303322-d69o3z8d	215	15	those	those	DT
cord-303322-d69o3z8d	215	16	produced	produce	VBN
cord-303322-d69o3z8d	215	17	for	for	IN
cord-303322-d69o3z8d	215	18	similar	similar	JJ
cord-303322-d69o3z8d	215	19	populations	population	NNS
cord-303322-d69o3z8d	215	20	nationally	nationally	RB
cord-303322-d69o3z8d	215	21	and	and	CC
cord-303322-d69o3z8d	215	22	internationally	internationally	RB
cord-303322-d69o3z8d	215	23	.	.	.
cord-303322-d69o3z8d	216	1	Finally	finally	RB
cord-303322-d69o3z8d	216	2	,	,	,
cord-303322-d69o3z8d	216	3	the	the	DT
cord-303322-d69o3z8d	216	4	intervention	intervention	NN
cord-303322-d69o3z8d	216	5	would	would	MD
cord-303322-d69o3z8d	216	6	also	also	RB
cord-303322-d69o3z8d	216	7	offer	offer	VB
cord-303322-d69o3z8d	216	8	the	the	DT
cord-303322-d69o3z8d	216	9	possibility	possibility	NN
cord-303322-d69o3z8d	216	10	of	of	IN
cord-303322-d69o3z8d	216	11	preventing	prevent	VBG
cord-303322-d69o3z8d	216	12	(	(	-LRB-
cord-303322-d69o3z8d	216	13	or	or	CC
cord-303322-d69o3z8d	216	14	reducing	reduce	VBG
cord-303322-d69o3z8d	216	15	)	)	-RRB-
cord-303322-d69o3z8d	216	16	the	the	DT
cord-303322-d69o3z8d	216	17	high	high	JJ
cord-303322-d69o3z8d	216	18	rates	rate	NNS
cord-303322-d69o3z8d	216	19	of	of	IN
cord-303322-d69o3z8d	216	20	long	long	JJ
cord-303322-d69o3z8d	216	21	-	-	HYPH
cord-303322-d69o3z8d	216	22	term	term	NN
cord-303322-d69o3z8d	216	23	respiratory	respiratory	JJ
cord-303322-d69o3z8d	216	24	dysfunction	dysfunction	NN
cord-303322-d69o3z8d	216	25	seen	see	VBN
cord-303322-d69o3z8d	216	26	in	in	IN
cord-303322-d69o3z8d	216	27	Australian	australian	JJ
cord-303322-d69o3z8d	216	28	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	216	29	children	child	NNS
cord-303322-d69o3z8d	216	30	and	and	CC
cord-303322-d69o3z8d	216	31	adults	adult	NNS
cord-303322-d69o3z8d	216	32	.	.	.
cord-303322-d69o3z8d	217	1	Risk	risk	NN
cord-303322-d69o3z8d	217	2	factors	factor	NNS
cord-303322-d69o3z8d	217	3	for	for	IN
cord-303322-d69o3z8d	217	4	bronchiectasis	bronchiectasis	NN
cord-303322-d69o3z8d	217	5	in	in	IN
cord-303322-d69o3z8d	217	6	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	217	7	children	child	NNS
cord-303322-d69o3z8d	217	8	include	include	VBP
cord-303322-d69o3z8d	217	9	recurrent	recurrent	JJ
cord-303322-d69o3z8d	217	10	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	217	11	for	for	IN
cord-303322-d69o3z8d	217	12	ALRIs	alri	NNS
cord-303322-d69o3z8d	217	13	and	and	CC
cord-303322-d69o3z8d	217	14	severity	severity	NN
cord-303322-d69o3z8d	217	15	of	of	IN
cord-303322-d69o3z8d	217	16	previous	previous	JJ
cord-303322-d69o3z8d	217	17	ARLIs	arli	NNS
cord-303322-d69o3z8d	217	18	(	(	-LRB-
cord-303322-d69o3z8d	217	19	measured	measure	VBN
cord-303322-d69o3z8d	217	20	by	by	IN
cord-303322-d69o3z8d	217	21	duration	duration	NN
cord-303322-d69o3z8d	217	22	of	of	IN
cord-303322-d69o3z8d	217	23	stay	stay	NN
cord-303322-d69o3z8d	217	24	and	and	CC
cord-303322-d69o3z8d	217	25	requirement	requirement	NN
cord-303322-d69o3z8d	217	26	for	for	IN
cord-303322-d69o3z8d	217	27	oxygen	oxygen	NN
cord-303322-d69o3z8d	217	28	supplementation	supplementation	NN
cord-303322-d69o3z8d	217	29	during	during	IN
cord-303322-d69o3z8d	217	30	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	217	31	)	)	-RRB-
cord-303322-d69o3z8d	217	32	[	[	-LRB-
cord-303322-d69o3z8d	217	33	7	7	CD
cord-303322-d69o3z8d	217	34	]	]	-RRB-
cord-303322-d69o3z8d	217	35	.	.	.
cord-303322-d69o3z8d	218	1	In	in	IN
cord-303322-d69o3z8d	218	2	the	the	DT
cord-303322-d69o3z8d	218	3	context	context	NN
cord-303322-d69o3z8d	218	4	of	of	IN
cord-303322-d69o3z8d	218	5	the	the	DT
cord-303322-d69o3z8d	218	6	high	high	JJ
cord-303322-d69o3z8d	218	7	burden	burden	NN
cord-303322-d69o3z8d	218	8	of	of	IN
cord-303322-d69o3z8d	218	9	bronchiectasis	bronchiectasis	NN
cord-303322-d69o3z8d	218	10	in	in	IN
cord-303322-d69o3z8d	218	11	our	-PRON-	PRP$
cord-303322-d69o3z8d	218	12	setting	setting	NN
cord-303322-d69o3z8d	218	13	,	,	,
cord-303322-d69o3z8d	218	14	we	-PRON-	PRP
cord-303322-d69o3z8d	218	15	considered	consider	VBD
cord-303322-d69o3z8d	218	16	that	that	IN
cord-303322-d69o3z8d	218	17	the	the	DT
cord-303322-d69o3z8d	218	18	most	most	RBS
cord-303322-d69o3z8d	218	19	important	important	JJ
cord-303322-d69o3z8d	218	20	outcomes	outcome	NNS
cord-303322-d69o3z8d	218	21	are	be	VBP
cord-303322-d69o3z8d	218	22	LOS	LOS	NNP
cord-303322-d69o3z8d	218	23	,	,	,
cord-303322-d69o3z8d	218	24	requirement	requirement	NN
cord-303322-d69o3z8d	218	25	for	for	IN
cord-303322-d69o3z8d	218	26	oxygen	oxygen	NN
cord-303322-d69o3z8d	218	27	supplementation	supplementation	NN
cord-303322-d69o3z8d	218	28	during	during	IN
cord-303322-d69o3z8d	218	29	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	218	30	and	and	CC
cord-303322-d69o3z8d	218	31	readmission	readmission	NN
cord-303322-d69o3z8d	218	32	within	within	IN
cord-303322-d69o3z8d	218	33	a	a	DT
cord-303322-d69o3z8d	218	34	6-month	6-month	CD
cord-303322-d69o3z8d	218	35	period	period	NN
cord-303322-d69o3z8d	218	36	.	.	.
cord-303322-d69o3z8d	219	1	Length	length	NN
cord-303322-d69o3z8d	219	2	of	of	IN
cord-303322-d69o3z8d	219	3	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	219	4	is	be	VBZ
cord-303322-d69o3z8d	219	5	a	a	DT
cord-303322-d69o3z8d	219	6	common	common	JJ
cord-303322-d69o3z8d	219	7	outcome	outcome	NN
cord-303322-d69o3z8d	219	8	measure	measure	NN
cord-303322-d69o3z8d	219	9	in	in	IN
cord-303322-d69o3z8d	219	10	studies	study	NNS
cord-303322-d69o3z8d	219	11	on	on	IN
cord-303322-d69o3z8d	219	12	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	219	13	.	.	.
cord-303322-d69o3z8d	220	1	However	however	RB
cord-303322-d69o3z8d	220	2	in	in	IN
cord-303322-d69o3z8d	220	3	our	-PRON-	PRP$
cord-303322-d69o3z8d	220	4	setting	setting	NN
cord-303322-d69o3z8d	220	5	,	,	,
cord-303322-d69o3z8d	220	6	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	220	7	children	child	NNS
cord-303322-d69o3z8d	220	8	often	often	RB
cord-303322-d69o3z8d	220	9	come	come	VBP
cord-303322-d69o3z8d	220	10	from	from	IN
cord-303322-d69o3z8d	220	11	remote	remote	JJ
cord-303322-d69o3z8d	220	12	comunities	comunitie	NNS
cord-303322-d69o3z8d	220	13	and	and	CC
cord-303322-d69o3z8d	220	14	may	may	MD
cord-303322-d69o3z8d	220	15	have	have	VB
cord-303322-d69o3z8d	220	16	multiple	multiple	JJ
cord-303322-d69o3z8d	220	17	co	co	NNS
cord-303322-d69o3z8d	220	18	-	-	NNS
cord-303322-d69o3z8d	220	19	morbidities	morbidity	NNS
cord-303322-d69o3z8d	220	20	[	[	-LRB-
cord-303322-d69o3z8d	220	21	33	33	CD
cord-303322-d69o3z8d	220	22	]	]	-RRB-
cord-303322-d69o3z8d	220	23	that	that	IN
cord-303322-d69o3z8d	220	24	influences	influence	VBZ
cord-303322-d69o3z8d	220	25	their	-PRON-	PRP$
cord-303322-d69o3z8d	220	26	discharge	discharge	NN
cord-303322-d69o3z8d	220	27	.	.	.
cord-303322-d69o3z8d	221	1	Thus	thus	RB
cord-303322-d69o3z8d	221	2	we	-PRON-	PRP
cord-303322-d69o3z8d	221	3	used	use	VBD
cord-303322-d69o3z8d	221	4	LOS	LOS	NNP
cord-303322-d69o3z8d	221	5	defined	define	VBN
cord-303322-d69o3z8d	221	6	in	in	IN
cord-303322-d69o3z8d	221	7	accordance	accordance	NN
cord-303322-d69o3z8d	221	8	with	with	IN
cord-303322-d69o3z8d	221	9	'	'	``
cord-303322-d69o3z8d	221	10	ready	ready	JJ
cord-303322-d69o3z8d	221	11	for	for	IN
cord-303322-d69o3z8d	221	12	respiratory	respiratory	JJ
cord-303322-d69o3z8d	221	13	discharge	discharge	NN
cord-303322-d69o3z8d	221	14	'	'	''
cord-303322-d69o3z8d	221	15	.	.	.
cord-303322-d69o3z8d	222	1	Our	-PRON-	PRP$
cord-303322-d69o3z8d	222	2	study	study	NN
cord-303322-d69o3z8d	222	3	only	only	RB
cord-303322-d69o3z8d	222	4	addresses	address	VBZ
cord-303322-d69o3z8d	222	5	infants	infant	NNS
cord-303322-d69o3z8d	222	6	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	222	7	for	for	IN
cord-303322-d69o3z8d	222	8	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	222	9	.	.	.
cord-303322-d69o3z8d	223	1	The	the	DT
cord-303322-d69o3z8d	223	2	impact	impact	NN
cord-303322-d69o3z8d	223	3	of	of	IN
cord-303322-d69o3z8d	223	4	variable	variable	JJ
cord-303322-d69o3z8d	223	5	presentation	presentation	NN
cord-303322-d69o3z8d	223	6	particularly	particularly	RB
cord-303322-d69o3z8d	223	7	that	that	RB
cord-303322-d69o3z8d	223	8	related	relate	VBD
cord-303322-d69o3z8d	223	9	to	to	IN
cord-303322-d69o3z8d	223	10	the	the	DT
cord-303322-d69o3z8d	223	11	potential	potential	JJ
cord-303322-d69o3z8d	223	12	influence	influence	NN
cord-303322-d69o3z8d	223	13	of	of	IN
cord-303322-d69o3z8d	223	14	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	223	15	's	's	POS
cord-303322-d69o3z8d	223	16	acute	acute	JJ
cord-303322-d69o3z8d	223	17	immune	immune	JJ
cord-303322-d69o3z8d	223	18	modulation	modulation	NN
cord-303322-d69o3z8d	223	19	effect	effect	NN
cord-303322-d69o3z8d	223	20	is	be	VBZ
cord-303322-d69o3z8d	223	21	a	a	DT
cord-303322-d69o3z8d	223	22	limitation	limitation	NN
cord-303322-d69o3z8d	223	23	of	of	IN
cord-303322-d69o3z8d	223	24	our	-PRON-	PRP$
cord-303322-d69o3z8d	223	25	study	study	NN
cord-303322-d69o3z8d	223	26	.	.	.
cord-303322-d69o3z8d	224	1	However	however	RB
cord-303322-d69o3z8d	224	2	our	-PRON-	PRP$
cord-303322-d69o3z8d	224	3	study	study	NN
cord-303322-d69o3z8d	224	4	design	design	NN
cord-303322-d69o3z8d	224	5	minimises	minimise	VBZ
cord-303322-d69o3z8d	224	6	the	the	DT
cord-303322-d69o3z8d	224	7	impact	impact	NN
cord-303322-d69o3z8d	224	8	of	of	IN
cord-303322-d69o3z8d	224	9	variable	variable	JJ
cord-303322-d69o3z8d	224	10	presentation	presentation	NN
cord-303322-d69o3z8d	224	11	by	by	IN
cord-303322-d69o3z8d	224	12	:	:	:
cord-303322-d69o3z8d	224	13	(	(	-LRB-
cord-303322-d69o3z8d	224	14	a	a	LS
cord-303322-d69o3z8d	224	15	)	)	-RRB-
cord-303322-d69o3z8d	224	16	standardising	standardise	VBG
cord-303322-d69o3z8d	224	17	our	-PRON-	PRP$
cord-303322-d69o3z8d	224	18	inclusion	inclusion	NN
cord-303322-d69o3z8d	224	19	criteria	criterion	NNS
cord-303322-d69o3z8d	224	20	,	,	,
cord-303322-d69o3z8d	224	21	(	(	-LRB-
cord-303322-d69o3z8d	224	22	b	b	NN
cord-303322-d69o3z8d	224	23	)	)	-RRB-
cord-303322-d69o3z8d	224	24	limiting	limit	VBG
cord-303322-d69o3z8d	224	25	enrolment	enrolment	NN
cord-303322-d69o3z8d	224	26	to	to	IN
cord-303322-d69o3z8d	224	27	within	within	IN
cord-303322-d69o3z8d	224	28	24	24	CD
cord-303322-d69o3z8d	224	29	hours	hour	NNS
cord-303322-d69o3z8d	224	30	of	of	IN
cord-303322-d69o3z8d	224	31	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	224	32	;	;	,
cord-303322-d69o3z8d	224	33	(	(	-LRB-
cord-303322-d69o3z8d	224	34	c	c	NN
cord-303322-d69o3z8d	224	35	)	)	-RRB-
cord-303322-d69o3z8d	224	36	adopting	adopt	VBG
cord-303322-d69o3z8d	224	37	a	a	DT
cord-303322-d69o3z8d	224	38	strategy	strategy	NN
cord-303322-d69o3z8d	224	39	(	(	-LRB-
cord-303322-d69o3z8d	224	40	double	double	RB
cord-303322-d69o3z8d	224	41	blind	blind	JJ
cord-303322-d69o3z8d	224	42	,	,	,
cord-303322-d69o3z8d	224	43	placebo	placebo	NN
cord-303322-d69o3z8d	224	44	controlled	control	VBN
cord-303322-d69o3z8d	224	45	,	,	,
cord-303322-d69o3z8d	224	46	allocation	allocation	NN
cord-303322-d69o3z8d	224	47	concealed	conceal	VBN
cord-303322-d69o3z8d	224	48	methodology	methodology	NN
cord-303322-d69o3z8d	224	49	)	)	-RRB-
cord-303322-d69o3z8d	224	50	that	that	WDT
cord-303322-d69o3z8d	224	51	would	would	MD
cord-303322-d69o3z8d	224	52	theoretically	theoretically	RB
cord-303322-d69o3z8d	224	53	distribute	distribute	VB
cord-303322-d69o3z8d	224	54	any	any	DT
cord-303322-d69o3z8d	224	55	effect	effect	NN
cord-303322-d69o3z8d	224	56	equally	equally	RB
cord-303322-d69o3z8d	224	57	between	between	IN
cord-303322-d69o3z8d	224	58	groups	group	NNS
cord-303322-d69o3z8d	224	59	.	.	.
cord-303322-d69o3z8d	225	1	Additionally	additionally	RB
cord-303322-d69o3z8d	225	2	in	in	IN
cord-303322-d69o3z8d	225	3	the	the	DT
cord-303322-d69o3z8d	225	4	event	event	NN
cord-303322-d69o3z8d	225	5	that	that	IN
cord-303322-d69o3z8d	225	6	differences	difference	NNS
cord-303322-d69o3z8d	225	7	in	in	IN
cord-303322-d69o3z8d	225	8	baseline	baseline	JJ
cord-303322-d69o3z8d	225	9	data	datum	NNS
cord-303322-d69o3z8d	225	10	between	between	IN
cord-303322-d69o3z8d	225	11	groups	group	NNS
cord-303322-d69o3z8d	225	12	are	be	VBP
cord-303322-d69o3z8d	225	13	found	find	VBN
cord-303322-d69o3z8d	225	14	,	,	,
cord-303322-d69o3z8d	225	15	we	-PRON-	PRP
cord-303322-d69o3z8d	225	16	will	will	MD
cord-303322-d69o3z8d	225	17	use	use	VB
cord-303322-d69o3z8d	225	18	statistical	statistical	JJ
cord-303322-d69o3z8d	225	19	methods	method	NNS
cord-303322-d69o3z8d	225	20	(	(	-LRB-
cord-303322-d69o3z8d	225	21	multivariate	multivariate	JJ
cord-303322-d69o3z8d	225	22	analysis	analysis	NN
cord-303322-d69o3z8d	225	23	)	)	-RRB-
cord-303322-d69o3z8d	225	24	to	to	TO
cord-303322-d69o3z8d	225	25	adjust	adjust	VB
cord-303322-d69o3z8d	225	26	as	as	IN
cord-303322-d69o3z8d	225	27	required	require	VBN
cord-303322-d69o3z8d	225	28	.	.	.
cord-303322-d69o3z8d	226	1	In	in	IN
cord-303322-d69o3z8d	226	2	summary	summary	NN
cord-303322-d69o3z8d	226	3	,	,	,
cord-303322-d69o3z8d	226	4	given	give	VBN
cord-303322-d69o3z8d	226	5	the	the	DT
cord-303322-d69o3z8d	226	6	very	very	RB
cord-303322-d69o3z8d	226	7	high	high	JJ
cord-303322-d69o3z8d	226	8	burden	burden	NN
cord-303322-d69o3z8d	226	9	of	of	IN
cord-303322-d69o3z8d	226	10	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	226	11	in	in	IN
cord-303322-d69o3z8d	226	12	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	226	13	infants	infant	NNS
cord-303322-d69o3z8d	226	14	(	(	-LRB-
cord-303322-d69o3z8d	226	15	the	the	DT
cord-303322-d69o3z8d	226	16	age	age	NN
cord-303322-d69o3z8d	226	17	when	when	WRB
cord-303322-d69o3z8d	226	18	lung	lung	NN
cord-303322-d69o3z8d	226	19	growth	growth	NN
cord-303322-d69o3z8d	226	20	is	be	VBZ
cord-303322-d69o3z8d	226	21	most	most	RBS
cord-303322-d69o3z8d	226	22	critical	critical	JJ
cord-303322-d69o3z8d	226	23	post	post	NN
cord-303322-d69o3z8d	226	24	-	-	NN
cord-303322-d69o3z8d	226	25	natally	natally	RB
cord-303322-d69o3z8d	226	26	)	)	-RRB-
cord-303322-d69o3z8d	226	27	,	,	,
cord-303322-d69o3z8d	226	28	and	and	CC
cord-303322-d69o3z8d	226	29	the	the	DT
cord-303322-d69o3z8d	226	30	association	association	NN
cord-303322-d69o3z8d	226	31	between	between	IN
cord-303322-d69o3z8d	226	32	ALRI	ALRI	NNP
cord-303322-d69o3z8d	226	33	and	and	CC
cord-303322-d69o3z8d	226	34	future	future	JJ
cord-303322-d69o3z8d	226	35	lung	lung	NN
cord-303322-d69o3z8d	226	36	dysfunction	dysfunction	NN
cord-303322-d69o3z8d	226	37	,	,	,
cord-303322-d69o3z8d	226	38	our	-PRON-	PRP$
cord-303322-d69o3z8d	226	39	RCT	RCT	NNP
cord-303322-d69o3z8d	226	40	on	on	IN
cord-303322-d69o3z8d	226	41	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	226	42	in	in	IN
cord-303322-d69o3z8d	226	43	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	226	44	Australian	australian	JJ
cord-303322-d69o3z8d	226	45	infants	infant	NNS
cord-303322-d69o3z8d	226	46	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	226	47	with	with	IN
cord-303322-d69o3z8d	226	48	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	226	49	has	have	VBZ
cord-303322-d69o3z8d	226	50	the	the	DT
cord-303322-d69o3z8d	226	51	potential	potential	NN
cord-303322-d69o3z8d	226	52	to	to	TO
cord-303322-d69o3z8d	226	53	have	have	VB
cord-303322-d69o3z8d	226	54	both	both	DT
cord-303322-d69o3z8d	226	55	short	short	JJ
cord-303322-d69o3z8d	226	56	term	term	NN
cord-303322-d69o3z8d	226	57	gains	gain	NNS
cord-303322-d69o3z8d	226	58	and	and	CC
cord-303322-d69o3z8d	226	59	a	a	DT
cord-303322-d69o3z8d	226	60	long	long	JJ
cord-303322-d69o3z8d	226	61	-	-	HYPH
cord-303322-d69o3z8d	226	62	term	term	NN
cord-303322-d69o3z8d	226	63	benefit	benefit	NN
cord-303322-d69o3z8d	226	64	for	for	IN
cord-303322-d69o3z8d	226	65	reducing	reduce	VBG
cord-303322-d69o3z8d	226	66	morbidity	morbidity	NN
cord-303322-d69o3z8d	226	67	of	of	IN
cord-303322-d69o3z8d	226	68	respiratory	respiratory	JJ
cord-303322-d69o3z8d	226	69	illness	illness	NN
cord-303322-d69o3z8d	226	70	.	.	.
cord-303322-d69o3z8d	226	71	 	 	_SP
cord-303322-d69o3z8d	227	1	Subcommittee	Subcommittee	NNP
cord-303322-d69o3z8d	227	2	on	on	IN
cord-303322-d69o3z8d	227	3	Diagnosis	Diagnosis	NNP
cord-303322-d69o3z8d	227	4	and	and	CC
cord-303322-d69o3z8d	227	5	Management	Management	NNP
cord-303322-d69o3z8d	227	6	of	of	IN
cord-303322-d69o3z8d	227	7	Bronchiolitis	Bronchiolitis	NNP
cord-303322-d69o3z8d	227	8	:	:	:
cord-303322-d69o3z8d	228	1	Diagnosis	Diagnosis	NNP
cord-303322-d69o3z8d	228	2	and	and	CC
cord-303322-d69o3z8d	228	3	Management	Management	NNP
cord-303322-d69o3z8d	228	4	of	of	IN
cord-303322-d69o3z8d	228	5	Bronchiolitis	Bronchiolitis	NNP
cord-303322-d69o3z8d	228	6	Predicting	predict	VBG
cord-303322-d69o3z8d	228	7	respiratory	respiratory	JJ
cord-303322-d69o3z8d	228	8	syncytial	syncytial	JJ
cord-303322-d69o3z8d	228	9	virus	virus	NN
cord-303322-d69o3z8d	228	10	hospitalisation	hospitalisation	NN
cord-303322-d69o3z8d	228	11	in	in	IN
cord-303322-d69o3z8d	228	12	Australian	australian	JJ
cord-303322-d69o3z8d	228	13	children	child	NNS
cord-303322-d69o3z8d	228	14	Bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	228	15	:	:	:
cord-303322-d69o3z8d	228	16	assessment	assessment	NN
cord-303322-d69o3z8d	228	17	and	and	CC
cord-303322-d69o3z8d	228	18	evidence	evidence	NN
cord-303322-d69o3z8d	228	19	-	-	HYPH
cord-303322-d69o3z8d	228	20	based	base	VBN
cord-303322-d69o3z8d	228	21	management	management	NN
cord-303322-d69o3z8d	228	22	From	from	IN
cord-303322-d69o3z8d	228	23	infancy	infancy	NN
cord-303322-d69o3z8d	228	24	to	to	IN
cord-303322-d69o3z8d	228	25	young	young	JJ
cord-303322-d69o3z8d	228	26	adulthood	adulthood	NN
cord-303322-d69o3z8d	228	27	:	:	:
cord-303322-d69o3z8d	228	28	health	health	NN
cord-303322-d69o3z8d	228	29	status	status	NN
cord-303322-d69o3z8d	228	30	in	in	IN
cord-303322-d69o3z8d	228	31	the	the	DT
cord-303322-d69o3z8d	228	32	Northern	Northern	NNP
cord-303322-d69o3z8d	228	33	Territory	Territory	NNP
cord-303322-d69o3z8d	228	34	2006	2006	CD
cord-303322-d69o3z8d	228	35	.	.	.
cord-303322-d69o3z8d	229	1	Department	Department	NNP
cord-303322-d69o3z8d	229	2	of	of	IN
cord-303322-d69o3z8d	229	3	Health	Health	NNP
cord-303322-d69o3z8d	229	4	andCommunity	andCommunity	NNP
cord-303322-d69o3z8d	230	1	Services	Services	NNPS
cord-303322-d69o3z8d	230	2	Hospitalisation	Hospitalisation	NNP
cord-303322-d69o3z8d	230	3	of	of	IN
cord-303322-d69o3z8d	230	4	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	230	5	children	child	NNS
cord-303322-d69o3z8d	230	6	in	in	IN
cord-303322-d69o3z8d	230	7	the	the	DT
cord-303322-d69o3z8d	230	8	Northern	Northern	NNP
cord-303322-d69o3z8d	230	9	Territory	Territory	NNP
cord-303322-d69o3z8d	230	10	for	for	IN
cord-303322-d69o3z8d	230	11	lower	low	JJR
cord-303322-d69o3z8d	230	12	respiratory	respiratory	JJ
cord-303322-d69o3z8d	230	13	illness	illness	NN
cord-303322-d69o3z8d	230	14	in	in	IN
cord-303322-d69o3z8d	230	15	the	the	DT
cord-303322-d69o3z8d	230	16	first	first	JJ
cord-303322-d69o3z8d	230	17	year	year	NN
cord-303322-d69o3z8d	230	18	of	of	IN
cord-303322-d69o3z8d	230	19	life	life	NN
cord-303322-d69o3z8d	230	20	Risks	risk	NNS
cord-303322-d69o3z8d	230	21	of	of	IN
cord-303322-d69o3z8d	230	22	severity	severity	NN
cord-303322-d69o3z8d	230	23	and	and	CC
cord-303322-d69o3z8d	230	24	readmission	readmission	NN
cord-303322-d69o3z8d	230	25	of	of	IN
cord-303322-d69o3z8d	230	26	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	230	27	and	and	CC
cord-303322-d69o3z8d	230	28	non	non	JJ
cord-303322-d69o3z8d	230	29	-	-	JJ
cord-303322-d69o3z8d	230	30	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	230	31	children	child	NNS
cord-303322-d69o3z8d	230	32	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	230	33	for	for	IN
cord-303322-d69o3z8d	230	34	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	230	35	A	a	DT
cord-303322-d69o3z8d	230	36	hospital	hospital	NN
cord-303322-d69o3z8d	230	37	-	-	HYPH
cord-303322-d69o3z8d	230	38	based	base	VBN
cord-303322-d69o3z8d	230	39	case	case	NN
cord-303322-d69o3z8d	230	40	-	-	HYPH
cord-303322-d69o3z8d	230	41	control	control	NN
cord-303322-d69o3z8d	230	42	study	study	NN
cord-303322-d69o3z8d	230	43	of	of	IN
cord-303322-d69o3z8d	230	44	bronchiectasis	bronchiectasis	NN
cord-303322-d69o3z8d	230	45	in	in	IN
cord-303322-d69o3z8d	230	46	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	230	47	children	child	NNS
cord-303322-d69o3z8d	230	48	in	in	IN
cord-303322-d69o3z8d	230	49	Central	Central	NNP
cord-303322-d69o3z8d	230	50	Australia	Australia	NNP
cord-303322-d69o3z8d	230	51	Lifecourse	Lifecourse	NNP
cord-303322-d69o3z8d	230	52	predictors	predictor	NNS
cord-303322-d69o3z8d	230	53	of	of	IN
cord-303322-d69o3z8d	230	54	adult	adult	NN
cord-303322-d69o3z8d	230	55	respiratory	respiratory	JJ
cord-303322-d69o3z8d	230	56	function	function	NN
cord-303322-d69o3z8d	230	57	:	:	:
cord-303322-d69o3z8d	230	58	results	result	NNS
cord-303322-d69o3z8d	230	59	from	from	IN
cord-303322-d69o3z8d	230	60	the	the	DT
cord-303322-d69o3z8d	230	61	Newcastle	Newcastle	NNP
cord-303322-d69o3z8d	230	62	Thousand	Thousand	NNP
cord-303322-d69o3z8d	230	63	Families	Families	NNPS
cord-303322-d69o3z8d	230	64	Study	Study	NNP
cord-303322-d69o3z8d	230	65	Lung	Lung	NNP
cord-303322-d69o3z8d	230	66	parenchyma	parenchyma	NN
cord-303322-d69o3z8d	230	67	at	at	IN
cord-303322-d69o3z8d	230	68	maturity	maturity	NN
cord-303322-d69o3z8d	230	69	is	be	VBZ
cord-303322-d69o3z8d	230	70	influenced	influence	VBN
cord-303322-d69o3z8d	230	71	by	by	IN
cord-303322-d69o3z8d	230	72	postnatal	postnatal	JJ
cord-303322-d69o3z8d	230	73	growth	growth	NN
cord-303322-d69o3z8d	230	74	but	but	CC
cord-303322-d69o3z8d	230	75	not	not	RB
cord-303322-d69o3z8d	230	76	by	by	IN
cord-303322-d69o3z8d	230	77	moderate	moderate	JJ
cord-303322-d69o3z8d	230	78	preterm	preterm	JJ
cord-303322-d69o3z8d	230	79	birth	birth	NN
cord-303322-d69o3z8d	230	80	in	in	IN
cord-303322-d69o3z8d	230	81	sheep	sheep	NN
cord-303322-d69o3z8d	230	82	Postnatal	postnatal	JJ
cord-303322-d69o3z8d	230	83	growth	growth	NN
cord-303322-d69o3z8d	230	84	rate	rate	NN
cord-303322-d69o3z8d	230	85	,	,	,
cord-303322-d69o3z8d	230	86	but	but	CC
cord-303322-d69o3z8d	230	87	not	not	RB
cord-303322-d69o3z8d	230	88	mild	mild	JJ
cord-303322-d69o3z8d	230	89	preterm	preterm	JJ
cord-303322-d69o3z8d	230	90	birth	birth	NN
cord-303322-d69o3z8d	230	91	,	,	,
cord-303322-d69o3z8d	230	92	influences	influence	VBZ
cord-303322-d69o3z8d	230	93	airway	airway	NN
cord-303322-d69o3z8d	230	94	structure	structure	NN
cord-303322-d69o3z8d	230	95	in	in	IN
cord-303322-d69o3z8d	230	96	adult	adult	NN
cord-303322-d69o3z8d	230	97	sheep	sheep	NNS
cord-303322-d69o3z8d	230	98	challenged	challenge	VBN
cord-303322-d69o3z8d	230	99	with	with	IN
cord-303322-d69o3z8d	230	100	house	house	NN
cord-303322-d69o3z8d	230	101	dust	dust	NN
cord-303322-d69o3z8d	230	102	mite	mite	NNP
cord-303322-d69o3z8d	230	103	The	the	DT
cord-303322-d69o3z8d	230	104	mammalian	mammalian	JJ
cord-303322-d69o3z8d	230	105	respiratory	respiratory	JJ
cord-303322-d69o3z8d	230	106	system	system	NN
cord-303322-d69o3z8d	230	107	and	and	CC
cord-303322-d69o3z8d	230	108	critical	critical	JJ
cord-303322-d69o3z8d	230	109	windows	window	NNS
cord-303322-d69o3z8d	230	110	of	of	IN
cord-303322-d69o3z8d	230	111	exposure	exposure	NN
cord-303322-d69o3z8d	230	112	for	for	IN
cord-303322-d69o3z8d	230	113	children	child	NNS
cord-303322-d69o3z8d	230	114	's	's	POS
cord-303322-d69o3z8d	230	115	health	health	NN
cord-303322-d69o3z8d	230	116	.	.	.
cord-303322-d69o3z8d	231	1	Environ	Environ	NNP
cord-303322-d69o3z8d	231	2	Health	Health	NNP
cord-303322-d69o3z8d	231	3	Perspect	Perspect	NNP
cord-303322-d69o3z8d	231	4	Australian	Australian	NNP
cord-303322-d69o3z8d	231	5	Health	Health	NNP
cord-303322-d69o3z8d	231	6	Ministers	Ministers	NNPS
cord-303322-d69o3z8d	231	7	'	'	POS
cord-303322-d69o3z8d	231	8	Advisory	Advisory	NNP
cord-303322-d69o3z8d	231	9	Council	Council	NNP
cord-303322-d69o3z8d	231	10	2	2	CD
cord-303322-d69o3z8d	231	11	:	:	:
cord-303322-d69o3z8d	232	1	Aboriginal	Aboriginal	NNP
cord-303322-d69o3z8d	232	2	and	and	CC
cord-303322-d69o3z8d	232	3	Torres	Torres	NNP
cord-303322-d69o3z8d	232	4	Strait	Strait	NNP
cord-303322-d69o3z8d	232	5	Islander	Islander	NNP
cord-303322-d69o3z8d	232	6	Health	Health	NNP
cord-303322-d69o3z8d	232	7	Performance	Performance	NNP
cord-303322-d69o3z8d	232	8	Framework	Framework	NNP
cord-303322-d69o3z8d	232	9	Report	Report	NNP
cord-303322-d69o3z8d	232	10	.	.	.
cord-303322-d69o3z8d	233	1	AHMAC	AHMAC	NNP
cord-303322-d69o3z8d	233	2	,	,	,
cord-303322-d69o3z8d	233	3	Canberra	Canberra	NNP
cord-303322-d69o3z8d	233	4	Non	Non	NNP
cord-303322-d69o3z8d	233	5	-	-	NNP
cord-303322-d69o3z8d	233	6	CF	cf	NN
cord-303322-d69o3z8d	233	7	bronchiectasis	bronchiectasis	NN
cord-303322-d69o3z8d	233	8	-	-	HYPH
cord-303322-d69o3z8d	233	9	clinical	clinical	JJ
cord-303322-d69o3z8d	233	10	and	and	CC
cord-303322-d69o3z8d	233	11	HRCT	hrct	JJ
cord-303322-d69o3z8d	233	12	evaluation	evaluation	NN
cord-303322-d69o3z8d	234	1	Bronchiectasis	Bronchiectasis	NNP
cord-303322-d69o3z8d	234	2	:	:	:
cord-303322-d69o3z8d	234	3	so	so	RB
cord-303322-d69o3z8d	234	4	much	much	RB
cord-303322-d69o3z8d	234	5	yet	yet	RB
cord-303322-d69o3z8d	234	6	to	to	TO
cord-303322-d69o3z8d	234	7	learn	learn	VB
cord-303322-d69o3z8d	234	8	and	and	CC
cord-303322-d69o3z8d	234	9	to	to	TO
cord-303322-d69o3z8d	234	10	do	do	VB
cord-303322-d69o3z8d	234	11	Frequent	frequent	JJ
cord-303322-d69o3z8d	234	12	detection	detection	NN
cord-303322-d69o3z8d	234	13	of	of	IN
cord-303322-d69o3z8d	234	14	human	human	JJ
cord-303322-d69o3z8d	234	15	rhinoviruses	rhinovirus	NNS
cord-303322-d69o3z8d	234	16	,	,	,
cord-303322-d69o3z8d	234	17	paramyxoviruses	paramyxovirus	NNS
cord-303322-d69o3z8d	234	18	,	,	,
cord-303322-d69o3z8d	234	19	coronaviruses	coronaviruse	NNS
cord-303322-d69o3z8d	234	20	,	,	,
cord-303322-d69o3z8d	234	21	and	and	CC
cord-303322-d69o3z8d	234	22	bocavirus	bocavirus	NN
cord-303322-d69o3z8d	234	23	during	during	IN
cord-303322-d69o3z8d	234	24	acute	acute	JJ
cord-303322-d69o3z8d	234	25	respiratory	respiratory	JJ
cord-303322-d69o3z8d	234	26	tract	tract	NN
cord-303322-d69o3z8d	234	27	infections	infection	NNS
cord-303322-d69o3z8d	235	1	Prenatal	prenatal	JJ
cord-303322-d69o3z8d	235	2	inflammation	inflammation	NN
cord-303322-d69o3z8d	235	3	and	and	CC
cord-303322-d69o3z8d	235	4	lung	lung	NN
cord-303322-d69o3z8d	235	5	development	development	NN
cord-303322-d69o3z8d	235	6	Contribution	Contribution	NNP
cord-303322-d69o3z8d	235	7	of	of	IN
cord-303322-d69o3z8d	235	8	inflammation	inflammation	NN
cord-303322-d69o3z8d	235	9	to	to	IN
cord-303322-d69o3z8d	235	10	lung	lung	NN
cord-303322-d69o3z8d	235	11	injury	injury	NN
cord-303322-d69o3z8d	235	12	and	and	CC
cord-303322-d69o3z8d	235	13	development	development	NN
cord-303322-d69o3z8d	236	1	Intermittent	intermittent	JJ
cord-303322-d69o3z8d	236	2	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	236	3	treatment	treatment	NN
cord-303322-d69o3z8d	236	4	for	for	IN
cord-303322-d69o3z8d	236	5	respiratory	respiratory	JJ
cord-303322-d69o3z8d	236	6	symptoms	symptom	NNS
cord-303322-d69o3z8d	236	7	in	in	IN
cord-303322-d69o3z8d	236	8	patients	patient	NNS
cord-303322-d69o3z8d	236	9	with	with	IN
cord-303322-d69o3z8d	236	10	chronic	chronic	JJ
cord-303322-d69o3z8d	236	11	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	236	12	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	236	13	infection	infection	NN
cord-303322-d69o3z8d	236	14	Rate	rate	NN
cord-303322-d69o3z8d	236	15	of	of	IN
cord-303322-d69o3z8d	236	16	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	236	17	trachomatis	trachomatis	NN
cord-303322-d69o3z8d	236	18	and	and	CC
cord-303322-d69o3z8d	236	19	Chlamydia	Chlamydia	NNP
cord-303322-d69o3z8d	236	20	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	236	21	in	in	IN
cord-303322-d69o3z8d	236	22	paediatric	paediatric	JJ
cord-303322-d69o3z8d	236	23	respiratory	respiratory	JJ
cord-303322-d69o3z8d	236	24	infections	infection	NNS
cord-303322-d69o3z8d	237	1	High	high	JJ
cord-303322-d69o3z8d	237	2	rate	rate	NN
cord-303322-d69o3z8d	237	3	of	of	IN
cord-303322-d69o3z8d	237	4	Simkania	Simkania	NNP
cord-303322-d69o3z8d	237	5	negevensis	negevensis	NN
cord-303322-d69o3z8d	237	6	among	among	IN
cord-303322-d69o3z8d	237	7	Canadian	canadian	JJ
cord-303322-d69o3z8d	237	8	inuit	inuit	JJ
cord-303322-d69o3z8d	237	9	infants	infant	NNS
cord-303322-d69o3z8d	237	10	hospitalized	hospitalize	VBN
cord-303322-d69o3z8d	237	11	with	with	IN
cord-303322-d69o3z8d	237	12	lower	low	JJR
cord-303322-d69o3z8d	237	13	respiratory	respiratory	JJ
cord-303322-d69o3z8d	237	14	tract	tract	NN
cord-303322-d69o3z8d	237	15	infections	infection	NNS
cord-303322-d69o3z8d	237	16	Bacteraemia	Bacteraemia	NNP
cord-303322-d69o3z8d	237	17	and	and	CC
cord-303322-d69o3z8d	237	18	antibiotic	antibiotic	JJ
cord-303322-d69o3z8d	237	19	use	use	NN
cord-303322-d69o3z8d	237	20	in	in	IN
cord-303322-d69o3z8d	237	21	respiratory	respiratory	JJ
cord-303322-d69o3z8d	237	22	syncytial	syncytial	JJ
cord-303322-d69o3z8d	237	23	virus	virus	NN
cord-303322-d69o3z8d	237	24	infections	infection	NNS
cord-303322-d69o3z8d	237	25	Antibiotics	antibiotic	NNS
cord-303322-d69o3z8d	237	26	for	for	IN
cord-303322-d69o3z8d	237	27	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	237	28	in	in	IN
cord-303322-d69o3z8d	237	29	children	child	NNS
cord-303322-d69o3z8d	237	30	.	.	.
cord-303322-d69o3z8d	238	1	Cochrane	Cochrane	NNP
cord-303322-d69o3z8d	238	2	Database	Database	NNP
cord-303322-d69o3z8d	238	3	Syst	Syst	NNP
cord-303322-d69o3z8d	238	4	Rev	Rev	NNP
cord-303322-d69o3z8d	238	5	Streptococcus	Streptococcus	NNP
cord-303322-d69o3z8d	238	6	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	238	7	colonisation	colonisation	NN
cord-303322-d69o3z8d	238	8	:	:	:
cord-303322-d69o3z8d	239	1	the	the	DT
cord-303322-d69o3z8d	239	2	key	key	NN
cord-303322-d69o3z8d	239	3	to	to	IN
cord-303322-d69o3z8d	239	4	pneumococcal	pneumococcal	JJ
cord-303322-d69o3z8d	239	5	disease	disease	NN
cord-303322-d69o3z8d	239	6	Bacterial	bacterial	JJ
cord-303322-d69o3z8d	239	7	colonization	colonization	NN
cord-303322-d69o3z8d	239	8	of	of	IN
cord-303322-d69o3z8d	239	9	the	the	DT
cord-303322-d69o3z8d	239	10	nasopharynx	nasopharynx	NN
cord-303322-d69o3z8d	239	11	predicts	predict	VBZ
cord-303322-d69o3z8d	239	12	very	very	RB
cord-303322-d69o3z8d	239	13	early	early	JJ
cord-303322-d69o3z8d	239	14	onset	onset	NN
cord-303322-d69o3z8d	239	15	and	and	CC
cord-303322-d69o3z8d	239	16	persistence	persistence	NN
cord-303322-d69o3z8d	239	17	of	of	IN
cord-303322-d69o3z8d	239	18	otitis	otitis	NN
cord-303322-d69o3z8d	239	19	media	medium	NNS
cord-303322-d69o3z8d	239	20	in	in	IN
cord-303322-d69o3z8d	239	21	Australian	australian	JJ
cord-303322-d69o3z8d	239	22	aboriginal	aboriginal	JJ
cord-303322-d69o3z8d	239	23	infants	infant	NNS
cord-303322-d69o3z8d	239	24	Mechanisms	Mechanisms	NNPS
cord-303322-d69o3z8d	239	25	of	of	IN
cord-303322-d69o3z8d	239	26	action	action	NN
cord-303322-d69o3z8d	239	27	and	and	CC
cord-303322-d69o3z8d	239	28	clinical	clinical	JJ
cord-303322-d69o3z8d	239	29	application	application	NN
cord-303322-d69o3z8d	239	30	of	of	IN
cord-303322-d69o3z8d	239	31	macrolides	macrolide	NNS
cord-303322-d69o3z8d	239	32	as	as	IN
cord-303322-d69o3z8d	239	33	immunomodulatory	immunomodulatory	JJ
cord-303322-d69o3z8d	239	34	medications	medication	NNS
cord-303322-d69o3z8d	239	35	Clarithromycin	Clarithromycin	NNP
cord-303322-d69o3z8d	239	36	in	in	IN
cord-303322-d69o3z8d	239	37	the	the	DT
cord-303322-d69o3z8d	239	38	treatment	treatment	NN
cord-303322-d69o3z8d	239	39	of	of	IN
cord-303322-d69o3z8d	239	40	RSV	RSV	NNP
cord-303322-d69o3z8d	239	41	bronchiolitis	bronchiolitis	NNP
cord-303322-d69o3z8d	239	42	:	:	:
cord-303322-d69o3z8d	239	43	a	a	DT
cord-303322-d69o3z8d	239	44	double	double	JJ
cord-303322-d69o3z8d	239	45	-	-	HYPH
cord-303322-d69o3z8d	239	46	blind	blind	JJ
cord-303322-d69o3z8d	239	47	,	,	,
cord-303322-d69o3z8d	239	48	randomised	randomised	JJ
cord-303322-d69o3z8d	239	49	,	,	,
cord-303322-d69o3z8d	239	50	placebo	placebo	NN
cord-303322-d69o3z8d	239	51	-	-	HYPH
cord-303322-d69o3z8d	239	52	controlled	control	VBN
cord-303322-d69o3z8d	239	53	trial	trial	NN
cord-303322-d69o3z8d	239	54	Azithromycin	Azithromycin	NNP
cord-303322-d69o3z8d	239	55	does	do	VBZ
cord-303322-d69o3z8d	239	56	not	not	RB
cord-303322-d69o3z8d	239	57	improve	improve	VB
cord-303322-d69o3z8d	239	58	disease	disease	NN
cord-303322-d69o3z8d	239	59	course	course	NN
cord-303322-d69o3z8d	239	60	in	in	IN
cord-303322-d69o3z8d	239	61	hospitalized	hospitalize	VBN
cord-303322-d69o3z8d	239	62	infants	infant	NNS
cord-303322-d69o3z8d	239	63	with	with	IN
cord-303322-d69o3z8d	239	64	respiratory	respiratory	JJ
cord-303322-d69o3z8d	239	65	syncytial	syncytial	JJ
cord-303322-d69o3z8d	239	66	virus	virus	NN
cord-303322-d69o3z8d	239	67	(	(	-LRB-
cord-303322-d69o3z8d	239	68	RSV	RSV	NNP
cord-303322-d69o3z8d	239	69	)	)	-RRB-
cord-303322-d69o3z8d	239	70	lower	low	JJR
cord-303322-d69o3z8d	239	71	respiratory	respiratory	JJ
cord-303322-d69o3z8d	239	72	tract	tract	NN
cord-303322-d69o3z8d	239	73	disease	disease	NN
cord-303322-d69o3z8d	239	74	:	:	:
cord-303322-d69o3z8d	239	75	A	a	DT
cord-303322-d69o3z8d	239	76	randomized	randomized	JJ
cord-303322-d69o3z8d	239	77	equivalence	equivalence	NN
cord-303322-d69o3z8d	239	78	trial	trial	NN
cord-303322-d69o3z8d	239	79	Non	non	JJ
cord-303322-d69o3z8d	239	80	-	-	JJ
cord-303322-d69o3z8d	239	81	cystic	cystic	JJ
cord-303322-d69o3z8d	239	82	-	-	HYPH
cord-303322-d69o3z8d	239	83	fibrosis	fibrosis	NN
cord-303322-d69o3z8d	239	84	bronchiectasis	bronchiectasis	NN
cord-303322-d69o3z8d	239	85	in	in	IN
cord-303322-d69o3z8d	239	86	children	child	NNS
cord-303322-d69o3z8d	239	87	:	:	:
cord-303322-d69o3z8d	239	88	a	a	DT
cord-303322-d69o3z8d	239	89	persisting	persist	VBG
cord-303322-d69o3z8d	239	90	problem	problem	NN
cord-303322-d69o3z8d	239	91	in	in	IN
cord-303322-d69o3z8d	239	92	developing	develop	VBG
cord-303322-d69o3z8d	239	93	countries	country	NNS
cord-303322-d69o3z8d	239	94	Diagnosis	diagnosis	NN
cord-303322-d69o3z8d	239	95	and	and	CC
cord-303322-d69o3z8d	239	96	testing	testing	NN
cord-303322-d69o3z8d	239	97	in	in	IN
cord-303322-d69o3z8d	239	98	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	239	99	:	:	:
cord-303322-d69o3z8d	239	100	a	a	DT
cord-303322-d69o3z8d	239	101	systematic	systematic	JJ
cord-303322-d69o3z8d	239	102	review	review	NN
cord-303322-d69o3z8d	239	103	Acute	acute	JJ
cord-303322-d69o3z8d	239	104	viral	viral	JJ
cord-303322-d69o3z8d	239	105	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	239	106	:	:	:
cord-303322-d69o3z8d	239	107	to	to	TO
cord-303322-d69o3z8d	239	108	treat	treat	VB
cord-303322-d69o3z8d	239	109	or	or	CC
cord-303322-d69o3z8d	239	110	not	not	RB
cord-303322-d69o3z8d	239	111	to	to	TO
cord-303322-d69o3z8d	239	112	treat	treat	VB
cord-303322-d69o3z8d	240	1	-that	-that	WP
cord-303322-d69o3z8d	240	2	is	be	VBZ
cord-303322-d69o3z8d	240	3	the	the	DT
cord-303322-d69o3z8d	240	4	question	question	NN
cord-303322-d69o3z8d	240	5	The	the	DT
cord-303322-d69o3z8d	240	6	management	management	NN
cord-303322-d69o3z8d	240	7	of	of	IN
cord-303322-d69o3z8d	240	8	acute	acute	JJ
cord-303322-d69o3z8d	240	9	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	240	10	.	.	.
cord-303322-d69o3z8d	241	1	Thoracic	Thoracic	NNP
cord-303322-d69o3z8d	241	2	Society	Society	NNP
cord-303322-d69o3z8d	241	3	of	of	IN
cord-303322-d69o3z8d	241	4	Australia	Australia	NNP
cord-303322-d69o3z8d	241	5	and	and	CC
cord-303322-d69o3z8d	241	6	New	New	NNP
cord-303322-d69o3z8d	241	7	Zealand	Zealand	NNP
cord-303322-d69o3z8d	241	8	Respiratory	respiratory	JJ
cord-303322-d69o3z8d	241	9	syncytial	syncytial	JJ
cord-303322-d69o3z8d	241	10	virus	virus	NN
cord-303322-d69o3z8d	241	11	infection	infection	NN
cord-303322-d69o3z8d	241	12	and	and	CC
cord-303322-d69o3z8d	241	13	immunoprophylaxis	immunoprophylaxis	NN
cord-303322-d69o3z8d	241	14	for	for	IN
cord-303322-d69o3z8d	241	15	selected	select	VBN
cord-303322-d69o3z8d	241	16	high	high	JJ
cord-303322-d69o3z8d	241	17	-	-	HYPH
cord-303322-d69o3z8d	241	18	risk	risk	NN
cord-303322-d69o3z8d	241	19	children	child	NNS
cord-303322-d69o3z8d	241	20	in	in	IN
cord-303322-d69o3z8d	241	21	Central	Central	NNP
cord-303322-d69o3z8d	241	22	Australia	Australia	NNP
cord-303322-d69o3z8d	241	23	Zinc	Zinc	NNP
cord-303322-d69o3z8d	241	24	and	and	CC
cord-303322-d69o3z8d	241	25	Vitamin	vitamin	NN
cord-303322-d69o3z8d	241	26	-	-	HYPH
cord-303322-d69o3z8d	241	27	A	a	DT
cord-303322-d69o3z8d	241	28	supplementation	supplementation	NN
cord-303322-d69o3z8d	241	29	in	in	IN
cord-303322-d69o3z8d	241	30	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	241	31	children	child	NNS
cord-303322-d69o3z8d	241	32	hospitalised	hospitalise	VBN
cord-303322-d69o3z8d	241	33	with	with	IN
cord-303322-d69o3z8d	241	34	episodes	episode	NNS
cord-303322-d69o3z8d	241	35	of	of	IN
cord-303322-d69o3z8d	241	36	lower	low	JJR
cord-303322-d69o3z8d	241	37	respiratory	respiratory	JJ
cord-303322-d69o3z8d	241	38	tract	tract	NN
cord-303322-d69o3z8d	241	39	infection	infection	NN
cord-303322-d69o3z8d	241	40	:	:	:
cord-303322-d69o3z8d	241	41	a	a	DT
cord-303322-d69o3z8d	241	42	randomised	randomised	JJ
cord-303322-d69o3z8d	241	43	controlled	control	VBN
cord-303322-d69o3z8d	241	44	trial	trial	NN
cord-303322-d69o3z8d	242	1	How	how	WRB
cord-303322-d69o3z8d	242	2	should	should	MD
cord-303322-d69o3z8d	242	3	we	-PRON-	PRP
cord-303322-d69o3z8d	242	4	study	study	VB
cord-303322-d69o3z8d	242	5	responses	response	NNS
cord-303322-d69o3z8d	242	6	to	to	IN
cord-303322-d69o3z8d	242	7	treatment	treatment	NN
cord-303322-d69o3z8d	242	8	in	in	IN
cord-303322-d69o3z8d	242	9	children	child	NNS
cord-303322-d69o3z8d	242	10	with	with	IN
cord-303322-d69o3z8d	242	11	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	242	12	?	?	.
cord-303322-d69o3z8d	243	1	Respiratory	respiratory	JJ
cord-303322-d69o3z8d	243	2	bacterial	bacterial	JJ
cord-303322-d69o3z8d	243	3	pathogens	pathogen	NNS
cord-303322-d69o3z8d	243	4	in	in	IN
cord-303322-d69o3z8d	243	5	the	the	DT
cord-303322-d69o3z8d	243	6	nasopharynx	nasopharynx	NN
cord-303322-d69o3z8d	243	7	and	and	CC
cord-303322-d69o3z8d	243	8	lower	low	JJR
cord-303322-d69o3z8d	243	9	airways	airway	NNS
cord-303322-d69o3z8d	243	10	of	of	IN
cord-303322-d69o3z8d	243	11	Australian	australian	JJ
cord-303322-d69o3z8d	243	12	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	243	13	children	child	NNS
cord-303322-d69o3z8d	243	14	with	with	IN
cord-303322-d69o3z8d	243	15	bronchiectasis	bronchiectasis	NN
cord-303322-d69o3z8d	243	16	Streptococcus	Streptococcus	NNP
cord-303322-d69o3z8d	243	17	pneumoniae	pneumoniae	NN
cord-303322-d69o3z8d	243	18	and	and	CC
cord-303322-d69o3z8d	243	19	noncapsular	noncapsular	JJ
cord-303322-d69o3z8d	243	20	Haemophilus	Haemophilus	NNP
cord-303322-d69o3z8d	243	21	influenzae	influenzae	NN
cord-303322-d69o3z8d	243	22	nasal	nasal	NN
cord-303322-d69o3z8d	243	23	carriage	carriage	NN
cord-303322-d69o3z8d	243	24	and	and	CC
cord-303322-d69o3z8d	243	25	hand	hand	NN
cord-303322-d69o3z8d	243	26	contamination	contamination	NN
cord-303322-d69o3z8d	243	27	in	in	IN
cord-303322-d69o3z8d	243	28	children	child	NNS
cord-303322-d69o3z8d	243	29	:	:	:
cord-303322-d69o3z8d	243	30	a	a	DT
cord-303322-d69o3z8d	243	31	comparison	comparison	NN
cord-303322-d69o3z8d	243	32	of	of	IN
cord-303322-d69o3z8d	243	33	two	two	CD
cord-303322-d69o3z8d	243	34	populations	population	NNS
cord-303322-d69o3z8d	243	35	at	at	IN
cord-303322-d69o3z8d	243	36	risk	risk	NN
cord-303322-d69o3z8d	243	37	of	of	IN
cord-303322-d69o3z8d	243	38	otitis	otitis	NN
cord-303322-d69o3z8d	243	39	media	medium	NNS
cord-303322-d69o3z8d	243	40	Random	Random	NNP
cord-303322-d69o3z8d	243	41	colony	colony	NN
cord-303322-d69o3z8d	243	42	selection	selection	NN
cord-303322-d69o3z8d	243	43	versus	versus	IN
cord-303322-d69o3z8d	243	44	colony	colony	NN
cord-303322-d69o3z8d	243	45	morphology	morphology	NN
cord-303322-d69o3z8d	243	46	for	for	IN
cord-303322-d69o3z8d	243	47	detection	detection	NN
cord-303322-d69o3z8d	243	48	of	of	IN
cord-303322-d69o3z8d	243	49	multiple	multiple	JJ
cord-303322-d69o3z8d	243	50	pneumococcal	pneumococcal	JJ
cord-303322-d69o3z8d	243	51	serotypes	serotype	NNS
cord-303322-d69o3z8d	243	52	in	in	IN
cord-303322-d69o3z8d	243	53	nasopharyngeal	nasopharyngeal	JJ
cord-303322-d69o3z8d	243	54	swabs	swab	NNS
cord-303322-d69o3z8d	244	1	The	the	DT
cord-303322-d69o3z8d	244	2	impact	impact	NN
cord-303322-d69o3z8d	244	3	of	of	IN
cord-303322-d69o3z8d	244	4	viral	viral	JJ
cord-303322-d69o3z8d	244	5	respiratory	respiratory	JJ
cord-303322-d69o3z8d	244	6	infection	infection	NN
cord-303322-d69o3z8d	244	7	on	on	IN
cord-303322-d69o3z8d	244	8	the	the	DT
cord-303322-d69o3z8d	244	9	severity	severity	NN
cord-303322-d69o3z8d	244	10	and	and	CC
cord-303322-d69o3z8d	244	11	recovery	recovery	NN
cord-303322-d69o3z8d	244	12	from	from	IN
cord-303322-d69o3z8d	244	13	an	an	DT
cord-303322-d69o3z8d	244	14	asthma	asthma	NN
cord-303322-d69o3z8d	244	15	exacerbation	exacerbation	NN
cord-303322-d69o3z8d	244	16	Newly	newly	RB
cord-303322-d69o3z8d	244	17	identified	identify	VBD
cord-303322-d69o3z8d	244	18	respiratory	respiratory	JJ
cord-303322-d69o3z8d	244	19	viruses	virus	NNS
cord-303322-d69o3z8d	244	20	in	in	IN
cord-303322-d69o3z8d	244	21	children	child	NNS
cord-303322-d69o3z8d	244	22	with	with	IN
cord-303322-d69o3z8d	244	23	asthma	asthma	NN
cord-303322-d69o3z8d	244	24	exacerbation	exacerbation	NN
cord-303322-d69o3z8d	244	25	not	not	RB
cord-303322-d69o3z8d	244	26	requiring	require	VBG
cord-303322-d69o3z8d	244	27	admission	admission	NN
cord-303322-d69o3z8d	244	28	into	into	IN
cord-303322-d69o3z8d	244	29	hospital	hospital	NN
cord-303322-d69o3z8d	244	30	CONSORT	CONSORT	NNP
cord-303322-d69o3z8d	244	31	2010	2010	CD
cord-303322-d69o3z8d	244	32	Statement	statement	NN
cord-303322-d69o3z8d	244	33	:	:	:
cord-303322-d69o3z8d	244	34	updated	update	VBN
cord-303322-d69o3z8d	244	35	guidelines	guideline	NNS
cord-303322-d69o3z8d	244	36	for	for	IN
cord-303322-d69o3z8d	244	37	reporting	report	VBG
cord-303322-d69o3z8d	244	38	parallel	parallel	JJ
cord-303322-d69o3z8d	244	39	group	group	NN
cord-303322-d69o3z8d	244	40	randomised	randomised	JJ
cord-303322-d69o3z8d	244	41	trials	trial	NNS
cord-303322-d69o3z8d	244	42	Respiratory	respiratory	JJ
cord-303322-d69o3z8d	244	43	morbidity	morbidity	NN
cord-303322-d69o3z8d	244	44	in	in	IN
cord-303322-d69o3z8d	244	45	central	central	JJ
cord-303322-d69o3z8d	244	46	Australian	australian	JJ
cord-303322-d69o3z8d	244	47	Aboriginal	aboriginal	JJ
cord-303322-d69o3z8d	244	48	children	child	NNS
cord-303322-d69o3z8d	244	49	with	with	IN
cord-303322-d69o3z8d	244	50	alveolar	alveolar	JJ
cord-303322-d69o3z8d	244	51	lobar	lobar	NN
cord-303322-d69o3z8d	244	52	abnormalities	abnormality	NNS
cord-303322-d69o3z8d	245	1	Once	once	RB
cord-303322-d69o3z8d	245	2	-	-	HYPH
cord-303322-d69o3z8d	245	3	weekly	weekly	JJ
cord-303322-d69o3z8d	245	4	azithromycin	azithromycin	NN
cord-303322-d69o3z8d	245	5	in	in	IN
cord-303322-d69o3z8d	245	6	cystic	cystic	JJ
cord-303322-d69o3z8d	245	7	fibrosis	fibrosis	NN
cord-303322-d69o3z8d	245	8	with	with	IN
cord-303322-d69o3z8d	245	9	chronic	chronic	JJ
cord-303322-d69o3z8d	245	10	Pseudomonas	Pseudomonas	NNP
cord-303322-d69o3z8d	245	11	aeruginosa	aeruginosa	NN
cord-303322-d69o3z8d	245	12	infection	infection	NN
cord-303322-d69o3z8d	246	1	Azithromycin	Azithromycin	NNP
cord-303322-d69o3z8d	246	2	induces	induce	VBZ
cord-303322-d69o3z8d	246	3	anti	anti	JJ
cord-303322-d69o3z8d	246	4	-	-	JJ
cord-303322-d69o3z8d	246	5	viral	viral	JJ
cord-303322-d69o3z8d	246	6	responses	response	NNS
cord-303322-d69o3z8d	246	7	in	in	IN
cord-303322-d69o3z8d	246	8	bronchial	bronchial	JJ
cord-303322-d69o3z8d	246	9	epithelial	epithelial	JJ
cord-303322-d69o3z8d	246	10	cells	cell	NNS
cord-303322-d69o3z8d	246	11	Evidence	evidence	NN
cord-303322-d69o3z8d	246	12	of	of	IN
cord-303322-d69o3z8d	246	13	human	human	JJ
cord-303322-d69o3z8d	246	14	coronavirus	coronavirus	NN
cord-303322-d69o3z8d	246	15	HKU1	HKU1	NNP
cord-303322-d69o3z8d	246	16	and	and	CC
cord-303322-d69o3z8d	246	17	human	human	JJ
cord-303322-d69o3z8d	246	18	bocavirus	bocavirus	NN
cord-303322-d69o3z8d	246	19	in	in	IN
cord-303322-d69o3z8d	246	20	Australian	australian	JJ
cord-303322-d69o3z8d	246	21	children	child	NNS
cord-303322-d69o3z8d	247	1	Randomized	randomized	JJ
cord-303322-d69o3z8d	247	2	placebo	placebo	NN
cord-303322-d69o3z8d	247	3	-	-	HYPH
cord-303322-d69o3z8d	247	4	controlled	control	VBN
cord-303322-d69o3z8d	247	5	trial	trial	NN
cord-303322-d69o3z8d	247	6	on	on	IN
cord-303322-d69o3z8d	247	7	azithromycin	azithromycin	NNP
cord-303322-d69o3z8d	247	8	to	to	TO
cord-303322-d69o3z8d	247	9	reduce	reduce	VB
cord-303322-d69o3z8d	247	10	the	the	DT
cord-303322-d69o3z8d	247	11	morbidity	morbidity	NN
cord-303322-d69o3z8d	247	12	of	of	IN
cord-303322-d69o3z8d	247	13	bronchiolitis	bronchiolitis	NN
cord-303322-d69o3z8d	247	14	in	in	IN
cord-303322-d69o3z8d	247	15	Indigenous	indigenous	JJ
cord-303322-d69o3z8d	247	16	Australian	australian	JJ
cord-303322-d69o3z8d	247	17	infants	infant	NNS
cord-303322-d69o3z8d	247	18	:	:	:
cord-303322-d69o3z8d	247	19	rationale	rationale	NN
cord-303322-d69o3z8d	247	20	and	and	CC
cord-303322-d69o3z8d	247	21	protocol	protocol	NN
cord-303322-d69o3z8d	248	1	We	-PRON-	PRP
cord-303322-d69o3z8d	248	2	thank	thank	VBP
cord-303322-d69o3z8d	248	3	the	the	DT
cord-303322-d69o3z8d	248	4	research	research	NN
cord-303322-d69o3z8d	248	5	staff	staff	NN
cord-303322-d69o3z8d	248	6	(	(	-LRB-
cord-303322-d69o3z8d	248	7	Lesley	Lesley	NNP
cord-303322-d69o3z8d	248	8	Versteegh	Versteegh	NNP
cord-303322-d69o3z8d	248	9	,	,	,
cord-303322-d69o3z8d	248	10	Clare	Clare	NNP
cord-303322-d69o3z8d	248	11	Wilson	Wilson	NNP
cord-303322-d69o3z8d	248	12	,	,	,
cord-303322-d69o3z8d	248	13	Nerida	Nerida	NNP
cord-303322-d69o3z8d	248	14	Jacobsen	Jacobsen	NNP
cord-303322-d69o3z8d	248	15	,	,	,
cord-303322-d69o3z8d	248	16	Susan	Susan	NNP
cord-303322-d69o3z8d	248	17	Pizzutto	Pizzutto	NNP
cord-303322-d69o3z8d	248	18	and	and	CC
cord-303322-d69o3z8d	248	19	Amber	Amber	NNP
cord-303322-d69o3z8d	248	20	Revell	Revell	NNP
cord-303322-d69o3z8d	248	21	)	)	-RRB-
cord-303322-d69o3z8d	248	22	for	for	IN
cord-303322-d69o3z8d	248	23	facilitating	facilitate	VBG
cord-303322-d69o3z8d	248	24	the	the	DT
cord-303322-d69o3z8d	248	25	study	study	NN
cord-303322-d69o3z8d	248	26	,	,	,
cord-303322-d69o3z8d	248	27	Joseph	Joseph	NNP
cord-303322-d69o3z8d	248	28	McDonnell	McDonnell	NNP
cord-303322-d69o3z8d	248	29	for	for	IN
cord-303322-d69o3z8d	248	30	generating	generate	VBG
cord-303322-d69o3z8d	248	31	the	the	DT
cord-303322-d69o3z8d	248	32	randomisation	randomisation	NN
cord-303322-d69o3z8d	248	33	sequences	sequence	NNS
cord-303322-d69o3z8d	248	34	and	and	CC
cord-303322-d69o3z8d	248	35	Jana	Jana	NNP
cord-303322-d69o3z8d	248	36	Lai	Lai	NNP
cord-303322-d69o3z8d	248	37	for	for	IN
cord-303322-d69o3z8d	248	38	assistance	assistance	NN
cord-303322-d69o3z8d	248	39	with	with	IN
cord-303322-d69o3z8d	248	40	labelling	label	VBG
cord-303322-d69o3z8d	248	41	the	the	DT
cord-303322-d69o3z8d	248	42	bottles	bottle	NNS
cord-303322-d69o3z8d	248	43	.	.	.
cord-303322-d69o3z8d	249	1	We	-PRON-	PRP
cord-303322-d69o3z8d	249	2	are	be	VBP
cord-303322-d69o3z8d	249	3	also	also	RB
cord-303322-d69o3z8d	249	4	grateful	grateful	JJ
cord-303322-d69o3z8d	249	5	to	to	IN
cord-303322-d69o3z8d	249	6	members	member	NNS
cord-303322-d69o3z8d	249	7	of	of	IN
cord-303322-d69o3z8d	249	8	the	the	DT
cord-303322-d69o3z8d	249	9	Indigenous	Indigenous	NNP
cord-303322-d69o3z8d	249	10	Reference	Reference	NNP
cord-303322-d69o3z8d	249	11	Group	Group	NNP
cord-303322-d69o3z8d	249	12	of	of	IN
cord-303322-d69o3z8d	249	13	the	the	DT
cord-303322-d69o3z8d	249	14	Child	Child	NNP
cord-303322-d69o3z8d	249	15	Health	Health	NNP
cord-303322-d69o3z8d	249	16	Division	Division	NNP
cord-303322-d69o3z8d	249	17	at	at	IN
cord-303322-d69o3z8d	249	18	Menzies	Menzies	NNP
cord-303322-d69o3z8d	249	19	for	for	IN
cord-303322-d69o3z8d	249	20	supporting	support	VBG
cord-303322-d69o3z8d	249	21	this	this	DT
cord-303322-d69o3z8d	249	22	study	study	NN
cord-303322-d69o3z8d	249	23	and	and	CC
cord-303322-d69o3z8d	249	24	for	for	IN
cord-303322-d69o3z8d	249	25	over	over	RB
cord-303322-d69o3z8d	249	26	-	-	HYPH
cord-303322-d69o3z8d	249	27	seeing	see	VBG
cord-303322-d69o3z8d	249	28	the	the	DT
cord-303322-d69o3z8d	249	29	cultural	cultural	JJ
cord-303322-d69o3z8d	249	30	aspects	aspect	NNS
cord-303322-d69o3z8d	249	31	.	.	.
cord-303322-d69o3z8d	250	1	We	-PRON-	PRP
cord-303322-d69o3z8d	250	2	also	also	RB
cord-303322-d69o3z8d	250	3	thank	thank	VBP
cord-303322-d69o3z8d	250	4	Drs	Drs	NNP
cord-303322-d69o3z8d	250	5	KA	KA	NNP
cord-303322-d69o3z8d	250	6	O'Grady	O'Grady	NNP
cord-303322-d69o3z8d	250	7	,	,	,
cord-303322-d69o3z8d	250	8	Alan	Alan	NNP
cord-303322-d69o3z8d	250	9	Isles	Isles	NNP
cord-303322-d69o3z8d	250	10	,	,	,
cord-303322-d69o3z8d	250	11	Alan	Alan	NNP
cord-303322-d69o3z8d	250	12	Ruben	Ruben	NNP
cord-303322-d69o3z8d	250	13	and	and	CC
cord-303322-d69o3z8d	250	14	William	William	NNP
cord-303322-d69o3z8d	250	15	Frischman	Frischman	NNP
cord-303322-d69o3z8d	250	16	for	for	IN
cord-303322-d69o3z8d	250	17	voluntarily	voluntarily	RB
cord-303322-d69o3z8d	250	18	providing	provide	VBG
cord-303322-d69o3z8d	250	19	their	-PRON-	PRP$
cord-303322-d69o3z8d	250	20	time	time	NN
cord-303322-d69o3z8d	250	21	in	in	IN
cord-303322-d69o3z8d	250	22	their	-PRON-	PRP$
cord-303322-d69o3z8d	250	23	participation	participation	NN
cord-303322-d69o3z8d	250	24	in	in	IN
cord-303322-d69o3z8d	250	25	the	the	DT
cord-303322-d69o3z8d	250	26	study	study	NN
cord-303322-d69o3z8d	250	27	's	's	POS
cord-303322-d69o3z8d	250	28	data	data	NN
cord-303322-d69o3z8d	250	29	safety	safety	NNP
cord-303322-d69o3z8d	250	30	monitoring	monitoring	NNP
cord-303322-d69o3z8d	250	31	committee	committee	NNP
cord-303322-d69o3z8d	250	32	.	.	.
cord-303322-d69o3z8d	251	1	We	-PRON-	PRP
cord-303322-d69o3z8d	251	2	are	be	VBP
cord-303322-d69o3z8d	251	3	also	also	RB
cord-303322-d69o3z8d	251	4	very	very	RB
cord-303322-d69o3z8d	251	5	appreciative	appreciative	JJ
cord-303322-d69o3z8d	251	6	to	to	IN
cord-303322-d69o3z8d	251	7	the	the	DT
cord-303322-d69o3z8d	251	8	Channel	Channel	NNP
cord-303322-d69o3z8d	251	9	7	7	CD
cord-303322-d69o3z8d	251	10	Children	Children	NNP
cord-303322-d69o3z8d	251	11	's	's	POS
cord-303322-d69o3z8d	251	12	Foundation	Foundation	NNP
cord-303322-d69o3z8d	251	13	and	and	CC
cord-303322-d69o3z8d	251	14	the	the	DT
cord-303322-d69o3z8d	251	15	Financial	Financial	NNP
cord-303322-d69o3z8d	251	16	Markets	Markets	NNPS
cord-303322-d69o3z8d	251	17	Foundation	Foundation	NNP
cord-303322-d69o3z8d	251	18	for	for	IN
cord-303322-d69o3z8d	251	19	Children	child	NNS
cord-303322-d69o3z8d	251	20	for	for	IN
cord-303322-d69o3z8d	251	21	funding	fund	VBG
cord-303322-d69o3z8d	251	22	the	the	DT
cord-303322-d69o3z8d	251	23	preliminary	preliminary	JJ
cord-303322-d69o3z8d	251	24	study	study	NN
cord-303322-d69o3z8d	251	25	that	that	WDT
cord-303322-d69o3z8d	251	26	provided	provide	VBD
cord-303322-d69o3z8d	251	27	us	-PRON-	PRP
cord-303322-d69o3z8d	251	28	with	with	IN
cord-303322-d69o3z8d	251	29	essential	essential	JJ
cord-303322-d69o3z8d	251	30	pilot	pilot	NN
cord-303322-d69o3z8d	251	31	data	datum	NNS
cord-303322-d69o3z8d	251	32	for	for	IN
cord-303322-d69o3z8d	251	33	our	-PRON-	PRP$
cord-303322-d69o3z8d	251	34	successful	successful	JJ
cord-303322-d69o3z8d	251	35	NHMRC	NHMRC	NNP
cord-303322-d69o3z8d	251	36	grant	grant	NN
cord-303322-d69o3z8d	251	37	submission	submission	NN
cord-303322-d69o3z8d	251	38	.	.	.
cord-303322-d69o3z8d	252	1	Funding	Funding	NNP
cord-303322-d69o3z8d	252	2	Study	Study	NNP
cord-303322-d69o3z8d	252	3	is	be	VBZ
cord-303322-d69o3z8d	252	4	funded	fund	VBN
cord-303322-d69o3z8d	252	5	by	by	IN
cord-303322-d69o3z8d	252	6	a	a	DT
cord-303322-d69o3z8d	252	7	3-year	3-year	JJ
cord-303322-d69o3z8d	252	8	Australian	Australian	NNP
cord-303322-d69o3z8d	252	9	National	National	NNP
cord-303322-d69o3z8d	252	10	Health	Health	NNP
cord-303322-d69o3z8d	252	11	and	and	CC
cord-303322-d69o3z8d	252	12	Medical	Medical	NNP
cord-303322-d69o3z8d	252	13	Research	Research	NNP
cord-303322-d69o3z8d	252	14	Council	Council	NNP
cord-303322-d69o3z8d	252	15	(	(	-LRB-
cord-303322-d69o3z8d	252	16	NHMRC	NHMRC	NNP
cord-303322-d69o3z8d	252	17	)	)	-RRB-
cord-303322-d69o3z8d	252	18	project	project	NN
cord-303322-d69o3z8d	252	19	grant	grant	NN
cord-303322-d69o3z8d	252	20	(	(	-LRB-
cord-303322-d69o3z8d	252	21	605809	605809	CD
cord-303322-d69o3z8d	252	22	)	)	-RRB-
cord-303322-d69o3z8d	252	23	.	.	.
cord-303322-d69o3z8d	253	1	ABC	ABC	NNP
cord-303322-d69o3z8d	253	2	is	be	VBZ
cord-303322-d69o3z8d	253	3	supported	support	VBN
cord-303322-d69o3z8d	253	4	by	by	IN
cord-303322-d69o3z8d	253	5	a	a	DT
cord-303322-d69o3z8d	253	6	NHMRC	NHMRC	NNP
cord-303322-d69o3z8d	253	7	fellowship	fellowship	NN
cord-303322-d69o3z8d	253	8	(	(	-LRB-
cord-303322-d69o3z8d	253	9	545216	545216	CD
cord-303322-d69o3z8d	253	10	)	)	-RRB-
cord-303322-d69o3z8d	253	11	.	.	.
cord-303322-d69o3z8d	254	1	Authors	author	NNS
cord-303322-d69o3z8d	254	2	'	'	POS
cord-303322-d69o3z8d	254	3	contributions	contribution	NNS
cord-303322-d69o3z8d	254	4	AC	AC	NNP
cord-303322-d69o3z8d	254	5	conceived	conceive	VBD
cord-303322-d69o3z8d	254	6	the	the	DT
cord-303322-d69o3z8d	254	7	study	study	NN
cord-303322-d69o3z8d	254	8	,	,	,
cord-303322-d69o3z8d	254	9	and	and	CC
cord-303322-d69o3z8d	254	10	participated	participate	VBD
cord-303322-d69o3z8d	254	11	in	in	IN
cord-303322-d69o3z8d	254	12	its	-PRON-	PRP$
cord-303322-d69o3z8d	254	13	design	design	NN
cord-303322-d69o3z8d	254	14	and	and	CC
cord-303322-d69o3z8d	254	15	coordination	coordination	NN
cord-303322-d69o3z8d	254	16	and	and	CC
cord-303322-d69o3z8d	254	17	drafted	draft	VBD
cord-303322-d69o3z8d	254	18	the	the	DT
cord-303322-d69o3z8d	254	19	manuscript	manuscript	NN
cord-303322-d69o3z8d	254	20	.	.	.
cord-303322-d69o3z8d	255	1	PM	PM	NNP
cord-303322-d69o3z8d	255	2	,	,	,
cord-303322-d69o3z8d	255	3	KG	KG	NNP
cord-303322-d69o3z8d	255	4	,	,	,
cord-303322-d69o3z8d	255	5	TS	TS	NNP
cord-303322-d69o3z8d	255	6	,	,	,
cord-303322-d69o3z8d	255	7	AW	AW	NNP
cord-303322-d69o3z8d	255	8	,	,	,
cord-303322-d69o3z8d	255	9	AS	AS	NNP
cord-303322-d69o3z8d	255	10	,	,	,
cord-303322-d69o3z8d	255	11	CM	CM	NNP
cord-303322-d69o3z8d	255	12	participated	participate	VBD
cord-303322-d69o3z8d	255	13	in	in	IN
cord-303322-d69o3z8d	255	14	its	-PRON-	PRP$
cord-303322-d69o3z8d	255	15	design	design	NN
cord-303322-d69o3z8d	255	16	,	,	,
cord-303322-d69o3z8d	255	17	analysis	analysis	NN
cord-303322-d69o3z8d	255	18	plan	plan	NN
cord-303322-d69o3z8d	255	19	and	and	CC
cord-303322-d69o3z8d	255	20	submission	submission	NN
cord-303322-d69o3z8d	255	21	to	to	IN
cord-303322-d69o3z8d	255	22	the	the	DT
cord-303322-d69o3z8d	255	23	NHMRC	NHMRC	NNP
cord-303322-d69o3z8d	255	24	.	.	.
cord-303322-d69o3z8d	256	1	GM	GM	NNP
cord-303322-d69o3z8d	256	2	participated	participate	VBD
cord-303322-d69o3z8d	256	3	in	in	IN
cord-303322-d69o3z8d	256	4	initiating	initiate	VBG
cord-303322-d69o3z8d	256	5	and	and	CC
cord-303322-d69o3z8d	256	6	running	run	VBG
cord-303322-d69o3z8d	256	7	the	the	DT
cord-303322-d69o3z8d	256	8	project	project	NN
cord-303322-d69o3z8d	256	9	and	and	CC
cord-303322-d69o3z8d	256	10	IM	IM	NNP
cord-303322-d69o3z8d	256	11	in	in	IN
cord-303322-d69o3z8d	256	12	the	the	DT
cord-303322-d69o3z8d	256	13	viral	viral	JJ
cord-303322-d69o3z8d	256	14	analysis	analysis	NN
cord-303322-d69o3z8d	256	15	plan	plan	NN
cord-303322-d69o3z8d	256	16	.	.	.
cord-303322-d69o3z8d	257	1	All	all	DT
cord-303322-d69o3z8d	257	2	authors	author	NNS
cord-303322-d69o3z8d	257	3	read	read	VBP
cord-303322-d69o3z8d	257	4	and	and	CC
cord-303322-d69o3z8d	257	5	approved	approve	VBD
cord-303322-d69o3z8d	257	6	the	the	DT
cord-303322-d69o3z8d	257	7	final	final	JJ
cord-303322-d69o3z8d	257	8	manuscript	manuscript	NN
cord-303322-d69o3z8d	257	9	.	.	.
cord-303322-d69o3z8d	258	1	The	the	DT
cord-303322-d69o3z8d	258	2	authors	author	NNS
cord-303322-d69o3z8d	258	3	declare	declare	VBP
cord-303322-d69o3z8d	258	4	that	that	IN
cord-303322-d69o3z8d	258	5	they	-PRON-	PRP
cord-303322-d69o3z8d	258	6	have	have	VBP
cord-303322-d69o3z8d	258	7	no	no	DT
cord-303322-d69o3z8d	258	8	competing	compete	VBG
cord-303322-d69o3z8d	258	9	interests	interest	NNS
cord-303322-d69o3z8d	258	10	.	.	.
cord-303322-d69o3z8d	258	11	 	 	_SP